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Abstract
Historically,  our  perception  of  the  nuclear  envelope  has  evolved  from  a 
simple barrier isolating the genome from the rest of a cell to a complex system that 
regulates functions including transcription, splicing, DNA replication and repair and 
development. Several recent proteomic studies uncovered a great variety of nuclear 
envelope transmembrane proteins (NETs). Diseases associated with several nuclear 
envelope proteins, mostly NETs, affect many tissues e.g. muscle, adipose tissue, skin, 
bones. Many NETs of the inner nuclear membrane have been shown to interact with 
chromatin,  suggesting  that  their  influencing  gene  expression  might  explain  NET 
roles in disease.
This work is focused on finding novel interactions of NETs with chromatin. 
First,  SUN2  post-translational  modifications  were  analysed  and  the  effect  of 
phosphomimetic and phospho-null mutants on heterochromatin and the cytoskeleton 
was tested by overexpression. However, no obvious changes were found. Second, 
several tissue-preferential NETs were tested in an adipocyte differentiation system. 
NET29 changed chromosome 6 position in pre-adipocytes. This matched changes in 
chromosome positioning that occur during adipocyte differentiation when NET29 is 
normally  induced.  Post-translational  modifications  of  NET29 are  likely to  play a 
vital  role  in  this  process  because  a  phospho-null  mutant  dominantly  blocked 
chromosome repositioning.  The effect  of  over-expression  and down-regulation  of 
NET29  on  transcription  was  tested  and  results  suggest  that  NET29  negatively 
regulates expression of myogenic genes during adipogenesis.
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This thesis is split into six chapters. Chapter I is an overview of the nuclear 
envelope,  adipogenesis  and  chromatin  remodelling,  Chapter  II  is  a  detailed 
description of methods used in this study. Chapter III focuses on post-translational 
modifications of SUN2, as well as trials to identify novel partners of SUN2. Chapter 
IV and V deal with a novel nuclear envelope transmembrane protein and its role in 
adipogenesis. Finally, the last chapter includes a discussion and recommended future 
directions.
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The nuclear  envelope  (NE)  is  a  double membrane system that  provides  a 
barrier between cytoplasmic processes and those inside of the nucleus. The NE is 
comprised of  an inner  nuclear  membrane (INM) and an outer  nuclear  membrane 
(ONM) (Fig 1.1.1). The space between them is around 50 nm and is called the lumen 
(Callan  and  Tomlin,  1950).  The  ONM  is,  basically,  an  extension  of  the  rough 
endoplasmic reticulum (ER) and connects with the INM in areas  adjacent  to  the 
nuclear pore complexes (NPCs). The INM and ONM connect at where NPCs are 
inserted  in  what  is  often  referred  to  as  the  pore  membrane  (PoM)  (reviewed  in 
Newport and Forbes, 1987). Underlying the INM is a meshwork made of polymers 
of different lamin isoforms (Gerace  et al., 1984). A large body of evidence argues 
that the NE has many complex functions (reviewed in  Akhtar  and Gasser,  2007; 
Stewart et al., 2007; Batrakou et al., 2009).
1
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1.1.2 Outer Nuclear Membrane vs Inner Nuclear Membrane 
Until  recently,  the  ONM  was  considered  to  be  simply  an  ER  membrane 
extension with the same pool of proteins. Both the ER and the ONM are decorated 
with  ribosomes engaged in protein  synthesis.  But  it  was  shown that  at  least  one 
protein family is distinct to the ONM – nesprins (Zhen et al., 2002). Nesprins are 
giant  spectrin  repeat-containing  transmembrane proteins  that  connect  the 
cytoskeleton to the nucleus.
On the other  hand,  the  INM was determined as  a unique membrane long 
before the ONM. Between 1988 -  2001 eleven INM transmembrane proteins had 
been discovered and initially described: LBR – lamin B receptor (Worman et al., 
2
Fig 1.1.1: The nuclear envelope (modified from Batrakou et al., 2009)
The nuclear envelope is a double membrane system that separates the nucleus from the cytoplasm.  
The inner nuclear membrane (INM), the outer nuclear membrane (ONM) and the pore membrane  
(PoM) contain specific sets of transmembrane proteins. The ONM is also encrusted with ribosomes  
and the INM is underlined with the nuclear lamina – a meshwork of intermediate filaments.  The  
nuclear  pore  complex  (NPC)  connects  the  cytoplasm  with  the  nucleoplasm.  The  ONM  located  
nesprins interact with the cytoskeleton and, possibly through a partner protein, with the INM located  
SUN  proteins.  SUN  proteins  interact  with  the  lamina,  thus  the  nesprin-SUN  protein  interaction  
bridges the cytoskeleton with the peripheral nuclear skeleton. Several proteins of the INM interact  
with various chromatin components (more detailed in Fig 1.1.3).
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1988),  LAP1  and  LAP2  –  lamina  associated  polypeptides  1  and  2  (Senior  and 
Gerace, 1988), gp210 (Greber et al., 1990), POM121 (Hallberg et al., 1993), emerin 
(Manilal et al., 1996), nurim (Rolls et al., 1999), SUN1 (Malone et al., 1999), SUN2 
(Hoffenberg et al., 2000), MAN1 (Lin et al., 2000) and LUMA (Dreger et al., 2001).
1.1.3 INM resident proteins and heterochromatin
There is a great potential  for the NE to be involved in genome regulation 
because of its many connections to chromatin (Fig 1.1.3). Both lamins and several 
LEM  domain-containing  INM  proteins  have  been  shown  to  interact  with  core 
histones,  transcription  factors  and  transcriptional  repressors  and  the  DNA 
crosslinking  factor  BAF  (reviewed  in  Mattout-Drubezki  and  Gruenbaum,  2003; 
Tsuchiya, 2008). SUN1 is functionally associated with the histone acetyltransferase 
hALP (NET43) and they are both required for chromosome de-condensation after 
mitosis (Chi et al., 2007). In vitro, LBR binds to heterochromatin protein 1 (Ye and 
Worman,  1996),  which  associates  with  under-acetylated  chromatin  through  its 
interaction with histone H3/H4 oligomers (Polioudaki et al., 2001). Recent studies 
suggest a much greater variety of the integral proteins of the NE and their functions, 
respectively (Schirmer et al., 2003; Malik et al., 2010; Korfali et al., 2010; Wilkie et  
al., 2010).
3
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1.1.4 The nuclear envelope and DNA double strand break repair
Recent  studies  linked  the  NE with  DNA repair,  specifically  the  repair  of 
persistent double strand breaks (DSB).
DNA DSB repair  is  an  important  mechanism of  cell  defence  against  the 
serious  threats  to  chromatin integrity  by external  (for  example,  gamma-rays) and 
internal (free radicals) factors. There are two main mechanisms to re-join two ends of 
DNA - homologous recombination (HR) and non-homologous end joining (NHEJ). 
The former mechanism prevails in S and G2 phases of the cell cycle when an exact 
copy of the damaged strand is available in a sister chromatid. The intact copy is used 
then as a template to repair the damaged locus error-free.
However,  when no homology to the damaged locus is found, NHEJ takes 
place.  The Ku70/Ku80 heterodimer  binds  to  the  broken ends  and recruits  DNA-
dependent  protein  kinase  (DNA-PK),  which  binds  to  the  DNA  ends  and 
4
Fig 1.1.3: Proteins of the INM (modified from Batrakou et al., 2009)
Proteins that reside within the INM are connected with the chromatin. Barrier to autointegration  
factor  (BAF)  was  shown to  mediate  this  connection  in  the  case  of  the  LEM domain-containing  
proteins  LAP2,  emerin and MAN1 (Furukawa,  1999,  Lee  et  al.,  2001,  Liu et  al.,  2003).  LBR is  
associated with heterochromatin protein 1 (HP1) which binds to H3K9me3 marked chromatin and  
appears to enhance and maintain its inactive state (Lachner et al.,  2001, Bannister et al.,  2001).  
Germ cell-less (Gcl), a transcriptional repressor, also was shown to bind LAP2β, emerin and MAN1  
(Nili et al., 2001; Holaska et al., 2003; Mansharamani and Wilson, 2005). LAP2β was also shown to  
bind histone deacetylase-3 HDAC3 associated with the silent chromatin (Somech et al., 2005).
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autophosphorylates itself. Upon autophosphorylation it changes conformation and is 
then  released  from  the  DSB  ends,  allowing  DNA ligase  to  join  the  ends.  The 
processing step of DNA ends is likely to introduce deletions into the re-joined locus.
A histone 2 variant, H2AX, seems to play an important role in DSB response. 
This histone variant is distributed throughout chromatin and is phosphorylated upon 
DNA damage by DNA-PK and ATM kinase that is involved in the HR repair (Burma 
et al., 2001). The phosphorylated serine 139 form of the histone is called gamma-
H2AX (γ-H2AX) and it marks several megabases of DNA flanking a DSB (Rogakou 
et al., 1998).
Despite many sophisticated mechanisms of DNA repair, there are occasions 
when a DSB persists for a long time. Even a single DSB will lead to a cell cycle 
arrest at the G2/M DNA damage checkpoint in yeast. However, the checkpoint was 
shown to be overridden after about 15 hours despite the continued presence of DSBs 
(Toczyski et al., 1997). Another study showed that persistent DSBs are relocated to 
the nuclear periphery and a SUN domain-containing protein, Mps3p, is required for 
the peripheral localisation of DSBs in yeast (Oza et al., 2009). Nagai  et al. (2008) 
have  also  shown that  DSBs are  tethered  to  the  NE and this  requires  the  Nup84 
subcomplex of nuclear pores and a SUMO-dependent ubiquitin ligase.
A more detailed mechanism of the DSB tethering to the NE in yeast was 
described in a recent study (Kalocsay et al., 2009). Rad51 which is involved in HR 
was shown to spread outward of persistent DSBs and, thus, mark the entire pieces of 
the broken chromosome. H2AZ, another variant of the H2A family of histones, is 
also  recruited  to  the  DSB  and  its  SUMOylation  is  important  for  the  DSB 
translocation to the NE. The DNA damage checkpoint seems to be required for the 
translocation as well.
Thus, at least in yeast, a SUN domain-containing protein of the NE appears to 
play  a  role  in  the  DNA damage response.  It  is  not  yet  clear  why the  DSBs are 
tethered to the periphery. There could be a NE-associated backup mechanism of DSB 
repair. Alternatively, association of persistent DSBs with the NE might enable the 
5
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arrested  cell  to  divide.  But  it  is  obvious  that  there  is  an  active  mechanism that 
recognises the broken chromosome and relocates either adjacent to the DSB domains 
or moves the whole chromosome to the nuclear periphery.
1.1.5 The nuclear envelope and disease
Mutations of NE proteins have been shown to be responsible for at least 15 
heritable human diseases - the nuclear envelopathies (diseases associated with NE 
proteins).  Several  mutations  of  Emerin,  a  predominantly  INM  protein,  are 
responsible for X-linked Emery-Dreifuss muscular dystrophy, EDMD (Bione et al., 
1994).  A range of diseases with distinct tissue-specific pathologies are caused by 
mutations in NE proteins. These include lipodystrophies, neuropathy, dermopathy, 
dystonia and premature ageing syndromes (reviewed in Worman and Bonne, 2007).
Specifically familial  partial  lipodystrophy of the Dunnigan type (FPLD) is 
characterized by a lack of adipose tissue in the limbs, buttocks and trunk with fat 
accumulation in the neck and face. It is caused by heterozygous missense mutations 
in  LMNA (Shackleton et al., 2000) and possibly by disrupting the differentiation of 
adipocytes. This is supported by the interaction between the sterol response element 
binding factor 1 (SREBF1), an adipocyte differentiation factor, and lamin A, which is 
noticeably reduced by FPLD causing mutations  (Lloyd et  al.,  2002).  It  was  also 
shown that  overexpression of  lamin A inhibits  the  in  vitro 3T3-L1 pre-adipocyte 
differentiation to adipocytes by suppressing PPARγ and Slc2a4 (Boguslavsky et al., 
2006).  The same study describes  that  murine embryonic fibroblasts  derived from 
lamin A knockout mice accumulate more lipids and synthesize more triglycerides 
compared to wild-type fibroblasts.
1.2 LINC complex
1.2.1 Discovery
The term LINC complex was coined by Crisp et al. (2006) and it is defined as 
6
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a complex that links the nucleoskeleton and cytoskeleton. It consists of SUN proteins 
and  the  KASH  domain-containing  nesprins  proteins  and  connects  all  major 
components of the cytoskeleton through the NE to the peripheral nuclear skeleton – 
the lamina (Fig 1.2.1).  Crisp  et  al. (2006)  showed a direct  interaction of murine 
SUN1 and SUN2 with all types of lamins whilst the rest of the complex interactions 
were shown earlier in C. elegans. First, the SUN domain-containing protein UNC-84 
and  the  KASH  domain-containing  protein  Syne/ANC-1  have  been  shown  to  be 
important  for  nuclear  migration  and  anchoring  (Sulston  and  Horvitz,  1981; 
Hedgecock  and  Thomson,  1982).  Decades  later  the  C.  elegans KASH  domain-
containing  ANC-1  was  cloned  and  shown  to  localise  at  the  NE in  an  UNC84-
dependent  manner,  as  well  as  to  interact  with  filamentous  actin  (Starr  and  Han, 
2002).
7
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1.2.2 Cytoplasmic side of the LINC complex: KASH domain proteins
The KASH domain (for Klarsicht, Anc-1, Syne homology) is a small (around 
60 aa) conserved domain that includes a transmembrane region and less than 35 C-
terminal amino acids. C. elegans has three KASH domain containing proteins: ANC-
1,  UNC-83  and  ZYG-12.  Only  two  proteins  of  the  family  are  found  in  D. 
melanogaster:  Klarsicht  and  MSP300.  Mammals  have  four  KASH  domain 
containing proteins: nesprin-1, nesprin-2, nesprin-3 and nesprin-4. Genes encoding 
nesprins, syne1-4 (for synaptic nuclei expressed), give rise to many isoforms (more 
than 12 for syne-1 and syne-2 each) (Zhang et al., 2001; Zhen et al., 2002).
8
Fig 1.2.1: The LINC complex
The LINC complex connects the peripheral  nucleoskeleton (lamina) to  the cytoskeleton. Different  
forms  of  nesprins  have  been  shown  to  interact  directly  or  indirectly  with  all  major  cytoskeletal  
components:  actin  filaments  (directly),  microtubules  (through kinesin)  and intermediate  filaments  
(through plectin, which also binds actin and tubulin). SUN domain-containing proteins, on the other  
hand, bind the lamina – a polymer of intermediate filaments that are underlying the inner nuclear  
membrane.  It  is  possible that the interaction between SUN proteins  and nesprins  is  mediated by  
another yet unidentified protein (question mark).
Nuclear envelope transmembrane proteins in differentiation systems
Nesprins  (Fig  1.2.1)  are  type  II  integral  membrane  proteins  with  a  short 
lumenal KASH domain and a large (around 1MDa for Nesprin-1 and 0.8 MDa for 
Nesprin-2) cytoplasmic N-terminal domain,  composed of spectrin repeats that are 
predicted to form a rod domain similar to that of dystrophin, a giant protein that 
connects the muscle fibre to the extracellular matrix (Zhang et al., 2001). Apart from 
that, Nesprin-1 and Nesprin-2 have N-terminal calponin-homology domains that bind 
to actin, the building block of microfilaments and thin filaments of muscle (Starr and 
Han, 2002). Nesprin-3 does not have the domain but it was shown to bind plectin, a 
protein  that  links  microfilaments,  intermediate  filaments  and  microtubules 
(Wilhelmsen et al., 2005). Furthermore, UNC83, a KASH domain-containing protein 
from C. elegans, has been shown to interact with the kinesin-1 light chain, a motor 
protein that binds microtubules (Meyerzon et al., 2009). As nesprins are anchored in 
the ONM and are linked to actin, plectin and, indirectly, to tubulin, they potentially 
connect  the  nucleus  to  the  cytoskeleton  that  is  comprised  of  microfilaments, 
intermediate filaments and microtubules.  It  should be mentioned that cytoplasmic 
localisation of nesprins is not exclusive. It was shown that some short isoforms of 
Nesprin-1 and Nesprin-2 are localised to the nucleus where they co-localise with 
heterochromatin and bind lamin A and emerin (Zhang et al., 2001; Mislow et al., 
2002; Zhang et al., 2005).
1.2.3 Nucleoplasmic side of the LINC complex: SUN domain proteins
The SUN domain (for Sad, Unc-84 homology) encompasses about 130 aa. 
Apart  from the SUN domain, sequences of SUN proteins are quite diverse. After 
molecular  cloning  of  UNC-84 (Malone et  al.,  1999)  and  establishing  its  role  in 
connecting the peripheral nucleoskeleton to the cytoskeleton (Starr and Han, 2002), 
many laboratories have focused their research on SUN domain proteins. Studies of 
mammalian homologues of the protein revealed multiple functions of proteins of the 
family.
Mammalian  SUN  domain  proteins  include  six  members  –  SUN1,  SUN2, 
SUN3, SUN4 (SPAG4), SUN5 (SPAG4L) and SPAG4L2. SUN1 and SUN2 proteins 
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are ubiquitously expressed whereas others are found mainly in testis. 
SUN1 is a type 2 transmembrane protein with a nucleoplasmic N-terminus 
and a C-terminus present in the NE lumen. Its nucleoplasmic domain can bind lamin 
A and,  to lesser  degree,  lamin B (Crisp et  al.,  2006).  The N-terminus of SUN1, 
lacking the  transmembrane  region,  localises  in  the  cytoplasm and  forms dot-like 
structures, presumably at centrosomes (Wang et al., 2006). Thus, transient interaction 
of SUN1 and the microtubule organising organelle is possible during the cell cycle 
when the NE is disassembled.
A recent report has argued that SUN1 has a functional association with NPCs 
– knocking down the protein caused NPCs to cluster (Liu et al., 2007) suggesting 
that SUN1 is important for the uniform distribution of NPCs in the NE. Confocal 
microscopy showed a spatial pattern and partial co-localisation of SUN1 with NPCs 
(Lu et al., 2008). Furthermore, the high immobility of the protein in the NE suggests 
that it is a part of a big complex.
SUN2 is  also  a  type  II  transmembrane  protein  with  a  nucleoplasmic  N-
terminus and a lumenal C-terminus. As for SUN1, it has been shown to bind Lamin A 
and Lamin B (Crisp et al., 2006). Interestingly, a fraction of endogenous SUN2 was 
shown to localise at the centrosomes in a cell cycle dependent manner (Wang et al., 
2006); however, no functional data was provided.
A recent paper revealed that SUN2 is involved in repositioning of telomeres 
during meiotic prophase I (Schmitt et al., 2007). It was shown in rat testicular cells to 
be a part of a fibrillar complex that interconnects the cytoskeleton with telomeres. In 
budding  yeast  a  SUN  domain  containing  protein,  Sad1,  was  shown  to  change 
localisation pattern with depletion of another NET Ima I, a homolog of NET5 (King 
et  al.,  2008).  Ima  I  was  shown  to  indirectly  bind  to  the  heterochromatin  of 
centromere regions of chromosomes.
Thus,  SUN  domain  proteins  are  linked  to  the  peripheral  nucleoskeleton 
through  their  direct  interaction  with  lamins  and  to  chromosomes  through  as  yet 
unidentified partners. Known partners of SUN2 are listed in Table 1.
10
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Table 1: SUN2 interactors





1 Rab5 C-terminus after TM Y2H,  in  vitro 
binding assays
Yes Hoffenberg et al., 2000
2 SUN2 C-terminus  after  TM, 
N-terminus
Co-IP  of  tagged 
expressed proteins
N/A Wang et al., 2006 
3 SUN1 N/A Co-IP  of  tagged 
expressed proteins
N/A Wang et al., 2006 
3 Lamin A N-terminus, first 165aa Pull-down Yes Crisp et al., 2006 
4 PreLamin A N-terminus, first 165aa Pull-down, 
cotransfection/IF
Yes Crisp et al., 2006 
5 Nesprin2G N/A Co-IP N/A Crisp et al., 2006 
6 Nesprin3α N/A Co-IP N/A Ketema et al., 2007
7 Emerin N-terminus Co-IP, pull-down N/A Haque et al., 2010
1.2.4 Connection between SUN and KASH domains 
It is well established that SUN domains interact with KASH domains (Starr 
et al., 2001; Crisp et al., 2006; Haque et al., 2010) in the NE lumen and bridge the 
INM and the ONM. Moreover, localisation of nesprins is dependent on both SUN1 
and SUN2 proteins (Crisp et al., 2006), or only SUN1 (Padmakumar et al., 2005). 
The last two studies gave different results most likely due to different anti-Nesprin-2 
antibodies  used,  one  that  recognises  specifically  Nesprin-2  Giant  isoform 
(Padmakumar et  al.,  2005)  and the  other  that  recognises  many  nesprin  isoforms 
(Crisp et al., 2006).
However, the length of the lumenal C-termini of SUN1 or SUN2 is about 500 
aa and includes only a few coiled-coil domains; the rest is presumably globular. The 
KASH domain without the transmembrane region is about 35 aa. It is unlikely that 
these two structures cover about 50 nm of lumenal distance between INM and ONM 
(Fig 1.2.1). Moreover, when direct binding of SUN1 and Nesprin-2 was tested using 
the yeast two hybrid assay, the SUN domain showed only a weak interaction with the 
KASH domain (Padmakumar et al., 2005). It is the part of SUN1 between the SUN 
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and  coiled-coil  domains  that  showed  a  strong  interaction.  Also,  both  SUN1 and 
SUN2 N-termini have been shown to interact with nesprins (Haque et al., 2010). The 
last fact suggests that a fraction of both SUN and KASH domain-containing proteins 
are located within the same membrane, either the INM or the ONM or both. This 
could potentially explain results that were interpreted as a consequence of interaction 
between SUN and KASH domains.  Further,  the  N-terminus  of  nesprins  contains 
spectrin repeats and the C-terminus of SUN proteins contains coiled coil domains. 
Both motifs are known to interact non-specifically.
Based on the statements  above it  can be hypothesised that  the interaction 
between KASH and SUN domains through the NE lumen is indirect. Hence, it is 
mediated by a partner(s) located in NE lumen and interacting with both SUN and 
KASH domains. One possible candidate for the mediator is torsin A, a protein that 
resides in the NE lumen. It was shown that the KASH domain of Nesprin 3 binds 
torsin A (Nery et al., 2008). The NE localisation of Torsin A-ΔE, a mutant of torsin 
that causes torsion dystonia, is SUN1-dependent (Jungwirth et al., 2011). Moreover, 
the protein was found to co-immunoprecipitate with SUN2, though it needs to be 
confirmed (present work, see Table 13).
1.3 Nuclear envelope proteome
1.3.1 Pre-proteomics studies
Xenopus laevis oocytes served as an excellent model system for studying NE 
components, especially NPC transport (reviewed in Peters, 2006). Extracts from the 
oocytes can assemble a NE  upon addition of sperm chromatin (Lohka and Masui, 
1983).  Two  distinct  vesicle  fractions  of  the  oocytes  extract  were  identified  and 
named  NEP-A and  NEP-B,  for  nuclear  envelope  precursor  (Vigers  and  Lohka, 
1991). Both fractions are involved in NPC formation (Salpingidou et al., 2008).
The very first NET was identified through its interaction with lamin polymers 
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as the latter  were already biochemically characterised.  LBR was co-purified with 
lamin B1, hence the name - lamin B receptor (Worman et al., 1988). LAP proteins 
appeared to be major antigens in a NE fraction from rat liver (Senior and Gerace, 
1988).  Gp210 was identified as a major transmembrane glycoprotein of the NPC 
(Greber et al., 1990). POM121 was identified from a rat liver NE fraction through its 
binding to WGA (Hallberg et al., 1993). Emerin was first shown to cause X-linked 
EDMD (Bione et  al.,  1994) and later described as a NET (Manilal et  al.,  1996). 
Nurim was found at the NE in a visual screen with a GFP-tagged library of proteins 
(Rolls et al., 1999). SUN1 was identified due to its effect on nuclear migration and 
anchoring in C. elegans (Malone et al., 1999). SUN2 was first described as a protein 
interacting with  Rab5 (Hoffenberg et  al.,  2000)  and later  was defined as  a  NET 
(Hodzic et  al.,  2004). MAN1  was  identified  as  a  protein  recognised  by 
autoantibodies  in  a  patient  with  a  collagen  vascular  disease  (Lin et  al.,  2000). 
Nesprin-1 was identified through its binding to muscle kinase (Apel et al., 2000).
Thus, only 12 NETs were identified before 2001, and only a few studies were 
aiming  to  identify  novel  NETs.  Development  of  mass  spectrometry  and  the  NE 
fractionation  techniques  lead  to  a  new stage  of  NETs  identification  -  proteomic 
approaches.
1.3.2 Proteomic analysis of the NE
Whereas some of the NETs were and continue to be identified by traditional 
approaches, the development of mass spectrometry allowed more directed studies of 
NE proteomes. However, to obtain a clean NE fraction two major obstacles had to be 
overcome. First of all, the outer nuclear membrane is continuous with ER and any 
attempt to purify the NE will co-purify proteins from ER. Second of all, the lamina is 
tightly  associated  with  chromatin  that  will  also  add  contaminants  into  the  NE 
fraction.
In  order  to  overcome  the  problems  mentioned  above,  the  Otto  group 
compared insoluble material from chaotropes (urea and sodium carbonate) and non-
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ionic  detergent  (Triton  X-100)  extractions  using  2D  SDS-PAGE  (Dreger et  al., 
2001). While chaotropes should solubilise the lamina and most of the protein-protein 
interactions,  leaving  the  membranes  intact,  detergent  extraction  should  remove 
membranes and proteins that are weakly associated with the lamina. Hence, insoluble 
material  in  both  extractions  represents  potential  INM  NETs  that  are  strongly 
associated with the lamina. This approach identified two novel NETs - mammalian 
SUN1 and LUMA. Such a poor number of identified proteins could be explained by 
the fact that the purified fractions were resolved on gels, visualised with Coomassie, 
then digested in the gel and subjected to MALDI TOF mass spectrometry. Each of 
these steps has introduced limitations into the final number of identified proteins.
On the other hand, Schirmer et al.  (2003) used a subtractive approach. Both 
crude  NEs  and,  separately,  microsomes  were  purified  and  analysed  by 
multidimensional protein identification technology (MudPIT) that avoids gels and 
couples multiple  chromatography steps with tandem mass spectrometry.  Then the 
proteins that were identified 
in  the  microsomal  fraction 
were  subtracted  from  the 
proteins  identified  in  the 
crude  NE  fraction.  The 
presence  of  predicted 
transmembrane  domains 
among  the  rest  of  the 
proteins defined a large (67) 
number  of  novel  putative 
NETs.  Subsequent  studies 
identified in total  over five 
hundred  potential  NETs  in 
three  different  tissues 
(Korfali et al., 2010; Wilkie 
et  al.,  2010),  with  only 
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Fig 1.3.2: Distribution of putative NETs identified in  
three different tissues
Total number of proteins that were over-represented in the NE 
fractions compared to microsomal fractions and contain at least  
one  strongly  predicted  transmembrane  domain  is  compared  
between three different tissues. Only a third of putative NETs is  
shared between liver, muscles and blood, suggesting that some  
of  the NETs are tissue-specific.  Liver  and muscle tissues  are  
from rat and leukocytes are from human peripheral blood.
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about a third being shared between the tissues (Fig 1.3.2, N Korfali, GS Wilkie, SK 
Swanson, V Srsen,  J de las Heras, DG Batrakou, ARW Kerr,  L Florens,  and EC 
Schirmer, manuscript in preparation), suggesting tissue-specific or tissue preferential 
expression for the other two thirds of corresponding genes.
Existing  transcriptome  data  supports  this  mass  spectrometry  based 
observation  (refer  to  results,  Fig  4.1.1  a).  Interestingly,  many  known  diseases 
associated with NE have tissue-specific phenotypes. This suggests that mutations in 
some of the newly identified putative (with about 70 of them being confirmed at the 
time of writing this manuscript) NETs could cause or contribute to the tissue-specific 
disease phenotypes. Any investigation of tissue-specific proteins should be done in 
cells of the corresponding tissue; moreover, the pre-differentiated state of the same 
cells  could  provide  additional  insights  into  role  of  the  tissue  preferential  NETs. 
Among a few in vitro differentiation systems adipogenesis is considered to be both 
robust  and  reliable.  More  importantly,  several  NETs  were  found  to  be  highly 
expressed in adipocytes (refer to results, Fig 4.1.1 a). Thus we took advantage of the 




Adipocytes  are  specialised  cells  that  store  energy  in  the  form  of 
triacylglycerol  in  order  to  provide  energy  when  the  more  preferential  source  of 
energy  -  glucose  -  is  not  available.  Apart  from  acting  as  storage  for  energy, 
adipocytes  also  secrete  adipokines  and  play  a  role  in  the  control  of  metabolism 
(reviewed in Vázquez-Vela et al., 2008).
There are two types of mammalian adipocytes, white and brown adipocytes. 
Brown adipocytes store less lipid, have more mitochondria and are able to dissipate 
energy as heat without the generation of ATP. Expression profiles of white and brown 
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adipocytes are similar, however brown adipocytes additionally express some distinct 
genes.  In  infancy,  humans have large amounts  of  brown adipose tissue,  but  only 
small amounts persist in adults (reviewed in Koppen and Kalkhoven, 2010).
The  adipose  tissue,  together  with  muscle  and  bone,  develops  from  the 
mesenchymal stem cells derived from the mesodermal layer of the embryo (reviewed 
in  Park et al., 2008). Multipotent precursor cells in the vascular stroma of adipose 
tissue become restricted to  the adipocyte lineage without  actually  expressing any 
markers  of  terminal  expression.  Multiple  transcription  factors  are  subsequently 
activated  causing  the  cells  to  differentiate.  This  process  is  initiated  by  factors 
secreted by cells in the vascular stroma and/or adipocytes undergoing hypertrophy.
The 3T3-L1 cell line is a well-established murine preadipocyte cell line that 
has already been committed to the adipocyte lineage. The 3T3-L1 cells were selected 
for their  ability to accumulate cytoplasmic triacylglycerol while in a resting state 
(Green and Kehinde, 1975). The cells cannot be distinguished from their precursor 
cells morphologically, but can be induced to terminally differentiate to adipocytes 
using a cocktail of insulin, 3-isobutyl-1-methylxanthine (IBMX) and dexamethasone 
(DMS) (Student et al., 1980). 3T3-L1 cells offer a homogeneous cell population and 
a stable pre-differentiated state.
1.4.2 Transcriptional regulation of adipogenesis
The transcriptional networks in adipogenesis are highly regulated and involve 
many different factors, of which a part may still be unknown (Fig 1.4.2).
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Different members of the C/EBP (CCAAT enhancer binding protein) family 
are  temporally  expressed  during  adipocyte  differentiation.  Early  expression  of 
C/EBPβ and C/EBPδ leads to induction of C/EBPα. C/EBPα is directly involved in 
the induction of some adipocyte genes and in vivo studies suggest it has an important 
role  in  the  development  of  white  adipose  tissue (Chen et  al.,  2000).  Despite  the 
important role of C/EBPs in adipocyte differentiation these factors are not able to 
function without peroxisome proliferator-activated receptor γ, PPARγ (Rosen et al., 
2002).
PPARγ belongs to the nuclear-receptor superfamily. It is absolutely required 
for  adipogenesis  and able  to  induce  adipocyte  differentiation  in  fibroblasts  when 
overexpressed  (Tontonoz et  al.,  1994).  The  function  of  the  most  pro-adipogenic 
factors seems to be at  least  partially to activate PPAR expression.  There are two 
protein-isoforms, PPARγ1 and PPARγ2, which are produced by alternative splicing 
and promoter usage. Both isoforms are induced during adipogenesis and PPARγ1 is 
also expressed in other cell types. PPARγ2 appears not to be absolutely required for 
adipogenesis  and plays  a  role  in  insulin  sensitivity  (Medina-Gomez et  al.; 2005, 
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Fig 1.4.2: Overview of the 3T3-L1 differentiation cascade
Different sets of genes are expressed at different stages of adipogenesis. Most notably, Krox20 C/EBP  
family proteins are activated upon addition of a differentiation cocktail and activate expression of  
PPARG, SREBF1 KLF5. The latter, in their turn, activate expression of a large number of adipogenic  
genes, including Slc2a4 (GLUT4).
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Zhang et al., 2004).
The  expression  of  sterol  response  element  binding  factor  (SREBF1)  is 
regulated by C/EBP transcription factors that are expressed earlier in adipogenesis 
(Payne et  al.,  2010).  It  induces  PPARγ (Kim et  al.,  1998; Kim and Spiegelman, 
1996) and influences  the induction of  lipid biosynthesis  by insulin in  adipocytes 
(Kim et al., 1998).
The roles  of  PPARγ,  C/EBPs and SREBF1 in  adipogenesis  are  now well 
defined, but there are over a hundred other factors expressed in adipocytes which all 
have  a  role  in  the  differentiation  process.  Many  transcription  factors  repress 
adipogenesis  by  promoting  alternative  cell  fates  and  are  down-regulated  in 
adipocytes, which suggests that repression of these genes is an important task for 
pro-adipogenic  factors.  For  example,  addition  of  sonic  hedgehog  or  its  activated 
receptor  diverges  3T3-L1  cells  from differentiation  into  adipocytes  and activates 
expression of osteogenic genes. The hedgehog pathway regulates gene expression 
through members of the GLI family and Smo (reviewed in  Cousin et  al.,  2007). 
Conversely, the over-expression of dominant negative GLI as well as the addition of 
Smo inhibitor promotes adipogenesis (Suh et al., 2006).
The tight regulation of both positive and negative gene expression is crucial 
to effective adipogenesis and it is very likely that there are other mechanisms in place 
to fine tune the regulation.
1.4.3 Signalling cascades in adipogenesis
Different  extracellular  and intracellular  factors  activate  different  signalling 
pathways that in their turn activate downstream transcription factors that induce the 
expression of genes responsible for adipogenesis.
One of the most important regulators of adipogenesis is insulin. At the onset 
of adipogenesis it acts through insulin-like growth factor receptors, however with the 
progress of differentiation expression of a more specific insulin receptor increases 
(Smith et al., 1988). Insulin has been shown to activate expression of SREBF1, a 
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transcription factor important for adipogenesis (Kim et al., 1998). It also prevents 
activation  of  forkhead  transcription  factor  FoxO1  early  in  adipogenesis.  Active 
FoxO1 is able to block adipogenesis by inhibition of expression of adipogenic genes 
(Nakae et al., 2003). Insulin also induces transcription of Krox20 through MED23 
(Wang et al., 2009). Krox20 is induced transiently after addition of the differentiation 
cocktail  and  its  over-expression  with  C/EBPβ  can  induce  full  differentiation  of 
adipocytes (Chen et al., 2005).
Recent  studies  provide  solid  evidence  that  SMAD  signalling  plays  an 
important role in adipogenesis. A Smad3 -/- mouse was shown to be protected from 
diet-induced  obesity  and  diabetes  (Yadav et  al.,  2011).  What's  more,  SMAD3-/- 
white  adipocytes  acquire  the  expression  profile  of  brown  adipocytes  and, 
accordingly, contain an increased number of mitochondria. This suggests that SMAD 
signalling  is  important  for  switching  the  cell  fate  of  pre-adipocytes  towards 
differentiation into brown adipose tissue. Recent studies show that proteins of the 
inner nuclear membrane affect SMAD signalling. The NET MAN1 binds to receptor-
regulated SMADs and reduces signalling by transforming growth factor-beta, activin 
and bone morphogenic protein (Pan et al., 2005). The phosphorylation of SMADs 
also seems to be regulated by Lamin A and C (Van Berlo et al., 2005). This shows 
that  proteins  within  and  associated  with  the  inner  nuclear  membrane  influence 
signalling pathways that regulate adipogenesis.
The  Wnt  signalling  pathway  is  highly  conserved  and  functions  through 
secreted glycoproteins to influence cell fate and development. Wnt signalling was 
shown to inhibit adipocyte differentiation by blocking the expression of PPARγ and 
C/EBPα (Ross et al., 2000). The Wnt signalling pathway is also affected by a NE 
protein. Emerin regulates the activity of a downstream target of the Wnt signalling 
pathway, β-catenin, by restricting its accumulation in the nucleus (Markiewicz et al., 
2006).
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1.4.4 Chromatin rearrangement during adipogenesis
Adipogenesis  is  influenced  by  almost  every  important  signalling  pathway 
some of which exercise both positive and negative regulation. All of the events lead 
to the activation of genes involved in adipogenesis and the repression of those that 
are  not  needed,  or  are  inhibitory  to,  adipogenesis.  However,  expression  of 
transcription  factors  is  not  sufficient  for  adequate  gene  activation.  The  other 
important factor is accessibility of target genes and it is postulated that in every cell a 
part  of  the  genome  is  tightly  packed  into  heterochromatin  and  therefore  silent. 
During  gross  changes  of  a  cell's  fate,  such  as  differentiation,  some  of  this 
heterochromatin  must  be  made  accessible,  i.e.  de-compacted  to  promote  gene 
activation. Conversely, a part of the previously active chromatin must be assembled 
into  higher  order  structures  to  inactivate  undesirable  genes  and  free  some room 
inside of the nucleus.
A recent study used DNAse I hypersensitive site (DHS) analysis of genomic 
DNA of 3T3-L1 cells to gain information 
about changes in active chromatin during 
adipogenesis  (Siersbæk et  al.,  2011). 
Sensitivity  to  DNAse  I  treatment 
corresponds  to  accessibility  of  the 
genomic DNA as open chromatin is more 
readily  subjected  to  DNAse  I 
degradation.  Interestingly,  major 
chromatin  rearrangements  take  place  in 
the  first  hours  after  pharmacological 
induction  (Fig  1.4.4).  What's  more, 
undifferentiated  and  differentiated  cells 
have  substantial  similarity  in  the  open 
chromatin content.
These observations suggest that, shortly after induction a large number of chromatin 
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Fig 1.4.4: DNAse I hypersensitive site  
analysis of differentiating 3T3-L1 cells
Venn diagram representing the overlap between  
DHS sites in pre-adipocytes immediately before  
induction  of  differentiation  (day  0;  red),  in  
adipocytes  (day  6;  green),  and  in  cells  
stimulated  for  4  h  with  the  differentiation  
cocktail (blue). From Siersbæk et al., 2011.
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sites become open. One obvious reason for this would be activation of adipogenic 
genes and it was shown that sites open at 4 h correlate with induced and transiently 
induced genes. The latter suggests that some of the genes, despite the association 
with transcription factors, are not expressed at the time. This opening and association 
with transcription factors significantly preceding transcription could be explained by 
recording  of  an  epigenetic  program  of  differentiation.  Post-translational 
modifications  (PTMs)  of  histones  or  even  histone  variant  exchanging  could 
potentially mark the sites as active at certain times later in adipogenesis. In any case, 
opening  of  large  areas  of  chromatin  might  be  undesirable  for  many  reasons, 
including overloading of transcriptional complexes and lack of intranuclear space. 
Thus growth-arrested 3T3-L1 cells re-enter the cell cycle, which highly condenses 
the  chromosomes.  After  two  rounds  of  mitosis,  regions  of  the  chromatin  are 
activated,  possibly  in  accordance  with  recorded  earlier  epigenetic  marks.  Hence, 
adipocyte differentiation involves the opening of a large number of chromatin sites 
followed  by  total  condensation  of  chromatin.  Subsequently,  a  different  set  of 
chromatin sites are then opened allowing the activation of alternative genes.
Some evidence exists to support involvement of the chromatin remodeling 
complex (RSC) in activation of PPARγ (Salma et al., 2004) and SREBF1 (Lee et al., 
2007), but it is not clear whether opening of chromatin upon induction is achieved by 
this  complex.  Changes  in  gene  and  even  whole  chromosome  positioning  during 
adipogenesis have been described (Kuroda et al., 2004, Szczerbal et al., 2009). Thus 
it  is clear that chromatin remodelling is  important for differentiation and that the 
most likely outcome of the remodelling is altered gene expression.
1.5 Spatial genome organisation
1.5.1 Introduction
Considering  the  enormous  size  of  the  genome  it  could  only  fit  into  the 
nucleus if it is highly compacted. However it is not packed the same way in different 
cells or, even, in the same cell. Some of it is universally archived and represents the 
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constitutive heterochromatin.  Some of  it  can be found either  condensed or open, 
depending on a cell needs. That is so called facultative heterochromatin. The rest is 
euchromatin,  a  fraction  that  is  always  open.  It  is  reasonable  that  the  state  of 
chromatin  is  linked  to  transcriptional  activity  of  the  genes  located  within. 
Housekeeping  genes  that  are  always  expressed  are  located  within  euchromatin. 
Conversely,  heterochromatin  is  associated  with  gene  silencing,  and  constitutive 
chromatin represents gene poor areas and centromeric and pericentromeric regions.
Regulation of facultative heterochromatin appears to be crucial as it is the 
way for a cell to react to changes in conditions. What is astonishing is that every cell,  
despite its origin and differentiation, seems to possess the full spectrum of responses. 
This is derived from observations that the nucleus of a differentiated somatic cell 
from an adult organism, when transferred to an enucleated unfertilised egg, is able to 
program development of a new individual and fulfil what was programmed (Wilmut 
et al., 1997).
Differentiation is, perhaps, the most challenging task out of all responses that 
a cell accomplishes upon receiving signals from outside. It involves gross changes in 
the gene expression profile and is often associated with changing cell morphology 
and function. Therefore cell systems that can be differentiated in a controlled way 
serve as good model systems to investigate chromatin dynamics.
1.5.2 Two distinct mechanisms of chromosome relocation
A study of localisation of two human chromosomes, 18 and 19, showed that 
they have distinct places inside of the nucleus (Croft et al., 1999). In several cell 
lines, including primary lymphocytes and fibroblasts, gene-rich chromosome 19 was 
located preferably in the nuclear interior. On the other hand, gene-poor chromosome 
18 was localised mostly at the nuclear periphery.
Chromosome 18 also appeared to occupy less volume than chromosome 19, 
despite  containing  more  DNA.  One  suggested  explanation  was  that  because 
chromosome 19 is transcriptionally more active, it is located in the nuclear centre in 
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a more open state to allow transcription. This is in accordance with the observation 
that  upon  inhibition  of  transcription  chromosome  19  seemed  more  compact. 
However,  absence  of  transcription  did  not  affect  its  localisation.  Interestingly, 
chromosome  18  moves  towards  the  centre  of  the  nucleus  when  cells  become 
quiescent or senescent and re-locates back to the nuclear periphery when the cell 
cycle in quiescent cells is induced, but the re-location seems to require a cell division 
(Bridger et al., 2000). While restoration of chromosome 18 to the nuclear periphery 
depends upon the cell cycle, movement of the chromosome into the interior of the 
nucleus is rapid and complete after 15 minutes of serum starvation (Mehta et al., 
2010). What's more, it requires energy and nuclear myosin and, possibly, actin.
Obviously,  there 
seems to be at least two 
different mechanisms of 
chromosome  reloca-
tions. One is a response 
to  withdrawal  from cell 
cycle.  It  is  rapid  and 
requires  motor  activity 
within  the  nucleus.  The 
other  one  happens 
shortly after the first cell 
cycle  of  previously 
quiescent  cells.  The 
requirement of a cell division suggests that the INM associated proteins could play a 
role in this relocation mechanism. The NE breaks down during mitosis and it was 
shown that lamina-depleted NE membranes bind chromosomes (Foisner and Gerace, 
1993). However, the described 2-4 h time window early in G1, when the movement 
takes place (Bridger et al., 2000), seems to be contradictory to this hypothesis as 
affinity between a chromosome and a NET should bring the chromosome to NE upon 
the NE reformation in telophase. On the other hand, the delay could be explained by 
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Fig  1.5.2:  Human  chromosome  18  and  19  position  
within the nucleus (Croft et al., 1999)
Human chromosomes 18 and 19 have similar size (78 Mb and 59  
Mb,  respectivey),  yet  their  localisation  within  the  interphase  
nucleus is completely different. Most of the chromosome 18 territory  
is  at  the  nuclear  periphery  whereas  chromosome 19 is  centrally  
located. The cells depicted are primary lymphocytes. The scale bar  
is 2 µm.
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the NE invaginations at the NET-chromosome attachment sites. This would suggest 
that the cytoskeleton, LINC complex and lamina might be involved in this type of 
chromosome  movement.  These  structures  are  responsible  for  positioning  of  the 
nucleus and, therefore, are capable of transmitting forces significant for chromosome 
movement.
Interestingly,  chromosome  positioning  of  proliferating  fibroblasts  from 
patients  with  Hutchinson-Gilford  Progeria  Syndrome  (HGPS)  resembles  that  of 
quiescent control  fibroblasts  (Mehta et  al.,  2011).  HGPS is  a rare disease that  is 
caused by point mutations in the  LMNA gene and leads to translation of truncated 
lamin  A.  Therefore  lamin  A  is  required  for  normal  chromosome  distribution. 
Moreover,  the  nuclear  lamina  has  been  shown  to  be  in  proximity  to  multiple 
chromosomal loci (Guelen et al., 2008).
1.5.3 Gene repositioning and its effect on transcription
In uninduced murine erythroleukemia cells both alleles of the β-globin locus 
are associated with peripheral and centromeric heterochromatin (Francastel et  al., 
2001). Upon terminal differentiation these loci move to euchromatic regions of the 
nucleus  which  correlates  with  activation  of  β-globin  expression.  Hence  upon 
induction to differentiate one of the allele moves away from the nuclear periphery 
and becomes transcriptionally active. A more recent study corroborated this finding 
and showed that transcription of β-globin starts even before its translocation into the 
nuclear interior (Ragoczy et al., 2006).
Zink et al. (2004) investigated localisation of a human chromosome 7 locus, 
containing  three  genes,  in  different  cell  lines.  The  localisation  was  compared  to 
expression level of these genes in corresponding cells. Although transcription levels 
of the genes were individual, localisation of the whole locus seemed to be correlated 
with the sum of transcription levels of all three genes. Interestingly, a synteny locus 
on mouse chromosome 6 did not display a similar correlation in a follow up study 
(Sadoni et al., 2008). On the other hand human chromosomes in mouse hybrid cells 
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behave  similarly  to  their  syntenic  mouse  chromosomes  (Meaburn et  al.,  2008; 
Sengupta  et  al.,  2008).  This  suggests  that  chromosome positioning is  one  of  the 
features that changed dramatically during evolution of mammals.
A number of adipogenic genes are translocated towards the nuclear centre in 
porcine adipogenesis which correlates with their becoming more actively transcribed 
(Fig 1.5.3;  Szczerbal et al., 2009). Some of these genes were not co-localised with 
their chromosome territories in differentiated cells. This is in agreement with other 
observations that transcriptionally active genes may loop away from the main body 
of the chromosome they belong to. This also explains why more transcriptionally 
active  chromosomes  take  up  more  intranuclear  volume  compared  to  gene-poor 
chromosomes of similar size.
Therefore,  emerging  evidence  argues  that  both  chromosome  and  gene 
repositioning  during  differentiation  are  able  to  influence  gene  expression  in 
differentiation (for extended review see  Schöfer and Weipoltshammer, 2008). The 
general idea is that less active chromosomes are located at the nuclear periphery and 
are more compact. Conversely, gene-rich and highly transcribed chromosomes reside 
closer  to  the  centre  of  the  nucleus  and are  spread  over  a  bigger  volume due to 
massive gene looping. However just as gene looping from peripheral chromosomes 
may allow their expression, accessible genes of centrally located chromosomes may 
not be transcribed due to lack of corresponding transcription factors or presence of 
repressors.
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1.6 Summary
It is clear that the NE is involved in many processes within the cell, mainly 
owing to the proteins that are anchored in its membranes. Some of the 13 originally 
identified  NETs  have  been  linked  to  cell  division  (Liu  et  al.,  2003),  signalling 
pathways (Pan et al., 2005; Markiewicz et al., 2006), transcription (Nili et al., 2001; 
Holaska et al., 2003), mechanical stability of the nucleus (Crisp et al., 2006), DNA 
replication  (Gant  et  al.,  1999)  and DNA repair  (Oza  et  al.,  2009).  Proteomics 
identified hundreds of putative novel NETs, many of which have been confirmed to 
reside at  the NE (Schirmer  et al.,  2003; Malik  et al.,  2010; Korfali  et al.,  2010; 
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Fig 1.5.3: Localisation of adipogenic gene loci during porcine  adipogenesis (from  
Szczerbal et al., 2009)
In blue – DNA visualised with DAPI. In green: genes visualised with specific BAC probes. MCS –  
mesenchymal stem cells, AD7 – preadipocytes, AD14 – adipocytes. PPARG, FABP4 and CREB –  
adipogenic  markers,  MYL1  –  control,  myosin  light  chain.  Adipogenic  gene  loci  move  from the  
nuclear periphery during adipogenesis, which correlates with activation of their transcription. The  
scale bar is 10 µm.
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Wilkie et al., 2010). It is likely that some of the novel NETs have new functions that 
link the NE to yet more vital cellular processes.
One predictable function for the INM proteins is involvement in chromatin 
organisation. The goal of the present work is to find novel interactions between NETs 
and chromatin. First, PTMs of SUN2 were identified and their effect on chromatin 
distribution was tested. Second, a novel protein NET29 and its effect on chromosome 
positioning was studied.
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CHAPTER II: Materials and Methods
2.1 Materials
Chemicals were purchased from Sigma Aldrich, Calbiochem, Invitrogen and 
VWR.  Restriction  enzymes,  T4  DNA  ligase,  T4  Polynucleotide  kinase, 
ThermoScriptTM RNAse H- Reverse Transcriptase were from New England Biolabs, 
Fermentas  and  Invitrogen.  Phusion®  High-Fidelity  DNA Polymerase  was  from 
Finnzymes.  Oligodeoxynucleotide  primers  were  synthesised  by  Eurogentec  and 
Sigma-Genosys. SybrGreen Master Mix was from Roche.
Cell culture media was from Lonza. Foetal bovine serum was bought in large 
stocks from HyClone. Penicillin-Streptomycin solution, MEM non-essential amino 
acids and sodium pyruvate were from Invitrogen.
Plasmids  and  their  relevant  features  are  listed  in  Table  2.  Fugene  6  and 
Fugene HD were from Roche, JetPRIME reagent was from Polyplus transfection TM.
Table 2: Plasmids used in this study
Name Type Promoter Features Source
pSC-B Intermediate cloning Amp, Kan, lacZ Stratagene
pEGFP Mammalian transient CMV early E-GFP, Kan Clontech
pLKO.1-puro Mammalian transient/stable SV40, U6 Amp Sigma
pET28a Bacterial expression T7 Kan Novagen
Isoelectrofocusing gels  DryStrip  and IPG buffers  were  obtained  from GE 
Healthcare. Immobilon PVDF membrane was from Millipore, Odyssey nitrocellulose 
membrane was from Li-Cor.
Primary and secondary antibodies are listed in Table 3 and Table 4.
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Table 3: Primary antibodies used in this study
Antigen Source species WB dilution IF dilution Source
β-actin mouse 1:5000 1:500 Sigma
α-tubulin mouse 1:5000 1:1000 Sigma
SUN2 rabbit 1:1000 1:200 Didier Hodzic
GFP rabbit 1:1000 1:250 this study
NET29 rabbit 1:1000 N/A Millipore
γ-H2AX mouse 1:2000 1:800 Millipore
vimentin mouse 1:5000 1:500 Sigma
SUN2 (new) rabbit 1:1000 1:250 Millipore
Lamin A/C rabbit 1:5000 1:1000 Larry Gerace
Table 4: Secondary antibodies used in this study





Rabbit IgG AlexaFluor 488 goat NA 1:1000 Invitrogen
Rabbit IgG AlexaFluor 594 donkey NA 1:1000 Invitrogen
Rabbit IgG IRDye 800CW donkey 1:5000 NA LI-COR
Rabbit IgG HRP donkey 1:3000 NA GE Healthcare
Mouse IgG AlexaFluor 488 goat 1:1000 NA Invitrogen
Mouse IgG AlexaFluor 568 goat 1:1000 NA Invitrogen
Mouse IgG IRDye 680CW donkey 1:5000 NA LI-COR
Mouse IgG HRP 1:3000 NA Promega
Biotin AlexaFluor 488 NA NA 1:1000 Invitrogen
Biotin AlexaFluor 594 NA NA 1:1000 Invitrogen
Matrix support for affinity medium included Protein-A Agarose beads, CNBr-
activated  SepharoseTM 4B  (GE  Healthcare),  streptavidin  coated  magnetic  beads 
(Roche),  chitin  beads  (New  England  Biolabs)  and  His-SelectTM Nickel  beads 
(Sigma). Affinity columns were from BioRad and Pierce.
Commercial kits included QiaFilter Plasmid Midi Prep kit, ZymocleanTM Gel 
DNA Recovery Kit and Illumina® TotalPrep RNA Amplification Kit.
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2.2 Tissue culture techniques
2.2.1 Cell culture and transfection
Leukocytes
Human buffy  coats  from healthy  donors  were  obtained  from the  Scottish 
National Blood Transfusion service. After diluting 4 times with PBS the blood was 
gently  overlayed  on  top  of  an  equal  amount  of  HISTOPAQUETM-1077  media 
(Sigma) and centrifuged at 400x g for 30 min at room temperature. The white middle 
layer containing leukocytes was collected and washed 3 times with PBS spinning the 
cells  down  at  250  x  g  for  10  min  at  room  temperature.  Then  the  cells  were 
resuspended  in  RPMI  medium  supplemented  with  10%  FBS  and  100  units/mL 
penicillin, 100 µg/mL streptamycin to a final cell concentration of 1-5 x 106/ml.
HT1080, HCT116
Human fibrosarcoma cell line HT1080 and human colorectal carcinoma cell 
line  HCT116 were  maintained  in  Dulbecco's  Modified  Eagle  Medium  (Lonza) 
containing 4.5 g/L glucose and L-Glutamine and supplemented with 10% FBS and 
1% penicillin/streptamycin.
Transfection  of  HT1080  and  HCT116  cells  was  done  using  Fugene6 
transfection reagent (Roche) following the manufacturer's recommendations.
3T3-L1
Mouse 3T3-L1 cells  were cultured in  Dulbecco's  Modified Eagle Medium 
(Lonza) containing 4.5 g/L glucose and L-Glutamine and supplemented with 10% 
FBS,  0.1  M  non-essential  amino  acids,  1  mM  sodium  pyruvate  and  1% 
penicillin/streptamycin. Cells were incubated at 37°C in a humid atmosphere with 
5% CO2, split at 80-90% confluency and diluted 1:4 to 1:6 for plating.
Transfection  of  30-40%  confluent  uninduced  3T3-L1  was  done  using 
QiaFilterTM Plasmid Midi  Prep kit  purified  DNA. For  each 10 cm plate  27µl  of 
FugeneHD and 7.5  µg of DNA were used, for 1 well of a 6 well plate, 4 µL of  
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FugeneHD  and  1  µg  of  DNA were  used.  The  cells  were  allowed  to  express 
exogenous proteins for 3 days without reaching confluency. Transfection of siRNA 




On  day  7  after  lymphocyte  isolation  phytohaemagglutinin  PHA (Sigma 
L1668) was added to the cells to 1% final concentration.
Double strand break induction
HCT116 cells were treated with 20  µM etoposide (Sigma). Alternatively, a 
short time period (5 min) of UV radiation from sterile hood built-in UV lamps was 
used on cells with the lid off the culture dish.
Adipocyte differentiation
To differentiate into adipocytes,  3T3-L1 cells  were left  for two days after 
reaching confluency, and fresh medium containing 10 µg/ml insulin, 0.5 mM IBMX 
and 1  µM dexamethasone was added and replaced after two days. After four days, 
medium containing  10  µg/ml  of  insulin  was added and replaced every two days 
onward.
2.2.3 Generation of stable cell lines
Low passage undifferentiated 3T3-L1 cells were transfected using FugeneHD 
with linearised plasmid DNA containing the puromycin resistance marker. After two 
days, puromycin was added to a final concentration of 5  µg/ml and after overnight 
selection the medium was replaced. After that the cells were maintained in medium 
supplemented with 2.5 µg/ml of puromycin.
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2.3 Nucleic acid techniques
2.3.1 Total RNA/protein isolation
Total  RNA and proteins  were isolated using TRIzol  reagent  following the 
manufacturers protocol. Briefly, cells were washed once with PBS on plates and 1 
mL of TRIzol per confluent 10 cm plate was added. Then the plate was rotated for a 
minute or until  the cells were lysed (for differentiated 3T3-L1 a cell  scraper was 
used) and 1 mL of the lysate was transferred into a 1.5 mL microcentrifuge tube. 200 
µL of chloroform were added and the tube was vigorously shaken for 30 s and phases 
were  allowed to  separate  for  7  min.  The lysates  were  centrifuged for  15 min  at 
12000x g, 4°C and the top half of the aqueous phase (about 300 µl) was transferred 
into a fresh tube. 0.5 mL of isopropanol was added, incubated for 7 min and RNA 
was pelleted by centrifugation at 12000x g for 10 min, 4°C. The pellet was washed 
once with 1 mL of 70% ethanol, air-dried and resuspended in 50 µL of water. The 
quality  and  concentration  of  the  RNA  were  accessed  using  NanoDrop  2000c 
spectrophotometer. The RNA was stored at -80°C.
To recover proteins from the same lysates as total RNA samples, the rest of 
the aqueous phase and genomic DNA (white intermediate layer) were discarded. 1 
mL of isopropanol was added to the organic bottom phase, followed by brief mixing 
and 5 min incubation. The proteins were pelleted by centrifugation at 12000x g for 
10 min, 4°C. The pellet was washed once with 0.3 M guanidine·HCl in 95% ethanol 
and stored in 80% acetone at -20°C. The protein pellet was centrifuged for 10 min at 
18000x g, 4°C. The supernatant was removed and the pellet was air-dried for 5 min. 
200  µL of  reducing  buffer  was  added  and  the  pellet  was  sonicated  until  it  was 
dissolved. The resuspended proteins were stored at -20°C.
2.3.2 Reverse transcription
10  µg of total  RNA was brought  to  11.5 µL with water.  2 µL of  reverse 
primers mix (6.66 µM each), 4µl of Thermoscript RNAse H– 5x reaction buffer, 0.5 
µL of RNAsin, 0.5 µL of 0.1 M DTT and 0.5 µL of dNTPs mix (25 mM each) were 
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added and mixed by pipetting. The mix was divided into two halves, 9.5 µL each. To 
one half, 0.5 µL of Thermoscript RNAse H– Reverse Transcriptase was added; to the 
other half, 0.5 µL of water was added. The tubes were vortexed, centrifuged briefly, 
and incubated  at  51°C in a  thermocycler  with  heated  lid  at  80°C for  2  h.  Upon 
completion of the incubation, 1 µL of 7 mg/ml RNAse A was added to each tube, and 
incubated at 37°C in a thermocycler with heated lid at 80°C for 30 min. 90 µL of 
water were added to each tube and the reactions were stored at -20°C.
2.3.3 Real-time polymerase chain reaction
Primers  for  real-time  PCR were  designed  using  RealTime PCR web  tool 
(http://eu.idtdna.com/Scitools/Applications/RealTimePCR)  with  default  parameters 
except for amplicon size, which was set to 100 bp minimum, 150 bp optimum and 
200 bp maximum.
20 µL reactions  containing 8.4 µL of  diluted  cDNA (serial  dilutions  of  5 
fold), 800 nM each of forward and reverse primers and 1x LightCycler® 480 SYBR 
Green I  Master  were carried out in  a LightCycler® 480 Multiwell  Plate  96.  The 
plates  were  briefly  vortexed  and  centrifuged.  Polymerase  chain  reactions  were 
carried out in a LightCycler® 480 using the program detailed in  Table 5. Primers 
used are listed in Table 6.
Expression data was analysed using LightCycler® 480 Software v1.5.0.39.
Table 5: LightCycler® 480 program







72 Single 00:21 4.4
Melting Curve, 1 cycle
95 00:05 4.4
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Target (°C) Acquisition mode Hold (mm:ss) Ramp rate (°C/s) Acquisitions (per °C)
65 01:00 2.2
97 Continuous 0.19 3
Cooling, 1 cycle
40 00:30 2.2
Table 6: Primers used for quantitative real time PCR
Gene Name Forward primer Reverse primer
Adipoq tgtctgtacgattgtcagtgg agtaacgtcatcttcggcatg






Scara5 (NET33) agcttcaagggactttctgg tcaaagatggagccgttgtc
Slc2a4 (GLUT4) gtaacttcattgtcggcatgg tgctctaaaagggaaggtgtc
Srebf1 gaacctgaccctacgaagtg tttcatgccctccatagacac
Tmem120a (NET29) gaaaaccagatgaaagagcgc gtgaaggagatgacgatgagg
Tmem53 (NET4) aagaacagacaaggtgggaag acgcgaagtgaagggatg
2.3.4 Processing of RNA samples for microarray hybridisation
RNA  was  labelled  with  biotin  using  the  Illumina® TotalPrep  RNA 
Amplification Kit following the manufacturer's instructions. Briefly, 500 ng of total 
RNA was brought to 11 µL with water and 9 µL of reverse transcription master mix, 
consisting of T7 oligo primer, 1x First Strand Buffer, dNTP mix, RNase Inhibitor and 
ArrayScript,  were  added.  The  reactions  were  incubated  for  2  h  at  42  °C  in  a 
thermocycler with 50  °C heated lid. After the incubation, reactions were placed on 
ice and 80 µL of Second Strand Master Mix, consisting of 1x Second Strand Buffer, 
dNTP  mix,  DNA Polymerase  and  RNase  H,  were  added.  The  reactions  were 
incubated  for  2  h  at  16  °C in  a  thermocycler  with  the  heated  lid  off.  After  the 
incubation double-stranded cDNA was purified on a filter cartridge and eluted with 
20 µL of water. The in vitro translation reaction was carried out in a thermocycler at 
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37°C with 105°C heated lid for 13-14 h. The resulting cRNA was purified on a filter 
cartridge  and  eluted  with  100  µL of  water.  The  eluate  was  stored  at  -80  °C  in 
aliquotes.
2.3.5 Microarray data processing and analysis
Microarray data were quantile normalised and analysed in the R environment 
using  the  Bioconductor  package  Limma  (Wettenhall  and  Smyth,  2004).  A low 
intensity filter was applied, eliminating transcripts that do not reach a log2(signal) 
threshold of at least 6.5 in one of the samples, and we chose a low fold-difference 
cut-off  of  1.4  (abs(log2  NET/ref)=0.5)  to  remove  transcripts  exhibiting  small 
differences.
2.3.6 Site-directed mutagenesis
Site-directed mutagenesis was performed using the Phusion® Site-Directed 
Mutagenesis Kit from NEB following the manufacturer's recommendations, with the 
following  modifications.  Briefly,  non-phosphorylated  reverse-phase  cartridge 
purified  primers  (Table  7)  were  used  in  the  PCR reaction  with  Phusion® High-
Fidelity DNA Polymerase (NEB, F-530S), the PCR product was gel purified using 
ZymocleanTM Gel DNA Recovery Kit according to the manufacturer's instructions, 
followed by simultaneous phosphorylation and ligation by T4 Polynucleotide Kinase 
(Fermentas, EK0031) and T4 DNA Ligase (NEB, M0202S) in T4 DNA Ligase buffer 
at room temperature for 2 h. Chemically competent DH5α cells were transformed 
with the resulting ligation mix.  Selected clones  were verified by Sanger dideoxy 
sequencing.
Table 7: Mutagenic primers
Name Sequence Name Sequence 
sun2.S12A.f gcccggggtgacgatgac sun2.S12E.f gagcggggtgacgatgacgg
sun2.S12.r gtagcgcgtgaggcgc sun2.S63A.f gcagcagatgcacacacctcctactacagt
sun2.S63E.f gaggaggatgcacacacctcctactacagt sun2.S63.r cgggcccagctgtgg
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Name Sequence Name Sequence 
sun2.S295A.f gcagcaaactggcagaaggaggcca sun2.S295E.f gaggagaactggcagaaggaggcca
sun2.S295.r aaattcagcagcaagagcttccagac sun2.S641A.f gcagcagcccccaaggacttcgc
sun2.S641E.f gaggaggcccccaaggacttcgc sun2.S641.r gatagtgctgttgggtgacaaggc
sun2.S68A.f gcatactacagtgagtcgctggtcca sun2.S68E.f gagtactacagtgagtcgctggtcca
sun2.S68.r ggtgtgtgcatcagaggacgg
net29Hs.PhM.f cgaggaggagaagttcaagctctacctcac net29Hs.PhM.r tccttctcggcaaacttagcctgcttgc
net29Hs.Ph0.f cgagttcgagaagttcaagctctacctcac net29Hs.Ph0.r tccttgaaggcaaacttagcctgcttgc
2.4 Protein techniques
2.4.1 Western blotting 
The proteins were transferred onto PVDF membranes with a pore size 0.45 
µm (Millipore, IPFL00010) using a Trans-Blot SD (BioRad, 170-3848) at 15 V for 
25 min.  The membrane was blocked with 6% BSA in PBS for  1  day,  following 
incubation with anti-Phosphoserine mouse antibody in 6% BSA (PBS) for 1 day, 
washing  with  6%  BSA (PBS)  and  incubation  with  anti-mouse  HRP conjugated 
antibody. In-house made ECL reagents were mixed prior to adding to the membrane. 
For  other  antibodies  6% non fat  milk in  PBST (0.1% Tween 20)  was used as  a 
blocking solution and incubation times were shortened. Signals were detected either 
with HRP or InfraRed Dye conjugated secondary antibody. HRP was detected with 
ECL solutions and processed using an automatic  X-Ray developer.  InfraRed Dye 
visualised  bands  were  scanned  on  a  LiCor  scanner  connected  to  a  PC  running 
Odyssey software.
2.4.2 Immunoprecipitation 
To  immobilize  antibodies,  ProteinA Sepharose  CL-4B  beads  (Pharmacia 
Biotech AB, 17-0780-01) were used. The beads were swollen in PBS and washed 
extensively first with PBS and the last three washes with 1x RIPA buffer (50 mM 
Tris-HCl pH 7.4, 1% NP-40, 0.25% Na-deoxycholate, 150 mM NaCl, 1 mM EDTA, 
36
Nuclear envelope transmembrane proteins in differentiation systems
1mM Na3VO4, 1mM NaF). Antibody was added to the beads in 1x RIPA buffer and 
incubated at room temperature for 1 h. The supernatant was removed and the beads 
were washed three times with 1x RIPA buffer. 
To  covalently  crosslink  antibody  CNBr-activated  Sepharose  4B  (GE 
Healthcare) was used. 30 mg of the beads were swollen in 0.01M HCl and washed 
extensively to remove additives. Antibody was added to the beads in 1 ml of 0.1M 
NaHCO3,  0.5M  NaCl  and  incubated  at  room  temperature  for  3-5  h.  Then  the 
supernatant  was  removed  and  the  beads  were  washed  three  times  with  0.1M 
NaHCO3, 0.5M NaCl. After that the beads were incubated with 0.1M Tris pH 8 at 
4°C overnight. After altered washes, 3 times with each buffer – 0.1M Na acetate, 
0.5M NaCl pH 4 and 0.1M Tris, 0.5M NaCl pH 8.0 – the beads were used or stored 
at 4°C in 0.1M Tris, 0.5M NaCl pH 8, 1mM EDTA, 0.02% NaN3. 
Isolated from buffy coats lymphocytes were either directly lysed or nuclei 
were isolated to perform the crosslinking assay. For lysis, the cells were spun down 
and  resuspended  in  a  protease  inhibitor  cocktail  supplemented  with  the  serine 
protease inhibitor isocoumarin. Then 3x RIPA buffer was added and the cells were 
incubated at room temperature for 20 min. Water was added dilute the RIPA buffer to 
1x and the lysate was centrifuged at 3000x g for 3 min to remove insoluble material.  
The supernatant was applied to the immobilized or covalently crosslinked antibody. 
To minimise crosslinking of contaminants from the cytoplasm, isolation of nuclei 
was performed prior to crosslinking. Leukocytes were swollen in hypotonic buffer 
and burst in a loose dounce homogenizer by 10 vigorous strokes. 2.2 M SHKM and 1 
M KCl were added immediately to the buffer to make it isotonic. The nuclei were 
pelleted at  2000x g in a swinging bucket rotor for 30 min at  4°C. To digest  the 
chromatin,  the  nuclei  were  resuspended  in  10%  SHM  and  incubated  at  room 
temperature for 20 min with 20 units/ml of DNAse I and 10 ug/ml of RNAse A.
For the crosslinking of proteins, the isolated nuclei were incubated for 20 min 
at 30°C with 2 mM CuSO4 and 4 mM 1,10-orthophenanthroline. To stop the reaction 
EDTA to 5mM was added. 
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Immunoprecipitation was carried out on a rotating wheel either for 1 hour at 
room temperature or overnight at 4°C. The beads were washed 3 times in 1x RIPA 
buffer and immunocomplexes were eluted by adding either Laemmli protein sample 
buffer (50 mM Tris pH 6.8, 2% SDS, 5% Glycerol, 0.05% Bromophenol Blue) or 3% 
SDS solution, supplemented with 50 mM DTT.
2.4.3 2D SDS-PAGE
The  lymphocyte  concentration  was  measured  by  counting  cells  using  a 
haemocytometer and 40 million of resting and activated cells were incubated with 
100 mM of the potent phosphatase inhibitor calyculin A (NEB) for 40 min at 37°C, 
5% CO2 in humid atmosphere. The cells were then centrifuged at 250x g, 4ºC for 10 
min. The supernatant was discarded and the cells were washed with 50 ml of ice cold 
PBS and resuspended in 50 µl of freshly prepared inhibitor cocktail (5 µl protease 
inhibitor cocktail Sigma D-7910, 1 mM 3,4-Dichloroisocoumarin, 20 mM activated 
sodium orthovanadate, 200 mM naphtyl acid phosphate in PBS). 450 µL of 1.1x lysis 
buffer (8.8M urea, 2.2% CHAPS, freshly added 55 mM DTT) was added and the 
lysate was vortexed for 1 min, briefly sonicated and stored at -80ºC. One day before 
the first dimension run the lysates were thawed on ice and appropriate IPG buffer 
was added to 1% final concentration. 250 µL of lysate was used to re-swell the first 
dimension gel (DryStrip pH 3-11 NL, GE Healthcare) overnight under mineral oil. 
The  next  day  the  gels  were  mounted  onto  a  Multiphor  II  (Pharmacia  Biotech) 
electrophoresis  unit  equipped  with  a  water  cooling  system.  Settings  of  the  first 
dimension run are listed in Table 8.
Table 8: Isoelectric focusing program
Step V mA W Time (h:mm) Mode 
1 300 1 5 00:01 Gradient 
2 300 1 5 06:00 Gradient 
3 3500 1 5 05:00 Gradient 
4 3500 1 5 06:00 Gradient 
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After the first dimension the strips were frozen and stored at -80°C. Before 
the second dimension run,  the gels were treated with DTT and iodoacetamide to 
reduce cysteins and SDS to denature and negatively charge proteins. Separation of 
proteins  based  on  mass  was  performed  on  an  SE  400  Sturdier  Vertical 
Electrophoresis Unit (Hoefer, SE400-15-1.5) in Tris/Glycine buffer at 40 mA for 3-5 
h.
2.4.4 Silver staining
After SDS-PAGE, the gel was briefly rinsed in water and fixed for 1 hour in 
40% ethanol, 10% acetic acid. Then the gel was washed twice in 30% ethanol and 
once in water, 20 min each wash. The gel was sensitized in 0.02% Na2S2O3 for 1 min, 
washed 3 times in water, 20 s each wash. Staining was done at 4°C for 20 min in 
0.2% AgNO3, 0.02% formaldehyde. After staining, the gel was washed 3 times in 
water, 20 s each wash and moved to a different chamber. Developing was done in 3% 
Na2CO3,  0.05% formaldehyde, changing the solution when its  colour was turning 
yellow. When developing was complete, the gel was briefly washed in water and 
incubated for a few minutes in 5% acetic acid. The stained gel was stored in 1% 
acetic acid at 4ºC. Digital imaging of the stained gels was performed using the film 
mode of an HP scanner.
2.4.5 TCA precipitation
To precipitate proteins, sodium deoxycholate was added protein solutions to 
0.1% and mixed. 100% w/v TCA was then added to a final concentration of 25% and 
vortexed. The solution was placed on ice for 30 min and centrifuged at 20800x g, 
4°C, for 30 min. Ice-cold acetone was added to the pellet, incubated at -20°C for 30 
min and pelleted by centrifugation at 20800x g, 4°C for 10 min. The pellet was air-
dried at room temperature.
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2.5 Fluorescence microscopy
2.5.1 Immunofluorescence microscopy
After 30 h cells were either directly fixed for 7 min in 3.7% formaldehyde or 
washed with PBS, then extracted for 1 min with 20 mM HEPES pH 7.4, 110 mM 
KOAc, 2 mM Mg(OAc)2, 1 mM EDTA, 2 mM DTT, 0.2% Triton X-100, washed 
again with PBS and then fixed with formaldehyde. For antibody staining, cells that 
were not pre-extracted were permeabilised for 6 min in 0.2% Triton X-100 after 
fixation. Cells were then blocked with 5% FBS in PBS and incubated for 1 h at RT 
with relevant antibodies. DNA was visualised with Hoechst 33342 and coverslips 
mounted in Fluoromount-G (Southern Biotech). 
2.5.2 2D Fluorescence  in situ  Hybridization
Cells  plated  on 13 mm coverslips  were washed with PBS and fixed with 
-20°C cold methanol/acetic acid (3:1) for 30 min at room temperature. The fixation 
step  was  repeated  with  -20°C  cold  methanol/acetic  acid  for  10  min  at  room 
temperature.  Coverslips  were left  to dry at  room temperature,  incubated with 0.7 
µg/ml RNAse A in PBS for 30 min at 37°C, washed 3 times with 2x SSC buffer, and 
the cells were dehydrated by incubation with 70%, 90% and 100% ethanol, 2 min 
each.  Consequently,  coverslips  were  left  to  dry  at  room  temperature  and  then 
incubated  for  5  min  at  70°C.  DNA was  denatured  with  70% formamide (Sigma 
F7503) in 2x SSC at 80°C for 7-15 min, followed by dehydration in 70%, 90% and 
100% ethanol (with 70% being at -20°C). Drying at room temperature and incubation 
at 70°C were repeated, then the coverslips were incubated at 80°C for 5 min and 
moved to 42°C.  1.5µl of biotin-labelled concentrated chromosome probes  (Cambio 
1187-”Chromosome  number”MB-02) were  resuspended  in  6  µL  of  supplied 
hybridization buffer containing 7 µg of mouse C0t1 DNA and 4 µg of salmon sperm 
DNA, denatured at 80°C for 5 min, pre-annealed at 42°C for 3 min and spotted onto 
pre-heated at 42°C slides, then covered with the processed coverslips and sealed with 
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rubber cement. The slides were incubated in a humid chamber overnight at 37°C. 
After the incubation the coverslips were washed 4 times with 2x SSC buffer at 45°C, 
4 times with 0.1x SSC buffer at 60°C and 1 time with 4x SSC, 0.1% Tween 20 at 
room temperature, 3 min each wash. Cells were blocked with 5% non-fat milk in 2x 
SSC  for  10  min,  followed  by  incubation  with  594  Alexa  Fluor  conjugated 
streptavidin and Hoechst 33342 in blocking buffer for 1 h. After the incubation was 
complete, the coverslips were washed 3 times with 4x SSC, 0.1% Tween 20 for 2 
min, and mounted on slides with Fluoromount-G (Southern Biothech).
2.5.3 3D Fluorescence  in situ  Hybridization
The cells  on coverslips were washed once with PBS and fixed with 3.7% 
freshly diluted formaldehyde in PBS for 7-10 min. After fixing, the cells were rinsed 
with PBS once and, optionally, left for up to 7 days at 4°C with addition of 0.05% of 
sodium azide. Cell membranes were permebilised with 0.5% Saponin, 0.5% Triton 
X-100 in PBS for 10 min, followed by 3 washes in PBS. Non-specific binding was 
blocked  with  2%  BSA,  fraction  V,  in  PBS  for  20  min,  and  anti-GFP antibody 
(Invitrogen) was added, followed by incubation for 1 h. The coverslips were washed 
3 times with PBS, re-fixed with 1% formaldehyde in PBS for 45 s and washed twice 
with  PBS,  briefly,  and once  with  0.1  M Tris·HCl pH 7.4 for  10 min.  After,  the 
coverslips  were  incubated  in  20% glycerol  in  0.8x  PBS  and  subjected  to  three 
freeze/thaw cycles, freezing in liquid nitrogen and thawing in 20% glycerol in PBS. 
After rinsing with PBS, the coverslips were incubated with 0.1 M HCl for 10 min, 
followed by incubation in 0.5% saponin, 0.5% Triton X-100 in PBS. The coverslips 
were rinsed with PBS and incubated in 70% formamide in 2x SSC for 15 min at 
80°C. 1.5 µl of biotin-labelled concentrated chromosome probes were resuspended in 
6 µL of supplied hybridization buffer, containing 15 µg of mouse C0t1 DNA and 7 µg 
of salmon sperm DNA, denatured at 80°C for 5 min, pre-annealed at 42°C for 3 min 
and spotted onto pre-heated at 42°C slides. Coverslips incubated in formamide were 
mounted onto the slides, and sealed with rubber cement. Hybridization was carried 
out overnight in a humid chamber at 37°C. The next day, the coverslips were washed 
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4 times with 2x SSC buffer at 45°C, 4 times with 0.1x SSC buffer at 60°C and 1 time 
with 4x SSC, 0.1% Tween 20 at room temperature, 3 min each wash. Blocking was 
done in 2x SSC containing 0.1% Tween 20 for 5 min. After that, coverslips were 
incubated  with  AlexaFluor  488  conjugated  secondary  antibody,  Alexa  Fluor  594 
conjugated streptavidin and Hoechst 33342 in blocking buffer, followed by 3 washes 
in 4x SSC containing 0.1% Tween 20, 2 min each wash, rinsed in PBS and mounted 
on slides in Fluoromount-G (Southern Biotech). Modified from Solovei et al., 2002.
2.5.4 Image acquisition and analysis
Microscope  pictures  were  obtained  using  a  Nikon  TE-2000  microscope 
equipped with a 1.45 numerical aperture 100x objective, Sedat quad filter set and 
CoolSnapHQ  High  Speed  Monochrome  charge-coupled  device  camera 
(Photometrics) connected to a PC running Metamorph software. The erosion macro 




GeneDoc Multiple sequence alignment http://www.nrbsc.org/gfx/genedoc/
GENtle Multipurpose, molecular biology http://gentle.magnusmanske.de/
Vector NTI® Multipurpose, molecular biology Invitrogen
JalView Sequence alignment editor http://www.jalview.org/
Metamorph Image acquisition Molecular Devices
ImageJ Image processor http://rsbweb.nih.gov/ij/
Image-Pro Plus Image processor Media Cybernetics
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2.6.2 Web-based services
Service Description URL
NetPhos 2.0 Server Prediction of 
phosphorylation
http://www.cbs.dtu.dk/services/NetPhos/
TMHMM Server v. 2.0 Prediction of 
transmembrane domains
http://www.cbs.dtu.dk/services/TMHMM/
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CHAPTER III: Testing for SUN2 interactions with 
chromatin and the cytoskeleton
A distinct feature of diseases associated with NE proteins is remarkable tissue 
specificity.  For  example,  mutations  of  Lamin  A  have  been  shown  to  cause 
lipodystrophy, dermopathy, cardiomyopathy, muscular dystrophy, nerve atrophy and 
progeria  (reviewed  in  Worman  and  Bonne,  2007).  One  of  the  hypotheses  that 
explains  such  diverse  effects  of  mutations  in  an  ubiquitously  expressed  protein 
postulates the presence of tissue specific interacting partners. Thus tissues lacking 
those partners do not show a phenotype, but in the affected tissue, dissociation of 
normally interacting proteins leads to severe malfunctioning. The fact that mutations 
in a few identified Lamin A interactors can cause the same diseases as mutations of 
Lamin A itself serves as a strong supporting evidence of the hypothesis (reviewed in 
Maraldi et al., 2011).
Given  nuclear  localisation  of  the  putative  Lamin  A binding  partners  and, 
hence, proximity to the chromatin, it is possible to speculate that at least some of the 
partners may alter gene expression by direct or indirect modification of chromatin. It 
has been shown that simple attraction of chromatin to the nuclear periphery may alter 
gene transcription (Ruault et al., 2008; Finlan et al., 2008).
The  aim  of  the  present  work  is  to  identify  NETs  that  cause  chromatin 
rearrangements and investigate the mechanism and consequences of this.
3.1 SUN2 PTMs
3.1.1 Human  lymphocytes  as  a  model  system  for  chromatin 
rearrangement
Human peripheral blood lymphocytes provide an excellent model system for 
44
Nuclear envelope transmembrane proteins in differentiation systems
chromatin rearrangement studies. These cells have the advantage of having two states 
- resting and inducible activated state. The resting state is characterised by a minimal 
gene expression profile and small cell size. Upon stimulation with an antigen the 
resting lymphocytes become activated and this induces the expression of many genes 
and cell growth. What's more, abundant peripheral heterochromatin of resting cells 
dissipates upon activation (Fig 3.1.1, A and B). Intriguingly, disruption of peripheral 
heterochromatin is a hallmark of many diseases associated with NE proteins (Fig 
3.1.1, A). The cytoskeleton has also been shown to undergo drastic changes after 
lymphocyte activation (Samstag et al., 2003).
Apart  from  this  specific  feature,  lymphocytes  are  useful  in  research  as 
primary  cells  that  are  easy  to  isolate  from  donor  blood  obtained  from  local 
transfusion  centres.  The  cells  can  be  easily  activated  in  vitro by  addition  of 
phytohaemagglutinin (PHA), a lectin from plants. PHA binds to the T lymphocyte 
antigen receptor (Chilson et al., 1984) and stimulates activation of cells.
However, there are also some drawbacks of using lymphocytes as a model 
system. First of all, purification of white blood cells from peripheral blood yields a 
rather  heterogeneous  population  of  cells,  lymphocytes  being  ~70%  of  the  total 
number of cells ( Fig 3.1.1, C). Second, only about 20% of lymphocytes are activated 
after a week of stimulation with PHA ( Fig 3.1.1, D). Third, primary cells are very 
difficult to transfect and sufficient expression of exogenous proteins is difficult to 
achieve.
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Fig 3.1.1: Lymphocytes as a model system for investigation of changes in peripheral  
heterochromatin distribution
A - Electron micrographs. Upon activation of lymphocytes, dense heterochromatin dissipates from  
the nuclear periphery. Scale bar represents 1 µm. Fibroblasts with LMNA gene knockout also appear  
to have peripheral heterochromatin disturbed (arrow). B - Acridine orange staining of lymphocytes.  
Acridine orange stains single stranded RNA and DNA. White lines outline the nucleus. More intense  
staining in activated lymphocytes indicates chromatin decompaction.  C - FACS analysis of white  
cells  from  peripheral  blood.  The  leukocyte  population  was  determined  by  flow  cytometry  after  
staining for specific antigens. Activated CD4+ and CD8+ cells are increased in PHA-stimulated cells.  
D - Content of CD4+ and CD8+ cells in resting and PHA-activated peripheral blood cells. Upon 
addition of PHA, number of activated cells increases three-fold.
Leukocyte and lymphocyte data is from Korfali et al., 2010, fibroblast data is from Sullivan et  
al., 1999.
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3.1.2 Differences  in  PTMs  of  some  NETs  between  states  of  the 
leukocytes indicated by peptide recovery1
One of the focuses of our laboratory was the question whether NETs might be 
responsible  for  major  changes  in  chromatin  and  cytoskeletal  organisation  during 
lymphocyte  activation.  An optimised  protocol  (Korfali et  al.,  2009)  was  used  to 
determine  the  proteome  of  NEs  and  two  datasets  of  proteins  identified  in  NE 
fractions of resting and activated leukocytes were generated and analysed (Korfali et  
al., 2010). Out of a total 3174 identified proteins, 423 proteins were predicted to 
contain at least one transmembrane domain by TMHMM v2.0 (Krogh et al., 2001) or 
a membrane anchor by SignalP v 3.0 (Nielsen et al., 1997). About three quarters of 
the proteins were common for resting and PHA-activated leukocytes, but the rest of 
the proteins that were distinct to either of the states had a low peptide recovery and 
thus were not accounted for. Low peptide recovery might be explained by sequence 
specific reasons (excessive fragmentation, hydrophobicity, charges), low abundance 
of  the  protein  in  the  sample  or  heavy  PTMs.  In  either  case  it  means  that  the 
assignment  of poorly recovered proteins  to one state  but  not  the other  is  of low 
confidence.  Thus our  next  hypothesis  was that  post-translational  modifications of 
abundant proteins might explain changes in the heterochromatin distribution and/or 
cytoskeleton  re-organisation.  The  process  of  post-translational  modification  of 
existing proteins would also ensure rapid response upon activation.
Due to the complexity of the NE proteome, initial peptide mass fingerprinting 
was done without any predictions of PTMs. As a consequence, modified peptides 
were not assigned to the proteins they belong to in the initial analysis. Taking this 
into account, identified peptides of most abundant NETs were mapped and aligned 
with serines, predicted to be phosphorylated by NetPhos v2.0 (Blom et al., 1999). As 
a  rule,  there  tended to  be  fewer  or  no peptides  found in  the  regions  with many 
predicted phosphorylation sites (Fig 3.1.2). The absence of peptides in these regions 
thus strongly suggests that predicted phosphorylation occurs at these sites  in vivo. 
More  significantly,  in  some  of  these  regions  with  predicted  modification  sites, 
1 Fig 3.1.2 and data associated with it is part of my Diploma thesis
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peptides were found only in one of the two states of the leukocytes, either resting or 
activated. This suggested that in those places the phosphorylation is specific to the 
state  where peptides  were not  recovered.  Based on this  hypothesis,  prediction of 
putative sites of phosphorylation specific to one state of leukocytes was made. In 
activated leukocytes these included S49, S52, S57 and S58 of emerin, S66 and S67 
of  LAP2β,  S267,  S324  and  S337  of  SUN2.  In  resting  leukocytes  putative 
phosphorylated residues were assumed as S141, S142 and S143 of emerin and S407 
of SUN22.
2 Number of phosphorylation sites depicted in Fig 3.1.2 was expanded at the time of writing. However, prediction of state-
specific PTMs was made based on the information available to time.
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Fig 3.1.2: Recovery of peptides suggests state-specific PTMs of NETs in lymphocytes
Recovered peptides from resting and activated lymphocytes were aligned to the full-length proteins to  
relative scale. Serines predicted to be phosphorylated with NetPhos are depicted as stars. As a rule,  
there are no or  few peptides  recovered in  the places with many serines  that are predicted to  be  
phosphorylated. However, in some of these places peptides are still  found in either the resting or  
activated state, suggesting absence of PTMs in this state and presence in the other state of leukocytes.
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3.1.3 Search for PTMs of four NETs in the NE databases3.
As explained earlier, it is nearly impossible to identify the modifications of all 
peptide masses in a complex mixture of proteins such as a NE fraction. However, 
when a clear protein identification has been made from unmodified peptides, it is 
possible to look for modified peptides that belong to these identified proteins among 
previously unassigned masses. The whole NE MS/MS dataset was first searched in 
parallel for modifications against a database containing only the sequences for the 
proteins of interest; then MS/MS spectra matching modified peptides were searched 
for PTMs against the complete sequence database to make sure that the best possible 
matches were obtained (Fig 3.1.3, A).
First,  raw files were searched without specifying differential  modifications 
against  a  database  combining  non-redundant  human,  mouse  and  rat  protein 
sequences downloaded from NCBI, sequences for NET proteins, and 177 sequences 
for usual contaminants (keratins, proteases, IgG etc.). In addition, to estimate false 
discovery rates, each non-redundant protein entry was randomized and the resulting 
sequences were added to the database for a final search space of 175024 amino acid 
sequences (Table 9). This SEQUEST “ASAP” (All Spectra against All Proteins) step 
allowed  establishing  the  list  of  proteins  detected  in  the  samples.  To account  for 
carboxamidomethylation, +57 Da were added statically to cysteine residues for all 
the searches.
Table 9: Amino acid sequence database used to search the MS/MS dataset
Database Sequences Contaminant Shuffled 
Homo sapiens NCBI (05/09/2006) 29890 0 0 
Mus musculus NCBI (22/06/2007) 29998 0 0 
Rattus norvegicus NCBI (10/07/2006) 28400 0 0 
NETs annotated (17/07/2007) 313 0 0 
Contaminants (15/06/2005) 177 177 0 
Combined (including shuffled) 175024 177 87512
3 The analysis of PTMs described in this chapter is done by Dr Laurence Florens, Stowers Institute, Kansas, USA
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Second, the same database was also searched for PTMs against a database containing 
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Fig 3.1.3: Analysis of phosphorylation of selected NETs
A - Phosphorylation analysis  scheme.  The NE proteome was processed  by  MudPIT followed by  
tandem mass spectrometry (LC-LC MS-MS). Resulting spectra were searched against  a combined  
human, rat and mouse database of proteins to gain the list of identified NE proteins. Out of this list, a  
few abundant proteins were selected and total NE spectra were searched for masses, corresponding to  
peptides modified by phosphorylation of the selected NETs. To eliminate false identification, spectra  
of the modified peptides were searched against the combined database of proteins and matches were  
removed. B - Phosphorylation levels of selected NETs. Modified and unmodified peptides of LAP2β,  
SUN2, LBR and emerin, recovered from resting and activated leukocytes, are plotted.
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For the third round of searches, only spectra matching modified peptides were 
selected. The resulting database contained a few hundreds of MS/MS spectra that 
could be subjected to the differential search against the complete database without 
having to pay too high of a computer-hour price (SEQUEST “MSAP”: Modified 
Spectra against All Proteins). This step allowed the spectra that matched modified 
peptides from the NETs sequences to be checked that they did not find a better match 
against the larger protein database.
As a  result  of these three searches,  a number of  spectra  corresponding to 
peptides modified by phosphorylation from SUN2, LBR, emerin and LAP2β, were 
identified. Data about phosphorylated residues is presented in tables  10 and 11 and 
depicted in Fig 3.1.3, B.



























Y343 0.03 1 1 1 1 0 1
S348 0.14 2 0 1 0 1 0
S425 0 1 1 1 1 0 1
Emerin
S8 0.9 0 2 0 2 0 1
S60 0.9 2 3 2 1 4 1
S62 0.11 2 3 2 0 5 0
Y74 0.67 0 0 0 2 1 2
S171 0.99 1 0 1 1 1 1
S180 0.98 1 4 1 1 2 1
Y181 0.03 1 4 1 2 2 2
Y182 0.07 1 4 1 1 2 1
S187 0.25 1 4 1 1 2 1
S196 0.96 1 3 1 1 4 1
T202 0.43 0 4 0 3 1 2
Lap2 β
S66 0.98 8 35 1 2 4 1
S67 0.99 9 34 1 1 5 1
T74 0.97 18 25 2 3 3 1
T96 0.86 2 0 1 0 0 0
T99 0.5 2 0 1 0 0 0
T154 0.57 0 2 0 2 0 1
S156 0.98 1 2 1 1 2 1
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S158 0.9 1 4 1 1 5 1
S159 0.99 1 4 1 3 3 2
T160 0.96 3 2 3 3 3 2
T229 0.13 1 17 1 1 23 1
T231 0.05 1 17 1 2 22 1
S237 0.9 2 16 1 0 24 0
T251 0.61 0 1 0 2 0 1
S278 0.11 2 13 1 0 18 0
T279 0.85 2 13 1 0 18 0
T299 0.02 1 1 1 1 0 1
Twenty-six  phosphorylation  sites  were  confidently  identified  (i.e.  detected 
with  more  than  one  spectrum)  on  SUN2,  twenty  of  which  are  located  within 
nucleoplasmic N-terminus (Table 11). Two of these sites, S12 and S54, have been 
reported in the literature as part of a large-scale screen for phosphorylated peptides 
(Grønborg et al., 2002), the remaining 24 sites are novel. 5 of the sites appear to be 
lymphocyte state-specific: S12, S63, S295 and S641 phosphorylations were detected 
only in activated lymphocytes, whereas phosphorylation on S68 was detected only in 
resting lymphocytes (Table 11, in grey).


























T9 0.43 1 2 1 2 2 1
Y11 0.21 1 7 1 2 10 2
S12 0.99 0 0 0 2 12 2
S19 0.8 4 8 1 1 14 1
S20 0.94 2 11 1 3 12 2
S21 0.94 2 11 1 2 13 2
S22 0.96 5 8 2 1 14 1
S25 0.81 1 11 1 3 12 2
S26 0.58 4 9 1 3 12 2
S30 0.84 2 8 1 4 11 3
S32 0.01 1 7 1 2 13 1
T33 0.46 2 7 1 1 14 1
S38 0.99 2 2 1 2 4 2
S47 0.99 1 0 1 1 1 1
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S48 0.5 1 0 1 1 1 1
S54 0.99 7 7 3 6 22 2
S63 0.12 0 0 0 2 26 2
T67 0.03 1 14 1 1 27 1
S68 0.81 2 13 1 0 0 0
S73 0.02 1 10 1 1 27 1
S295 0.02 0 0 0 2 54 2
S384 0.84 1 0 1 1 0 1
T399 0.2 1 8 1 1 12 1
S512 0.07 1 4 1 1 5 1
T514 0.03 1 4 1 1 5 1
S641 0.02 0 0 0 2 0 1
A fair number of phosphorylated sites were reproducibly detected in the NE 
leukocyte dataset on SUN2, LBR, emerin and LAP2β. Some of these modifications 
might  be  regulated  by  the  cell  state:  SUN2  S12/S63/S295/S641,  emerin 
S8/Y74/T202,  and LAP2 T154/T251 are found to be phosphorylated only in  the 
active leukocytes,  while SUN2 S68, emerin S62, LAP2 T96/T99/S237, and LBR 
S348 seem specific to the resting cells. It should be mentioned that the analysed NE 
samples were prepared without phosphatase inhibitors as there was no intention to do 
phosphorylation analysis at the time.
Only LAP2β S66 and S67 out of these originally predicted phosphorylation 
sites have been confirmed by re-analysis of PTMs of the four NETs. However, there 
is no evidence that these residues are phosphorylated exclusively in activated cells. 
There are multiple reasons why the described approach may have failed to correctly 
identify PTMs. First of all, it used a prediction algorithm, and only phosphorylation 
has been accounted for. Failure of a peptide's identification, while it is identified in a 
similar  sample,  suggests  modification  of  its  mass,  however,  it  cannot  distinguish 
between many possible modifications. Second of all, good enrichment of the proteins 
of interest is necessary to obtain a large number of recovered peptides. Few peptides 
in one state but not the other could represent sample variation. And third of all, to 
ensure optimal comparison, normalization between two different samples should be 
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done, possibly based on total spectra.
3.1.4 2D  SDS-PAGE  analysis  of  SUN2  from  resting  or  activated 
lymphocytes
We focused on SUN2 because of its abundance in lymphocytes and its known 
function in the cell as a part of the LINC complex. On the one hand, its N-terminus is 
nucleoplasmic  (Hodzic et  al.,  2004),  and  could  potentially  cause  changes  to 
heterochromatin. On the other hand, its C-terminal SUN domain interacts with the 
KASH domains of Nesprins. As different Nesprins have been shown to bind actin, 
plectin  and  tubulin,  the  SUN/KASH  interaction  links  the  cytoskeleton  to  the 
nucleoskeleton and so it is possible for PTMs of SUN2 to affect the cytoskeleton.
To confirm differences in the phosphorylation of SUN2 between the resting 
and activated cells, two-dimensional polyacrylamide gel electrophoresis was applied 
followed by Western blotting. Similar amounts of total cell lysate were first separated 
based on pI followed by molecular mass. Anti-SUN2 serum was used for detection of 
endogenous SUN2 (from Didier Hodzic). Differential distribution of detected spots 
supported  the  considerable  changes  in  PTMs  of  SUN2  with  activation  of  the 
leukocytes (Fig 3.1.4 a).
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However, even the affinity-purified antibody obtained from the serum under 
standard Western blotting conditions recognises two lower MW species apart from 
the  full  length  SUN2  (Hodzic et  al.,  2004).  Neither  of  those  were 
immunoprecipitated  under  more 
stringent conditions (Fig 3.1.4 b).
To  clarify  that  the 
different  phosphorylated  species 
were  not  due  to  cross-reactivity 
of  the  antibody,  the  experiment 
was repeated using a new peptide 
antibody against SUN2 that was 
raised  in  collaboration  with 
Millipore.  The  antibody  from 
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Fig 3.1.4 a: 2D SDS-PAGE analysis suggests multiple changes in SUN2 PTMs upon  
activation of leukocytes.
Similar  amounts  of  resting and activated  leukocytes  were lysed  and separated by protein pI  and  
molecular weight, followed by Western blotting using an anti-SUN2 antibody from Didier Hodzic. The  
different pattern of the signals suggests multiple PTM differences between resting and activated cells.
Fig 3.1.4 b: SUN2 antibody precipitates only  
the full length SUN2
Two  exposures  of  the  same  blot  are  shown.  Asterisk  
represents the expected size of SUN2. Input – cleared  
lysate,  IP –  immunoprecipitated  material,  FT –  flow-
through.
Nuclear envelope transmembrane proteins in differentiation systems
rabbit 11905 recognises an antigen that migrates according to the full-length SUN2 
(Fig 3.1.4 c).
2D SDS-PAGE analysis 
followed  by  WB  with  the 
Millipore  peptide  anti-SUN2 
antibody  was  repeated  for 
resting  lymphocytes  only  (Fig 
3.1.4  d).  The  membrane  was 
also  probed  with  an  anti-
phosphoserine antibody (P3430, 
Sigma)  but  the  signal  did  not 
co-localize  with  any  of  the 
SUN2  dots.  However,  known 
limitations  of  phosphoserine 
antibodies  and/or  lack  of 
specific  phosphatase  inhibitors 
could  explain  this  (only 
Calyculin  A,  activated  sodium 
orthovanadate and naphtyl acid 
phosphate were used).
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Fig 3.1.4 c: New anti-SUN2 antibody recognises  
a single antigen of expected molecular weight
5  rabbits  were  injected  with  a  synthesised  peptide  
corresponding to aa 1-17 of human SUN2. Rabbit 11905  
developed a specific antibody.
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3.1.5 Analysis of phospho-null and phosphomimetic mutants of SUN2
In order to determine whether identified phosphorylation sites are responsible 
for any of the changes in heterochromatin or the cytoskeleton during lymphocyte 
activation,  site-directed  mutagenesis  was  performed  on  SUN2  cDNA (from  D. 
Hodzic)  to  replace serines  of interest  to  either  alanine (phospho-null  mutants)  or 
glutamic acid (phosphomimetic mutant), mimicking either of the lymphocyte states. 
Thus, the cDNA mimicking SUN2 from the resting state of lymphocytes contained 
combined mutations S12A, S63A, S68E, S295A and S641A; the cDNA mimicking 
SUN2  from  activated  lymphocytes  contained  combined  mutations  S12E,  S63E, 
S68A, S295E and S641E.
HT1080 cells were transiently transfected with either wild type SUN2 fused 
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Fig 3.1.4 d: An anti-phosphoserine antibody does not recognise SUN2
The resting leukocytes lysate was resolved by pI and MW, followed by Western blotting using an  
anti-phosphoserine antibody. The same membrane was then probed with the new anti-SUN2  
antibody (insert box). No co-localisation of the signals from the two antibodies is found.
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with GFP, or one of the two mutants of SUN2. The cells were allowed to express 
exogenous proteins for two days after transfection and then fixed with formaldehyde 
and stained with an antibody against histone 3 tri-methylated on lysine 9 (a mark of 
transcriptionally  repressed  chromatin),  histone  3  methylated  on  lysine  27  (a 
heterochromatin  mark)  (Fig  3.1.5  a),  vimentin  (an  intermediate  filament)  and  γ-
tubulin (microtubules) (Fig 3.1.5 b). In the case of heterochromatin we anticipated 
changes  in  peripheral  nuclear  staining  similar  to  changes  in  lymphocytes  upon 
activation.  Thus,  the  resting  state  is  characterised  by  dense  peripheral 
heterochromatin, whereas activation leads to its dissipation. If the effect was present, 
it  could have been quantified by a macro that is used for quantification of FISH-
stained  chromosomes  (Croft  et  al.,  1999).  In  the  case  of  the  cytoskeleton,  we 
anticipated  structural  changes  that  would  lead  to  reduced  cell  stiffness.  Wound 
healing assays would be used to quantify effect of the SUN2 mutations. However, no 
apparent  changes  in  the  heterochromatin  or  cytoskeleton  stainings  were  noticed 
between cells over-expressing wild type SUN2 or its mutants.
As  endogenous  SUN2  was  present  in  the  cells  over-expressing  SUN2 
mutants, only dominant negative mutant would potentially show an effect. Thus to 
remove  endogenous  SUN2  we  decided  to  construct  a  plasmid  that  would 
simultaneously express an shRNA against endogenous SUN2 and either wild type or 
mutated SUN2 fused to GFP, modified to be resistant to the knockdown. A short 
hairpin  RNA-encoding  oligo  designed  based  on  efficient  siRNA  oligo  (Didier 
Hodzic, personal communication) was cloned into a modified pLKO.1-puro plasmid 
(TRC1, Sigma) under the control of U6 promoter. Next, a GFP expression cassette 
including  the  CMV  early  promoter  and  SV40  poly-adenylation  sequence  was 
subcloned from pEGFP-C3 vector (Promega). However, transient over-expression of 
this construct in HT1080 cells and staining with anti-SUN2 antibody did not show 
efficient knock-down of endogenous SUN2 (Fig 3.1.5 c).
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Fig 3.1.5 a:  Heterochromatin  is  not  changed upon overexpression  of  SUN2  
mutants
HT1080  cells  were  transfected  with  either  wild  type  SUN2-GFP fusion  or  SUN2  mutants  
(Resting – combined S12A, S63A, S68E, S295A, S641A, Activated – combined S12E, S63E,  
S68A, S295E, S641E) and stained with antibodies against epigenetic marks of transcriptionally  
repressed chromatin (H3K9Me3) and heterochromatin (H3K27Me1). No changes in distribution  
of the signals were observed upon overexpression of SUN2 mutants. Scale bars represent 10  
µm.
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Fig 3.1.5 b: Cytoskeleton is not affected by overexpression of SUN2 mutants
HT1080 cells were transfected with either the wild type SUN2-GFP fusion or SUN2 mutants  
(Resting – combined S12A, S63A, S68E, S295A, S641A, Activated – combined S12E, S63E,  
S68A,  S295E,  S641E)  and  stained  with  antibodies  against  different  components  of  the  
cytoskeleton: intermediate filaments (vimentin) and microtubules  (α-tubulin).  No changes in  
distribution of the signals were observed upon overexpression of SUN2 mutants. Scale bars  
represent 10 µm.
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Although siRNA against SUN2 could provide sufficient knockdown, the project was 
not continued after this point due to multiple reasons (see below).
3.2 Potential interactors of SUN2
3.2.1 Immunoprecipitation of SUN24
To  identify  additional  binding  partners  of  SUN2  and,  possibly,  identify 
partners  that  differ  between  the  resting  and  activated  lymphocytes,  we  have 
immunoprecipitated the protein from resting and activated lymphocyte cell lysates. 
4 Mass-spectrometry in this chapter was done by Dr Laurence Florens, Stowers Institute, Kansas, USA
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Fig 3.1.5 c: SUN2 shRNA failed to down-regulate SUN2
HT1080 cells were transfected with plasmid DNA containing an shRNA against SUN2 and  
GFP expression cassette. After 72 hours after transfection the cells were fixed and stained  
with anti-SUN2 antibody. The signal from SUN2 was similar between transfected and non-
transfected cells. Scale bar represents 10 µm.
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IPs were performed both with regular  lysates and also from isolated lymphocyte 
nuclei  with  reversibly  covalently  cross-linked  cysteines.  This  procedure  was 
developed in our laboratory because many binding partners of NETs are likely to be 
lost  with  the  extraction  conditions  required  to  remove  the  proteins  from  the 
membrane  and  their  associations  with  the  insoluble  lamin  polymer.  The  protein 
mixture that was eluted from the anti SUN2 antibody after the IP was analysed by 
tandem  mass  spectrometry.  Identified  proteins  were  sorted  by  number  of  times 
detected in 6 different immunoprecipitations, and only proteins that were detected at 
least 4 times were analysed further (the threshold was chosen based on a low number 
of proteins identified in immunoprecipitations with CnBr coupled antibody). Next, 
proteins  were  ranked  according  to  enrichment  in  resting  lymphocytes,  CnBr-
crosslinked  antibody,  crosslinked  cysteines  immunoprecipitation  over  control 
immunoprecipitation. The proteins that were enriched 2-fold and more are listed in 
Table 8.
























unc-84 homolog B NP056189 275 46 65 65 538 266 32 
S100 calcium-binding protein A9 NP002956 31 7 0 0 157 112 72 
S100 calcium-binding protein A8 NP002955 89 11 0 0 143 606 69 
H2B histone family, member S NP059141 3 7 0 0 75 28 24 
ATP  synthase,  H+  transporting, 




85 16 1 3 57 102 26 
histone 1, H2ad NP066409 8 5 2 13 52 143 18 
lamin B receptor NP919424 14 3 0 0 15 16 1 
profilin 1 NP005013 9 13 0 6 14 37 1 
heterogeneous  nuclear  ribonucleoprotein 
H1 
NP005511 6 8 0 11 11 20 4 
heterogeneous nuclear ribonucleoprotein F NP004957 4 4 0 5 11 22 4 
adenylyl cyclase-associated protein NP006358 20 4 0 0 10 32 4 
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desmoplakin isoform I NP004406 0 17 1 30 7 10 2 
heat shock 70kDa protein 9B precursor NP004125 1 2 0 0 7 29 3 
heterogeneous nuclear ribonucleoprotein C 
isoform a
NP112604 4 2 0 18 5 15 2 
SAM domain- and HD domain-containing 
protein 1
NP056289 111 8 0 0 3 17 1 
hypothetical protein LOC345651 NP0010179
92
75 24 28 11 28 19 21 
F-actin capping protein alpha-1 subunit NP006126 165 38 0 0 25 9 17 
WD repeat-containing protein 1 isoform 1 NP059830 27 1 0 0 8 33 6 
filamin 1 (actin-binding protein-280) NP001447 639 25 0 0 189 128 409 
actinin, alpha 1 NP001093 448 72 0 1 120 41 137 
gelsolin isoform b NP937895 409 15 0 9 42 40 79 
PREDICTED:  similar  to  Prostate,  ovary, 
testis expressed protein on chromosome 2
XP934799 312 30 31 26 31 70 44 
junction plakoglobin NP068831 1 10 0 10 2 5 4
In  order  to  analyse  only  immunoprecipitations  with  reversible  cysteine 
crosslinking,  proteins  were  sorted  by the  number  on  spectra  identified  in  resting 
lymphocytes, CnBr-crosslinked antibody, crosslinked cysteines immunoprecipitation 
and proteins that were not detected in this IP were removed from analysis.

















lamin B receptor NP919424 14 3 0 0 15 16 1 
profilin 1 NP005013 9 13 0 6 14 37 1 
PREDICTED:  similar  to  peptidylprolyl 
isomerase A isoform 1
XP945701 23 0 0 0 37 25 3 
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H2A histone family, member X NP006017 8 0 0 0 37 123 5 
peptidoglycan recognition protein 1 NP005082 1 0 0 0 15 18 3 
hexokinase 1 isoform HKI-R NP277031 14 1 0 0 5 23 1 
Fc  fragment  of  IgG,  high  affinity  Ia, 
receptor (CD64)
NP000557 2 3 0 1 8 4 0 
cytochrome  c  oxidase  subunit  VIIc 
precursor
NP001858 0 0 0 0 6 0 0 
HIG1 domain family, member 1A NP054775 0 0 0 0 5 0 0 
guanine  nucleotide  binding  protein  (G 
protein),  alpha  inhibiting  activity 
polypeptide 3
NP006487 11 5 0 0 5 13 0 
myosin, heavy polypeptide 14 NP079005 16 7 0 1 5 1 0 
PREDICTED: similar to filaggrin 2 XP0011274
46
0 0 0 1 4 2 0 
surfeit 4 NP149351 9 0 0 0 4 8 0 
UV  excision  repair  protein  RAD23 
homolog B 
NP002865 0 0 0 0 4 9 0 
solute  carrier  family  2  (facilitated 
glucose transporter), member 3
NP008862 0 0 0 0 4 12 0 
hypothetical protein LOC79887 NP079105 0 0 0 0 4 0 0 
GDP dissociation inhibitor 1 NP001484 0 1 0 0 3 15 0 
grancalcin,  EF-hand  calcium  binding 
protein
NP036330 34 0 0 0 3 2 0 
translocator  protein  (18kDa)  isoform 
PBR
NP000705 13 0 0 0 3 12 0 
cell division cycle 10 isoform 1 4 0 0 0 3 11 0 
torsin A NP000104 4 0 0 0 3 1 0 
granzyme A precursor NP006135 0 0 0 0 3 77 0 
progesterone membrane binding protein NP006311 0 0 0 0 3 10 0 
bleomycin hydrolase NP000377 0 0 0 0 3 2 0 
cytochrome  c  oxidase  subunit  VIa 
polypeptide 1 precursor
NP004364 0 0 0 0 3 0 0
It is obvious that too many proteins were identified as potential interactors in 
the SUN2 immunoprecipitations.  Although SUN2 was identified with the highest 
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number of spectra in every sample, it was also present in the negative control (Table
12). This can be explained by its association with the cytoskeleton, and the abundant 
components  of  the  latter  are  common contaminants  in  pull-down assays.  As  the 
negative control was processed in a similar way and from the same amount of cells, 
it is most comparable with the SUN2 immunoprecipitation from resting leukocytes 
with reversible crosslinking. The number of SUN2 spectra is about 15 times less in 
the negative control than in the IP sample. A similar spectral ratio was observed for 
LBR, profilin 1 and histone H2AX (Tables 12 and 13).
LBR  is  an  interesting  candidate  for  a  SUN2  binding  partner.  Given  its 
multiple membrane-spaning domains and INM localisation, it could anchor the LINC 
complex  in  the  NE  and,  therefore,  transmit  pulling  or  pushing  forces  from  the 
cytoskeleton laterally in the NE. In the support of this idea, mutations of LBR causes 
huclear hyposegmentation of neutrophils called Pelger-Huët anomaly (Hoffmann et  
al.,  2002).  Healthy  neutrophils  have  segmented  nuclei,  however  homozygous 
mutations in the LBR gene can lead to the nuclei being round.
Profilin 1, on the other hand, is an actin monomer-binding protein that can 
regulate actin polymerisation and cellular motility (Bae  et al.,  2010).  The protein 
localises in the cytoplasm and the direct binding to SUN2 could be explained only by 
dual localisation of SUN2 to both the INM and the ONM. However, the link between 
the LINC complex and the cell motility is obvious as the nucleus of a migrating cell  
also migrates (Meindl et al., 1994).
The  significance  of  the  potential  interaction  between  SUN2  and  histone 
H2AX is discussed in chapter 3.3.
3.3 DNA double strand break repair and SUN2
A recent study revealed that a  S. cerevisiae SUN domain-containing protein 
Mps3 is required for peripheral localisation of slowly repaired DNA double strand 
breaks (Oza et al., 2009). However, the molecular mechanism of this is still unclear. 
On  the  other  hand,  mass  spectrometry  analysis  of  SUN2  immunoprecipitation 
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involving cysteine cross-linking identified H2AX as a potential binding partner of 
SUN2  (Table  13).  Apart  from  cross-linking  of  cysteines,  the  last  SUN2 
immunoprecipitation protocol included isolation of nuclei and digestion of chromatin 
with DNAse I, which generated a large number of non-repairable DNA double strand 
breaks prior to cross-linking. Hence it was hypothesised that it is the phosphorylated 
form of H2AX, one of the proteins that directly bind DNA near DSB, which interacts 
with SUN2 and brings DSBs to the nuclear periphery. In support of the hypothesis, a 
number  of  proteins  involved  in  DSB  repair  were  detected  in  the 
immunoprecipitations  (Table  14).  Moreover,  the  peptide  of  H2AX  containing 
phosphorylated upon DNA DSB serine 140 was not identified, suggesting it might 
have been modified post-translationally (Fig 3.3 a, A).
Table  14:  Co-immunoprecipitated  proteins  involved  in  DNA double  strand break  
repair






Name                              \                            DNAseI - + - + + 
SUN2 275 538 46 266 32 
H2A.X NP006017 8 37 0 123 5 
RAD23 homolog B NP002865 0 4 0 9 0 
FK506  binding  protein  12-rapamycin  associated 
protein 1
NP004949 8 0 0 0 0 
branched chain ketoacid dehydrogenase kinase NP005872 2 0 0 0 0 
flap structure-specific endonuclease 1 NP004102 2 0 0 0 0 
transformation/transcription domain-associated protein NP003487 5 0 0 0 0 
ATP-dependent DNA helicase II, 70 kDa subunit NP001460 3 3 1 20 9 
ATP-dependent DNA helicase II NP066964 4 1 0 22 8 
APEX nuclease NP542380 0 1 0 9 4
In order to probe the hypothesis, first a mammalian system with inducible 
DNA DSB had to be tested. Human colorectal carcinoma-derived HCT116 cells were 
treated  either  with  etoposide,  a  topoisomerase  II  inhibitor,  or  UV,  fixed  with 
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formaldehyde  and  stained  with  a  commercial  anti-γ-H2AX  antibody.  After  the 
treatments there was clearly an increase of the γ-H2AX signal (3.3 a, B) that seemed 
to be accumulate at the nuclear periphery.
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Fig 3.3 a: DNA double strand breaks are found at the nuclear periphery
A - Analysis of peptides recovered from H2AX co-immunoprecipitated with SUN2. First line - H2AX 
sequence, serine 140 is in bigger font size. Second line - products of complete trypsin digestion of  
H2AX, in red are unique peptides that may be identified by mass spectrometry. Blue lines represent  
recovered H2AX peptides with corresponding number of spectra, green lines - identified products of  
incomplete trypsin digestion. B - Etoposide- and UV-induced DNA DSB can be found at the nuclear  
periphery. Both etoposide and UV induced DSB are accumulated at the NE after prolonged periods of  
time after their induction. It is consistent with the hypothesis that unrepairable DSB are translocated  
to the NE. Scale bar represents 10 µm.
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Second, the distribution of the  γ-H2AX-positive dots was to be tested upon 
SUN2 knock-down. However, as the cloned shRNA against SUN2 did not reduce the 
level of SUN2 significantly, it was decided instead over-express soluble N-terminus 
of  SUN2 and  look for  its  effect  on  the  distribution  of  the  γ-H2AX.  SUN2 was 
reported to be a type II transmembrane protein with N-terminus in the nucleus and C-
terminus in the nuclear envelope lumen (Hodzic et al.,  2004). In order to predict 
transmembrane regions two different tools were used: TMHMM v2.0 (Krogh et al., 
2001) and TMpred (Hofmann and Stoffel, 1993). While TMHMM predicted strongly 
one  transmembrane  domain  (aa  213-325),  TMpred  strongly  predicted  3 
transmembrane regions (aa 159-177, 183-204, 212-234). As both variants could be 
applicable for a type II transmembrane protein, three SUN2 deletion mutants were 
generated - amino acids 1 to 158, 1 to 182 and 1 to 213 of SUN2 fused to GFP at the 
C-terminus. The resulting constructs were transfected into HCT116 cells and allowed 
to express for one day. The cells were fixed with formaldehyde and GFP signal was 
monitored.  While  both  SUN2  1-182  and  SUN2  1-213  constructs  showed  rim 
staining, the SUN2 1-158 construct localised mainly in the nucleus (Fig 3.3 b). This 
suggests that SUN2 has 3 transmembrane domains.
The soluble N-terminal fragment of SUN2 was then tested for co-localisation 
with  γ-H2AX-positive  dots  with  or  without  etoposide  treatment.  However,  no 
correlation between γ-H2AX and SUN2 signals was found (Fig 3.3 b). This suggests 
that the N-terminus of SUN2 does not interact with  γ-H2AX. Furthermore, it was 
reported that the DNA ends that appeared as a result of a double strand break do not 
move significantly in mammalian cells (Soutoglou et al., 2007). Therefore it seemed 
less likely that the yeast mechanism of DSB tethering to the NE is functional in 
higher organisms.
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Fig 3.3 b: SUN2 NTD is not enriched within γ-H2AX-positive dots
A -  N-terminus  of  SUN2  has  mostly  nuclear  localisation. SUN2  is  most  likely  to  have  three  
transmembrane  domains,  as  predicted  by  Tmpred.  B -  No  apparent  correlation  found  between  
localisation of N-terminal fragment of SUN2 and  γ-H2AX. Etoposide-induced DNA double strand  
breaks are marked by phosphorylated H2AX. GFP fusion of the soluble nucleoplasmic domain of  
SUN2 does not seem to co-localise with  γ-H2AX. Scale bars represent 10µm.
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3.4 Summary and conclusions
The  SUN2 phosphorylation  data  presented  in  this  chapter  is  unclear  and 
contradictory. On the one hand, the search within the whole NE datasets identified 
masses  corresponding  to  the  phosphorylated  peptides  of  SUN2.  Two  of  the  26 
identified phospho-sites were identified previously in a high-throughput analysis of 
phospho-peptides that were captured using phospho-specific antibody (Grønborg et  
al., 2002). On the other hand, Western blot analysis of SUN2 in resting leukocytes 
showed  no  co-staining  with  anti-phosphoserine  antibody.  Furthermore,  mass-
spectrometry analysis of SUN2 immunoprecipitations did not confirm any phospho-
sites on the protein. The immunoprecipitation samples are much less complex than 
the NE fractions and, therefore, the data obtained from the former should be more 
confident. Thousands of proteins were identified in NE preparations, and the vast 
majority  of masses recorded (about 90%) could not be assigned to  the identified 
proteins due to  multiple  reasons,  including non-unique peptides,  modifications of 
peptides and inaccurate mass identification due to charge or hydrophobicity issues. 
Moreover,  while  SUN2  IPs  were  done  in  the  presence  of  the  activated  sodium 
orthovanadate and alpha-naphthyl acid phosphate, general phosphatase inhibitors, the 
isolation of NEs was done without phosphatase inhibitors in most of the repeats. 
However,  differences  in  the  buffers  used  for  immunoprecipitations  and  the  NE 
isolations could also explain the contradiction.  Also, it was impossible to control for 
similarity between the donor blood used for leukocyte isolation as the samples were 
anonymous.
Mass  spectrometry  analysis  of  SUN2  immunoprecipitations  identified  too 
many proteins  as  potential  binding partners.  The covalent  cross-linking approach 
relied on cysteines from SUN2 and its potential binding partner to lie within a short 
distance, and the occurrence of cysteines is low in an average protein. There are only 
4  cysteines  in  SUN2,  one  of  which  is  most  probably  within  the  transmembrane 
domain, and none in the nucleoplasmic N-terminal fragment. Hence, the probability 
of successful crosslinking is quite low. Although the hypothesis of SUN2 mediated 
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tethering of DNA double strand breaks to the NE is not likely to apply to mammalian 
cells, H2AX is still a potential SUN2 partner. However a lack of a sufficient amount 
of anti-SUN2 antibody and further evidence of the interaction stopped us from a 
more careful investigation.
At this point it was inconclusive whether the project was viable. Further work 
would  include  SUN2  immunoprecipitation  in  denaturating  conditions  with 
subsequent  mass  spectrometry-based  analysis  of  phosphorylation.  Different 
crosslinking  reagents  would  be  tested  in  order  to  identify  SUN2  partners  more 
conclusively.
On the other hand, a screen in our laboratory identified several novel NETs 
that affected the localisation of a LacO array integrated into human chromosome 5 
(N Zuleger, S Boyle, DA Kelly, J de Las Heras, DG Batrakou, V Lazou, GR Otti, N 
Korfali,  KN Randles,  GE Morris,  DJ Harrison,  WA Bickmore  and EC Schirmer, 
paper in submission). Thus, NET29 tethered the LacO array to the nuclear periphery 
upon overexpression.  Moreover, transcriptome data (Wu  et al.,  2009) suggested a 
tissue-specific  expression  of  NET29,  raising  the  possibility  of  tissue-specific 
chromatin  organisation  orchestrated  by  the  NE.  After  consideration,  I  decided  to 
focus my research on NET29 and its link with chromatin. The goal of this project is 
to uncover the significance of NET-chromatin interactions in cell differentiation.
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CHAPTER IV: NET-chromatin interactions in 
adipogenesis
4.1 Several NETs are upregulated in adipogenesis
4.1.1 Tissue specificity of novel NETs
One of the hypotheses to explain tissue-specific phenotypes of the nuclear 
envelopathies postulates that there are tissue-specific NETs. In order to test this NE 
proteomes from 3 different tissues were purified and analysed by MudPIT followed 
by tandem mass spectrometry (Schirmer et al., 2003; Korfali et al., 2010; Wilkie et  
al., 2010). Supporting this initial hypothesis, only about a third of putative NETs was 
shared between the tissues analysed.
To corroborate  further  that  novel  NETs might  be  tissue-specific  or  tissue-
preferential, transcriptome data was extracted from the public database bioGPS (Wu 
et  al.,  2009).  As  was  anticipated,  some  of  the  NETs  have  tissue-preferential 
expression based on mRNA expression profiles (Fig 4.1.1 a). For example, NET4, 
NET29 and NET33 are expressed highly in adipose tissue. As fat is one of the tissues 
affected by mutations in Lamin A, it was decided first of all to confirm upregulation 
of the three NETs in adipocytes and, second of all, investigate their role in fat cells.
To confirm upregulation  of  NET4,  NET29 and NET33 in  adipocytes,  the 
3T3-L1 inducible system was chosen. 3T3-L1 is a mouse cell line established from 
NIH 3T3 cells (Green and Kehinde, 1975). The cells have fibroblast-like morphology 
and can be rapidly differentiated into adipocytes by addition of a drug cocktail con-
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sisting  of  a  glucocorticoid  dexa-
methasone  (DMS),  a  phospho-
diesterase  inhibitor  3-isobutyl-1-
methylxanthine  (IBMX)  and 
hormone insulin (Rubin et al., 1978). 
Some  of  the  key  players  of 
differentiation  have  been  identified 
and the order of their upregulation is 
well described (reviewed in  Fajas et  
al.,  1998).  Differentiated  cells 
change  their  shape  and  accumulate 
lipid droplets  that  can be visualised 
with lipid dyes (Fig 4.1.1 b).
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Fig 4.1.1 a: Transcription profiling of some novel NETs
Data extracted from BioGPS database (Wu et al., 2009) and plotted in medians of 78 different mouse  
tissues and cells. Median is a middle value of a list of values. Representative tissues were selected.
Fig 4.1.1 b: Undifferentiated and differen-
tiated 3T3-L1 cells
Differentiated adipocytes accumulate lipid droplets  
that can be visualised with lipophilic dyes (here –  
Nile Red). Scale bar represents 10 µm.
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4.1.2 Upregulation of adipogenic markers
In order to confirm the reproducibility of results it was decided to first assess 
expression of adipogenic markers by reverse transcription followed by quantitative 
PCR. RNA from undifferentiated sub-confluent  3T3-L1 cells or cells differentiated 
for 1, 2, 3, 4, 6 and 8 days was isolated and reverse transcribed using gene-specific 
reverse primers. First, primer pairs for different genes have been calibrated on cDNA 
obtained from reverse transcribed RNA from 3T3-L1 cells differentiated for 6 days. 
RNA from differentiated cells was used for calibration as some of the adipogenic 
markers are  not  expressed in  preadipocytes and therefore could not  be amplified 
from undifferentiated  cells.  Primer  efficiency  was  between  1.879  for  Pparg and 
2.047  for  Srebf1 (Fig  4.1.2,  A).  To  ensure  specificity  of  the  amplified  product, 
melting curves also have been measured at the end of all reactions and analysed (Fig 
4.1.2, B).
The amount of synthesised cDNA was measured by SYBR Green I  based 
qPCR on LightCycler  480 apparatus.  LMNA cDNA was used as  a  reference;  the 
primer set was specific to lamin A and did not amplify lamin C, which is a splicing 
isoform of the LMNA gene.
A good correlation between published data on adipogenic markers and our 
qPCR  results  was  obtained  (4.1.2,  C).  Two  master  regulators  of  adipogenesis, 
peroxisome  proliferator-activated  receptor  gamma  (Pparg)  and  sterol  regulatory 
element binding transcription factor 1 (Srebf1) are upregulated on the second day 
after  addition  of  differentiation cocktail.  The rest  of  the  tested  genes,  expressing 
proteins of lipid metabolism such as fatty acid synthase (Fasn), fatty acid binding 
protein 4 (Fabp4), solute carrier family 2 (facilitated glucose transporter), member 4 
(Slc2a4, Glut4) and adiponectin (Adipoq), were upregulated later in adipogenesis.
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Fig 4.1.2: qRT-PCR analysis of adipogenic markers in adipocyte differentiation
A - Callibration curves of primer pairs used for PCR. Callibration curves are built to determine  
efficiency of the primer pairs. Efficiency should be close to 2 with an acceptable range of 1.8-2.1. B -  
Melting curves of amplified products. Specificity of amplified products is assessed upon reaction  
completion. Single melting peaks represent high specificity of primer pairs. C - Relative mRNA level  
of corresponding adipogenic markers. Relative levels of adipogenic markers mRNA were detected  
with SYBR green and ratio to LMNA mRNA level is plotted.
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4.1.3 NETs 4, 29 and 33 are upregulated in adipogenesis
Having established the model system, expression of NETs 4, 29 and 33 was 
assessed the same way. First, primer pairs were calibrated and their efficiency was 
calculated, ranging from 1.979 for NET33 to 1.99 for NET4 (Fig 4.1.3, A). Single 
peaks  with  melting  curve  genotyping  were  obtained  (Fig  4.1.3,  B)  supporting 
specificity of the amplified products.
After that, cDNA levels of the three NETs have been measured in reverse 
transcribed RNA isolated from subconfluent undifferentiated 3T3-L1 cells and cells 
differentiated for 1, 2 ,3, 4, 6 and 8 days. cDNA levels are plotted relative to lamin A 
in Fig 4.1.3, C. All three NETs are upregulated during adipogenesis, but each one has 
a different pattern.
NET4 is upregulated on day 6, similar to Adipoq and Slc2a4 (Glut4). NET4, 
or transmembrane protein 53 (Tmem53), is a 277 aa protein with one transmembrane 
domain strongly predicted by TMHMM2 and two other hydrophobic regions. It also 
contains  a  domain  of  unknown  function  DUF829.  It  has  been  shown  by 
overexpression and downregulation with siRNA to alter cell cycle progression and 
change the level of phosphorylated Rb (Korfali et al., 2011).
NET29  is  upregulated  on  day  2,  similar  to  Pparg and  Srebf1,  a  master 
regulator of adipogenesis and a key transcription factor. NET29 is transmembrane 
protein 120a (Tmem120a), also known as transmembrane protein induced by tumor 
necrosis factor α (TMPIT), however no evidence of it being regulated by TNFα was 
published.  It  is  343  aa  long  and  has  5  transmembrane  regions  predicted  by 
TMHMM2. Interestingly, this protein has been identified to alter the chromosome 5 
position  in  HT1080  cells  with  a  LacO  array  integrated  into  chromosome  5  (N 
Zuleger, S Boyle, DA Kelly, J de Las Heras, DG Batrakou, V Lazou, GR Otti, N 
Korfali,  KN Randles,  GE Morris,  DJ Harrison,  WA Bickmore  and EC Schirmer, 
paper in submission).
NET33 is upregulated already on day 1 of adipogenesis, however changes in 
its  expression  are  less  than  that  of  NET4  and  NET29.  NET33  is  known  as  a 
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(putative) scavenger receptor class A, member 5 (Scara5). It is 495 aa long and has 
one strongly predicted transmembrane domain.  It also has been found to have an 
effect on the chromosome 5 position in HT1080 cells,  albeit  weaker than that of 
NET29.
After  consideration,  I  have  decided  to  focus  on  NET29  for  a  number  of 
reasons. First  of all,  it  is upregulated at the same time as important adipogenesis 
factors  as  Pparg and  Srebf1 (Fig  4.1.3,  D).  Second  of  all,  the  chromosome 
repositioning effect it possesses might explain its role in adipogenesis. And third of 
all, we have an affinity purified antibody generated against a NET29 peptide that 
recognises a protein of the correct molecular weight. It was used to confirm that 
NET29 protein level is increased during adipogenesis (Fig 4.1.3, E).
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Fig 4.1.3: NET29 is upregulated early in adipogenesis
A - Callibration curves of primer pairs used for PCR. Callibration curves are built to determine  
efficiency of the primer pairs. Efficiency should be close to 2 with an acceptable range 1.8-2.1. B -  
Melting curves of amplified products. Specificity of amplified products is assessed upon reaction  
completion. Single melting peaks represent high specificity of primer pairs. C - NETs 4, 29 and 33 are  
upregulated in adipogenesis. NET33 is upregulated on the first day of differentiation, NET29 - on the  
second  day,  and  NET4  is  upregulated  late  in  adipogenesis.  D  -  NET29  follows  the  pattern  of  
transcription factors. Normalized to day 6 of differentiation mRNA levels of two transcription factors,  
Pparg and Srebf1,  two lipid metabolism proteins,  Slc2a4 and Adipoq, and NET29 are compared.  
Upregulation on the second day suggests important role in adipogenesis for NET29.  E - NET29 
upregulation on protein level. Protein extracts from undifferentiated or differentiated for 3 and 8  
days 3T3-L1 cells were probed with AP NET29 antibody. Lamin A protein level was used as a loading  
control.
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4.2 NET29 effect on chromatin and its consequences
4.2.1 Chromosome repositioning effect of NET295
As  mentioned  before,  NET29  has  a  chromosome  repositioning  effect  in 
human HT1080 cells where it alters the position of chromosome 5. To investigate if 
it has a similar role in 3T3-L1 mouse cells we took advantage of a fluorescence in  
situ hybridization (FISH) approach upon overexpression of human NET29 cDNA 
fused to an encoding GFP sequence. Chromosomes 6 and 16 were chosen for testing 
because they both bear adipogenic markers: PPARG and LEP on chromosome 6 and 
ADIPOQ on chromosome 16. Chromosome 7 was chosen to be used as a control.
Undifferentiated  subconfluent  3T3-L1  cells  were  transfected  either  with  a 
NET29-GFP fusion or GFP alone and were stained for chromosomes 6, 7 and 16. In 
order to quantify the effect, a macro for Image-Pro Plus, adapted by David Kelly 
from Croft et al. (1999), was applied. The macro divides the nucleus (based on DAPI 
signal) into 5 concentric rings, equal in area (Fig 4.2.1 a) and counts area and pixel 
intensity  of  whole  chromosome  painting  intersected  with  different  rings.  Hence, 
when a chromosome is located in the central area of the nucleus, higher proportion of 
its signal will be in central rings. Similarly, if a chromosome is located close to the 
nuclear periphery, most of its signal will belong to the peripheral rings. However, the 
nucleus is a three-dimensional structure, and for the analysis only one focal plane 
that contains most of the chromosomes 6 was used. This underestimates the number 
of peripherally located chromosomes, as peripheral chromosomes, located at the top 
or at the bottom of the nucleus (relative to the slide) will appear centrally located. 
This underestimation, though, should be similar among all the samples.
5 Gerlinde Otti has performed FISH experiments and macro analysis in this chapter.
6 3T3-L1 cells, similar to many other cell lines, do not have a stable karyotype and often are polyploid. However this should 
not affect the analysis as the signal that is quantified as relative to the total chromosomal signal of a cell.
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As  the  changes  in  chromosome  positioning  are  not  observed  in  every 
transfected cell, analysis of a large population of cells had to be performed. 100 cells 
for each chromosome/protein combination have been analysed using the Image-Pro 
Plus macro. Relative intensities (percent of total signal from chromosomes in each 
cell) have been calculated for each ring. As chromosomes are rather large structures, 
it  was decided to sum signals from rings 1 and 2 (peripheral signal) and 4 and 5 
(central  signal).  The resulting values are plotted (Fig 4.2.1 b).  It  is  obvious,  that 
NET29-GFP overexpression  has  no effect  on chromosomes 7 and little  effect  on 
chromosome  16.  However,  chromosome  6  tends  to  localize  more  often  at  the 
periphery in cells overexpressing NET29-GFP, but not GFP alone.
As NET29 is upregulated during adipogenesis, it was decided to test whether 
chromosome  6  is  relocated  to  the  periphery  during  adipocyte  differentiation. 
However, fluorescence in situ hybridization failed to produce any specific signal in 
differentiated  adipocytes  fixed  with  formaldehyde.  To  overcome  this  problem, 
methanol/acetic acid fixation has been employed. This type of fixation, along with an 
ethanol  dehydration  series  also  used  in  this  procedure,  flatten  nuclei  and  thus 
destroys  its  three-dimensional  structure.  On  the  other  hand,  methanol/acetic  acid 
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Fig 4.2.1 a: A macro divides the nucleus into 5 concentric rings of the same area
Rings contain 20% of nuclear area (in blue) each and numbered 1-5 from the periphery to the centre.  
Upon overexpression of NET29-GFP fused protein, chromosome 6 (in red) is found more often at the  
nuclear periphery.
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fixation  also  destroys  GFP fluorescence  and  epitopes,  making  it  impossible  to 
distinguish expressing exogenous protein cells from not expressing ones. As transient 
transfection  of  3T3-L1  cells  in  our  hands  was  at  best  around  60%,  this  would 
diminish the chromosome repositioning effect measured if NET29-GFP expressing 
preadipocytes  had  been  processed  the  same  way.  However  despite  the  fact  that 
overexpressing NET29-GFP preadipocytes have been processed differently from this 
experiment, they have also been analysed using the two-dimensional macro. Thus, 
the results of both series of experiments should be qualitatively comparable.
4 and 7 days differentiated 3T3-L1 cells have been tested, and chromosome 6, 
indeed, has been found at the nuclear periphery more often in 7 days differentiated 
adipocytes  (Fig  4.2.1  b).  This  suggests  that  upregulation  of  endogenous  NET29 
during adipogenesis leads to chromosome 6 repositioning. However, it is not clear 
whether  only  NET29  is  responsible  for  the  effect.  Knock-down  of  endogenous 
NET29 expression must be done along with a rescue experiment in order to confirm 
this  suggestion.  If  cells  with  downregulated  endogenous  protein  will  not  exhibit 
chromosome 6 repositioning in adipogenesis, and introduction of exogenous NET29 
will  be  able  to  rescue  the  phenotype,  then  NET29 is,  indeed,  the  only factor  of 
chromosome 6 repositioning in differentiating into adipocytes cells.
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Fig 4.2.1 b: Chromosome 6 positioning is altered by NET29 overexpression and in  
adipogenesis
The graphs display the distribution of chromosome signal in each of the five shells. Shell 1 is the  
nuclear periphery, and shell 5 is the centre of the nucleus. 100 cells per each chromosome/protein  
combination have been analysed. 4 and 7 days differentiated samples were normaslised by DAPI  
signal.  The  asterisks  represent  significant  differences (* -  p  < 0.05,  ** -  p  < 0.01,  Kolmogorov  
-Smirnov test) for the shell when compared to the corresponding shell of GFP overexpressing cells  
(for NET29 overexpression) or 4 days differentiated cells (for 7 days differentiation).
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4.2.2 Transcription  analysis  of  cells  undergoing  chromosome 
repositioning7
It  has  been  already  shown  using  artificial  systems,  that  tethering  of  a 
chromosomal loci to the nuclear periphery may lead to both silencing or activation of 
gene expression (Finlan et al., 2008; Ruault et al., 2008). The presence of tissue-
specific proteins that are able to rearrange chromosomes and tune expression of their 
genes could provide another way to regulate global changes that cells undergo during 
differentiation.
To  identify  consequences  of  chromosome  6  and,  possibly,  other  untested 
chromosomes repositioning on gene expression, microarray analysis was carried out. 
Along  with  NET29,  both  NET4  and  NET33  (the  latter  also  had  a  chromosome 
repositioning effect in HT1080 cells) have also been tested. Total RNA was isolated 
from 3T3-L1 cells,  transiently transfected with either mRFP alone,  or C-terminal 
fusions of NETs 4, 29 and 33 with mRFP. Three independent RNA isolations have 
been done for all overexpressed proteins. The RNA have been reverse transcribed 
into cDNA, and double-stranded, biotin-labelled cRNA have been synthesized and 
amplified  using  the  Illumina® TotalPrep  RNA  Amplification  Kit  following 
manufacturers  instructions.  Louise  Evenden at  Wellcome Trust  Clinical  Research 
Facility  in  Edinburgh  has  performed  quality  analysis  of  cRNA using  an  Agilent 
Bioanalyser and hybridization to Sentrix® BeadChip (6 samples/chip). BeadArray 
technology from Illumina  (4.2.2  a,  A) was  chosen because  of  its  reproducibility, 
precision  (detects  1.3  fold  difference  with  95%  probability)  and  economical 
effectiveness (Kuhn et al., 2004).
First,  the distribution of raw signals from controls (4.2.2 a, B) and all the 
samples (4.2.2 a, C) has been assessed. As array chips are scanned as 16 bit images, 
values of signals can only be within a 0 and 65535 interval, or, more conveniently, 
logarithms  to  base  2  of  signal  values  can  only  be  between  0  and 16.  However, 
7 Analysis of microarray data on transiently over-expressed NETs and, partially, stable cell lines over-expressing NET29 has  
been performed by Jose de las Heras
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practically, logarithms to base 2 of background values are about six, so the dynamic 
range of  expressed RNA signals  is  roughly between 6 and 168,  where  the  lower 
threshold is calculated based on negative control values and the upper threshold is 
defined by scanner intensity, and should not be too close to 16 to prevent saturation. 
This way, up to a 1000-fold difference in expression could be observed.
Microarray controls (4.2.2 a, B) include negative controls (probes, that should 
not hybridize with any cRNA), and positive biotin controls (probes labelled with 
biotin).  The  former  indicate  background  level  in  a  particular  chip  and the  latter 
should give high signals close to the upper limit of detection9. All of the samples 
showed  good  distribution  of  negative  (below 7)  and  positive  biotin  (around  14) 
controls.
Distribution of all sample signals (4.2.2 a, C) shows that over 50% of the 
probes are within the background level (boxes are below 7). This could be due to 
different and not mutually exclusive reasons. First of all, Illumina arrays often have 
more than one probe per gene, and while some of them detect all splice variants, 
most of them detect single splice variants. So that if only one particular splice form is 
expressed, only two probes will detect it, but not the others. Second of all, uninduced 
3T3-L1 cells are not fully differentiated and, hence, many cell type specific genes are 
not expressed. Another possibility is poor labelling of cRNA with biotin, but the fact 
that some of the probe values were as high as 15 disproves this possibility. Despite 
this,  the  level  of  biotin  incorporation  into  cRNA has  been  compared  to  that  of 
commercial biotinylated oligonucleotides by dot blot assay (as described in  Dölken 
et al., 2008) and was found to be at similar levels. Poor handling of samples during 
hybridization is excluded by good distribution of controls.
Signals  of  different  samples  have  been normalized  in  R v2.11.1  (RTeam, 
2010)  using  the  quantile  method of  the  Limma package (Wettenhall  and Smyth, 
2004). Normalized data has been averaged between 3 repeats of each sample and 
plotted as two-dimensional scatter plots, where on the vertical axis plotted probe va-
8 Here and later, when signals from microarray are discussed, the numbers are logarithms to base 2.
9 Due to differences in biotin incorporation and length between probes and hybridized RNA, highly expressed and, mostly, 
long RNA might give signals higher than biotin control.
85
Nuclear envelope transmembrane proteins in differentiation systems
86
Fig 4.2.2 a: Transient overexpression of three NETs does not affect transcription
A - Schematic overview of Illumina Sentrix Bead Array technology. Each array is in a format of a  
glass slide with imprinted hollows. Each hollow holds a single 3  µm silica bead with hundreds of  
thousands bar-coded oligonucleotides of the same sequence attached to it. Each array has about 20  
beads with the same oligonucleotides attached to it. B - Raw signal distribution of controls. Included 
into every array detection controls look good. Uneven distribution between samples indicates the  
need of normalisation of signals. C - Raw signal distribution of samples. Over a half of signals are at  
the background level (discussed in text). D-F - Normalized signals of NETs plotted against RFP. The 
easiest way spot differences in gene expression between two samples is to plot each probe on a two-
dimensional graph with values from one sample on x axis and values from another sample on y axis.  
Probes that are expressed differently between the samples will fall outside of the line.
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lues from NET-RFP fusion overexpressing sample, and on the horizontal axis - from 
RFP overexpressing  sample  (4.2.2  a,  D-F).  However,  no  significant  differences 
between  the  sample  pairs  could  be  observed.  As  the  exogenous  sequences  were 
human, upregulation was not detected in the mouse microarray, apart from one of the 
NET4 probes that is similar between the mouse and human sequence (4.2.2 a, D).
Absence  of  differences  in  expression  between  cells  overexpressing  RFP 
fusions of NETs and control cells (overexpressing RFP alone) could be due to low 
transfection  efficiency  and/or  insufficient  time  between  transfection  and  RNA 
isolation. Transfection of 3T3-L1 cells is a challenging task, out of different methods 
and reagents, including nucleofection, FugeneHD has performed best, transfecting up 
to 60% of the cells based on the RFP signal. However, the level of expression is 
greatly  variable  from  a  barely  visible  rim  to  bulks  of  overexpressed  protein 
aggregates in the ER.
To overcome problems with transfection efficiency, 3T3-L1 cell lines stably 
overexpressing  the  NET29-GFP  fusion  and  GFP  alone  were  generated.  The 
differentiation ability and the position of chromosome 6 in the cell lines has been 
assessed.  Both  cell  lines  have  been  able  to  differentiate  into  adipocytes  and 
chromosome  6  has  been  found  at  the  periphery  more  often  in  the  cell  line 
overexpressing  NET29-GFP fusion,  than  in  the  overexpressing  GFP cell  line.  3 
individual  RNA isolations  from  both  cell  lines  have  been  done  and  microarray 
analysis has been carried out. As a positive control of differential expression, RNA 
from undifferentiated and 9 days differentiated 3T3-L1 cells have also been used for 
microarray analysis, one repeat each.
Normalised averaged signals from NET29-GFP and GFP overexpressing cells 
have been analysed and plotted (Fig 4.2.2 b). Out of 11 highly scored genes that were 
expressed at  different levels in NET29-GFP cells  and GFP cells, GRB10 had the 
biggest difference. GRB10 is growth factor receptor bound protein 10 and it had been 
shown to be a negative regulator of insulin signalling (Mori et al., 2005). Reverse 
transcription followed by qPCR has been used to confirm over 3-fold upregulation of 
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GRB10  in  cells  overexpressing  the  NET29-GFP  fusion,  compared  to  the  cells 
overexpressing GFP alone (Fig 4.2.2 b, insertion box).
However, this way of analysis cannot distinguish whether a particular gene is 
downregulated in the NET29-GFP cell line, or upregulated in the GFP cell line. In 
order to normalize data to the “initial” state of the cells, signals from undifferentiated 
untransfected  cells  have  been  subtracted  from  signals  of  NET29-GFP and  GFP 
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Fig 4.2.2 b: Expression of several genes is affected by NET29 overexpression
Microarray  signals  from the  NET29-GFP overexpressing  cell  line  were  plotted  against  the  GFP  
overexpressing cell line. Several genes are upregulated (in red) in the NET29-GFP cell line while two  
(in blue) are downregulated. Insertion box is RT-qPCR analysis of GRB10 expression in NET29-GFP  
and GFP cell lines.
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overexpressing cells and plotted (Fig 4.2.2 c). This way, any signal that is uniform 
among all  the cells will  have coordinates roughly 0,0. The two most outstanding 
probes are EGFP and GRB10. EGFP is a probe against enchanced GFP, and since 
untransfected  cells  do  not  express  this  exogenous  sequence,  this  probe  is  most 
differently expressed between the cells. As the probes coordinates are roughly equal 
(6,6), it suggests that overexpression of the NET29-GFP fusion and GFP alone is at a 
similar  level,  hence the  two cell  lines  can  be  compared safely.  The other  probe, 
GRB10, has coordinates at about 3.5,1 which means that both stable cell lines have it 
upregulated, however the level of expression is higher in GFP cells and therefore it 
appeared downregulated in NET29-GFP cell lines in the previous analysis. Thus, it is 
not  likely that  the chromosome 6 repositioning is  the cause for the difference in 
GRB10 expression.
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To select for genes that are more likely to change expression due to NET29 
overexpression  two criteria  have  been applied:  the  difference  in  gene  expression 
must not exceed 0.3 (about 1.2-fold difference) in GFP overexpressing cells and must 
be more than 0.75 (about 1.7-fold difference) in NET29-GFP overexpressing cells 
(Fig  4.2.2  d).  The  selected  genes  included  10  upregulated  messages  and  7 
downregulated messages in the NET29-GFP cell line that are located on different 
chromosomes.
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Fig 4.2.2 c: Expression of GRB10 is also affected in the control cell line
Signals from undifferentiated cells were subtracted from corresponding signals from NET29-GFP and  
GFP overexpressing cells.
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Included into the microarray analysis controls, undifferentiated 3T3-L1 cells 
and 9-day differentiated cells, provide an opportunity to find more NETs upregulated 
or downregulated during adipogenesis. First, a list of genes with a two-fold and over 
difference in  expression during differentiation  have been built.  Then the  list  was 
searched for matching gene names of NETs. A number of NETs appeared in the list 
of genes up- or downregulated during adipogenesis. Apart from the already tested 
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Fig 4.2.2 d: Contrast analysis identifies genes affected by NET29 overexpression
Signals from undifferentiated cells were subtracted from corresponding signals from NET29-GFP and  
GFP overexpressing cells.  Genes expressed differently  in NET29-GFP, but not GFP cell  line are  
selected (upregulated genes are in red, downregulated - in blue).
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NETs 4, 29 and 33, upregulated NETs include lNETs 26 (TMEM14C), 50 (DHRS7) 
and  62  (MCAT)  identified  in  liver  dataset,  and  mNETs  20  (MBOAT5)  and  22 
(TMEM66) identified in muscle dataset. Liver NET3 (TMEM48/Ndc1), a core NPC 
protein, appears to be downregulated in adipogenesis.
In order  to  assess  the  quality  of  the  RT-qPCR data,  the  behaviour  of  the 
LMNA transcript  during adipogenesis  was monitored.  All  six  LMNA probes were 
downregulated about two fold on day 9 as compared to undifferentiated cells and 
therefore  LMNA should  not  be  used  as  a  loading  control  for  comparison  of 
undifferentiated and differentiating cells. This does not seriously affect the qRT-PCR 
results showing upregulation of NETs 4, 29 and 33 as microarray data supports their 
upregulation.  After  searching  for  an  appropriate  loading  control  for  qRT-PCR, 
GAPDH was chosen as a gene potentially unchanged during adipogenesis based on a 
relatively even level of transcript in both undifferentiated and differentiated cells.
4.2.3 Transcriptional analysis of differentiating 3T3-L1 cells with down-
regulated NET29
As preadipocytes might lack factors needed for the chromosome repositioning 
to affect transcription, it was decided to down-regulate NET29 in differentiating cells 
and test their transcription. siGENOME SMART pool, combining 4 siRNA oligos 
against NET29 was purchased from Dharmacon (M-040281-00). Either the SMART 
pool  or  a  non-target  siRNA oligo  (CGUACGCGGAAUACUUCGAdTdT)  were 
transfected into undifferentiated 3T3-L1 to 100 nM final (total) concentration. RNA 
from undifferentiated cells was isolated two days after transfection, and RNA from 
cells  differentiated for 2 days was isolated 4 days after transfection.  The NET29 
transcript level was measured by qRT-PCR using  LMNA as a loading control (Fig 
4.2.3,  A).  Although  the  NET29  mRNA  level  was  significantly  reduced  in 
undifferentiated  cells,  2  days  differentiated  cells  showed  no  difference  between 
SMART pool and non-target oligo transfected cells. This could be explained by two 
reasons - oligo degradation and NET29 upregulation.
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It is well known, that differentiated 3T3-L1 cells are extremely difficult to 
transfect, hence multiple transfections of differentiating cells would not be efficient. 
In order to obtain a significant decrease in NET29 mRNA level in differentiating 
cells, a set of shRNA vectors was purchased from Sigma, including 5 vectors with 
different anti-NET29 oligo sequences (Table 15) and one with a non-target  oligo 
sequence.  6  stable  cell  lines  were generated and RNA and proteins  from 5 days 
differentiated stable cells lines were isolated. NET29 transcript and protein levels 
were assessed by qRT-PCR and quantitative Western blot, accordingly. The cell line 
expressing  oligo  TRCN0000247877  (sh77)  was  the  most  successful  in 
downregulating NET29 (Fig 4.2.3, B-D).
Table 15: NET29 shRNA vectors sense oligo sequences






Total RNA from the sh77 cell line, cell line expressing non-target shRNA and 
non-transfected 3T3-L1 cells, all differentiated for 4 days, was isolated, labelled with 
biotin and microarray analysis was carried out. Raw signals have been plotted to 
control for large chip abnormalities  and distribution of in-built  controls  has been 
monitored  to  ensure  adequate  hybridisation.  After  normalisation,  subtractions  of 
signals  from either  non-target  shRNA expressing  cell  line  or  sh77  cell  line  and 
signals from non-transfected cells have been plotted (Fig 4.2.3, E). To select genes 
that  are  specifically  affected  by  NET29  down-regulation  two  rules  have  been 
applied:  the  difference  between  non-target  shRNA expressing  cell  line  and  non-
transfected  cells  must  not  exceed 0.5 and the  difference  between sh77 and non-
transfected cells must be not less than 0.75. Genes upregulated upon NET29 knock-
down are listed in Table 16, downregulated genes are listed in Table 17.
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Fig 4.2.3: Downregulation of NET29 affects transcription in adipocytes
A -  siRNA downregulates  NET29  in  pre-adipocytes.  SMART pool  oligos  were  transfected  into  
undifferentiated 3T3-L1 cells and RNA was extracted either after two days post transfection or the  
cell were allowed to become confluent and induced to differentiate. Then RNA was extracted from two  
days differentiated cells (in total 4 days after transfection). B-D - shRNA downregulates NET29 in  
adipocytes.  Stable  cells  lines  expressing  shRNA  hairpin  against  NET29  were  established  and  
simultaneous RNA and protein isolation was done from 5 days differentiated cells.  sh77 cell  line  
shows best  down-regulation of  NET29 on mRNA and protein levels.  E -  Microarray analysis  of  
differentiating 3T3-L1 cells with downregulated NET29. In text.
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coiled-coil domain containing 74A (2310015A05Rik) 16 1
actinin alpha 3 (Actn3) 19 2
brain-specific angiogenesis inhibitor 2 (Bai2) 4 1
cDNA sequence BC011487 (BC011487) 6 1
cDNA sequence BC064033 (BC064033) 6 1
crystallin, alpha B (Cryab) 9 1 up in myogenesis
chemokine (C-X-C motif) ligand 12 (Cxcl12) 6 2 induces  myogenic differentiation
eyes absent 1 homolog (Drosophila) (Eya1) 1 1
glucuronyl C5-epimerase (Glce) 9 1
hyaluronan and proteoglycan link protein 2 (Hapln2) 3 1
histone cluster 1, H3e (Hist1h3e) 13 1
histone cluster 1, H4a (Hist1h4a) 13 1
histone cluster 1, H4h (Hist1h4h) 13 1
histone cluster 1, H4j (Hist1h4j) 13 1
histone cluster 2, H2aa1, (Hist2h2aa1) 3 1
histone cluster 2, H2aa2 (Hist2h2aa2) 3 1
histone cluster 2, H2be, (Hist2h2be) 3 1
kallikrein 1-related peptidase b24 (Klk1b24) 7 1
kallikrein 1-related pepidase b4 (Klk1b4) 7 1
keratin 16 (Krt16) 11 1
keratin 42 (Krt42) 11 3
PREDICTED: similar to histone H4 (LOC100041230) 13 1
PREDICTED: similar to clusterin (LOC100046120) 14 1 discontinued 
NAD(P)H dehydrogenase, quinone 1 (Nqo1) 8 1
procollagen C-endopeptidase enhancer 2 (Pcolce2) 9 1 down in myogenesis
phosphofructokinase, platelet (Pfkp) 13 1
Src homology 2 domain containing F (Shf) 2 2
solute  carrier  family  9  (sodium/hydrogen  exchanger), 
member 3 regulator 1 (Slc9a3r1)
11 1
transmembrane protein 132A (Tmem132a) 19 1
tetraspanin 17 (Tspan17) 13 1
PREDICTED:  WAS/WASL  interacting  protein  family, 
member 3 (Wipf3)
6 1
WW domain containing E3 ubiquitin protein ligase 2 (Wwp2) 8 2
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zinc finger and BTB domain containing 7C (Zbtb7c) 18 1






RIKEN cDNA 6330406I15 gene (6330406I15Rik) 5 2
angiopoietin-like 7 (Angptl7) 4 1
endoplasmic reticulum metallopeptidase 1 (Ermp1) 19 1
fibulin 1 (Fbln1) 15 1 down in myogenesis
GATA binding protein 6 (Gata6) 18 1
insulin-like growth factor binding protein 4 (Igfbp4) 11 2 up in myogenesis
insulin-like growth factor binding protein 7 (Igfbp7) 5 1
mannosidase 2, alpha B1 (Man2b1) 8 1
nucleotide-binding  oligomerization  domain  containing  1 
(Nod1)
6 1
prolactin family 2, subfamily c, member 2 (Prl2c2) 13 2 inhibits  myogenesis differentiation
prolactin family 2, subfamily c, member 3 (Prl2c3) 13 1
prolactin family 2, subfamily c, member 4 (Prl2c4) 13 1
resistin like alpha (Retnla) 16 1
ribonuclease, RNase A family 4 (Rnase4), transcript variant 1 14 1
sema domain, seven thrombospondin repeats (type 1 and type 
1-like),  transmembrane domain (TM) and short cytoplasmic 
domain, (semaphorin) 5A (Sema5a)
15 2
sulfatase 2 (Sulf2) 2 1
transmembrane protein 120A (Tmem120a) 5 1 NET29
Not  surprisingly,  the  genes  affected  by  NET29  are  located  on  several 
chromosomes, including the tested chromosome 6. Most notably, chromosome 13 is 
highly affected by NET29 knock-down. It would be interesting to test whether the 
chromosome 13 nuclear localisation is also affected by NET29.
Interestingly, a number of genes affected by NET29 downregulation are also 
affected in myogenesis. Moreover, chemokine (C-X-C motif) ligand 12 was shown to 
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induce myogenic differentiation (Melchionna  et al., 2010) and is also upregulated 
upon NET29 depletion. On the other hand, prolactin family 2, subfamily c, member 2 
was shown to inhibit myogenesis (Wilder and Linzer, 1989) and it is repressed in the 
NET29-depleted cell  line. This suggests that NET29 upregulation in adipogenesis 
helps to inhibit an alternative differentiation pathway – myogenesis.
4.3 Summary and conclusions
Three  NETs  are  shown  to  be  upregulated  during  in  vitro adipogenesis. 
Available  transcriptomics  data  suggests  that  these  NETs  are  highly  expressed  in 
mouse  fat  tissue.  In  a  separate  screen,  two  of  the  NETs  affected  chromatin 
distribution.  This study is focused on NET29, a NET that is upregulated early in 
adipogenesis along with crucial adipogenic genes such as Peroxisome proliferator-
activated receptor gamma and Sterol regulatory element-binding transcription factor 
1. This suggests an important function of NET29 in adipogenesis.
We tested the effect of NET29 overexpression in preadipocytes on the radial 
distribution of several chromosomes. Most notably, chromosome 6 was relocated to 
the  nuclear  periphery  by  NET29  overexpression.  Transcriptomic  analysis  of 
preadipocytes with upregulated NET29 revealed several genes that are affected by 
NET29. However, downregulation of NET29 in the differentiating cells had a more 
pronounced  effect  on  transcription.  Two  genes  important  for  myogenesis  were 
affected among several others.  Chemokine (C-X-C motif)  ligand 12 (CXCL12)  is 
upregulated upon NET29 knockdown, and it  can induce myogenic differentiation 
(Melchionna et al., 2010). Prolactin family 2, subfamily c, member 2 (PRL2C2) was 
shown to inhibit myogenesis (Wilder and Linzer, 1989) and it is downregulated along 
with  NET29.  Therefore  it  is  possible  that  NET29  helps  to  shut  alternative 
differentiation pathways down. It is not yet clear whether the effect on transcription 
is mediated by the NET29-mediated chromatin rearrangement.
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CHAPTER V: A Molecular Mechanism of 
Chromosome Repositioning
This  chapter  is  focused  on  uncovering  the  molecular  mechanism  of 
chromosome  repositioning  of  NET29.  It  is  mostly  ongoing  work  with  some 
significant and promising results.  First,  a dominant negative mutant of NET29 is 
described. Phosphorylation analysis of NET29 and attempt of identification of the 
protein's binding partners will also be described.
5.1 Dominant negative mutant of NET29
In order to facilitate identification of the region of NET29 that is involved in 
chromosome 6 repositioning, multiple protein sequence alignments of NET29 from 
diverse species have been done. Using OrthoMCL DB (Altschul et al., 1997), NET29 
orthologs  have been found in Plants and various classes of Animals:  Nematodes, 
Insects,  Amphibia,  Fish,  Birds  and Mammals.  JalView v2.6.1 (Waterhouse et  al., 
2009) was used to build the alignment of NET29 protein sequences from different 
animals (Fig 5.1 a). Along with this analysis, prediction of potential phosphorylation 
sites has been done using NetPhos v2.0 (Blom et al., 1999), as well as prediction of 
potential transmembrane domains using TMHMM v2.0 (Krogh et al., 2001).
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There are three residues highly scored for phosphorylation that are located 
within  highly  conserved  regions.  However,  the  T176  residue  resides  within  a 
hydrophobic sequence that is predicted to form a transmembrane helix. Both Y129 
and Y133, on the other hand, are located on the nucleoplasmic N-terminus and have 
the potential to be involved in chromatin binding. Considering all this, residues Y129 
and Y133 have been mutated to either phenylalanines (Y129F, Y133F - phospho-null 
mutations) or glutamic acids (Y129E, Y133E - phosphomimetic mutations). 3T3-L1 
cells have been transiently transfected with plasmid DNA encoding either wild type 
or mutated NET29 sequences in frame with the GFP coding sequence. Intracellular 
localisation was monitored by fluorescence microscopy after direct fixation with PFA 
or with Triton X-100 pre-extraction. The last procedure washes away proteins that 
are weakly associated with the NE. Wild type NET29 as well as its mutants formed 
rim-like structures that are characteristic to NETs. They also were retained at the NE 
after pre-extraction further supporting similarity in the localisation between wild type 
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Fig 5.1 a: ClustalW alignment of NET29 from multiple species
NET29  sequences  from  Caenorhabditis  elegans,  Drosophila  melanogaster,  Danio  rerio,  Xenopus  
laevis, Gallus gallus, and Homo sapiens were aligned to highlight the most conserved regions. Box  
outlines a very conserved region that contains two potentially phosphorylated tyrosines.
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and mutant proteins (Fig 5.1 b).
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Fig 5.1 b: Mutants of NET29 have a similar cellular localisation as the wild type  
protein
3T3-L1 pre-adipocytes expressing wild type NET29 or its mutants fused to GFP were directly fixed  
with PFA or pre-extracted with Triton X-100 and then fixed. The mutant's localisation and resistance  
to Triton X-100 pre-extraction is similar to wild type NET29. Scale bar represents 10 µm.
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3T3-L1 preadipocytes were allowed to express exogenous cDNA for three days and 
the  chromosome 6  position  was  assessed  using  FISH10.  Cells  overexpressing  the 
phosphomimetic  mutant  showed chromosome 6 distribution that  is  similar  to  the 
cells overexpressing wild type NET29 (Fig 5.1 c). However, cells overexpressing the 
phospho-null mutant had chromosome 6 in the centre of the nucleus more often than 
in cells overexpressing wild type NET29, or even non-transfected cells. This lead to 
two suggestions: first, the conserved region before the first predicted transmembrane 
domain interacts either directly or indirectly with chromatin. Second, this interaction 
most  probably  requires  phosphorylation  of  either  Y129  or  Y133,  or  both  of  the 
residues.
10 Initial FISH experiment has been done by Gerlinde Otti
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Fig 5.1 c: NET29 phospho-null mutant fails to tether chromosome 6
hromosome 6 localisation was determined  by  FISH upon overexpression of  NET29 mutants.  The  
phosphomimetic  mutant has a chromosome tethering effect  similar to the wild type. However the  
phospho-null mutant reverts the effect of NET29 overexpression. The asterisks represent significant  
differences (* - p < 0.05, ** - p < 0.01, *** - p < 0.001, Kolmogorov -Smirnov test) for the shell when  
compared to the corresponding shell of wild-type NET29 overexpressing cells.
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5.2 Analysis of PTMs of NET29
In order to confirm the presence of phosphorylation at Y129 and Y133 of 
NET29  in vivo, immunoprecipitation of over-expressed NET29-GFP fusion protein 
from undifferentiated 3T3-L1 cells was carried out. To avoid contamination of eluted 
material, an anti-GFP antibody was covalently cross-linked to CnBr-Sepharose 4B 
agarose  beads.  A rabbit  polyclonal  antibody  that  recognizes  GFP was  generated 
against full-length GFP protein purified from E.coli. The affinity purified antibody 
specifically  recognises  GFP (Fig  5.2  a)  and  works  well  in  immunoprecipitation 
assays.
Cell lysates are prone to de-phosphorylation by phosphatases present in every 
cell, hence phosphatase inhibitors were used for the immunoprecipitation assay. In 
order  to  obtain  information  about  phosphatases  that  are  highly  expressed  in 
differentiated  3T3-L1 cells,  microarray  data  from 9  days  differentiated  cells  was 
searched for annotated phosphatases or phosphatase subunits and results were scored 
by their  expression  level  (Table  18).  Based on these  data,  available  specific  and 
general phosphatase inhibitors were selected and used during the assay (Table 19).
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Fig 5.2 a: Affinity purified anti-GFP antibody staining
HT1080 cells stably expressing Lamin A - GFP fusion were fixed with PFA, stained  
with  affinity  purified  anti-GFP  antibody  and  labelled  with  anti-rabbit  
immunoglobulin  Cy5  conjugated  antibody.  Signal  of  anti-GFP  antibody  
corresponds to the signal of the GFP fluorescence thus showing the specificity of  
the antibody. Scale bar represents 10 µm.
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Table 18: Phosphatase genes, highly expressed in 3T3-L1 adipocytes
adip.log2 Target ID Definition
13.16 Ppp2ca Protein phosphatase 2 (formerly 2A), catalytic subunit, alpha isoform 
13.1 Ppp1r3c Protein phosphatase 1, regulatory (inhibitor) subunit 3C 
12.32 Ppp1ca Protein phosphatase 1, catalytic subunit, alpha isoform 
11.92 Ppm1a Protein phosphatase 1A, magnesium dependent, alpha isoform 
11.82 Ppp2cb Protein phosphatase 2 (formerly 2A), catalytic subunit, beta isoform 
11.46 Dusp1 Dual specificity phosphatase 1 
11.44 Ssu72 Ssu72 RNA polymerase II CTD phosphatase homolog 
11.34 Ppp2r1a Protein phosphatase 2 (formerly 2A), regulatory subunit A (PR 65), alpha 
isoform 
11.29 Ptplad1 Protein tyrosine phosphatase-like A domain containing 1 
11.16 Ppp6c Protein phosphatase 6, catalytic subunit 
11.12 Loc100046
393
PREDICTED:  Similar  to  Protein  phosphatase  2,  regulatory  subunit  B 
(B56), alpha 
11.04 Pptc7 PTC7 protein phosphatase homolog (S. cerevisiae) 
10.99 Ptpn11 Protein tyrosine phosphatase, non-receptor type 11 
10.71 Ppp4c Protein phosphatase 4, catalytic subunit 
10.69 Ublcp1 Ubiquitin-like domain containing CTD phosphatase 1 
10.58 Ctdsp2 CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small 
phosphatase 2 
10.57 Ppm1b PREDICTED:  Protein  phosphatase  1B,  magnesium  dependent,  beta 
isoform 
10.47 Dusp11 Dual specificity phosphatase 11 (RNA/RNP complex 1-interacting) 
10.34 Phpt1 Phosphohistidine phosphatase 1 
10.27 Ilkap Integrin-linked kinase-associated serine/threonine phosphatase 2C 
10.26 Ppp4r1 Protein phosphatase 4, regulatory subunit 1 
10.2 Ppp1r10 Protein phosphatase 1, regulatory subunit 10 
10.18 Ppm1g Protein  phosphatase  1G  (formerly  2C),  magnesium-dependent,  gamma 
isoform 
10.06 Ptp4a1 Protein tyrosine phosphatase 4a1 
10.05 Ppp2r5d Protein phosphatase 2, regulatory subunit B (B56), delta isoform 
Table 19: Phosphatase inhibitors used for immunoprecipitation
Inhibitor Concentration Target
bpV(bipy) 1 µM Protein tyrosine phosphatases
103
Nuclear envelope transmembrane proteins in differentiation systems
Inhibitor Concentration Target
4-methoxyphenacyl Br 500 µM Protein tyrosine phosphatases
Phenylarsine oxide 50 µM Protein tyrosine phosphatases
Sodium stibogluconate 100 µM Protein tyrosine phosphatases
Chelerythrine chloride 50 µM Dual specificity phosphatase 1
Ockadaic acid 50 nM Protein phosphatases 2A, 1, 2B
Sodium fluoride 10 mM Acid protein phosphatases
Imidazole 10 mM Alkaline protein phosphatases
Beta-glycerophosphate 25 mM Broad range
Alpha-naphthyl acid phosphate 10 mM Broad range
Western  blotting  on  eluted  material  with  anti-NET29  affinity  purified 
antibody showed a prominent band corresponding to the right molecular size of the 
NET29-GFP fusion (Fig 5.2 b, A). The rest of the eluted material was run on Bis-Tris 
4-12% gradient gel (Invitrogen) and stained with colloidal coomassie blue. A faint 
band of similar size was visible in the anti-GFP immunoprecipitate but not in the IgG 
control eluate (Fig 5.2 b, B). Covalently cross-linked rabbit IgGs (Sigma) were used 
to pre-clear the lysate before incubation with the anti-GFP antibody. The 70 kDa 
band, as well as the 110 kDa, 60 kDa and 45 kDa bands, were cut out of the gel and 
mass  spectrometry  analysis  of  the  thermolysin-digested  gel  pieces  is  ongoing  in 
collaboration with Dr Thierry Le Bihan at The University of Edinburgh.
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5.3 Identification of NET29 partners mediating chromosome 
repositioning effect
5.3.1 Development  of  in  vivo cross-linking  (IVCL)  approach  for 
identifying NET29 partner proteins
In  order  to  obtain  information  about  proteins,  interacting  with  NET29  in 
general and, more specifically, interactors responsible for chromosome relocation to 
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Fig 5.2 b: NET29-GFP immunoprecipitation
A - Western blot with anti-NET29 antibody shows enrichment of NET29 fused to GFP  
after  immunoprecipitation  with  anti-GFP  antibody. 3T3-L1  pre-adipocytes  were  
transiently  transfected  with  plasmid  DNA encoding  murine  NET29 fused  to  GFP and  
immunoprecipitation using anti-GFP antibody was carried out.
B - Coomassie staining of NET29-GFP immunoprecipitate. Eluted material, as well as  
control-bound (rabbit IgG) material were run on SDS-PAGE and stained with colloidal  
Coomassie.  Apart  from the  70  kDa  band that  corresponds  to  NET29-GFP fusion  size  
(asterisk), three other bands are visible and might represent co-precipitated partners of  
NET29.
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the nuclear periphery, an in vivo cross-linking (IVCL) approach was developed and 
applied.
Transmembrane proteins have always been considered difficult to work with, 
but transmembrane proteins of the NE are particularly hard to solubilise and require 
strict  conditions,  such  as  high  salt  and  detergent  concentration  and  excessive 
sonication. However under harsh conditions, most if not all of the interactors are 
likely  to  get  washed  away.  Alternatively,  exogenous  soluble  fragments  of 
transmembrane  proteins  could  be  used.  This  also  incorporates  a  few  potential 
drawbacks, including protein misfolding, mislocalisation to an unnatural compart-
ment  and  lack  of  PTMs  if  the  fragment  is  expressed  in  a  different  organism. 
Moreover,  soluble  fragments  of  NETs  tend  to  auto-activate  β-galactosidase 
expression  from  both  hunt  and  prey  vectors  in  yeast  two-hybrid  approach  (Dr 
Iakowos Karakesisoglou, personal communication).
Taking into account all  the above, an ideal method to co-precipitate NETs 
with their interacting partners would include, first of all, “freezing” of any interaction 
with  the  NET,  followed  by  isolation  of  the  “frozen”  complexes  under  stringent 
conditions. Bifunctional covalent crosslinkers provide excellent means for “freezing” 
interactions,  and  a  wide  range  of  tags  are  now  available  which  are  capable  of 
withstanding stringent conditions (reviewed in Lichty et al., 2005).
IVCL approach might be useful not only for transmembrane proteins. Many 
interactions  of  soluble  proteins  are  transient,  and  often  lost  during  purification 
procedures. Thus, covalent cross-linking prior to purification theoretically provides a 
way to identify even such transient partners as kinases and phosphatases.
Crosslinker selection
Crosslinkers differ  in  the specificity  of  their  functional  groups,  membrane 
permeability and cleavability.
Specificity of the crosslinker should be chosen based on the sequence of the 
protein of  interest  (Table  20).  An excellent  tool  which helps  to  choose  the  most 
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suitable  crosslinking  compounds  can  be  found  online  at  the  Pierce  web  site 
(http://www.piercenet.com/products/browse.cfm?fldID=26436A16-60A0-4A56-
85F7-213A50830440).
The specificity of the crosslinker defines the probability of two proteins being 
crosslinked. The more amino acids possessing the targeted functional group in their 
side chain, the greater the probability. Homobifunctional crosslinkers targeting the C-
terminal amino acid only have the least probability of covalently binding two given 
proteins, which decreases with increasing sizes of the proteins. Functional groups 
targeted  by  homobifunctional  sulfhydryl  crosslinkers  are  more  frequent,  as  the 
frequency of cystein in an average protein is about 1.4% (RandSeq, computed from 
Swiss-Prot).  Thus,  the  probability  of  two  proteins  being  crosslinked  by  these 
compounds is no greater than 0.0196%11. The latter is based on the assumption that 
two  interacting  proteins  are  close  to  each  other  throughout  their  entire  length. 
However this number ignores distances between the two cysteins, and since every 
crosslinker  has  different  spacer  arm  length,  this  will  affect  the  crosslinking 
probability.  Occurrence  of  lysines  is  about  5.8%  in  average  protein.  Thus,  a 
homobifunctional amine-targeting crosslinker has about 0.34% probability to detect 
an interaction, 17 times higher than with a homobifunctional sulfhydryl crosslinker. 
If a greater probability is required, non-selective and heterobifunctional crosslinkers 
are  also  available.  However,  excessive  crosslinking  might  make  it  impossible  to 
solubilize the protein extract, and thus the protein will not be effectively purified. It 
is  advantageous to  try  a  few crosslinkers  of  different  specificity,  and choose the 
optimal one by looking for either a band shift or absence of a corresponding band on 
Western blot12.
Table 20: Crosslinker specificity
Target functional 
group
Reactive group Instance crosslinkers
Carboxyl (C-terminus) Carbodiimide EDC  (1-Ethyl-3-[3-dimethyl-
11 Due to rather complex nature of defining real probability of crosslinking of two proteins, the numbers here serve only to  
compare different types of crosslinkers, i.e. only relation of these numbers is meaningful.
12 High molecular weight often fail enter a gel or transfer effectively to a membrane
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Target functional 
group
Reactive group Instance crosslinkers
aminopropyl]carbodiimide hydrochloride)
Amine
(N-terminus,  lysine 







EGS  (Ethylene  glycol  bis[succinimidyl-
succinate]),  DSP (Dithiobis[succinimidyl pro-
pionate])
DTBP  (Dimethyl  3,3´-dithiobispropion-
imidate•2 HCl)






BMB (1,4-Bismaleimidobutane),  DTME (Di-
thiobismaleimidoethane)
Any Diazirine
Hydroxyphenyl Azide NHS-ASA  (N-Hydroxysuccinimidyl-4-azido-
salicylic acid)
As the quintessence of the IVCL approach is to “freeze” interactions in the 
cells  in  a  closest  to  native  state,  it  is  preferable  to  use  membrane  permeable 
compounds. This will allow a direct fixation of cells with crosslinker, similar to the 
widely used formaldehyde. However, if a non-permeable compound has to be used, it 
is should still be possible to use the smallest amount of mild detergent sufficient for 
the crosslinker to have access to the cell. Alternatively, cells can be pre-crosslinked 
with formaldehyde.
Cleavability of crosslinkers, on the other hand, is not as crucial as membrane 
permeability.  Moreover,  non-cleavable  compounds  add  an  opportunity  to  map 
exactly sites of extramolecular crosslinking, giving information about regions most 
likely to interact (Rappsilber et  al.,  2000).  However,  for initial  analysis having a 
cleavable crosslinker is beneficial as it allows specific elution step, which minimises 
the amount of non-specific contaminants in the eluate.
Determining optimal conditions of crosslinking
The reaction  of  crosslinking,  as  any  chemical  reaction,  depends  on  many 
conditions such as concentration, temperature, pH and others.
The pH of the crosslinking reaction is the most important parameter, as even a 
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slight alteration might disrupt largely ionic binding of two proteins. Therefore, it is 
important to use a pH that is closest to the compartment of protein of interest and its 
possible binding partners (Table 21). Consequently, the pH of choice will limit the 
list  of  possible  crosslinkers,  as  different  reactive  groups  require  different  pH for 
optimal reaction. For example, the optimal pH for maleimides, functional groups of 
sulfhydryl crosslinkers, is 6.5-7.5, which is suitable for crosslinking proteins of the 
cytosol, but not those of the nucleus. On the other hand, imidoesters require more 
basic conditions of pH 8-10. This makes them more preferable in applications when 
nuclear or mitochondrial proteins are to be crosslinked. 
Table 21: pH of cellular compartments
Compartment pH Reference
Cytosol 7.09-7.35 Bright et al., 1987
Nucleus 7.74-7.95 Seksek and Bolard, 1996
Mitochondria 7.94-8.16 Abad et al., 2004
Lysosome 4-5 Pillay et al., 2002
The length and temperature of the crosslinking reaction are other factors to 
consider. If there is no particular requirement for the compound of choice, ambient 
temperature might be used for simplicity. In general, the higher the temperature, the 
faster the crosslinker reaction will proceed. However, excessive heat might denature 
proteins and strip their interactors. Consequently, 37°C should be an upper limit for 
IVCL when applied to most mammalian cells. Time, too, should be considered: a 
short time will introduce greater differences among samples, a long reaction time 
might  lead  to  complexes  dissociation  or  even  proteolysis  due  to  a  slow  rate  of 
crosslinking. Furthermore, it will senselessly increase the total time of the procedure.
When the reaction's pH, temperature and time are set, the buffer of choice and 
crosslinker  concentration  are  the  next  parameters  to  consider.  The  chosen  buffer 
should support the set pH and must not contain competing functional groups. The 
crosslinker concentration should be tested empirically by band shifting on Western 
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blot: successful crosslinking will change the molecular mass of protein of interest by 
the mass of the crosslinked interactor.
Lysis and pull-down conditions
Immunoprecipitation with a specific antibody is the best method to purify a 
covalently crosslinked complex of proteins, both because the antibody is added after 
the crosslinking reaction, thus eliminating potential problems with tags. Additionally, 
it also allows crosslinking and purification of the endogenous protein, rather than an 
overexpressed exogenous one. However, it  is not always available and, moreover, 
might fail to immunoprecipitate the complex due to an epitope being masked by a 
bound partner, which is especially relevant to monoclonal antibodies or polyclonal 
antibodies against a short peptide. Therefore, it is often necessary to use an affinity 
tag.
Conditions of lysis and purification depend largely upon the affinity tag used. 
Hence, the affinity tag should be chosen based on the crosslinker to be used. Ideally, 
the tag should allow for stringent binding and washing conditions and should lack the 
functional groups that are used for crosslinking. For example, the chitin binding tags 
affinity  to  chitin  is  lost  after  crosslinking  with  copper  orthophenanthroline,  a 
sulfhydryl crosslinker, most probably due to disruption of the tag's native structure 
(personal experience).
Since the crosslinking step introduces a covalent bond between the protein of 
interest  and its  partner  protein,  harsh  conditions  of  lysis  could  be  used to  allow 
greater solubilization. Moreover, it is possible to use denaturating conditions for lysis 
and protein purification. However, these conditions should be compatible with the 
tag used. Only polyhistidines affinity to a metal ion column and biotins affinity to 
streptavidin are capable of withstanding denaturating conditions (Tagwerker et al., 
2006). On the other hand, non-ionic detergents such as Triton X-100, NP-40 and 
Tween 20 often may be used at high concentrations without altering tag affinities and 
column integrity (refer to the manufacturers manual for the solid matrix of choice). 
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Ultrasonic waves should be used for effective lysis,  partially due to the genomic 
DNA shearing (McKee et al., 1977). On the occasion when lysis conditions must be 
beyond the range of tag compatibility, a dialysis step might be introduced between 
lysis and purification to facilitate renaturation.
Overview of in vivo crosslinking approach
Chemical crosslinkers are widely used in biological applications, including in 
conjugation with fluorophores or enzymes to antibodies, haptens to cargos and more. 
Development of highly sensitive tandem mass  spectrometry allowed use of  these 
bifunctional compounds in structural biology by crosslinking purified complexes and 
mapping  inter-  and intramolecular  interactions  by  analysing  crosslinked  products 
(Chen et al., 2010).
The approach developed here depicted in Fig 5.3.1, differs from the latter 
considerably. First of all,  purification and crosslinking steps are swapped in these 
two approaches. This allows the IVCL to catch transient interactions, but also might 
increase non-specificity. Second, the goal of IVCL is to identify partners of proteins 
that  otherwise  are  difficult  to  co-immunoprecipitate,  either  because  of  harsh 
solubilising conditions or transiency of interactions. On the other hand, crosslinking 
of  purified  complexes  aims  to  provide  information  about  the  structure  of  the 
complexes and their interacting domains. Although, once partners are identified, it is 
possible  to  use IVCL to  gain  information  about  domains  that  are  most  likely  to 
interact by analysis of crosslinked products.
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Fig 5.3.1: Schematic representation of the IVCL approach
A – Initial testing. DNA, encoding a protein of interest is subcloned into a plasmid, encoding an  
affinity tag and containing elements needed for expression of the fusion in target cells. The resulting  
plasmid is transfected into target cells and allowed to express. Different concentrations of crosslinker  
are  applied  and  mobility  of  the  fused  protein  is  analysed  with  a  specific  antibody.  The  least  
concentration of the crosslinker that decreases mobility of the protein should be determined.
B  –  Final  experiment.  Transfected  cells  are  crosslinked  using  a  determined  concentration  of  
crosslinker. After lysis, a dialysis step might be introduced to remove excess of detergent and salts.  
Cleavable crosslinkers  allow gentle  elution with washing buffer  containing cleaving reagent.  The  
eluate is then precipitated and analysed first by SDS PAGE, and then, if there are differences between  
the control and sample, by mass spectrometry.
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5.3.2 Application of the IVCL approach to NET29 and its mutant
Having  established  the  outline  of  the  method,  IVCL was  applied  to  SBP 
fusions of NET29 and its Y129F, Y133F mutant in order to determine its putative 
binding partner(s), responsible for the chromosome repositioning. The phospho-null 
mutant serves as the best control in this experiment, indeed, as it is different from 
wild type protein only by two amino acids. Hypothesising that phosphorylation of 
one or both of the tyrosines,  mutated in  the phospho-null  mutant,  is  vital  for an 
interaction  with  a  protein  directly  or  indirectly  linked  to  chromatin,  it  is 
consequential, that the phospho-null mutant should lack or, rather, have much less of 
the putative interactor co-precipitated than wild type NET29.
Analysis of the region of NET29 that contains putative phosphorylation sites 
revealed  a  high  number  of  lysines  (KQAKFAY129KDEY133EKFKL),  thus  a 
homobifunctional amine-targeting membrane permeable cleavable crosslinker DTBP 
was  chosen.  In  order  to  determine 
optimal  crosslinking  conditions, 
several  concentrations of DTBP were 
used on 3T3-L1 cells at fixed pH and 
time.  Resulting  crosslinked  material 
was lysed in  non-reducing conditions 
and  subjected  to  Western  blotting 
using  the  anti-NET29  antibody  (Fig 
5.3.2  a).  0.01%  DTBP  shows 
insufficient  crosslinking,  0.1% DTBP 
shows  optimal  crosslinking  with 
NET29 monomer,  dimer bands and a 
higher MW band that is specific to the 
wild  type  protein  and  not  the 
phosphonull  mutant.  0.2%  DTBP 
shows  excessive  crosslinking.  Based 
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Fig 5.3.2 a: Determination of the optimal  
concentration of DTBP
Different concentrations of DTBP were tested on  
3T3-L1 cell  expressing NET29 wild type  protein  
(wt)  or  phosphonull  mutant  (m).  *  -  NET29  
monomer, ** - NET29 dimer, *** - NET29 dimer  
with a crosslinked binding partner.
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on  this  test,  future  experiments  included  crosslinking  with  0.1%  DTBP  in 
triethanolamine pH 8.0 at room temperature for 15 min.
Next, the pulldown conditions were determined. NET29 was transfected into 
3T3-L1 cells as a fusion with an SBP tag and different combinations of buffers and 
detergents were tried. SDS proved to abolish SBP binding to streptavidin at minimal 
concentrations. The optimal tested conditions for pull-down was 1% Triton X-100 in 
TEN500 buffer and excessive sonication (Fig 5.3.2 b, A).
In the final experiment optimised conditions were used, but instead of harshly 
eluting  everything  from  streptavidin  beads,  a  gentle  elution  in  washing  buffer 
containing 100 mM of freshly added DTT was performed. This should have eluted 
only crosslinked material leaving bait (NET29-SBP) on the beads. Silver staining of 
the gel revealed a band of around 15 kDa that is present in NET29-SBP eluate but 
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Fig 5.3.2 b: A potential 15 kDa mediator of chromosome repositioning by NET29
A - IVCL followed by Western blot using anti-NET29 antibody. 1,4 - SBP input; 2,5 - NET29-SBP  
input; 3,6 - NET29Y129F/Y133F-SBP input; 7 - SBP pulled; 8 - NET29-SBP pulled; 9 - NET29Y129F/Y133F-
SBP pulled; 10 - SBP FT; 11 - NET29-SBP FT; 12 - NET29Y129F/Y133F-SBP FT.
B - Silver stained gel of eluted material. 1 - SBP eluate; 2 - NET29-SPB eluate; 3 - NET29Y129F/Y133F -  
SBP eluate. Arrow points at 15 kDa band that is co-precipitated with wild type NET29 fused to SBP.
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not  in  phosphomimetic  mutants  eluate  or  the  tag  alone  (Fig  5.3.2  b,  B).  Mass 
spectrometry analysis of a trypsin digest of this band is an ongoing collaboration 
with Dr Thierry Le Bihan.
5.4 Summary and conclusions
NET29 is evolutionary conserved and this suggests its important function in 
the  cell.  Combined  analysis  of  its  conservation  and  phosphorylation  prediction 
allowed identification of its dominant-negative mutant. The mutant mimicking the 
state of the protein without phosphorylation does not reposition chromosome 6 to the 
nuclear periphery. Therefore it is likely that the mutations disrupt NET29 binding to 
a protein that mediates the chromosome repositioning effect. In order to understand 
the  mechanism of  the  chromosome repositioning,  it  is  important  to  identify  this 
mediator.
Mutagenesis data suggests that NET29 exists  mainly in its phosphorylated 
form, at least in 3T3-L1 cells. On the other hand, its dephosphorylation will lead to 
disengagement from the bound chromosome loci and, therefore, is likely to present a 
mechanism of the regulation of the chromatin distribution.  The mechanism could 
function either in a time manner within the cell (i.e. in the cell cycle) or it could be  
distinct to a cell type (neurons, for example) and contribute to the tissue specific 
spatial genome organisation.
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CHAPTER VI: Discussion
The NE is no longer considered as a simple barrier between the cytoplasm 
and components of the nucleus. Instead, it has been shown to actively participate in 
many  vital  processes.  NETs  have  been  linked  to  nuclear  positioning,  cell  cycle, 
transcription, splicing, DNA replication and repair. Moreover, it is highly likely that 
INM proteins, functionally similar to lamins, are involved in regulation of chromatin 
organisation.  This study aimed to uncover potential  players of peripheral genome 
structuring and their possible post-translational regulation.
6.1 SUN2 and its potential links to chromatin
I first started out by looking at indication of differences in PTMs of abundant 
proteins in resting and activated lymphocytes. The cells have dramatic differences in 
the  distribution  of  peripheral  heterochromatin  between  the  two  states.  Several 
proteins that  seemed to have state-specific  PTMs were re-analysed using the NE 
proteome  datasets  in  order  to  confirm  the  predicted  modifications.  The  analysis 
revealed many phosphorylated residues of SUN2, LAP2β, emerin and LBR. I have 
focused  on  SUN2 mainly  because  of  its  role  in  linking  the  cytoskeleton  to  the 
peripheral nucleoskeleton, and its involvement in telomere anchoring. However, no 
effect on heterochromatin or the cytoskeleton upon overexpression of the generated 
phosphomimetic or phospho-null mutants of SUN2 was found.
Immunoprecipitation  followed  by  mass  spectrometry  identified  histone 
H2AX as a potential SUN2 interactor and I hypothesised that the interaction brings 
persistent  DNA double  strand  breaks,  marked  by  phosphorylated  H2AX,  to  the 
nuclear  periphery.  I  have  noticed  many  γ-H2AX-positive  spots  at  the  NE upon 
induced DNA damage.  However,  the  soluble  N-terminus  of  SUN2 did  not  show 
enrichment at these spots upon overexpression. The SUN2 part of the project was no 
longer pursued after this point, but there is a lot of potential remaining for SUN2 to 
be involved in chromatin rearrangement, cytoskeletal reorganisation or DNA double 
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strand break repair.
6.1.1 DNA repair and the NE
In  yeast,  DNA double  strand  breaks  have  been  shown  to  relocate  to  the 
nuclear periphery and associate with a nuclear pore sub-complex (Nagai et al., 2008). 
Oza et al. (2009) showed involvement of SUN domain-containing protein, Mps3p, in 
tethering of DNA DSB to the periphery. However, the molecular mechanism of this 
relocation remains unknown. One possible mechanism is suggested by my finding 
that  the DNA damage indicator  H2AX came down in immunoprecipitations with 
SUN2. Moreover, only the protocol that used DNAse I treatment before IP showed 
enrichment of H2AX in the co-precipitated material. Upon DNA damage, H2AX is 
rapidly  phosphorylated  and  is  recruited  to  the  chromosome  ends  near  DSBs. 
Therefore  it  would  seem  that  the  H2AX  likely  needs  to  be  phosphorylated  in 
response to DNA damage for it to interact with SUN2. 
The same protocol also used a cysteine crosslinking reagent, therefore it is 
possible that intermolecular crosslinking rather than DNAse I treatment explains the 
histone  enrichment.  However  the  nucleoplasmic  N-terminus  of  SUN2  does  not 
contain cysteines and therefore, provided that the interaction takes place inside of the 
nucleus,  crosslinking  cannot  explain  this  enrichment.  Thus,  I  hypothesised  that 
SUN2  interacts  with  γ-H2AX,  the  phosphorylated  histone,  and  this  interaction 
explains tethering of DSB to the NE.
In order to test  the hypothesis, I first established conditions of DNA DSB 
generations. I used both a topoisomerase inhibitor etoposide and UV light to induce 
DNA damage, and noticed that a few hours after induction many  γ-H2AX-positive 
loci were located at the NE. These most probably corresponded, as studies in yeast 
suggest, to slowly repaired breaks. Second, I generated a number of deletion mutants 
of SUN2, corresponding to its N-terminus. I showed that SUN2 is most likely to 
have 3 transmembrane domains and not one, as was described earlier (Hodzic et al., 
2004). This, however, preserves the previously suggested topology of the protein. 
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Contradictory to the initial hypothesis, the soluble N-terminus of SUN2 did not show 
enrichment at the γ-H2AX-positive loci.
There are a number of possible reasons why the soluble fragment of SUN2 
did not co-localise with  γ-H2AX and yet would not exclude the possibility of an 
interaction between full length SUN2 and the histone variant. First, folding of the 
soluble fragment could be different from the corresponding part of the full-length 
protein. However, this is something difficult to test as the structure of SUN2 is not 
yet resolved. Second, localisation at the NE could be mandatory for the interaction, 
either  because of  PTMs of SUN2 by a NE-anchored kinase or  other  enzyme,  or 
because of forming heterodimers with another necessary component,  for example 
SUN1. The latter raises possibility that it is SUN1 that interacts with γ-H2AX, and 
the histone was enriched in SUN2 IP due to SUN1/SUN2 heterodimerisation. This is 
supported by the observation in yeast where DSB were linked to a nuclear pore sub-
complex (Nagai et al., 2008). As it was mentioned in the introduction, SUN1 has also 
been shown to associate with the NPC (Liu et al., 2007).
Thus,  the  interaction  between  SUN  proteins  and  γ-H2AX  remains  to  be 
confirmed. The most crucial experiment would be to effectively knock-down SUN2 
(using siRNA) and quantify changes in peripheral γ-H2AX signal using the erosion 
macro that is used for chromosome repositioning quantification. If there would be a 
statistical difference between cells with and without SUN2, the project would prove 
viable. Then the possibility of interaction between γ-H2AX and C-terminus of SUN2 
should also be investigated. Although the C-terminus of SUN2 is presumably located 
in the NE lumen (Hodzic et al., 2004), it is still possible that a fraction of the protein 
adopts a different topology.
Mostly due to technical reasons (antibody availability and knockdown issues) 
and the time constrains, I had to switch the project. Several  reasons  led  me to work 
on NET29. First of all, the fact that chromatin can be actively translocated to the 
nuclear  periphery,  as  it  was  shown  in  the  case  of  DNA double  strand  breaks. 
Secondly, a screen in our laboratory identified several NETs that are able to affect 
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positioning of the LacO array integrated into a chromosome. What's more, some of 
the NETs appeared to have tissue-specific expression raising the possibility of the NE 
to be involved in tissue-specific chromatin organisation.
6.2 NET29 contribution to positional gene regulation in 
adipogenesis
One of the hypotheses  to  explain mechanisms of  the NE diseases implies 
involvement of NETs in chromatin organisation regulation. There are a number of 
chromatin-associated factors for which interaction with NETs and lamins have been 
shown. The factors include transcriptional repressors, DNA crosslinking factor BAF, 
histone modifying enzymes (histone deacetylase and histone acetyltransferase) and 
constitutive  heterochromatin associated  protein  HP1  (refer  to  introduction). 
However,  each  of  these  proteins  is  widely  expressed  and  cannot  explain  tissue-
specific phenotypes of the nuclear envelopathies. Therefore, there must be tissue-
specific NE components or chromatin-associated proteins, or combinations of both.
6.2.1 Tissue-specificity of NETs
Indeed,  based  on  research  I  also  contributed  to,  there  seems  to  be 
considerable tissue-specificity in the NE proteome. Identification of a large number 
of  putative  NETs  from  three  different  tissues,  liver,  muscle  and  blood,  allowed 
comparison of the NE proteome between the tissues. It is estimated that only about a 
third of all proteins identified by this approach were shared between the three tissues. 
Of  course,  it  is  only  estimation  and  the  number  of  identified  putative  NETs  is 
expected to differ to some degree from the real “ultimate” NE proteome of a cell 
type. First of all, every putative NET needs to be confirmed to reside within the NE 
by staining with a specific antibody of the corresponding tissue section. We have 
shown  that  over  70%  of  the  putative  NETs  show  NE  localisation  upon 
overexpression of tagged fusion proteins (Malik et al., 2010). The number might be 
higher as some of the proteins target to the NE only in specific cell lines, and not all 
possible  combinations  of  protein/cell  type  were  tested.  Second  of  all,  mass 
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spectrometry  analysis  of  complex mixtures  is  inherently  incomplete  and multiple 
independent repeats should be done to identify the vast majority of the proteins in the 
mixture.  We  have  also  shown  that  the  more  repeats  are  done,  the  more 
comprehensive the list of identified proteins is, with 5 repeats being a reasonable 
number (N Korfali, GS Wilkie, SK Swanson, V Srsen, J de las Heras, DG Batrakou, 
ARW Kerr, L Florens, and EC Schirmer, paper in submission). Hence, for each tested 
tissue we have done at least 5 repeats of independent mass spectrometry runs. And 
third of all, the tissues analysed were from different species. Liver and muscle were 
isolated from rat,  while peripheral blood was from human. However,  great tissue 
variability of NETs is likely to reflect a general tendency, and the more tissues are 
analysed, the less the number of shared proteins would be.
Existing  transcriptome  data  supports  tissue-specificity  of  novel  NETs. 
Moreover, we have done RT-PCR analysis of expression of some NETs in total RNA 
samples from multiple tissues and cell lines (Malik et al., 2010; Wilkie et al., 2010). 
This data also supports that certain NETs are more enriched in some tissues while 
being  expressed  at  low  levels  in  others.  NET-specific  antibody  staining  of 
commercial  blots  of  normalised  lysates  from  several  human  tissues  also  show 
significant differences in expression (N Zuleger, S Boyle, DA Kelly, J de Las Heras, 
DG Batrakou, V Lazou, GR Otti, N Korfali, KN Randles, GE Morris, DJ Harrison, 
WA Bickmore and EC Schirmer, in submission). Furthermore, we have shown that 
NETs may not localise to the NE in every cell line, suggesting that expression is not 
the only regulation mechanism of acquiring a tissue-specific NE proteome (Malik et  
al., 2010).
6.2.2 NETs that are induced during adipogenesis
The original indication of NETs being upregulated in adipocytes came from 
transcriptome data available at  biogps.org (Wu  et al.,  2009). qRT-PCR confirmed 
upregulation of all three tested NETs; NET4, NET29 and NET33.
Potentially,  NETs  could  play  many  different  roles  in  adipogenesis.  For 
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example, NET4 seems to withdraw cells from the cell cycle (Korfali et al., 2011) and 
senescence is one of the distinct features of differentiated cells. NET33 belongs to 
family of scavenger receptors, molecules that recognise low-density lipoprotein and 
therefore might play a role in signalling or mechanically anchoring lipid droplets to 
the NE at the ONM. NET29 seems to play a role in chromatin reorganisation during 
adipogenesis.
The application of microarray analysis during the course of this study allowed 
the simultaneous screening of many affected genes. Analysis of only one time point 
of 3T3-L1 differentiation revealed over a thousand genes that are affected during 
adipogenesis, including at least 9 novel NETs including the three already tested by 
qRT-PCR. 5 of  the  other  6  NETs were found to be  upregulated in  adipogenesis. 
NET50  is  an  INM  protein  that  is  targeted  almost  exclusively  to  the  NE  upon 
overexpression. A half of the protein has similarity to dehydrogenase and therefore 
could be playing role in triglyceride biosynthesis. mNET20 that was identified in 
muscle NE proteome contains O-acyltransferase domain and also could be involved 
in triacylglycerol synthesis. NET62 contains similarity to both S-malonyl and acyl 
transferases.  NET26 has  an  uncharacterised domain.  Similarly,  nothing is  known 
about mNET22.
NET3 is downregulated in adipogenesis. It was shown to be a part of NPC 
(Mansfeld et al., 2006). Interestingly, expression of many nucleoporins is diminished 
in  adipogenesis.  One  possible  explanation  would  be  that  differentiated  cells  are 
quiescent and no longer need to double the number of NPCs, so only nucleoporins 
with a short half-life are expressed at the same level.
6.2.3 Chromosome 6 relocation upon adipocyte differentiation
Historically, there were two models of chromatin organisation inside of the 
nucleus during interphase. The first model was proposed by Carl Rabl and enhanced 
by  Theodor  Boveri  and  postulated  that  interphase  chromosomes  have  distinct 
territories. A second theory postulated that chromosomes are randomly tangled in a 
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“spaghetti” manner. The Cremer brothers proved the first theory correct (reviewed in 
Cremer and Cremer, 2001). However, later studies suggest that both theories were 
right.  While  it  is  clear  that  chromosomes  do  occupy  distinct  positions,  studies 
visualising small chromosome loci clearly indicate that some of the loci are found far 
from  boundaries  of  corresponding  chromosome  territories.  Moreover,  internally 
located chromosomes appear less compact and are, most probably, tangled to some 
degree. Thus, internally located chromosome 19 was retained in the nucleus upon 
high  salt  treatment,  possibly  due  to  interlinking  with  other  central  chromosomes 
(Croft  et al.,  1999). Peripherally located chromosome 18, on the other hand, was 
released from the nuclei after the treatment.
A  few  studies  have  already  shown  chromosome  relocation  during 
differentiation (Stadler et al., 2004; Chambeyron and Bickmore, 2004; Mayer et al., 
2005), including adipogenesis (Kuroda et al., 2004; Szczerbal et al., 2009). Here we 
report that chromosome 6 is found more often at the nuclear periphery in 7 days 
differentiated 3T3-L1 adipocytes as compared to uninduced and 3 days differentiated 
cells.
It also has been reported that many chromosomes change their localisation 
upon the cells withdrawal from the cell cycle (Mehta et al., 2010). This is clearly not 
the case with the chromosome 6 in 3T3-L1 cell differentiation. The 3T3-L1 cells 
were induced to differentiate after reaching confluency, and the mitotic expansion of 
the  cells  takes  place  during  first  two  days  of  differentiation.  However  the 
chromosome 6 radial localisation is different between days 3 and 7 of differentiation.
The  consequences  of  the  chromosome  movement  are  questionable.  One 
expected outcome of this is a chromosome-wide effect on transcription. Thus, the 
ratio  of  up-  and  downregulated  genes  to  the  total  number  of  genes  on  each 
chromosome was calculated and plotted13 (Fig 6.2.3 a).
13 This analysis was done by Jose de las Jeras
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However, changes in chromosome 6 did not stand out compared to changes in other 
chromosomes. This would seem to contradict  the general idea of silencing at  the 
nuclear periphery, as the number of activated genes is higher than the number of 
downregulated genes. However it is possible that the activation is associated with 
gene looping away from the periphery. FISH staining of specific genes loci should 
provide an answer to this possibility.
Of course,  in  order  to  draw any conclusions,  repositioning analysis  of  all 
chromosomes should be done in this model system. Chromosomes 17 and 19 look 
particularly interesting as the first one seems to be comparatively most repressed and 
the latter - most activated in adipogenesis. Therefore analysis of the localisation of 
these  two  chromosomes  in  adipogenesis  should  indicate  whether  there  is  a 
correlation between chromosome positioning and whole chromosome transcription 
activation or repression.
Overall it seems that, at least in this model system, chromosome movement to 
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Fig 6.2.3 a: Relative changes in chromosomes expression during differentiation
Microarray data from undifferentiated and 9 days differentiated 3T3-L1 cells was analysed. For each  
chromosome  the  ratio  of  up-  and  downregulated  genes  to  the  total  number  of  genes  on  the  
chromosome is plotted. The chromosome 6 expression profile seems similar to that of many other  
chromosomes.
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the nuclear  periphery is  not likely to  directly correlate  with general activation or 
repression of particular chromosomes. On the other hand, the effect could be more 
specific  and  affect  particular  loci  on  the  chromosome.  One  possibility  could  be 
activation of specific genes by a membrane anchored transcription factor, or soluble 
transcription factor that is enriched at the NE due to binding to an NE-associated 
protein.  In  fact,  SREBF1,  a  major  transcription  factor  of  adipogenesis,  has  been 
shown  to  interact  with  lamin  A (Lloyd et  al.,  2002).  In  this  way,  bringing  a 
chromosome closer to the NE might facilitate activation of the genes that are under 
control of SREBF1. And, conversely, NE-associated transcription repressors could 
silence tethered loci. Mapping affected in adipogenesis genes to their chromosome 
loci shows that affected genes tend to cluster14 (Fig 6.2.3 b). However, only extensive 
FISH analysis using BAC clones containing affected genes could provide evidence 
whether some of those loci are located at the NE. Alternatively, application of the 
DamID  approach  (Guelen et  al.,  2008)  to  identify  lamina-associated  domains 
(LADs) of chromosomes in 3T3-L1 adipocytes, followed by comparison with the 
expression  data,  would  also  provide  evidence  regarding  peripherally  located 
chromosome loci.
14 This analysis was done by Jose de las Jeras
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Alternatively,  chromosome  repositioning  might  be  neither  a  cause  nor 
consequence of transcription activation/repression. One explanation could be that the 
chromosomes must be anchored to the NE in order to establish their chromosome 
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Fig 6.2.3 b: Genes affected in adipogenesis tend to cluster on chromosomes
Chromosome  locations  of  genes  upregulated  (in  red)  and  downregulated  (in  blue)  during  
adipogenesis are mapped on the mouse chromosomes. The affected loci often coincide in the same  
chromosome region suggesting that the nuclear location of a chromosomal locus may affect several  
genes involved in adipogenesis.
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territories.  Separation of individual  chromosomes into the chromosome territories 
keeps them organised so that processes such as replication, mitotic condensation and 
radial  repositioning would proceed flawlessly and without generating many DNA 
double strand breaks.  However,  in  dividing cells  they are anchored transiently  to 
allow  mitosis  and,  possibly,  randomly  to  some  degree.  With  cell  quiescence, 
chromosomes should be attached permanently, which is achieved by expression of 
NE-associated proteins that possess affinity towards either specific chromosomes or 
a set of chromosomes. And since passive tethering that could occur during mitosis is 
not possible, cells have an active mechanism to translocate chromosomes towards the 
NE for anchoring.
Interestingly, a study utilising Giemsa-like FISH analysis of several human 
chromosomes  argues  that  the  radial  chromatin  distribution  correlates  with  gene 
density (Küpper et al., 2007). Thus more gene-rich domains are located in the centre 
of  the nucleus,  whereas  gene-poor  regions  are  found preferably  at  the  periphery. 
Hence, chromosomes that contain more genes per chromosome size will have a more 
central location in the erosion macro analysis of the whole chromosome painting. It 
has also been shown that radial positioning of mouse chromosomes also correlates 
with gene density in several cell types, albeit to a lesser degree than in human cells 
(Mayer et al., 2005).
To address  this  hypothesis,  ratios  of  known protein-coding  genes  to  total 
DNA length have been plotted for each mouse chromosome (Fig 6.2.3 c). Consistent 
with  the  hypothesis,  mouse  chromosome  6  is  not  a  gene-rich  chromosome  and 
therefore it is located peripherally in quiescent differentiated 3T3-L1 cells. Again, 
positional  analysis  of  all  chromosomes  in  differentiated  adipocytes  is  needed  to 
prove this correlation.
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Data  available  for  human  cycling  and  quiescent  fibroblasts  chromosome 
positioning provides an opportunity to correlate a chromosomes gene density to its 
radial  localisation  in  the nucleus  (Mehta  et  al.,  2010).  The ratio  of  a  number  of 
known genes to the corresponding human chromosome size was plotted (6.2.3 d). 
The radial positioning of every chromosome in proliferating and quiescent cells is 
marked as  peripheral  (P),  internal  (I)  and intermediate  (IM).  However,  no  direct 
correlation is observed between gene density and chromosome radial positioning in 
any cells. In quiescent cells, however, chromosome positioning seems to correlate 
with  their  size  (Mehta  et  al.,  2010).  Thus,  the  large  chromosomes  are  located 
peripherally and the small ones - internally.
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Fig 6.2.3 c: Relative gene densities of mouse chromosomes
Number of known protein-coding genes was plotted as a ratio to respective chromosome length in kb.  
Several  chromosomes  appear  to  be  gene-rich:  2,  7,  9,  11,  17  and 19.  Data  was  extracted  from  
NCBIM37 database.
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6.2.4 Is NET29 likely to reposition during interphase or mitosis?
It is hypothesised that clonal expansion of 3T3-L1 cells, the two rounds of 
mitosis  following addition  of  the  differentiation  cocktail,  is  needed to  re-arrange 
chromatin  within  the  nucleus  and  thus  facilitate  expression  changes  during 
differentiation (MacDougald and Lane, 1995). Although it has been shown that the 
majority of chromatin remodelling happens shortly after induction of differentiation, 
i.e.  before  mitoses  (Siersbæk et  al.,  2011),  mitosis-dependent  changes  in  whole 
chromosome  localisations  also  seem to  be  important  for  cells.  Thus,  cells  from 
patients with HGPS have abnormal chromosomes positioning (Mehta et al., 2011). 
Consistent with this hypothesis, 3T3-L1 cells do not differentiate if clonal expansion 
is arrested at various cell cycle stages (Tang et al., 2003).
On the other hand, several studies have shown that affinity mechanisms can 
drive  changes  in  positioning  of  chromosome  loci  and  even  whole  chromosomes 
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Fig 6.2.3 d: Chromosome radial positioning does not correlate with gene density
Gene density  is  calculated  as  a ratio  of  a  number  of  known coding  genes  to  the  corresponding  
chromosome size.  P - peripheral,  I - internal,  IM - intermediate. Chromosome positioning data are  
from Mehta et al., 2010; Bridger et al., 2000; Boyle et al., 2001; Meaburn et al., 2008 and Meaburn  
et al., 2007.
Nuclear envelope transmembrane proteins in differentiation systems
(Finlan et  al.,  2008,  Kumaran  and  Spector,  2008).  Both  studies  used  artificially 
created affinities and no endogenous NETs that are able to relocate chromosomes 
have been reported until now.
NET29,  identified  in  the  NE proteomics,  had  an  effect  in  a  chromosome 
repositioning screen carried out in our laboratory. The overexpression of NET29 in 
mouse  pre-adipocytes  leads  to  chromosome  6  being  relocated  to  the  nuclear 
periphery.  Interestingly,  chromosome 6 is  also  relocated  to  the  nuclear  periphery 
during  normal  adipocyte  differentiation  and  that  correlates  with  up-regulation  of 
endogenous NET29.  This suggests that NET29 might  be one of the proteins that 
facilitate chromatin rearrangement during adipogenesis.
There  seem  to  be  at  least  two  different  mechanisms  of  chromosome 
repositioning: an ATP- and myosin-dependent and a mitosis-dependent. As NET29 is 
an  inner  nuclear  membrane  associated  protein  (Malik et  al.,  2010),  it  might  be 
involved  in  the  cell  cycle  dependent  mechanism.  We  have  noticed  that  NET29 
mediated  chromosome  repositioning  was  more  pronounced  after  3  days  post 
transfection when compared to 2 days. Therefore we have assumed that cell division 
is required for the induced repositioning without directly testing this. However in 
order to support this, both behaviour of chromosome 6 and localisation of NET29 
should be monitored in, and shortly after, mitosis.
Alternatively, NET29 could be a part of an active mechanism of bringing a 
chromosome  to  the  periphery,  similar  to  what  was  described  for  quiescent  cells 
(Mehta  et al., 2010). In this case, NET29 would provide only anchor points at the 
NE. It is possible that the active mechanism would at least partially reuse the same 
machinery that brings persistent DNA double strand breaks to the periphery. In fact, 
there is a potential link between DNA repair and aberrant chromosome positioning. 
Thus,  a  particular  family of microRNA was found to be upregulated in  a  HGPS 
mouse model and also upon DNA damage (Ugalde et al., 2011). Proliferating HGPS 
fibroblasts,  on the other  hand,  have a  chromosome distribution similar  to  that  of 
quiescent cells (Mehta  et al., 2011). Therefore chromosome repositioning might be 
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linked to DNA repair.
6.2.5 Effect of NET29 misregulation on transcription
A few studies aimed to find consequences of chromosome tethering to the 
NE. Thus,  Kumaran  and Spector (2008) have used LacO array integration into a 
human  chromosome and lamin  B fused  to  LacI  provided  tethering  point  for  the 
integrated  array.  First,  they  showed that  relocation  of  the  array  to  the  periphery 
required mitosis. Second, transcription of the integrated gene inserted into the same 
locus, under control of a minimal CMV promoter, was monitored. However its level 
was similar to that of control cells with the internally located locus. This lack of 
change could be due to the use of a viral promoter.
A similar mechanism was used by Reddy et al. (2008) with the exception that 
the GFP-LacI fusion was targeted to the NE by the C-terminal domain of emerin. 
This  combination,  however,  showed  repression  of  a  gene  included  in  the  array 
marker. Finlan et al. (2008) also used an affinity between LacO and LacI, the last one 
being  fused  to  the  INM  protein  LAP2β.  However  they  carried  out  microarray 
analysis of the cell line and found that, while chromosome-wide expression did not 
change significantly, genes located in 5 Mb regions flanking the array integration site 
did show repression.
Therefore,  transcription  of  genes  that  are  under  control  of  endogenous 
promoters seems to be affected by tethering of chromatin to the nuclear periphery. 
The discrepancies between the effects this relocalisation had on the expression of 
genes  within the vicinity  of  the tether  maybe a  consueqnce of differences  in the 
choice of peripheral tethering protein, the interaction partners of the tethering protein 
or in the exent and distribution of heterochromatin in the various cell lines used. 
Nonetheless, both studies used artificially created affinities between chromatin and 
the NE. On the other hand, NET29-mediated tethering allowed us to investigate the 
vivo consequences  of  chromosome  relocation  to  the  NE  following  endogenous 
interactions.
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Overexpression of NET29 in pre-adipocytes and, more so, down-regulation of 
NET29 in differentiating cells showed an effect on transcription. Affected genes were 
located  on  several  different  chromosomes,  including  chromosome  6.  The  other 
chromosomes could potentially be affected by NET29 in two ways. First, some of the 
chromosomes  could  also  be  tethered  to  the  nuclear  periphery  by  NET29 
overexpression  and,  conversely,  fail  to  relocate  upon  NET29  downregulation. 
Alternatively,  repositioning of a chromosome to the nuclear periphery is likely to 
displace another peripherally located chromosome with weaker affinity to the NE 
due to spatial constraints. Hence, overexpression of NET29 could indirectly cause 
some of the chromosomes to move away from the periphery. Therefore, all affected 
chromosomes should be tested individually in order to further validate microarray 
data.
It was noticed that some of the affected genes are important for myogenesis. 
Myogenesis is one of the alternative differentiation pathways for mesenchymal cells, 
which give rise to adipocytes. Thus, the gene that encodes chemokine (C-X-C motif) 
ligand 12 (Cxcl12, also known as Sdf1), located on chromosome 6, was upregulated 
upon NET29 knockdown. Cxcl12 has been shown to induce myogenic differentiation 
(Melchionna  et  al,.  2010).  On  the  other  hand  prolactin  family  2,  subfamily  c, 
member  2  (PRL2C2,  also known as  proliferin)  was  downregulated  upon NET29 
knockdown.  It  has  been  shown  to  inhibit  myogenic  differentiation  (Wilder  and 
Linzer, 1989). Therefore, the effect of NET29 upregulation in adipogenesis correlates 
with blocking myogenic differentiation. Given common progenitors of both fat and 
muscle tissue, it seems logical that activation of adipocyte differentiation should be 
accompanied by repression of differentiation into muscle or bone.
It is not entirely clear whether the observed changes in transcription are due 
to different localisation of chromosome 6 or any other untested chromosome, or if it 
is due to other unknown reasons. Moreover, it is not known whether chromosome 6 
fails to relocate to the nuclear periphery in differentiating cells with downregulated 
NET29. I have made several attempts to find this out, but FISH on differentiated 
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cells  has stopped giving a specific signal.  This is  most probably due to  different 
reagents being used as some of the originally used reagents are no longer supplied. 
While experiments in pre-adipocytes show that NET29 is a sufficient factor of the 
chromosome  movement,  it  is  not  known  whether  NET29  is  the  only  factor 
responsible for chromosome 6 peripheral location in adipocytes. What's more, there 
is a NET29 paralog, TMEM120B, which is similar to NET29 and is also upregulated 
during adipocyte differentiation. Therefore a double knockdown might be needed in 
order to block chromosome 6 relocation in differentiation.
The  possibility  remains  that  the  changes  in  gene  expression  are  not 
completely due to direct tethering of the chromosome loci, but are a consequence of 
affected regulators of gene expression such as microRNA, transcription inhibitors 
and activators. Indeed, if tethering of a locus containing a transcription regulator to 
the  periphery  affects  its  transcription,  expression  of  its  target  genes  will  also  be 
affected despite the localisation of the latter.
6.2.6 The dominant negative mutant of NET29
Multiple  alignment  of  the  NET29 protein sequence from different  species 
revealed a number of highly conserved regions in the protein, most notably a region 
within the N-terminus that is next to the NET29 first transmembrane sequence. As 
NET29 is an INM protein, it is likely that its N-terminus is involved in chromosome 
repositioning. Furthermore, this region contains highly conserved tyrosines that are 
predicted  to  be  phosphorylated  by  available  algorithms.  NetPhosK (Blom et  al., 
2004) weakly predicts the two tyrosins to be insulin receptor kinase targets. It has 
been  shown  that  the  insulin  receptor,  originally  membrane  anchored  in  the 
cytoplasm, is cleaved upon stimulation with insulin and translocated into the nucleus 
while retaining kinase activity (Podlecki et al., 1987). Hence we hypothesised that 
adding  differentiating  media  containing  insulin  to  3T3-L1  cells  promotes  insulin 
receptor cleavage and translocation into the nucleus, where it is able to phosphorylate 
NET29. This, in turn, might regulate the affinity between NET29 and chromatin. In 
order to test the hypothesis, the two tyrosines were mutated to either phenylalanines 
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or glutamic acids. Phenylalanine is very similar to tyrosine except that it is missing 
the OH-group and therefore cannot be phosphorylated. The glutamic acid residue, on 
the  other  hand,  is  negatively  charged  and,  therefore,  mimics  the  phosphorylated 
tyrosine state.
Overexpression  of  the  double  phosphomimetic  mutant  of  NET29  had  a 
similar  to  wild  type  effect  on  chromosome  6  relocation.  However,  the  double 
phospho-null mutant abolished the effect and chromosome 6 was found in the centre 
of the nucleus even more often than in untransfected cells. This defines the phospho-
null  mutant  as  a  dominant  negative  as  it  is  able  to  diminish  tethering  effect  of 
endogenously expressed wild type NET29 (Herskowitz, 1987). Comparison of the 
effects of phosphomimetic and phospho-null mutants to wild type protein suggests 
that NET29 is constitutively phosphorylated in pre-adipocytes. Hence chromosome 6 
repositioning effects in 3T3-L1 cells depend largely upon NET29 upregulation rather 
than post-translationally regulation, in contrast to our original hypothesis. However, 
it also most probably requires phosphorylation and it is possible that PTMs play an 
important regulatory role in the effect in other cell types or, for example, in mitosis.
The dominant negative effect of the NET29 mutant suggests that the protein 
forms oligomers, and each monomer must be phosphorylated in order for complex to 
have affinity to chromatin. This way, if the complex includes a non-phosphorylated 
monomer, it is unable to interact with a chromatin-associated protein.
Identification of a dominant negative mutant of NET29 offers us a unique 
reagent  for  pulldown experiments  aiming  to  find  NET29  binding  partner(s)  that 
mediate the chromosome tethering effect.
6.2.7 What makes repositioned chromosomes special?
The fact that specific chromosomes are repositioned within the nucleus, either 
rapidly  or  in  a  mitosis-dependent  manner,  suggests  that  the  chromosomes  have 
distinct features that are part of the affinity mechanisms.
One  possible  way  of  recognition  is  by  general  features  such  as  A,T-rich 
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regions corresponding to G bands, or a chromosome size. The last could be explained 
by low non-specific affinity between the NE and chromosomes, and therefore the 
bigger the chromosome, the more affinity towards the NE it has. This, however, does 
not account for differences in chromosome compaction where a larger chromosome 
could occupy less volume than a smaller one.
Another possibility is that each (or some) chromosome has a distinct feature 
that is potentially recognised by feature-specific factors. The feature is most likely to 
be sequence-specific, for example a short repetitive sequence within “junk” DNA, 
unique for each chromosome. This way, each chromosome potentially has a specific 
sequence that is recognised by a “reader” - a protein that binds that sequence. Hence, 
interaction of  the “reader” with an NE-anchored protein might  provide means of 
tethering  the  chromosome  to  the  NE.  And  loss  of  the  interaction,  either  due  to 
downregulation of one of the interactors expression (or both) or through their PTMs, 
will release the chromosome into the nuclear interior.
In order to investigate the possibility of chromosome barcoding, I would like 
to set up a de novo pattern search. The proposed brute force attack algorithm scheme 
should generate and check all possible sequence variations within a defined window. 
If searched for a 10 nucleotide long pattern, 410 (1048576) combinations are possible. 
Each combination  should  go  through a  pattern  search  in  individual  chromosome 
sequences and ratios between hit count and chromosome length should be compared 
between all chromosomes. A barcode pattern would be enriched in one chromosome 
compared to the other ones. However, if one combination takes about 1-2 min to 
compute (close to actual time), the whole search will take several years to complete. 
Therefore, either the task should be divided between many computers, or a faster 
search algorithm should be implemented.
According to this chromosome barcode hypothesis, NET29 might play a role 
of  NE  component  that  is  able  to  tether  a  specific  chromosome  to  the  nuclear 
periphery by interacting with a “reader” protein.
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6.3 Future directions
There are a number of questions that need to be answered before the role of 
NET29 in chromosome repositioning will be understood. First of all, whether the cell 
cycle is required for the repositioning effect to take place. This could be done by 
establishing a stable cell line transfected with a plasmid encoding NET29 under an 
inducible promoter. FISH analysis of chromosome 6 after simultaneously inducing 
quiescence  and  NET29  overexpression  in  the  cells  should  point  out  a  mitosis 
requirement, unless the chromosome undergoes repositioning upon cell quiescence in 
a control cell line. Second, investigation of chromosome 6 position in differentiated 
cells  with  downregulated  NET29  must  be  carried  out.  This  will  show  whether 
NET29 or a complex its associated with, is the only factor responsible for relocation 
of chromosome 6 in adipocytes. FISH staining using BAC clones containing genes 
affected  by  NET29  might  provide  evidence  of  correlation  between  specific  loci 
positioning  and  transcription  of  its  genes.  Also,  uncovering  of  a  molecular 
mechanism  of  the  chromosome  re-localisation  will  be  a  priority  task.  Mass 
spectrometry analysis of purified NET29 might confirm involvement of PTMs in the 
mechanism.  Despite  the  outcome  of  phosphorylation  analysis,  the  identified 
dominant  negative  mutant  of  NET29  serves  as  an  ideal  control  for  pulldown 
experiments aiming to find mediators of the chromosome repositioning. To identify 
possible characteristic features of chromatin associated with NET29 at the nucleotide 
sequence  level,  ChIP followed by next  generation  sequencing should  be  applied. 
Alternatively, the DamID approach could be used.
6.4 Final remarks
To summarise the current model, NET29 is an INM phosphoprotein that is 
expressed  at  a  low  level  in  pre-adipocytes.  Upon  terminal  differentiation  it  is 
upregulated  and  its  increased  concentration  at  the  NE  leads  to  chromosome 
repositioning (Fig 6.4, A), presumably by a mitosis-dependent affinity mechanism 
during  the  clonal  expansion  of  3T3-L1  cells  (Fig  6.4,  B).  The  chromosome 
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repositioning  includes  tethering  of  some  chromosomes  to  the  nuclear  periphery, 
which, in turn, leads to releasing of other peripheral chromosomes into the nuclear 
interior. The rearrangement also affects transcription of several genes either directly 
(by bringing them to the silencing peripheral environment or releasing from it) or 
indirectly  (by  altering  expression  of  transcription  regulators  such as  transcription 
factors, repressors and microRNA). And, finally, changes in transcription facilitate 
differentiation by suppressing alternative differentiation pathways.
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Fig 6.4: The current model of NET29-mediated chromosome repositioning effect
A - Upregulation of NET29 leads to chromosome tethering. In pre-adipocytes chromosome 6 (green)  
is located internally. Upregulation of either endogenous or exogenous NET29 leads to its increased  
concentration at the NE and a higher avidity to chromosome 6. Tethering of chromosome 6 to the  
periphery possibly displaces another chromosome into the nuclear interior.
B - Mitosis-dependent mechanism of chromosome tethering. Upon NE breakdown in prometaphase  
membranes  form micelles  that  comprise  NETs.  Micelles  that  include  NET29 are  concentrated  at  
chromosome 6. In telophase the NE is assembled back from the micelles. Affinity between NET29 and  
chromosome 6 brings the chromosome to the nuclear periphery, where it stays during interphase. 
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Comparative proteomic analyses of the nuclear envelope and
pore complex suggests a wide range of heretofore
unexpected functions
Dzmitry G. Batrakou, Alastair R.W. Kerr, Eric C. Schirmer⁎
Wellcome Trust Centre for Cell Biology and Institute of Cell Biology, University of Edinburgh, Edinburgh EH9 3JR, UK
A R T I C L E I N F O A B S T R A C T
Since the discovery of several inherited diseases linked to the nuclear envelope the number
of functions ascribed to this subcellular organelle has skyrocketed. However the molecular
pathways underlying these functions are not clear in most cases, perhaps because of
missing components. Several recent proteomic analyses of the nuclear envelope and
nuclear pore complex proteomes have yielded not only enough missing components to
potentially elucidate these pathways, but suggest an exponentially greater number of
functions at the nuclear periphery than ever imagined. Many of these functions appear to
derive from recapitulation of pathways utilized at the plasma membrane and from other
membrane systems. Additionally, many proteins identified in the comparative nuclear
envelope studies have sequence characteristics suggesting that they might also contribute
to nuclear pore complex functions. In particular, the striking enrichment for proteins in the
nuclear envelope fractions that carry phenylalanine–glycine (FG) repeats may be significant
for the mechanism of nuclear transport. In retrospect, these findings are only surprising in
context of the notion held for many years that the nuclear envelope was only a barrier
protecting the genome. In fact, it is arguably the most complex membrane organelle in
the cell.
© 2008 Elsevier B.V. All rights reserved.
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1. Introduction
The structure of the nuclear envelope (NE) is complex (for
reviews see [1–4]). It is a double membrane system continuous
with the endoplasmic reticulum (ER) that consists of three
connected but distinguishable membrane domains: the outer,
inner and pore membranes (Fig. 1A). The outer nuclear mem-
brane (ONM) is studded with ribosomes [5,6] and contains
many ER proteins in addition to having a set of unique
proteins, some of which appear to be involved in tethering the
nucleus to cytoplasmic filament systems [7–12]. Some of these
proteins in turn connect across the lumen of the nuclear
envelope to the inner nuclear membrane (INM), which
contains its own unique set of proteins (Fig. 1B; reviewed in
[3,13]). Many of these have been shown to bind both to the
intermediate filament lamin polymer [14–19] and chromatin
(reviewed in [20]). Nuclear pore complexes (NPCs) are inserted
at the pore membrane (PoM) that connects the ONM and
INM (Fig. 1A; reviewed in [4]). The NPCs regulate directional
transport of proteins and mRNA between the nucleus and
cytoplasm that exceed the measured maximum free diffusion
limit of ∼40–60 kDa [21] and can accommodate very large
molecules or complexes that have been experimentally tested
up to 39 nm diameter [22] (to put this in perspective the
longest dimension of an assembled ribosome is ∼25 nm). To
accommodate such large substrates, the NPCs are necessarily
large, on the order of 44 to 125MDa. These large complexes are
tethered to themembrane by at least three unique transmem-
brane proteins [23–28] that also contribute to a ring compo-
nent of the NPC in the NE lumen [29–31]. The lumen of the
nuclear envelope is largely unexplored territory, but is likely to
have its own unique functions.
NE proteins have now been shown to influence a wide
range of functions, although it is unclear whether their effects
are direct or indirect. These functions include nuclear mor-
phology and stability [32–36], nuclear anchoring/migration
within the cell [8–10], signaling cascades [37–40], and support
of DNA replication [41–43], transcription [44–46], and RNA
splicing [47]. Consistent with the notion that the nuclear
lamina carries out or facilitates a diverse range of basic cellular
functions, over a dozen inherited diseases and syndromes are
linked to lamins and certain associated NE proteins. NPC
proteins have also been linked to disease. These nuclear
envelope diseases include muscular dystrophies, lipodystro-
phies, neuropathy, cardiomyopathies, dermopathy, bone dis-
orders, and premature aging syndromes (reviewed in [48–51]).
The proteins thus far linked to disease are lamins A/C, B1,
and B2, emerin, LBR, LAP2, MAN1, Syne/Nesprin-1, FACE-1/
ZMPSTE24, torsin A, and the NPC proteins Aladin, and Nup62.
The favored hypotheses to explain how these proteins can
yield so many different diseases are: 1) reduced resistance to
mechanical stress, 2) disruption of gene regulation, 3) altera-
tions in cell cycle and signaling pathways. However, none of
these hypotheses can fully explain by themselves how
mutations in the same widely expressed proteins can yield
different diseases that each have distinctive tissue patholo-
gies. Correspondingly, it is hard to imagine the many func-
tions ascribed to lamins and associated proteins being due to
diverse enzymatic activities encoded within the same pro-
teins. The resolution in both cases likely involves additional
partner proteins that provide these functions and have yet to
be identified, hence the need for proteomic analysis.
The combination of its inclusion of cytoskeletal elements,
the lamin polymer, integral membrane proteins, NPCs, a
membrane and its lumenal content that is continuous with
the ER together with the many associations with chromatin
proteins, transport receptors and cargos, and indirectly
attached peripheral components of the cytoskeleton give the
NE a wide range of biochemical properties. This has the
consequence that any biochemical fractionationmethodology
will necessarily remove some true NE components and bring
along some contaminants. As the ONM is continuous with the
ER and connected to cytoplasmic filament systems [9,52] these
structures are difficult to separate. INM proteins bind chroma-
tin (reviewed in [20]) and in yeast the NPCs are connected to
nucleoplasmic filaments [53,54] that in turn connect to
telomeres [55,56]. All of these connections on both cytoplasmic
and nucleoplasmic faces of the NE and NPC further compound
difficulties in their purification.
2. The nuclear pore proteome
2.1. Pre-proteomics studies
As one of the largestmacromolecular complexes in biology it is
not surprising that most of the original characterization of the
NPC was through the electron microscope. This work deter-
mined that the Xenopus NPC had a diameter of ∼120 nm with
eight-fold radial symmetry perpendicular to the membrane
and a predicted mass of roughly 125 MDa [29,31,57] while the
yeast NPC was somewhat smaller at 55–72 MDa [58,59]. Thus
the NPC could be made up of a very large number of distinct
proteins. Determining its compositionwas therefore not trivial
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Fig. 1 –Schematic diagram of the NE with details of the NPC. (A) The nuclear envelope consists of outer and inner nuclear
membranes connected at the “poremembrane”. The outer nuclearmembrane (ONM) is continuouswith the rough and smooth
endoplasmic reticulum (ER). The inner nuclear membrane (INM) contains many unique integral proteins, which commonly are
associated with the intermediate filament lamin polymer. The pore membrane apposed to the nuclear pore complexes (NPCs)
contains specific integral proteins involved in membrane tethering of NPCs. Depending on their topology and membrane
subdomain, NE transmembrane proteins could have functions in the cytoplasm, nucleoplasm, or the perinuclear lumenal
space. SomeONM-specific proteins have been identified such as the Syne/Nesprin protein families, butmost proteins identified
in this region such as ribosomal proteins share functions with the ER. Only a few characterized proteins have both been shown
to contain most of their mass in the lumen, though more are likely based on proteomic results. (B) Many transmembrane
proteins of the INM directly interact with the lamin polymer and/or chromatin proteins, though only a small number of the first
identified proteins have been tested for such characteristics. Among these, LAP2ß interacts with the chromatin remodeling
protein histone deacetylase 3 (HDAC3). LAP2ß, emerin, andMAN1 all interact with the chromatin crosslinking protein BAF and
transcriptional repressors such as germ cell-less (Gcl). LBR binds to both the heterochromatin protein HP1 and histone H3, and
even lamins can directly bind to the core histones H2A and H2B. (C) The NPC proteomic studies identified many proteins that
recently have been mapped into a high resolution structure (compared to electron microscope images; [30]). A depiction of this
structure shows the rough positions of many nucleoporins and a density gradient of unstructured phenylalanine–glycine (FG)
repeat containing regions (represented as a haze around the NPC core components) that are thought to play a significant role in
the transport process.
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even in the eras of genomics and proteomics. As the average
mammaliannucleushas 2–3000NPCs [60] identificationofNPC
component proteins by biochemical fractionationwas initially
attempted and was successful in some cases. For example the
first individual NPC component identified was gp210 that was
isolated from a rat liver NE fraction and used to make anti-
bodies that labeled the NPCs by immunogold electron micro-
scopy ([61]; note this was originally called gp190 and renamed
after the gene was cloned 7 years later [28]). Many other NPC
proteinswere soon identifiedusing similar approaches and the
proteins were called nucleoporins or NUPs [62–64]. Many of
these antibodies cross-reacted among mammals, Xenopus
and yeast [65–67] thus facilitating cloning of NUPs. Xenopus
oocytes were the best system for biochemical purification
while yeast was themost genetically tractable, so thatmany of
the first NUP sequences were from yeast (e.g. NUP1 [66], NSP1
[68]). Once the first NUPswere identified it was discovered that
they tend to form subcomplexes with 3–5 proteins and this
rapidly facilitated further NUP identifications. For example p62
was among the first NUPs cloned [69] due to its abundance and
strong antigenicity and it was subsequently found to be part of
a complex with p54 and p58 in mammalian cells [70,71]. In
yeast Nup170p was found to be in a complex with Nup53p and
Nup59p [72] and Nic96p was identified through its interaction
with Nsp1p [73]. Many individual studies over nearly two
decades had identified 26 core NPC components in yeast
(Table 1) by the time that the first major proteomic studies
were done on the NPC. However, absent knowing how many
copies of each protein were in each NPC it was impossible to
gauge how many more components still needed to be
identified and it was generally thought that between 50 and
100 proteins would be required to account for the estimated 55
to 125 MDa mass predicted by electron microscopy.
2.2. The yeast NPC proteome
The first comprehensive determination of NPC composition
was the product of collaboration between the Rout, Aitchison
and Chait laboratories [74]. Critical to a successful proteomic
study is the choice of experimental system and the purity of
the fractions analyzed. This study used yeast (Saccharomyces
cerevisiae) because it had the highest NPC:nuclear volume
ratio of any organism tested [75]. A haploid yeast nucleus has
65–182 NPCs depending on the cell cycle stage [76]. Unlike
mammalian cells yeast do not have a lamina, which has the
advantage of less contamination from connections to such a
promiscuous structure and the disadvantage of losing the
added stability to NEs from the lamina during purification.
Yeast cells were spheroplasted, lysed and nuclei were isolated
on sucrose gradients. The chromatin was enzymatically
digested and extracted with heparin to isolate NEs. NPCs
were released from NEs with mild detergent followed by
isolation through their partitioning on a continuous sucrose
velocity gradient [58]. Three separate rounds of separation by
HPLC and SDS-PAGE yeilded 465 protein bands that were
digested and analyzed by matix-associated laser desorption
ionization time-of-flight (MALDI-TOF) mass spectrometry and
an additional 177 protein bands were analyzed by MALDI-ion
trap tandemmass spectrometry. A total of 174 protein identifi-
cations were made [74]. Among these were all previously
characterized NUPs, many proteins with known functions at
the NPC such as transport factors and chaperones,many other
proteins with known functions elsewhere that were consid-
ered to be contaminants, and 34 previously uncharacterized
ORFs.
All previously uncharacterized ORFs and several known
NUPs were genomically tagged with a protein A epitope and
tested in yeast for their localization at the NE by immuno-
fluorescence and specifically at the NPC by immuno-electron
microscopy. Those that fulfilled these criteria and also were
significantly enriched in a NE fraction by Western blot were
classified as core NPC components, a total of 30 proteins (two
of which are products of the same gene). Thus the yeast
proteomic analysis identified only 4 additional core NPC
components on top of those previously identified (Table 1).
An additional ten NPC-associated proteins that did not fulfill
their stringent criteria for inclusion as core components were






Nup1 17 1990 (2190694) Nup153 30 1993 (8422679)
Nsp1 33 1990 (2112428) Nup62 6 1990 (2295087)
Nic96 1 1993 (7688296) Nup93 3 1997 (9348540)
Nup145N 14 1994 (8044840) Nup98 40 1995 (7878057)
Nup145C 1 1994 (8044840) Nup96 1 1999 (10087256)
Nup133 0 1994 (7813444) Nup133 2 2001 (11564755)
Pom152 1 1994 (8138573) – – –
Nup42 29 1995 (7634338) NLP1/hCG1
(45)
14 1999 (10358091)
Nup49 18 1995 (1385442) Nup58 11 1991 (2050741)
Nup57 16 1995 (7828598) Nup54 8 1991 (2050741)
Nup82 2 1995 (7559750) Nup88 2 1997 (9049309)
Nup100 45 1995 (1385442) Nup98 40 1995 (7878057)
Nup116 47 1995 (1385442) Nup98 40 1995 (7878057)
Nup120 2 1995 (8557736) Nup160 3 2001 (11684705)
Nup157 2 1995 (8522578) Nup155 0 1993 (8458861)
Nup170 0 1995 (8522578) Nup155 0 1993 (8458861)
Nup159 28 1996 (8898365) Nup214/CAN 45 1994 (8108440)
Nup188 5 1996 (8682854) Nup188 3 2000 (11029043)
Gle1(62) 1 1996 (8848052) hGle1(85) 0 1998 (9618489)
Gle2(41) 0 1996 (8970155) Rae1/Gle2b
(41)
3 1997 (9370289)
Nup85 1 1996 (8816998) Nup75/Nup85 2 1996 (8816998)
Nup84 0 1997 (9166401) Nup107 3 1994 (8021268)
Ndc1 (74) 3 1998 (9864355) – – –
Nup53 4 1998 (9864357) Nup35 3 2002 (12196509)
Nup59 6 1998 (9864357) Nup35 3 2002 (12196509)
Nup192 4 1999 (10428845) Nup205 4 2000 (11029043)
Seh1 (39) 0 2000 (10684247) Sec13-like 0 2002 (12196509)
Nup60 0 2000 (10684247) – – –
CDC31 0 2000 (10684247) – – –
Pom34 1 2000 (10684247) – – –
– – – Pom121 24 1993 (8335683)
– – – Gp210 5 1990 (2184032)
– – – Nup358/
RanBP2
20 1995 (7775481)
– – – ALADIN (60) 1 2004 (15666842)
– – – Nup37 0 2002 (12196509)
– – – Nup43 1 2002 (12196509)
– – – Tpr (266) 0 1994 (7798308)
– – – Nup50 5 1997 (9073512)
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classified among those identified, leaving 134 of the 174
proteins identified classified as contaminants by the authors.
2.3. The mammalian NPC proteome
Subsequently the Matunis laboratory determined the compo-
sition of the mammalian NPC [77]. They used rat liver because
previous work had developed procedures for isolating extre-
mely clean fractions of nuclear envelopes from this material
[61,78–80]. These procedures take advantage of the relative
softness of liver as a tissue to lyse cells without breaking their
nuclei and also benefit from the stability conferred to theNE by
the lamin polymer to allow several steps of douncing, floating
contaminating membranes on sucrose cushions, chromatin
digestion and salt washes without fragmenting NEs. For fear
that someNPC componentsmight be also removedbyhigh salt
treatment, they however replaced the salt with heparin and
spermidine so that extraction would favor removal of just
histones. They next took advantage of the biochemical char-
acteristicsof the laminpolymer and its bindingpartners that are
highly resistent to extraction by high salt and detergent
treatments and tested a variety of mild detergents for those
that would solubilize NPC components while leaving lamina
components insoluble. They found that all well-characterized
NPC components could be extracted while leaving most of the
lamina components in the pellet using a hypotonic solution
containing a low concentration (0.3%) of the detergent Empigen
BB. Similarly to the yeast study, this material was separated by
HPLC prior to SDS-PAGE and analyzed using a combination of
single step and tandem mass spectrometry. Previously un-
characterized proteins were tagged with GFP and tested for
NPC colocalization using an antibody (mAb414) that recognizes
O-linked glycosylation on several nucleoporins [62]. This study
identified 23 proteins that were classified as core NUPs and 18
proteins classified as NPC-associated proteins (Table 1).
2.4. The revised NPC
The big surprise from both the yeast and mammalian studies
was the relatively small number of proteins identified. Original
estimates of protein content based on electron microscopy
studies had predicted between 50 and 100 distinct protein
components for the NPC [29,31,57]. The total number of only
∼30 can in part be explained by the observations that several
components have well above average molecular weights and
that many components are duplicated many times per NPC.
Based on the eight-fold symmetry of the NPC core NUPs would
be expected to be duplicated eight times, but the abundance of
many components suggested that they are represented 16 and
32 times within a single NPC [74,77]. Furthermore, the yeast
study excluded the Mlp (Tpr in mammals) proteins that make
upmuch of a “nuclear basket” extending into the nucleus from
the NPC that was observed in electron microscopy studies.
Nonetheless, even taking into account these considerations,
the totalmass of the coreNPC calculated fromsummingup the
components identified in the proteomic analyses (44 MDa in
yeast [74] and ∼60 MDa in mammals [77]) was surprisingly
lower than the mass predicted from electron microscopy
studies (55–72 MDa in yeast [58,59] and 125 MDa in mammals
[29,57].
A potential explanation for this discrepancy may lie in the
additional proteins that both studies identified, but excluded
because they did not fulfill their very conservative definition
for core NPC components. There are a great many NPC pro-
teins that have only transient associations during the trans-
port process. For example the Ran GTPase is a very abundant
protein that is involved in release of transport substrates from
NPC proteins in the nucleus (Fig. 2A). Importins and exportins
are transport receptors that bind to the transport cargo and
interact with “core” NPC components to facilitate transport of
the cargo through the central channel of the NPC (Fig. 2B
and C). These interactions presumably occur through repeat
motifs containing phenylalanine and glycine (FG repeats) that
appear on both NUPs and many transport receptors. Because
their associations are transient neither Ran proteins nor
transport receptors were considered as core NPC components,
yet due to their high abundance these proteins were also
identified in these studies and could moreover account for a
significant portion of themass difference between the calcula-
tions from the “core” NPC components and those measured
from electron microscopy studies. Even with these, however,
the mass difference of almost 2-fold for the mammalian NPC
would likely indicate the existence of additional proteins
not yet identified (either core components or transient NPC
proteins) that were extracted during the preparation of the
core NPC fraction. Another possibility is that some of the
proteins that were discounted because of other previously
characterized cellular functions and localizations actually
have separate functions at the NPC. For example the Sec13
proteins are known to function in vesicle formation in the ER
[81], yet also were shown to function in nucleo-cytoplasmic
transport [82]. Thus, additional NPC components might be
identified if these studies were repeated using multiple and
varied purification methodologies and if proteins identified
with distinct known cellular functions were also tested for
NPC function.
It is also worthy of note that the original 125 MDa mass
estimate for the NPC of higher eukaryotes was actually prin-
cipally determined from Xenopus, which was much more
accessible to analysis than mammalian nuclei. Thus it is
possible that the Xenopus NPC, not yet analyzed by proteomic
approaches, is larger than either yeast or mammalian NPCs.
Comparison of the yeast andmammalian NPCs would suggest
that if this is the case the mass difference likely is accounted
for mostly in more peripherally associated proteins because
the differences between the yeast and mammalian proteins
identified as core structural NPC components is smaller than it
appears (Table 1). While several proteins did not have
homologues, they nevertheless had analogues: although no
clear sequence homology links yeast Pom152 to the mamma-
lian Pom121, both are transmembrane proteins with similar
functions. Likewise yeast Ndc1 had no clear mammalian
homologue identifiable by genome mining and was not found
in the mammalian NPC study, but the mammalian Ndc1
analoguewas subsequently identified in a NE proteomic study
([26,83]; see below) giving direct support to the notion that
differences in purification methodologies will also contribute
to differences in identifications. The mammalian Nup50
appears to be an analogue of Nup2p in yeast, which was not
considered in the yeast proteomic study to be part of the core
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because its association is too dynamic. Although we cannot
tell if completely novel or as yet unidentified core components
are part of the Xenopus NPC until it has been also analyzed
by proteomics, nonetheless, blast searching yeast and mam-
malian nucleoporins against the Xenopus laevis and Xenopus
tropicalis genomes indicates only Nup133, PoM152, Gle1,
Fig. 2 –Transport through the NPC. (A) Transport through the central channel of the NPC is facilitated by the action of the small
GTPase Ran. RanGTP is concentrated in the nucleus and RanGDP in the cytoplasm. RanGAPs (Ran GTPase Activating Proteins)
facilitate conversion of the GTP to the GDP form in the cytoplasmwhile RanGEFs (Guanine nucleotide Exchange Factors) such as
RCC1 mediate replenishment of RanGTP in the nucleus. Ran is thus a very abundant protein that will be associated with NPC
proteins even though it is not part of the core NPC structure. (B) In nuclear import a transport cargo that has a nuclear
localization signal (NLS) (depicted as “⁎”) is recognized by the transport receptor importin α. Another transport receptor,
importin ß, then recognizes the importin α-receptor cargo and facilitates its transport through the central channel of the NPC.
This is thought to be mediated by interactions between the FG repeats on core NPC proteins and FG repeats on the transport
receptors that now coat the cargo. Once the receptor-cargo complex has passed through theNPC RanGTP in the nucleus binds to
importin ß to facilitate dissociation of the receptor-cargo complex and thus release of the free cargo into the nucleoplasm. (C) In
nuclear export a different kind of transport receptor called an exportin recognizes a nuclear export signal (NES) (depicted as “⁎”)
on the cargo and binds together with RanGTP. The complex then transports through the central channel of the NPC and GTP
hydrolysis initiated by the RanGAPs releases both the Ran and the exportin. (D) For RNA export several transport receptors have
been identified such as the Mex67-Mtr2 heterodimer. Several additional proteins, some of which contain FGs, have also been
found to be important that form a complex called the TREX complex in yeast. We propose that the many RNA-binding proteins
that harbor FGs identified in NE proteomic datasets might be part of an even greater complex of RNA-binding proteins that coat
the surface of the RNAs and expose FGs to interact with the FGs on the core NPC proteins and facilitate transport. The proteins
shown in Table 2 are good candidates for this task.
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Nup60, and PoM34 among the proteins listed in Table 1 do not
have homologs in frogs.
Phylogenetic analysis of the sequences of these core NPC
proteins brought another striking observation. The yeast NPC
proteins could be separated into pairs that clearly diverged
after a gene duplication event [84]. This is consistent with
predictions based on the yeast genome sequence of a general
genome duplication that was followed by asynchronous
differentiation of the duplicated genes [85]. The gene duplica-
tions expanded the range of phenylalanine–glycine (FG) repeat
motif NUPs and of beta barrel/alpha solenoid fold NUPs. These
latter are related to coatamer proteins and have been
suggested to facilitate bending of the pore membrane during
NE/NPC assembly [84]. Thus, though at the sequence level not
all NPC proteins are conserved, the central evolutionary
mechanism underlying their development argues that they
will be essentially conserved at the core.
3. The nuclear envelope proteome
3.1. Approaches prior to proteomics
The abundance (∼3 million copies per mammalian nucleus
[60]) and biochemical properties of the intermediate filament
lamins enabled their being the first NE proteins to be identified
[78,86]. Following on this the first NE transmembrane proteins
(NETs) identified were INM proteins that bound to lamins and
so were resilient to extraction by procedures for isolating NEs
that were based largely on the resistance of the supporting
lamin polymer to high salt and detergents. The lamin B
receptor (LBR) was so named because of its identification
through its binding to lamin B1 [19] while LAP1 and LAP2 that
also bind lamins were identified as major proteins in a NE/
lamina fraction that was used to generate monoclonal anti-
bodies [15,87]. The methods of discovering the next round of
NETs were surprisingly varied ranging from autoimmune
antibodies that stained the NE in the case of MAN1 [88] to a
2-hybrid screen for partners of a kinase of the postsynaptic
membrane in muscle that identified the Syne/Nesprin-1 pro-
teins [7].
As different groups were using different organisms to
identify NETs and the timing correlated with the beginning of
large-scale genome sequencing projects, once the first several
proteins had been identified, attempts were made to identify
related proteins through sequence similarity. This type of
analysis found the Syne/Nesprin-2 NE protein family from its
sequence similarity to Syne/Nesprin-1 [7], but it did not iden-
tify the Nesprin-3 family that was subsequently identified by
proteomics [12,83]. Moreover, the two first identifiedDrosophila
NETs do not have mammalian homologs (Otefin [89] and YA
[90]). Thus the only way to determine the components of the
NE would be directly through proteomic analyses.
3.2. Strategies for NE proteome determination
The continuity between the ONMand the peripheral ER on one
side and many connections to chromatin on the other require
creative approaches to the identification of NE proteins by
proteomics, especially after the high number of proteins
defined as contaminants in the NPC proteomes (provided
they are truly contaminants). Two studies that were relatively
similar in purifications yet different in strategies yielded
strikingly different results [83,91]. Both studies used equiva-
lent procedures for isolating mammalian NEs as were used in
the mammalian NPC study; however, the NEs were either
extracted to enrich for proteins associated with the inter-
mediate filament lamin polymer or to enrich for proteins
embedded in the membranes.
The first study from the Otto laboratory generated three
separate NE fractions: a chaotrope-insoluble fraction, a non-
ionic detergent-insoluble fraction and a salt-insoluble fraction
[91]. Extraction with chaotropes (4 M Urea, 200 mM sodium
carbonate) solubilizes the lamin polymer and most protein-
protein interactions, but has no effect on membranes so that
proteins embedded in the membrane are protected and
maintained in the membrane fraction. The extraction with
detergent (1% Triton X-100) should remove allmembranes and
so only proteins tightly bound to the lamin polymer should
remain. Finally extractionwith high salt (1MNaCl) should also
leave the lamina intact, but wash away soluble proteins that
are weakly associated with it. Each fraction was separated on
2-D gels, and the protein spots were excised and analyzed by
MALDI mass spectrometry. Proteins that were found in both
the chaotrope and detergent-resistant fractions were consid-
ered as candidate NETs. In this way they could remove con-
tamination from the ER and ONM proteins: as the chaotrope
fraction contains both NE and ER transmembrane proteins, it
alone is insufficient to distinguish INM proteins. This analysis
identified most, but not all, previously characterized INM
NETs, as well as mammalian Unc84A/SUN1 and a novel pro-
tein with no predicted functions that was named LUMA. Both
novel mammalian NETs were shown to target to the NE by
exogenous expression of the proteins fused to GFP [91].
Where the first study used a “comparative” approach to
exclude peripheral ER proteins that also were present in the
NE fraction, the second study from the Gerace and Yates
laboratories used a “subtractive” approach [83]. In this case a
microsomal membrane (MM) fraction was used to identify
peripheral ER proteins. The MM fraction was analyzed
separately from the NE fraction and all proteins appearing in
both fractions were subtracted from the NE fraction. As there
are no membranes in the nucleus besides the NE membrane
and contaminating membranes of the NE fraction should in
theory all also occur in theMM fraction, those transmembrane
proteins in just the NE fractions were considered to be true
NETs. Multiple NE fractions were also analyzed, but instead of
using chaotropes an alkali extraction (0.1 N NaOH) was used to
enrich for transmembrane proteins and salt and detergent
(400 mM NaCl, 1% Triton X-100) were combined in one
extraction to generate a cleaner lamina fraction. Combining
both fractions resulted in a more comprehensive analysis of
proteins with different biochemical characteristics as com-
pared to the other study in which the different fractions were
used to increase the stringency of inclusion. Fractions were
analyzed using Multi-Dimensional Protein Identification
Technology (MudPIT) [92,93], which couples tandem mass
spectrometry with multiple liquid chromatography steps
to analyze the complex mixture of peptides generated by
direct digestion of isolated membranes. This avoids loss of
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membrane proteins that are poorly resolved on 2-D gels [94].
Details of the method are given in [95]. The subtractive
approach was validated by the identification of all expected
previously characterized NETs in the NE fraction and their
absence from the MM fraction. Moreover, the numbers of
peptides recovered suggests that they are the most abundant
NETs and this is why theywere first identified by othermeans.
In addition, 67 previously uncharacterized putative NETs were
identified in the NE fraction, which were absent from the MM
fraction [83]. All of the original eight tested targeted to theNE in
the original study, suggesting that all would prove to be valid
identifications; however of the 2/3 now tested only ∼70% are
valid NETs that are integral to themembrane and target to the
NE (P. Malik, N. Korfali, N. Zuleger, V. Lazou, D. M. Kavanagh,
G. S. Wilkie, D. G. Batrakou, and E. C. Schirmer, in preparation).
Thus this method, like the NPC studies, still brings consider-
able contaminants. It appears, nonetheless, that some of this
failure rate is not due to mis-identification or contamination,
but rather to mis-prediction of transmembrane helices.
3.3. Comparison of benefits and disadvantages between
the two approaches
The “subtractive” and “comparative” approaches used to
identify NE-specific proteins both had limitations. The com-
parative approach disregarded NE-specific proteins that were
not associated with the salt and nonionic detergent-insoluble
lamina fraction, because no other basis was provided for dis-
tinguishing between the NE and ER transmembrane proteins
that were present in the membrane-enriched fraction. The
more conservative requirement of appearing in both mem-
brane-enriched and lamina-enriched fractions also served to
limit the number of identifications.
The subtractive approach had the disadvantage of dis-
regarding proteins that have functions in both the ER and the
NE. For example, a known ER protein, torsinA, appeared in
both NE and MM fractions. However, torsinA is now known to
move between the ER and INMwhere it interactswithmultiple
NETs [96].
While the subtraction limited the identifications, the
combining all proteins in membrane-enriched and lamina-
enriched datasets allowed for a more comprehensive analysis
that covered awider range of biochemical characteristics. This
approach is not unreasonable considering the wide range of
biochemical characteristics observed just for splice variants of
one of the first identified NETs, LAP1 [87]. There were three
variants of LAP1 recognized by a monoclonal antibody: the
smallest was extracted with less than 200 mM salt, the
intermediate sized variant was only about 50% extracted at
this salt concentration while the largest remained fully
associated with the lamin polymer [15]. Non-equivalence has
also been observed for different transmembrane proteins of
the NE with regard to their extraction to chaotropes and
different detergents. Just as empigen BB favored extraction of
NPC components over other integral membane proteins and
lamins, partitioning of NETs in the first NE proteomic study
indicated that emerin is more extractible by detergents than
many other NETs while LBR is more extractible by chaotropes
[91]. Thus the two studies highlight the persistent struggle
between comprehensive identifications and contaminants.
Another reason for discrepancies between datasets is the
randomness of getting single peptides into the mass spec and
in obtaining good fragmentation to make identifications.
In the present instance this was unlikely to be a primary
contributor to variation as 92.7% of the proteins identified in
the comparative study were also found in the subtractive
study. Moreover 32.9% of the proteins identified in the NPC
study were found in the comparative study (59.2% of core NPC
proteins) and 89.3% in the subtractive study (if accepting
variants or related proteins then this number jumps to 98.9%).
This argues that the subtractive study was the most compre-
hensive, but the caveat as discussed above is that it likely also
has the highest number of contaminants.
4. Recapitulation of other organellar functions
in the nuclear envelope
4.1. NPC and NE proteins with dual roles
There aremany previously characterized examples of proteins
that have dual functions in the NE and other cellular struc-
tures or organelles. The first was Sec13p that functions in both
ER vesicle formation [81] and NPC transport [82]. Additionally
the DEAD-box helicases An3 and Dbp5 that bind RNA were
also found to play an important role in RNA export [97–99].
Many core or peripheral NPC components have now been
found to play separate roles on mitotic chromosomes when
the NPCs are disassembled in mitosis. Ran, importinß and the
Nup107–160 complex have been found to function in mitotic
spindle assembly and on kinetochores [100–102].
NE proteins outside the NPC have also been found to have
dual localizations and/ or functions. Lamins were originally
thought to reside only under the inner nuclear membrane and
provide structural support [60]; however in the past several
years it has become apparent that lamins assemble and
function also in the nucleoplasm [103] and onmitotic spindles
[104]. Emerin is clearly an INM protein, binding to lamin A
[14,18], the INM protein MAN1 [17], the chromatin binding
protein BAF [105], the splicing factor YT521-B [106] and the
transcriptional repressors germ cell-less, Btf, and Lmo7 [107–
109], but emerin has recently been shown to function also in
the outer nuclear membrane and ER [110]. Nesprins were
named for their NE association, but are now recognized as a
complex family containing many splice variants located
throughout the cell [111]. Conversely Torsin A, like Sec13p,
was originally characterized as an ER protein but is now
known to normally sample the INM and accumulate there
with certain point mutants associated with disease [112,113].
Torsin A has also been found to bind LAP1 in the INM and
another protein that the authors renamed LULL1 and claimed
resides in the ER [96]. However LULL1 was originally identified
as NET9 [83] and has been confirmed in the INM [114].
Presumably NET9/LULL1, like Torsin A, can sample both
compartments.
4.2. Newly identified NE proteins with apparent dual roles
Only a small percentage of the total proteins identified in the
liver NE datasets were novel proteins with no predicted
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functions. Even among the 67 novel putative NETs identified,
nearly a third had predicted functions based on sequence
homology. An analysis of both predicted and characterized
functional regions indicates a wide range of functions
represented in both the NE and MM datasets (Fig. 2A;
[115,116]). These functions range from transport and signaling
functions to specialized functions of differentiated cells. Some
of the proteins associated with cell signaling might converge
on or add additional pathways to those recently identified at
the NE [37–40]. A clear enrichment in proteins associated with
DNA and RNA functions was noticable in the NE compared to
the MM. Lamins have been shown to have roles in DNA
replication [41,42], transcription [45,46], and RNA splicing [47],
but it is unclear whether lamin effects are direct or reflect their
serving as recruitment sites for specific enzymes. It has
already been shown that transcriptional regulators pRb and
germ cell-less respectively interact with lamins [46] and
several NETs [17,44,109]. These proteins are among those
identified in the liver NE dataset and so other proteins in this
dataset that function in DNA and RNA processes might also
mediate such lamin effects. Looking inmore detail at the types
of DNA functions represented in the NE dataset shows a
striking enrichment of proteins involved in chromatin orga-
nization and remodeling compared to the total proteins in the
human genome that function on DNA (Fig. 3A). For proteins
functioning on RNA there is both an abundance and enrich-
ment for those involved in RNA splicing and pre-mRNA
processing (Fig. 3B). Though less abundant, there is also
enrichment for those involved in mRNA end processing and
stability, RNA localization and rRNA metabolism. This indi-
cates that there are many potential mechanisms that could
direct disease pathology from the NE involving disruption of
gene expression beyond those currently being investigated.
Within the transporter category thereweremanypathways
at play in addition to the expected NPC transport-associated
proteins. This is not surprising in retrospect as regulated
transport of smaller molecules such as ions should be im-
portant in thenucleus andpotentially for disease, yet therehas
Fig. 3 –Functional distribution of proteins identified in the
liver NE and MM proteomic study. (A) As subtraction of all
proteins identified in the MM datasets would potentially
miss interesting proteins that are nonetheless enriched in
the NE, NE- and MM-enriched datasets were generated by
comparing the number of spectra recovered per run for each
dataset. If a NE protein had at least 5×more spectra thanwere
recovered in the MM or vice-versa they were included in
these datasets. The Panther (Protein ANalysis THrough
Evolutionary Relationships) Classification System [115,116]
was then used to organize proteins in each dataset according
to functional annotations. A clear enrichment for proteins
involved in DNA and RNA functions (DNA/RNA)was observed
in the NE compared to the MM. As only 2 proteins (b1%)
recovered in the liver MM had anything to do with DNA
function and 4 (1.7%) with RNA function, the % distribution of
all DNA or RNA functions in the human genome was
compared with that for the proteins recovered in the
NE-enriched dataset. The ratio of the percent of a function in
the NE to its percent represented in the total human
proteome is presented. (A) DNA functions represented 65/854
proteins in the NE-enriched dataset compared to 977/25431
proteins in the total human dataset (or 7.6% vs 3.8%). Within
the DNA set ther was a strong enrichment at the NE for
proteins involved in chromatin structure and remodeling. All
other categories showed a relative decrease in functions at
the NE. (B) RNA functions represented 330 of the 854 proteins
in the NE-enriched dataset compared to 4295 of the 25431
proteins in the total human dataset (or 38.6% vs 16.8%).
Within the RNA dataset functions in RNA splicing and
pre-mRNA processing were both abundant and enriched for.
Additionally functions inmRNA end processing and stability,
RNA localization and rRNA metabolism were enriched for,
though much less abundant.
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been very little focus in this area within the now chromatin-
oriented NE field. Inositol(1,4,5)P3 receptors were long ago
reported at the NE [117,118], and specific ones were also found
in the liver NE proteomic study that have been since directly
tested [119]. Other regulators of Ca2+ transport and signaling
were also found such as the ryanodine receptor, which has
since been shown to function in the NE from several studies
[120–122]. Indeed Ca2+ oscillations have been shown to affect
gene expression [123] and so regulation of ion transport could
also affect disease pathology through gene expression. Zn2+
transporters, Na2+/H+ exchangers and many other ion trans-
porters were also found in the NE proteomic datasets, many of
which have since been directly shown at the NE [124,125], and
there was a striking enrichment for electron transporters.
Detailed analysis of the enrichment in signaling proteins
indicates that lipid signaling mechanisms in particular could
be important in transducing signals to the nucleus in a sepa-
rate or backupmechanism to those that dependon transport of
molecules through the NPC. In support of this NET39 that was
identified in the liver NE proteomic study and confirmed at the
NE [83] is a lipid phosphatase/lipid phosphotransferase of the
candidate sphingomyelin synthase class and thus also now
calledCCS2ß [126]. This is the least studied subclass of the lipid
phosphatase/transferases, but others have been shown to play
roles in regulation of cell growth and survival. There appear to
be many proteins in the NE involved in these processes as
NET13, also identified in the liver NE study, has now been
shown to be a sphingomyelin synthase [127].
The various biochemical functions observed for these
proteins and our confirmation of their partial representation
in the NE has significant implications for many aspects of NE
biology. Some studies have argued that nuclear membrane
growth during interphase requires vesicle fusion or that ER
membranes perfuse around the NPCs, but the identification of
several enzymes involved in lipidgeneration inbothNEdatasets
argues for de novo generation of lipid during interphase when
theNEgrows3- to 4-fold.The recently reported functionofNET8
(LPGAT1) as a phosphatidylglycerol acyltransferase [128] could
serve todirect lipid content in thenuclearmembrane,whichhas
been reported to be one of the subcellular membranes contain-
ing phosphatidylglycerol [129]. Themembrane trafficking func-
tion of NET24 (ERGIC-32; [130]) could have relevance for NE
disassembly as Rab5 (which also appeared in theNE proteomics
datasets) functions in NE disassembly in addition to its normal
vesicle transport role [131]. Similarly, the signaling roles of
emerin, MAN1 and AKAP149 [37–40] could be facilitated by
functionsofNETs45and55 that respectivelyhavebeen reported
to directly function in signaling and to be a homolog of a protein
involved in signaling [132–134]. Thus these NETs could be
involved in signal transduction pathways similar to those of the
well-characterized NET MAN1 in Smad/BMP/TGFß signaling
[135].
5. Future directions
5.1. Tissue variation in the NE proteome
There is precedent for tissue differences in NE proteins from
the distribution of different lamin subtypes that have been
shown to vary in relative concentrations during development
and in different tissues [136–138]. There are also tissue-
specific splice variants of lamins such as the lamin C2 that
appears during spermatogenesis [139]. Although the first
identified NETs were widely expressed, comparison of the
novel NETs identified in the liver proteomic study to a
transcriptome database [140] indicated that a significant
percentage of the proteins recovered were preferentially
expressed in liver and/or had restricted tissue expression
[13,141]. Moderate tissue variation has been reported recently
in proteomes from mitochondria and other organelles
[142,143]. A current study analyzing the NE proteome from
several different tissues confirms that there is not only
considerable tissue variation in the NE proteome but further
suggests that there is more variation in the NE than these
other subcellular organelles (N. Korfali, G.S Wilkie, E.A.L.
Fairley, S.K. Swanson, D.G. Batrakou, P. Malik, A.R.W. Kerr, L.
Florens, and E.C. Schirmer, in preparation).
The finding of tissue variation in the NE proteome together
with observations that different epitopes on NE proteins are
occupied in different tissues [144] argue that tissue-prefer-
ential binding partners of the NE proteins mutated in disease
might mediate the tissue-preferential phenotypes of the wide
range of NE-related diseases [13,145]. Different diseases pre-
ferentially affect muscle, neurons, bone, skin, heart, fat, and
immune cells. Some diseases have partial overlap between a
subset of these tissues. Thus a particular point mutant might
disrupt a functional complex in one tissue where a specific
partner within the complex is expressed, but have only a
minimal effect on a different functional complex in another
tissue where a different partner that has slightly different
binding characteristics occupies the same general binding
site. If this is the case, then determining the protein com-
position of the NE in different tissues may be critical to
understanding these diseases. As variation will likely mostly
occur in terms of relative amounts of protein as opposed to all
or none effects, it will also be important for such future
analyses to be performed using recently developed quantita-
tive approaches such as SILAC, iTRAQ, and protein correlation
profiling.
This also applies for the NPC as a study on the integral NPC
component gp210 revealed that it has restricted tissue expres-
sion in mammals [146]. It is nonetheless essential for viability
in C. elegans by RNAi [147]. Gp210 was also reported to be
essential in HeLa cells [147] but other studies found that it
could be deleted and that, rather, another integral NPC com-
ponent, NDC1/NET3, is essential in HeLa cells [26,148,149].
Interestingly, they also found thatNDC1was not essential in C.
elegans [148]. It is possible thus that different combinations of
NPC components are expressed in different tissues, thus
rendering them essential depending on the tissue being
sampled. Accordingly it will be important to directly compare
knockdown of several different NUPs over a panel of tissues.
This, however, also means that aspects of nuclear pore
structure and function may differ between different tissues
and indicates a need to compare theNPCproteome in different
tissues using identical extraction methodologies and quanti-
tative approaches so that differences in extractability due to
different detergents or salt concentrations used are not mis-
read as tissue variation.
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5.2. A further use of proteomics to gain structural insights
into the NPC
The two NPC proteomic studies were considered at the time to
be the definitive conclusion to NPC proteomics, but a recent
yeast study indicates that mass spectrometry can contribute
much more to understanding the NPC even without counting
potential tissue variation. This study performed rapid pull-
downs with each component of the NPC followed by quanti-
tative mass spectrometry to identify binding partners and
their ratios [30,150]. Stringent conditions were used so that by
comparing the ratios of NUPs in different fractions those most
likely to be in direct contact with one another could be
ascertained. These data were combined with position mea-
surements from immuno-electronmicroscopy for epitopes on
NUPs and other available data to generate what is by far the
highest resolution structure of the NPC to date [30]. This
structure gives a more detailed view of the internal structure
of the core NPC and the organization of the many core NUPs
that is diagrammed schematically in Fig. 1C.
5.3. Additional NPC proteins in the NE proteome datasets?
It is noteworthy that the integral NPC component NDC1/NET3
was not identified in the mammalian NPC proteomic study
[77], apparently due to its resilience to the extraction with
empigen BB that was used to isolate the NPC proteins as their
method relied on extracting NPC components from the
membrane and lamina. NDC1/NET3 was, however, identified
in the less conservative study of the NE that enriched for
transmembrane proteins [83] and was later shown to be the
third integral component of the NPC in mammalian cells
[26,27,148] (it had previously been identified in yeast, but was
too divergent for mammalian homologs to be identified by
genome searching [23]), and this suggests that other proteins
may have been missed in the NPC studies that appear in the
NE proteomic datasets. If this is the case, it might account in
part for the large differences between themasses predicted by
electron microscopy studies and the final masses calculated
from the proteins identified in the proteomic studies.
Searching the liver NE datasets for characteristics of NPC
proteins such as the appearance of FG repeats indicates that
proteins containing this motif are significantly enriched in the
NE compared to the whole genome. FG repeats were observed
in some of the first NUPs identified and it soon became
apparent that they represented a common motif among most
of the NUPs when three NUPs were identified using an
antibody that recognized regions containing a GLFG motif:
NUP49, NUP100 and NUP116 were found to have respectively
13, 29 and 33 GLFG repeats [151]. It is noteworthy, however,
that only 10 of the 30 core NUPs have six or more FG repeats
and 13 have one to five FGs (Table 1). Thus very large numbers
may not be required for some FG functions. The FG repeat
regions of NUPs are thought to be disordered [152] and tend to
have N30% of polar residues between them. It has been
suggested that the FGs within unstructured regions interact
within the central channel of the NPC to provide an entropic
barrier to passive diffusion [153], though the exact nature of
that barrier is the subject of active debate [154,155]. One
possiblemechanism for transport through the entropic barrier
would be exchange of FG interactions in the barrier with FG
motifs on the surface of proteins associated with transport
cargos [156]. The transport receptor importinß has 3 FG
repeats so that coating the surface of the substrate cargo
with importinß could potentially provide these FG repeats on
the outer surface to facilitate navigation through the central
channel (Fig. 2B). If this hypothesis is correct, then other
proteins that have FG repeats could similarly coat cargoes to
facilitate their transport. A general search of all proteins in the
human genome database reveals that only 1.86% have 5 or
more FG repeats with 30% or more polar residues between at
least 4 of them. In contrast, in the liver NE-enriched dataset of
proteins 5.3% of proteins fulfill these criteria. It is particularly
interesting that some DEAD box helicases have been shown to
be important for nuclear export of mRNAs (including DEAD
box protein 5 that has 5 FGs; [98,99]) and among the com-
ponents of the TREX complex that is important for RNA export
[157] is Sub2p, a DEAD box ATPase containing 2 FGs [158].
Strikingly, several of the liver NE proteins carrying multiple
FGs are also RNA binding proteins including DEAD box
proteins (Table 2). Thus if these stay bound to the mRNA
during the process of transport they might facilitate the act of
transport by coating the surface of the RNA with FGs (Fig. 2D).
These observations indicate that the NE has a great many
more functions and diversity than ever considered. To gain
clarity of these functions it will be necessary to sample further
methods of enrichment to reduce the number of contami-
nants and also to sample from different tissues, in both cases
using new quantitative approaches. Even in the absence of
further sampling,mining of the existing NE proteome datasets
should yield considerable treasure for many years to come.
Acknowledgements
D.G. Batrakou is supported by the Darwin Trust: A.R.W. Kerr
and E.C. Schirmer are supported by the Wellcome Trust.
R E F E R E N C E S
[1] Hetzer MW, Walther TC, Mattaj IW. Pushing the envelope:
structure, function, and dynamics of the nuclear periphery.
Annu Rev Cell Dev Biol 2005;21:347–80.
Table 2 – RNA-binding proteins with FG repeats separated
by polar residues found in the liver NE datasets
FG repeats Protein name Accession
9 hnRNP core protein A1 NP_058944.1
9 hnRNP A2/B1 isoform 1 NP_058086.2
8 RNA binding motif protein 19 XP_222200.4
6 hnRNP M NP_446328.1
6 hnRNP A0 XP_001001311.1
6 U5 snRNP-specific protein, 116 kDa XP_001081526.1
6 DEAD box polypeptide 42 XP_001081592.1
Criteria used to search for FG repeat containing proteins were 5 or
more FG repeats, at least 4 of which have ≥30% polar residues
between them (provided N3 residues separate the FGs).
66 J O U R N A L O F P R O T E O M I C S 7 2 ( 2 0 0 9 ) 5 6 – 7 0
[2] Prunuske AJ, Ullman KS. The nuclear envelope: form and
reformation. Curr Opin Cell Biol 2006;18:108–16.
[3] Schirmer EC, Foisner R. Proteins that associate with lamins:
many faces, many functions. Exp Cell Res 2007;313:2167–79.
[4] Suntharalingam M, Wente SR. Peering through the pore:
nuclear pore complex structure, assembly, and function. Dev
Cell 2003;4:775–89.
[5] Callan HG, Tomlin SG. Experimental studies on amphibian
oocyte nuclei. I. Investigation of the structure of the nuclear
membrane by means of the electron microscope. Proc R Soc
of Lond [Biol] 1950;137:367–78.
[6] Fry DJ. The nuclear envelope in mammalian cells.
In: Jameson GA, Robinson DM, editors. Mammalian Cell
Membranes. Woburn, Mass: Butterworth; 1976. p. 197–265.
[7] Apel ED, Lewis RM, Grady RM, Sanes JR. Syne-1, a
dystrophin- and Klarsicht-related protein associated with
synaptic nuclei at the neuromuscular junction. J Biol Chem
2000;275:31986–95.
[8] Malone CJ, Fixsen WD, Horvitz HR, Han M. UNC-84 localizes
to the nuclear envelope and is required for nuclearmigration
and anchoring during C. elegans development. Development
1999;126:3171–81.
[9] Starr DA, Han M. Role of ANC-1 in tethering nuclei to the
actin cytoskeleton. Science 2002;298:406–9.
[10] Starr DA, Han M. A genetic approach to study the role of
nuclear envelope components in nuclear positioning.
Novartis Found Symp 2005;264:208–19 discussion 219–230.
[11] Zhang Q, Skepper JN, Yang F, Davies JD, Hegyi L, Roberts RG,
et al. Nesprins: a novel family of spectrin-repeat-containing
proteins that localize to the nuclear membrane in multiple
tissues. J Cell Sci 2001;114:4485–98.
[12] Wilhelmsen K, Litjens SH, Kuikman I, Tshimbalanga N,
Janssen H, van den Bout I, et al. Nesprin-3, a novel outer
nuclear membrane protein, associates with the cytoskeletal
linker protein plectin. J Cell Biol 2005;171:799–810.
[13] Schirmer EC, Gerace L. The nuclear membrane proteome:
extending the envelope. Trends Biochem Sci 2005;30:551–8.
[14] Clements L, Manilal S, Love DR, Morris GE. Direct interaction
between emerin and lamin A. Biochem Biophys Res
Commun 2000;267:709–14.
[15] Foisner R, Gerace L. Integral membrane proteins of the
nuclear envelope interact with lamins and chromosomes,
and binding is modulated by mitotic phosphorylation. Cell
1993;73:1267–79.
[16] Hodzic DM, Yeater DB, Bengtsson L, Otto H, Stahl PD. Sun2 is
a novel mammalian inner nuclear membrane protein. J Biol
Chem 2004;279:25805–12.
[17] Mansharamani M, Wilson KL. Direct binding of nuclear
membrane protein MAN1 to emerin in vitro and two modes
of binding to barrier-to-autointegration factor. J Biol Chem
2005;280:13863–70.
[18] Sakaki M, Koike H, Takahashi N, Sasagawa N, Tomioka S,
Arahata K, et al. Interaction between emerin and nuclear
lamins. J Biochem (Tokyo) 2001;129:321–7.
[19] Worman HJ, Yuan J, Blobel G, Georgatos SD. A lamin B
receptor in the nuclear envelope. Proc Natl Acad Sci U S A
1988;85:8531–4.
[20] Mattout-Drubezki A, Gruenbaum Y. Dynamic interactions of
nuclear lamina proteins with chromatin and transcriptional
machinery. Cell Mol Life Sci 2003;60:2053–63.
[21] Paine PL, Moore LC, Horowitz SB. Nuclear envelope
permeability. Nature 1975;254:109–14.
[22] Pante N, Kann M. Nuclear pore complex is able to transport
macromolecules with diameters of about 39 nm. Mol Biol
Cell 2002;13:425–34.
[23] Chial HJ, Rout MP, Giddings TH, Winey M. Saccharomyces
cerevisiae Ndc1p is a shared component of nuclear pore
complexes and spindle pole bodies. J Cell Biol
1998;143:1789–800.
[24] Greber UF, Senior A, Gerace L. A major glycoprotein of the
nuclear pore complex is a membrane-spanning polypeptide
with a large lumenal domain and a small cytoplasmic tail.
EMBO J 1990;9:1495–502.
[25] Hallberg E, Wozniak RW, Blobel G. An integral membrane
protein of the pore membrane domain of the nuclear
envelope contains a nucleoporin-like region. J Cell Biol
1993;122:513–21.
[26] Mansfeld J, Guttinger S, Hawryluk-Gara LA, Pante N, Mall M,
Galy V, et al. The conserved transmembrane nucleoporin
NDC1 is required for nuclear pore complex assembly in
vertebrate cells. Mol Cell 2006;22:93–103.
[27] Lau CK, Delmar VA, Forbes DJ. Topology of yeast Ndc1p:
predictions for the human NDC1/NET3 homologue. Anat Rec
A Discov Mol Cell Evol Biol 2006;288:681–94.
[28] Wozniak RW, Bartnik E, Blobel G. Primary structure analysis
of an integral membrane glycoprotein of the nuclear pore.
J Cell Biol 1989;108:2083–92.
[29] Akey CW, Radermacher M. Architecture of the Xenopus
nuclear pore complex revealed by three-dimensional
cryo-electron microscopy. J Cell Biol 1993;122:1–19.
[30] Alber F, Dokudovskaya S, Veenhoff LM, Zhang W, Kipper J,
Devos D, et al. The molecular architecture of the nuclear
pore complex. Nature 2007;450:695–701.
[31] Hinshaw JE, Carragher BO, Milligan RA. Architecture and
design of the nuclear pore complex. Cell 1992;69:1133–41.
[32] Lammerding J, Schulze P, Takahashi T, Kozlov S, Sullivan T,
Kamm R, et al. Lamin A/C deficiency causes defective
nuclear mechanics and mechanotransduction. J Clin Invest
2004;113:370–8.
[33] Liu J, Ben-Shahar T, Riemer D, Treinin M, Spann P, Weber K,
et al. Essential roles for Caenorhabditis elegans lamin gene in
nuclear organization, cell cycle progression, and spatial
organization of nuclear pore complexes. Mol Biol Cell
2000;11:3937–47.
[34] Rowat AC, Lammerding J, Ipsen JH. Mechanical properties
of the cell nucleus and the effect of emerin deficiency.
Biophys J 2006;91:4649–64.
[35] Schirmer EC, Gerace L. The stability of the nuclear lamina
polymer changes with the composition of lamin subtypes
according to their individual binding strengths. J Biol Chem
2004;279:42811–7.
[36] Schirmer EC, Guan T, Gerace L. Involvement of the lamin rod
domain in heterotypic lamin interactions important for
nuclear organization. J Cell Biol 2001;153:479–89.
[37] Osada S, Ohmori SY, Taira M. XMAN1, an inner nuclear
membrane protein, antagonizes BMP signaling by
interacting with Smad1 in Xenopus embryos. Development
2003;130:1783–94.
[38] Pan D, Estevez-Salmeron LD, Stroschein SL, Zhu X, He J, Zhou
S, et al. The integral inner nuclear membrane protein MAN1
physically interacts with the R-Smad proteins to repress
signaling by the transforming growth factor-{beta}
superfamily of cytokines. J Biol Chem 2005;280:15992–6001.
[39] Steen RL, Martins SB, Tasken K, Collas P. Recruitment of
protein phosphatase 1 to the nuclear envelope by A-kinase
anchoring protein AKAP149 is a prerequisite for nuclear
lamina assembly. J Cell Biol 2000;150:1251–62.
[40] Markiewicz E, Tilgner K, Barker N, van de Wetering M,
Clevers H, Dorobek M, et al. The inner nuclear membrane
protein emerin regulates beta-catenin activity by
restricting its accumulation in the nucleus. EMBO J
2006;25:3275–85.
[41] Ellis DJ, Jenkins H, Whitfield WG, Hutchison CJ. GST-lamin
fusion proteins act as dominant negative mutants in
Xenopus egg extract and reveal the function of the lamina in
DNA replication. J Cell Sci 1997;110:2507–18.
[42] Spann TP, Moir RD, Goldman AE, Stick R, Goldman RD.
Disruption of nuclear lamin organization alters the
67J O U R N A L O F P R O T E O M I C S 7 2 ( 2 0 0 9 ) 5 6 – 7 0
distribution of replication factors and inhibits DNA
synthesis. J Cell Biol 1997;136:1201–12.
[43] Martins S, Eikvar S, Furukawa K, Collas P. HA95 and LAP2
beta mediate a novel chromatin-nuclear envelope
interaction implicated in initiation of DNA replication. J Cell
Biol 2003;160:177–88.
[44] Nili E, Cojocaru GS, Kalma Y, Ginsberg D, Copeland NG,
Gilbert DJ, et al. Nuclear membrane protein LAP2beta
mediates transcriptional repression alone and together with
its binding partner GCL (germ-cell-less). J Cell Sci
2001;114:3297–307.
[45] Johnson BR, Nitta RT, Frock RL, Mounkes L, Barbie DA,
Stewart CL, et al. A-type lamins regulate retinoblastoma
protein function by promoting subnuclear localization and
preventing proteasomal degradation. Proc Natl Acad Sci
U S A 2004;101:9677–82.
[46] Ozaki T, Saijo M, Murakami K, Enomoto H, Taya Y, Sakiyama
S. Complex formation between lamin A and the
retinoblastoma gene product: identification of the domain
on lamin A required for its interaction. Oncogene
1994;9:2649–53.
[47] Kumaran RI, Muralikrishna B, Parnaik VK. Lamin A/C
speckles mediate spatial organization of splicing factor
compartments and RNA polymerase II transcription. J Cell
Biol 2002;159:783–93.
[48] Capell BC, Collins FS. Human laminopathies: nuclei gone
genetically awry. Nat Rev Genet 2006;7:940–52.
[49] Foisner R, Aebi U, Bonne G, Gruenbaum Y, Novelli G. 141st
ENMC International Workshop inaugural meeting of the
EURO-Laminopathies project “nuclear envelope-linked rare
human diseases: from molecular pathophysiology towards
clinical applications”, 10-12 March 2006, Naarden, The
Netherlands. Neuromuscul Disord 2007;17:655–60.
[50] Worman HJ, Bonne G. “Laminopathies”: a wide spectrum of
human diseases. Exp Cell Res 2007;313:2121–33.
[51] Shaklai S, Amariglio N, Rechavi G, Simon AJ. Gene silencing
at the nuclear periphery. FEBS J 2007;274:1383–92.
[52] Crisp M, Liu Q, Roux K, Rattner JB, Shanahan C, Burke B, et al.
Coupling of the nucleus and cytoplasm: role of the LINC
complex. J Cell Biol 2006;172:41–53.
[53] Kosova B, Pante N, Rollenhagen C, Podtelejnikov A, Mann M,
Aebi U, et al. Mlp2p, a component of nuclear pore attached
intranuclear filaments, associates with nic96p. J Biol Chem
2000;275:343–50.
[54] Strambio-de-Castillia C, Blobel G, Rout MP. Proteins
connecting the nuclear pore complex with the nuclear
interior. J Cell Biol 1999;144:839–55.
[55] Galy V, Olivo-Marin JC, Scherthan H, Doye V, Rascalou N,
Nehrbass U. Nuclear pore complexes in the organization of
silent telomeric chromatin. Nature 2000;403:108–12.
[56] Scherthan H, Jerratsch M, Li B, Smith S, Hulten M, Lock T,
et al. Mammalian meiotic telomeres: protein composition
and redistribution in relation to nuclear pores. Mol Biol Cell
2000;11:4189–203.
[57] Reichelt R, Holzenburg A, Buhle Jr EL, Jarnik M, Engel A, Aebi
U. Correlation between structure and mass distribution of
the nuclear pore complex and of distinct pore complex
components. J Cell Biol 1990;110:883–94.
[58] Rout MP, Blobel G. Isolation of the yeast nuclear pore
complex. J Cell Biol 1993;123:771–83.
[59] Yang Q, Rout MP, Akey CW. Three-dimensional
architecture of the isolated yeast nuclear pore complex:
functional and evolutionary implications. Mol Cell
1998;1:223–34.
[60] Gerace L, Burke B. Functional organization of the nuclear
envelope. Annu Rev Cell Biol 1988;4:335–74.
[61] Gerace L, Ottaviano Y, Kondor-Koch C. Identification of a
major polypeptide of the nuclear pore complex. J Cell Biol
1982;95:826–37.
[62] Davis LI, Blobel G. Identification and characterization of a
nuclear pore complex protein. Cell 1986;45:699–709.
[63] Park MK, D'Onofrio M, Willingham MC, Hanover JA. A
monoclonal antibody against a family of nuclear pore
proteins (nucleoporins): O-linked N-acetylglucosamine is
part of the immunodeterminant. Proc Natl Acad Sci U S A
1987;84:6462–6.
[64] Snow CM, Senior A, Gerace L. Monoclonal antibodies identify
a group of nuclear pore complex glycoproteins. J Cell Biol
1987;104:1143–56.
[65] Aris JP, Blobel G. Yeast nuclear envelope proteins cross react
with an antibody against mammalian pore complex
proteins. J Cell Biol 1989;108:2059–67.
[66] Davis LI, Fink GR. The NUP1 gene encodes an essential
component of the yeast nuclear pore complex. Cell
1990;61:965–78.
[67] Carmo-Fonseca M, Kern H, Hurt EC. Human nucleoporin p62
and the essential yeast nuclear pore protein NSP1 show
sequence homology and a similar domain organization. Eur J
Cell Biol 1991;55:17–30.
[68] Nehrbass U, Kern H, Mutvei A, Horstmann H, Marshallsay B,
Hurt EC. NSP1: a yeast nuclear envelope protein localized at
the nuclear pores exerts its essential function by its
carboxy-terminal domain. Cell 1990;61:979–89.
[69] Starr CM, D'Onofrio M, Park MK, Hanover JA. Primary
sequence and heterologous expression of nuclear pore
glycoprotein p62. J Cell Biol 1990;110:1861–71.
[70] Hu T, Guan T, Gerace L. Molecular and functional
characterization of the p62 complex, an assembly of nuclear
pore complex glycoproteins. J Cell Biol 1996;134:589–601.
[71] Kita K, Omata S, Horigome T. Purification and
characterization of a nuclear pore glycoprotein complex
containing p62. J Biochem 1993;113:377–82.
[72] Marelli M, Aitchison JD, Wozniak RW. Specific binding of the
karyopherin Kap121p to a subunit of the nuclear pore
complex containing Nup53p, Nup59p, and Nup170p. J Cell
Biol 1998;143:1813–30.
[73] Grandi P, Doye V, Hurt EC. Purification of NSP1 reveals
complex formation with ‘GLFG’ nucleoporins and a novel
nuclear pore protein NIC96. EMBO J 1993;12:3061–71.
[74] Rout MP, Aitchison JD, Suprapto A, Hjertaas K, Zhao Y, Chait
BT. The yeast nuclear pore complex: composition,
architecture, and transport mechanism. J Cell Biol
2000;148:635–51.
[75] Maul GG, Deaven L. Quantitative determination of nuclear
pore complexes in cycling cells with differing DNA content.
J Cell Biol 1977;73:748–60.
[76] Winey M, Yarar D, Giddings Jr TH, Mastronarde DN. Nuclear
pore complex number and distribution throughout the
Saccharomyces cerevisiae cell cycle by three-dimensional
reconstruction from electron micrographs of nuclear
envelopes. Mol Biol Cell 1997;8:2119–32.
[77] Cronshaw J, Krutchinsky A, Zhang W, Chait B, Matunis M.
Proteomic analysis of themammalian nuclear pore complex.
J Cell Biol 2002;158:915–27.
[78] Aaronson RP, Blobel G. Isolation of nuclear pore complexes
in association with a lamina. Proc Natl Acad Sci U S A
1975;72:1007–11.
[79] Blobel G, Potter VR. Nuclei from rat liver: isolation method
that combines purity with high yield. Science
1966;154:1662–5.
[80] Dwyer N, Blobel G. Amodified procedure for the isolation of a
pore complex-lamina fraction from rat liver nuclei. J Cell Biol
1976;70:581–91.
[81] Pryer NK, Salama NR, Schekman R, Kaiser CA. Cytosolic
Sec13p complex is required for vesicle formation from the
endoplasmic reticulum in vitro. J Cell Biol 1993;120:865–75.
[82] Siniossoglou S, Wimmer C, Rieger M, Doye V, Tekotte H,
Weise C, et al. A novel complex of nucleoporins, which
68 J O U R N A L O F P R O T E O M I C S 7 2 ( 2 0 0 9 ) 5 6 – 7 0
includes Sec13p and a Sec13p homolog, is essential for
normal nuclear pores. Cell 1996;84:265–75.
[83] Schirmer EC, Florens L, Guan T, Yates, Gerace L. Nuclear
membrane proteins with potential disease links found by
subtractive proteomics. Science 2003;301:1380–2.
[84] Devos D, Dokudovskaya S, Williams R, Alber F, Eswar N,
Chait BT, et al. Simple fold composition and modular
architecture of the nuclear pore complex. Proc Natl Acad Sci
U S A 2006;103:2172–7.
[85] Langkjaer RB, Cliften PF, Johnston M, Piskur J. Yeast genome
duplication was followed by asynchronous differentiation of
duplicated genes. Nature 2003;421:848–52.
[86] Gerace L, Blum A, Blobel G. Immunocytochemical
localization of the major polypeptides of the nuclear pore
complex-lamina fraction. Interphase and mitotic
distribution. J Cell Biol 1978;79:546–66.
[87] Senior A, Gerace L. Integral membrane proteins specific to
the inner nuclear membrane and associated with the
nuclear lamina. J Cell Biol 1988;107:2029–36.
[88] Paulin-Levasseur M, Blake DL, Julien M, Rouleau L. The MAN
antigens are non-lamin constituents of the nuclear lamina
in vertebrate cells. Chromosoma 1996;104:367–79.
[89] Ashery-Padan R, Weiss AM, Feinstein N, Gruenbaum Y.
Distinct regions specify the targeting of otefin to the
nucleoplasmic side of the nuclear envelope. J Biol Chem
1997;272:2493–9.
[90] Goldberg M, Lu H, Stuurman N, Ashery-Padan R, Weiss AM,
Yu J, et al. Interactions among Drosophila nuclear
envelope proteins lamin, otefin, and YA. Mol Cell Biol
1998;18:4315–23.
[91] Dreger M, Bengtsson L, Schoneberg T, Otto H, Hucho F.
Nuclear envelope proteomics: novel integral membrane
proteins of the inner nuclear membrane. Proc Natl Acad Sci
U S A 2001;98:11943–8.
[92] Washburn MP, Wolters D, Yates JR. Large-scale analysis of
the yeast proteome by multidimensional protein
identification technology. Nat Biotechnol 2001;19:242–7.
[93] Wolters DA, Washburn MP, Yates JR. An automated
multidimensional protein identification technology for
shotgun proteomics. Anal Chem 2001;73:5683–90.
[94] Santoni V, Molloy M, Rabilloud T. Membrane proteins and
proteomics: un amour impossible? Electrophoresis
2000;21:1054–70.
[95] Florens L, Korfali N, Schirmer EC. Subcellular fractionation
and proteomics of nuclear envelopes. Methods Mol Biol
2008;432:117–37.
[96] Goodchild RE, DauerWT. The AAA+ protein torsinA interacts
with a conserved domain present in LAP1 and a novel ER
protein. J Cell Biol 2005;168:855–62.
[97] Askjaer P, Bachi A, Wilm M, Bischoff FR, Weeks DL,
Ogniewski V, et al. RanGTP-regulated interactions of CRM1
with nucleoporins and a shuttling DEAD-box helicase. Mol
Cell Biol 1999;19:6276–85.
[98] Tseng SS, Weaver PL, Liu Y, Hitomi M, Tartakoff AM, Chang
TH. Dbp5p, a cytosolic RNA helicase, is required for poly(A)+
RNA export. EMBO J 1998;17:2651–62.
[99] Zhao J, Jin SB, Bjorkroth B, Wieslander L, Daneholt B. The
mRNA export factor Dbp5 is associated with Balbiani ring
mRNP from gene to cytoplasm. EMBO J 2002;21:1177–87.
[100] Ohba T, Nakamura M, Nishitani H, Nishimoto T.
Self-organization of microtubule asters induced in Xenopus
egg extracts by GTP-bound Ran. Science 1999;284:1356–8.
[101] Wiese C, Wilde A, Moore MS, Adam SA, Merdes A, Zheng Y.
Role of importin-beta in coupling Ran to downstream targets
in microtubule assembly. Science 2001;291:653–6.
[102] Belgareh N, Rabut G, Bai SW, van Overbeek M, Beaudouin J,
Daigle N, et al. An evolutionarily conserved NPC
subcomplex, which redistributes in part to kinetochores in
mammalian cells. J Cell Biol 2001;154:1147–60.
[103] Moir RD, Spann TP, Goldman RD. The dynamic properties
and possible functions of nuclear lamins. Int Rev Cytol
1995:141–82.
[104] Tsai MY, Wang S, Heidinger JM, Shumaker DK, Adam SA,
Goldman RD, et al. A mitotic lamin B matrix induced by
RanGTP required for spindle assembly. Science
2006;311:1887–93.
[105] Lee KK, Haraguchi T, Lee RS, Koujin T, Hiraoka Y, Wilson KL.
Distinct functional domains in emerin bind lamin A and
DNA-bridging protein BAF. J Cell Sci 2001;114:4567–73.
[106] Wilkinson FL, Holaska JM, Zhang Z, Sharma A, Manilal S,
Holt I, et al. Emerin interacts in vitro with the
splicing-associated factor, YT521-B. Eur J Biochem
2003;270:2459–66.
[107] Holaska JM, Rais-Bahrami S, Wilson KL. Lmo7 is an
emerin-binding protein that regulates the transcription of
emerin and many other muscle-relevant genes. Hum Mol
Gen 2006;15:3459–72.
[108] Bengtsson L, Wilson KL. Multiple and surprising new
functions for emerin, a nuclear membrane protein. Curr
Opin Cell Biol 2004;16:73–9.
[109] Holaska JM, Lee K, Kowalski AK, Wilson KL. Transcriptional
repressor germ cell-less (GCL) and barrier to autointegration
factor (BAF) compete for binding to emerin in vitro. J Biol
Chem 2003;278:6969–75.
[110] Salpingidou G, Smertenko A, Hausmanowa-Petrucewicz I,
Hussey PJ, Hutchison CJ. A novel role for the nuclear
membrane protein emerin in association of the centrosome
to the outer nuclear membrane. J Cell Biol 2007;178:897–904.
[111] Zhang Q, Ragnauth CD, Skepper JN, Worth NF, Warren DT,
Roberts RG, et al. Nesprin-2 is a multi-isomeric protein that
binds lamin and emerin at the nuclear envelope and forms a
subcellular network in skeletal muscle. J Cell Sci
2005;118:673–87.
[112] Goodchild RE, Dauer WT. Mislocalization to the nuclear
envelope: an effect of the dystonia-causing torsinA
mutation. Proc Natl Acad Sci U S A 2004;101:847–52.
[113] Naismith TV, Heuser JE, Breakefield XO, Hanson PI. TorsinA
in the nuclear envelope. Proc Natl Acad Sci U S A
2004;101:7612–7.
[114] Chen IH, Huber M, Guan T, Bubeck A, Gerace L. Nuclear
envelope transmembrane proteins (NETs) that are
up-regulated duringmyogenesis. BMC Cell Biology 2006;7:38.
[115] Mi H, Guo N, Kejariwal A, Thomas PD. PANTHER version 6:
protein sequence and function evolution data with
expanded representation of biological pathways. Nucleic
Acids Res 2007;35:D247–252.
[116] Thomas PD, Campbell MJ, Kejariwal A, Mi H, Karlak B,
Daverman R, et al. PANTHER: a library of protein families
and subfamilies indexed by function. Genome Res
2003;13:2129–41.
[117] Humbert JP, Matter N, Artault JC, Koppler P, Malviya AN.
Inositol 1,4,5-trisphosphate receptor is located to the inner
nuclear membrane vindicating regulation of nuclear
calcium signaling by inositol 1,4,5-trisphosphate. Discrete
distribution of inositol phosphate receptors to inner and
outer nuclear membranes. J Biol Chem 1996;271:478–85.
[118] Lanini L, Bachs O, Carafoli E. The calcium pump of the liver
nuclear membrane is identical to that of endoplasmic
reticulum. J Biol Chem 1992;267:11548–52.
[119] Cruttwell C, Bernard J, HillyM, Nicolas V, Tunwell RE, Mauger
JP. Dynamics of the inositol 1,4,5-trisphosphate receptor
during polarisation of MDCK cells. Biol Cell 2005.
[120] Gerasimenko JV, Maruyama Y, Yano K, Dolman NJ, Tepikin
AV, Petersen OH, et al. NAADP mobilizes Ca2+ from a
thapsigargin-sensitive store in the nuclear envelope by
activating ryanodine receptors. J Cell Biol 2003;163:271–82.
[121] Erickson ES, Mooren OL, Moore-Nichols D, Dunn RC.
Activation of ryanodine receptors in the nuclear envelope
69J O U R N A L O F P R O T E O M I C S 7 2 ( 2 0 0 9 ) 5 6 – 7 0
alters the conformation of the nuclear pore complex.
Biophys Chem 2004;112:1–7.
[122] Pare GC, Easlick JL, Mislow JM, McNally EM, Kapiloff MS.
Nesprin-1alpha contributes to the targeting of mAKAP to the
cardiac myocyte nuclear envelope. Exp Cell Res
2005;303:388–99.
[123] Dolmetsch RE, Xu K, Lewis RS. Calcium oscillations increase
the efficiency and specificity of gene expression. Nature
1998;392:933–6.
[124] Arteaga MF, Gutierrez R, Avila J, Mobasheri A, Diaz-Flores L,
Martin-Vasallo P. Regeneration influences expression of the
Na+, K+-atpase subunit isoforms in the rat peripheral
nervous system. Neuroscience 2004;129:691–702.
[125] Ronaldson PT, Bendayan M, Gingras D, Piquette-Miller M,
Bendayan R. Cellular localization and functional expression
of P-glycoprotein in rat astrocyte cultures. J Neurochem
2004;89:788–800.
[126] Sigal YJ, McDermott MI, Morris AJ. Integral membrane lipid
phosphatases/phosphotransferases: common structure and
diverse functions. Biochem J 2005;387:281–93.
[127] Krut O, Wiegmann K, Kashkar H, Yazdanpanah B, Kronke M.
Novel tumor necrosis factor-responsive mammalian neutral
sphingomyelinase-3 is a C-tail-anchored protein. J Biol
Chem 2006;281:13784–93.
[128] Yang Y, Cao J, Shi Y. Identification and characterization of a
gene encoding human LPGAT1, an endoplasmic
reticulum-associated lysophosphatidylglycerol
acyltransferase. J Biol Chem 2004;279:55866–74.
[129] HallmanM, Gluck L. Phosphatidylglycerol in lung surfactant.
II. Subcellular distribution and mechanism of biosynthesis
in vitro. Biochim Biophys Acta 1975;409:172–91.
[130] Breuza L, Halbeisen R, Jeno P, Otte S, Barlowe C, HongW, et al.
Proteomics of endoplasmic reticulum-Golgi intermediate
compartment (ERGIC) membranes from brefeldin A-treated
HepG2 cells identifies ERGIC-32, a new cycling protein that
interacts with human Erv46. J Biol Chem 2004;279:47242–53.
[131] Audhya A, Desai A, Oegema K. A role for Rab5 in structuring
the endoplasmic reticulum. J Cell Biol 2007;178:43–56.
[132] Jacobsson JA, Haitina T, Lindblom J, Fredriksson R.
Identification of six putative human transporters with
structural similarity to the drug transporter SLC22 family.
Genomics 2007;90:595–609.
[133] Coolen MW, Van Loo KM, Van Bakel NN, Pulford DJ, Serneels
L, De Strooper B, et al. Gene dosage effect on
gamma-secretase component Aph-1b in a rat model for
neurodevelopmental disorders. Neuron 2005;45:497–503.
[134] Diao F, Li S, Tian Y, Zhang M, Xu LG, Zhang Y, et al. Negative
regulation of MDA5- but not RIG-I-mediated innate antiviral
signaling by the dihydroxyacetone kinase. Proc Natl Acad Sci
U S A 2007;104:11706–11.
[135] Bengtsson L. What MAN1 does to the Smads TGFß/BMP
signaling and the nuclear envelope. FEBS J 2007;274:1374–82.
[136] Broers JL, Machiels BM, Kuijpers HJ, Smedts F, van den
Kieboom R, Raymond Y, et al. A- and B-type lamins are
differentially expressed in normal human tissues.
Histochem Cell Biol 1997;107:505–17.
[137] Jansen M, Machiels B, Hopman A, Broers J, Bot F, Arends J,
et al. Comparison of A and B-type lamin expression in
reactive lymph nodes and nodular sclerosing Hodgkin's
disease. Histopathology 1997;31:304–12.
[138] Rober RA, Weber K, Osborn M. Differential timing of nuclear
lamin A/C expression in the various organs of the mouse
embryo and the young animal: a developmental study.
Development 1989;105:365–78.
[139] Alsheimer M, Benavente R. Change of karyoskeleton during
mammalian spermatogenesis: expression pattern of nuclear
lamin C2 and its regulation. Exp Cell Res 1996;228:181–8.
[140] Su AI, Cooke MP, Ching KA, Hakak Y, Walker JR, Wiltshire T,
et al. Large-scale analysis of the human and mouse
transcriptomes. Proc Natl Acad Sci U S A 2002;99:4465–70.
[141] Kavanagh DM, Powell WE, Malik P, Lazou V, Schirmer EC.
Organelle proteome variation among different cell types:
lessons from nuclear membrane proteins. Subcell Biochem
2007;43:51–76.
[142] Kislinger T, Cox B, Kannan A, Chung C, Hu P, Ignatchenko A,
et al. Global survey of organ and organelle protein
expression in mouse: combined proteomic and
transcriptomic profiling. Cell 2006;125:173–86.
[143] Mootha VK, Bunkenborg J, Olsen JV, Hjerrild M, Wisniewski
JR, Stahl E, et al. Integrated analysis of protein composition,
tissue diversity, and gene regulation in mouse
mitochondria. Cell 2003;115:629–40.
[144] Tunnah D, Sewry CA, Vaux D, Schirmer EC, Morris GE. The
apparent absence of lamin B1 and emerin in many tissue
nuclei is due to epitopemasking. J Mol Histol 2005;36:337–44.
[145] Wilkie GS, Schirmer EC. Guilt by association: the nuclear
envelope proteome and disease. Mol Cell Proteomics
2006;5:1865–75.
[146] OlssonM, Scheele S, Ekblom P. Limited expression of nuclear
pore membrane glycoprotein 210 in cell lines and tissues
suggests cell-type specific nuclear pores in metazoans. Exp
Cell Res 2004;292:359–70.
[147] Cohen M, Feinstein N, Wilson KL, Gruenbaum Y. Nuclear
pore protein gp210 is essential for viability in HeLa cells and
Caenorhabditis elegans. Mol Biol Cell 2003;14:4230–7.
[148] Stavru F, Hulsmann BB, Spang A, Hartmann E, Cordes VC,
Gorlich D. NDC1: a crucial membrane-integral nucleoporin
of metazoan nuclear pore complexes. J Cell Biol
2006;173:509–19.
[149] Stavru F, Nautrup-Pedersen G, Cordes VC, Gorlich D. Nuclear
pore complex assembly and maintenance in POM121- and
gp210-deficient cells. J Cell Biol 2006;173:477–83.
[150] Alber F, Dokudovskaya S, Veenhoff LM, Zhang W, Kipper J,
Devos D, et al. Determining the architectures of
macromolecular assemblies. Nature 2007;450:683–94.
[151] Wente SR, Rout MP, Blobel G. A new family of yeast nuclear
pore complex proteins. J Cell Biol 1992;119:705–23.
[152] Denning DP, Patel SS, Uversky V, Fink AL, RexachM. Disorder
in the nuclear pore complex: the FG repeat regions of
nucleoporins are natively unfolded. Proc Natl Acad Sci U S A
2003;100:2450–5.
[153] Lim RY, Huang NP, Koser J, Deng J, Lau KH, Schwarz-Herion
K, et al. Flexible phenylalanine–glycine nucleoporins as
entropic barriers to nucleocytoplasmic transport. Proc Natl
Acad Sci U S A 2006;103:9512–7.
[154] Lim RY, Fahrenkrog B, Koser J, Schwarz-Herion K, Deng J,
Aebi U. Nanomechanical basis of selective gating by the
nuclear pore complex. Science 2007;318:640–3.
[155] Frey S, Richter RP, Gorlich D. FG-rich repeats of nuclear pore
proteins form a three-dimensional meshwork with
hydrogel-like properties. Science 2006;314:815–7.
[156] Rexach M, Blobel G. Protein import into nuclei: association
and dissociation reactions involving transport substrate,
transport factors, and nucleoporins. Cell 1995;83:683–92.
[157] Strasser K, Masuda S, Mason P, Pfannstiel J, Oppizzi M,
Rodriguez-Navarro S, et al. TREX is a conserved complex
coupling transcription with messenger RNA export. Nature
2002;417:304–8.
[158] Strasser K, Hurt E. Splicing factor Sub2p is required for
nuclear mRNA export through its interaction with Yra1p.
Nature 2001;413:648–52.
70 J O U R N A L O F P R O T E O M I C S 7 2 ( 2 0 0 9 ) 5 6 – 7 0
RESEARCH ARTICLE
Cell-specific and lamin-dependent targeting of novel
transmembrane proteins in the nuclear envelope
Poonam Malik • Nadia Korfali • Vlastimil Srsen • Vassiliki Lazou •
Dzmitry G. Batrakou • Nikolaj Zuleger • Deirdre M. Kavanagh •
Gavin S. Wilkie • Martin W. Goldberg • Eric C. Schirmer
Received: 2 November 2009 / Revised: 21 December 2009 / Accepted: 5 January 2010 / Published online: 21 January 2010
 The Author(s) 2010. This article is published with open access at Springerlink.com
Abstract Nuclear envelope complexity is expanding with
respect to identification of protein components. Here we
test the validity of proteomics results that identified 67
novel predicted nuclear envelope transmembrane proteins
(NETs) from liver by directly comparing 30 as tagged
fusions using targeting assays. This confirmed 21 as NETs,
but 4 only targeted in certain cell types, underscoring the
complexity of interactions that tether NETs to the nuclear
envelope. Four NETs accumulated at the nuclear rim in
normal fibroblasts but not in fibroblasts lacking lamin A,
suggesting involvement of lamin A in tethering them in the
nucleus. However, intriguingly, for the NETs tested alter-
native mechanisms for nuclear envelope retention could be
found in Jurkat cells that normally lack lamin A. This study
expands by a factor of three the number of liver NETs
analyzed, bringing the total confirmed to 31, and shows
that several have multiple mechanisms for nuclear enve-
lope retention.
Keywords Inner nuclear membrane 
Outer nuclear membrane  Nuclear lamina 
Integral membrane protein  Cell-type specificity
Introduction
Several proteins of the nuclear envelope (NE) are linked to
human diseases including muscular dystrophies, neuropa-
thy, and progeroid aging syndromes [1, 2]. Nuclear envelope
proteins associated with disease include the intermediate
filament A/C lamins and several NE transmembrane pro-
teins (NETs). Curiously, different variants of Emery-
Dreifuss muscular dystrophy are caused by mutations in the
LMNA gene, encoding lamins A and C [3] and NETs that
interact with A/C lamins [4–7]. This may be a clue to
explain how mutations in the widely expressed LMNA gene
could lead to distinct diseases that each yield pathology in
only a small subset of the tissues in which A/C lamins are
expressed, e.g., specificity is conferred by different combi-
nations of partner proteins in different cell types.
Already, a wide range of binding partners has been
reported for both lamins and NETs [8, 9]. These proteins
are likely to vary among cell types because different
combinations of lamin and emerin antibodies stained dif-
ferent tissues, e.g., two of three lamin B1 antibodies stained
human cardiomyocyte nuclei, whereas a different set of
two stained hippocampal neurons [10]. Thus, different
regions of the proteins might be occupied by binding
partners in each tissue. It follows that as yet unidentified
partners of lamins and NETs in tissue-specific complexes
may mediate the phenotypes of the wide range of lamin-
related diseases. Indeed, the three favored molecular
mechanisms to explain NE disease pathology—mechanical
instability from disruption of lamina-cytoskeletal interac-
tions, altered expression of genes regulated from the
nuclear periphery, and disabling of the cell cycle/stem cell
maintenance [1, 11]—all likely involve additional associ-
ated proteins to produce pathology. Because both gene
regulation and cytoskeletal connections have been
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implicated, NE proteins involved could reside in either the
inner nuclear membrane (INM) or outer nuclear membrane
(ONM).
A proteomic study of liver NEs recently increased the
number of putative NETs by fivefold [12]; however, some
of these could be erroneous assignments or contaminants of
the fractions, and so it is necessary to directly test them for
NE localization. We sought to test the validity of the
proteomic datasets by confirming the targeting of these
putative NETs to the NE and also to gauge whether lamin
interactions are likely to contribute to this targeting/reten-
tion. Work from several laboratories has so far confirmed
only 13 of the 67 new putative NETs for NE targeting [12–
15]. Here we investigate the targeting of 30 putative NETs,
bringing the total characterized to 40.
Our results classify only 70% of those tested as NETs by
their producing a distinctive ‘rim’ staining around the
nucleus. However, the remaining 30% do not necessarily
represent misidentifications in the proteomic analysis
because some only targeted to the nuclear rim in certain
cell types, likely reflecting the complexity of cell types
found in liver and underscoring the potential for error in
overuse of tissue culture systems in studying the NE. The
majority of confirmed NETs targeted to the INM with only
a few residing only in the ONM as determined using high-
resolution structured illumination microscopy. Further-
more, most resisted a pre-fixation extraction with
detergent—typically indicating association with the lamin
polymer—yet only 4 out of 12 NETs tested targeted less to
the NE in fibroblast cells deleted for lamin A, indicating
that other lamins or lamina-associated NETs suffice for
their NE retention. Surprisingly, among those that mistar-
geted in the absence of lamin A, those for which we had
antibodies did not require lamin A for association with the
NE in Jurkat cells that never had lamin A. This finding is
important as it may explain in part how lamin A-interacting
proteins could be involved in diseases where pathology is
only observed in a subset of tissues: they have distinct
mechanisms for NE retention in different cell types. This
study gives a better view of NE composition and its
potential functions, and indicates how its variability could
contribute to the tissue specificity of NE diseases.
Methods and materials
Plasmid construction
IMAGE clones for human NETs were obtained from RZPD
and Geneservice. NET numbers followed by IMAGE
numbers or gene IDs in parentheses are listed: NETs 5
(199953-gene ID), 15 (5270233), 11 (4798194), 13
(6023304), 14 (3640219), 16 (5267120), 17 (4812681), 20
(3872837), 21 (84135-gene ID), 23 (5762441), 24
(4907240), 25 (5240212), 29 (6201334), 30 (4299899), 32
(4248728), 33 (4138639), 34 (4865469), 35 (3451350), 36
(4819093), 37 (30341915), 38 (4698763), 43 (5166101), 44
(4577143), 45 (3462452), 46 (5189722), 47 (4214662), 48
(3355282), 49 (3354945), 50 (3344010), 55 (4720647), 59
(3959506), and 62 (6052380). The only available IMAGE
clone for NET5 was shorter than the original predicted
hypothetical orf, but is likely to be a shorter splice variant.
Coding sequences were amplified by PCR with added 50
and 30 restriction sites, sequenced from both ends in
intermediate cloning vectors, and then inserted into mam-
malian expression vector pHHS10B that carries an amino-
terminal HA epitope tag and/or pmRFP with a carboxyl-
terminal tag (derived from Clontech pEGFP-N2 by
replacing the GFP coding sequence with that of monomeric
red fluorescent protein). Additionally, the coding sequences
of previously characterized NETs 4, 31, 39, and 51 were
moved from their original HA-tagged vector [12] to
pmRFP and GFP vectors. Lamin A-GFP was obtained from
Anne Straube (MCRI, Oxted, UK) and Calreticulin-GFP
and RapM4-CFP from Tom Rapoport (Harvard, Boston).
Cell culture and transfections
Cell lines derived from human fibroblasts (HT1080),
human embryonic kidney cells (293T), mouse myoblasts
(C2C12), human myoblasts (RD), and human hepatocytes
(HepG2) were maintained in high glucose DMEM (Lonza)
supplemented with 10% fetal bovine serum (FBS), 100 lg/
ll penicillin, and 100 lg/ll streptomycin sulfate. To this
medium were added MEM non-essential amino acids and
1 mM sodium pyruvate for several mouse fibroblast cells:
NIH3T3 and 3T3-L1 cell lines, and 216-/- lamin A
knockout primary MEFs and their matched wild-type pri-
mary cells. Jurkat cells, a human lymphocyte cell line,
were cultured in RPMI with 10% FBS.
Cells were plated on coverslips at *10% confluency to
prevent their reaching confluency before fixation at 30 h
post-transfection. DNA was transfected 12 h after plating
using FuGENE 6 (Roche) according to the manufacturer’s
instructions.
Antibodies
Antibodies were: HA tag (mAb HA.11, Covance), lamin A
and B1 (3262 and 3931; [16]), Nup153 (Covance), Nup358
(raised against recombinant human protein aa 2595–2881,
kind gift of F. Melchior), Calreticulin (2891S, Cell Sig-
naling), Calnexin (SPA-860, Stressgen), or NETs: rabbit
anti-peptide polyclonal generated for this study by Milli-
pore NET4 (11780), NET23 (11815), NET29 (11796),
NET30 (11827), NET31 (11830), NET33 (11835), NET34
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(11231), NET39 (11668), NET50 (11850), NET51
(11856), NET55 (11862), NET59 (11866), and SUN2
(11905). All fluorophore-conjugated secondary antibodies
were minimal cross-reactivity from donkey (Jackson
ImmunoResearch) or goat (MolecularProbes).
Quantitative Western blotting
Liver NE and microsomal membranes (MM) were prepared
as previously described [17]. NE and MM were lysed in
50 mM Tris-HCl (pH 7.4), 150 mM NaCl, 2 mM MgCl2,
0.2% NP-40 in the presence of protease inhibitor cocktail
(Roche 11 873 580 001) by heating at 65C for 2 min and
soncation in a sonibath at 4C. Protein concentrations were
determined using the Bradford Method (BioRad). An equal
volume of protein sample buffer (100 mM Tris pH 6.8, 4 M
Urea, 2% SDS, 50 mM DTT, and 15% sucrose) was added,
and the samples were boiled at 100C for 5 min. Equal
amounts of protein were resolved by SDS-PAGE and
transferred to nitrocellulose membrane (LI-COR Biosci-
ences). Membranes were blocked in PBS, 5% milk, 0.2%
tween. Primary antibodies were diluted in this buffer (1/200
Millipore NET peptide antibodies, 1/500 calreticulin, 1/200
Calnexin, 1/2000 lamin A) and allowed to incubate overnight
at 4C. Secondary antibodies IR800 conjugated goat anti-
rabbit (LI-COR Biosciences) were added at a concentration
1/5,000 at RT for 2 h. Visualization and quantification were
performed using a LI-COR Odyssey and software (Odyssey
3.0.16) using median background subtraction. A minimum
of three independent blots were run for each NET and con-
trol. The averages from all three are presented in Fig. 3.
Microscopy
Cells were either directly fixed 7 min in 3.7% formalde-
hyde or washed with PBS, then extracted for 1 min with
1% Triton X-100, 25 mM Tris pH 8.0, 150 mM KOAc,
15 mM NaCl, and 5 mM MgCl2, washed again with PBS,
and then fixed with formaldehyde. In some cases cells were
instead extracted with 2 9 1 min incubations with 0.1%
Triton X-100 in PBS, which better maintained cell mor-
phology but removed more cells from coverslips. For
antibody staining, cells that were not pre-extracted were
permeabilized 6 min in 0.2% Triton X-100 after fixation.
Cells were then blocked with 10% FBS, 200 mM glycine
in PBS, and reacted 40 min at RT with antibodies. All
fluorophore-conjugated secondary antibodies were minimal
cross-reactivity from donkey (Jackson ImmunoResearch)
or goat (MolecularProbes). DNA was visualized with DAPI
(4,6-diamidino-2 phenylindole, dihydrochloride) and cov-
erslips mounted in fluoromount G (EM Sciences). Some
cells were costained with ER membrane dyes DiOC6 and
R6 (MolecularProbes).
For cryosections, rat liver was cut into 2–3-mm cubes,
embedded in OCT (Tissue-Tek), snap-frozen in liquid
nitrogen, and maintained at -80C. Sections were cut on a
Leica CM 1900 Cryostat at 6–8-lm thickness and immedi-
ately fixed in -20C methanol. After rehydration with PBS,
sections were incubated with anti-NET antibodies overnight
at 4C followed by secondary antibodies as above.
Most images were obtained using a Nikon TE-2000
microscope equipped with a 1.45 NA 1009 objective,
Sedat quad filter set, PIFOC Z-axis focus drive (Physik
Instruments), and CoolSnapHQ High Speed Monochrome
CCD camera (Photometrics) run by IPLab image acquisi-
tion software. Image stacks (0.2 lm steps) were
deconvolved using AutoquantX. Structured illumination
images (Fig. 5b) were taken on the OMX system at the
University of Dundee microscopy facility (details descri-
bed at http://microscopy.lifesci.dundee.ac.uk/omx/). High-
resolution images to distinguish ONM from INM were also
taken using a Deltavision (Applied Precision) microscope
system with 1009 1.4 NA objective, and 0.2-lm stacks
were deconvolved using DeconQ; images were processed
using SoftWorks (Fig. 5c, d). Cryosection images were
recorded using an SP5 confocal system (Leica) with 639
oil 1.4 NA objective using argon and UV lasers. Micro-
graphs were saved from source programs as TIF files and
prepared for figures using Photoshop 8.0.
Immuno-EM
Immuno-electron microscopy was performed on HeLa cells
transiently transfected with NET51, NET55, emerin, or
SUN2 all fused to GFP. Cells were fixed in 4% parafor-
maldehyde, pelletted and infiltrated with 2.3 M sucrose, then
frozen by plunging into liquid nitrogen. Frozen pellets were
sectioned on a cryo-ultramicrotome (Leica, UC6 with FC6
cryo-attachment). Cryosections were thawed, rinsed in PBS
with 1% glycine, incubated in PBS with 1% BSA, incubated
with rabbit anti-GFP antibody (Abcam, Cambridge, MA) at
1:400 dilution, rinsed in PBS then incubated with the sec-
ondary anti-rabbit IgG antibody conjugated to 5-nm
colloidal gold (Agar Scientific, UK). Grids were then rinsed
in PBS, transferred to 1% glutaraldehyde (Agar Scientific,
UK) in PBS, washed in water. and embedded in 2% methyl
cellulose containing 0.4% uranyl acetate (Agar Scientific,
UK). Images were taken on a Hitachi H7600 electron
microscope at 100 kV and 80,0009–100,0009 magnification.
Transmembrane prediction
Sequences were analyzed for transmembrane helices
using TMPred ‘http://www.ch.embnet.org/software/
TMPRED_form.html’ [18] or TMHMM 2.0 ‘http://www.
cbs.dtu.dk/services/TMHMM-2.0/’ [19]. Transmembrane
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helices predicted by TMPred were sometimes only weakly
predicted by TMHMM; in these cases the percent
probability is listed.
RT-PCR
Cells were lysed with Tri-Reagent (Sigma) and total RNA
extracted according to the manufacturer’s instructions.
Reactions were carried out with 100 ng of total RNA using
the Titan one-tube RT-PCR system (Roche) according to
the manufacturer’s instructions, except that the dNTP
concentration was increased to 500 lM and MgCl2
increased to 3 mM. Typical reaction conditions were
30 min reverse transcription at 50C, 2 min denaturation at
94C, then 24 cycles of 94C for 30 s, 60C for 30 s, and












Peptidylprolyl isomerase A (Ppia) was used as a loading
control, and reactions were repeated at least three times.
In vitro extraction assay
Jurkat clone E6-1 (freshly obtained from ATCC) was nu-
cleofected (Kit V, C-016) with lamin A-GFP in pCDNA3.1
linearized with Bgl II. Clones expressing GFP-lamin A
stably integrated in the genome were selected with 1 mg/
ml G418 and then further enriched by fluorescence acti-
vated cell sorting (FACS). Lamin A-GFP Jurkats, wild-
type Jukat cells that lack lamin A, normal wild-type mouse
fibroblasts (NIH 3T3), and lamin A-null mouse fibroblasts
(216-/-) were recovered from dishes and divided equally
into two tubes. One tube (non-extracted) was directly lysed
by first adding 1% Triton X-100 and 8 M urea followed by
SDS-sample buffer and sonication in a sonibath. The sec-
ond tube (extracted) was extracted by adding 1% Triton X-
100, 50 mM NaCl, 300 mM KOAc, 20 mM HEPES pH 8,
2 mM MgCl2, and 8% sucrose with rapid inversion for
2 min followed by centrifugation for 15 min at
13,000 rpm. The pellet was resuspended in SDS-sample
buffer containing 8 M urea. Lysates were loaded based on
cell number onto Western blots, probed with NET and
lamin antibodies, and bands quantified on a LI-COR
Odyssey.
Results
Thirteen novel proteins were confirmed as NETs by
their resistance to a pre-fixation detergent extraction in
cells
A proteomic study of rodent liver NEs identified 67 new
putative NETs, 8 of which were confirmed by targeting to
the NE when exogenously expressed [12]. To further test
the validity of this dataset and gain a more comprehensive
view of the human NE proteome, cDNAs were obtained
for the 32 putative NETs that were available in the human
IMAGE clone collection, in addition to the eight first
characterized. The coding sequences were placed into a
vector for fusing their C-termini to mRFP in most cases
and/or a vector for fusing their N-termini to a Heamag-
glutinin (HA) Tag. These were transiently transfected into
HT1080 human fibrosarcoma cells stably expressing
lamin A-GFP, and after 30 h cells were either directly
fixed or first extracted with detergent and then fixed. For
NET15 and NET48, no transfected cells were detected in
the cell lines tested, although sequencing suggested the
constructs were correct. This could reflect instability of
the fusion proteins or indicate that these NETs require
very specific backgrounds for stable expression. Binding
to the intermediate filament lamin polymer is thought to
drive INM accumulation of NETs [20]. Thus, as the
nuclear lamina is resistant to pre-extraction with detergent
(up to 1% Triton X-100) and high salt (up to 1 M NaCl),
similar biochemical resistance to extraction of NETs
typically indicates INM association. Some proteins,
however, may be in the ONM and also resist extraction
because of interactions with cytoskeletal components
(e.g., nesprins; [21]).
After detergent extraction, the emerin control was
clearly retained at the NE, whereas both ER membrane
(stained with DiOC6) and overexpressed ER proteins
calreticulin and RapM4 were completely removed by the
same treatment (Fig. 1 and data not shown). Thirteen of
the putative NETs tested were retained at the NE simi-
larly to emerin as affirmed by colocalization with Lamin
A, thus defining them as bona fide NETs (Fig. 1a).
Untransfected adjacent cells in some of the images show
that there was no bleedthrough of lamin signal (green)
into the NET channel (red). Nuclei were sometimes
misshapen as a result of the detergent treatment, but the
colocalization with lamins (yellow merge) confirms that
some of the protein was retained at the NE. All NETs
shown in Fig. 1 resisted detergent extraction in each of
multiple experiments, except for NETs 34 and 50 that
resisted extraction in three of five experiments using the
same HT1080 cells. It is possible that these NETs are
tethered more weakly, similar to some LAP1 isoforms
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that were previously found to extract at lower salt
concentrations than others [22]. This may indicate a
hierarchy in NET binding strength, but could also be a
simple consequence of a lower relative abundance of
binding partners to tether these NETs in the NE.
Some putative NETs accumulated at the NE but
did not resist pre-extraction with detergent
As the INM is only half of the NE, the NE proteomic
datasets likely include many ONM proteins that would be
less likely to resist detergent pre-extraction. Emerin has in
fact been shown to have both INM and ONM populations
[23]. In cells that were not pre-extracted, both emerin and
the NETs confirmed in Fig. 1 also accumulated in the ER,
yet distinct nuclear rim accumulation and colocalization
with lamins could still be observed. This is in contrast to
cells overexpressing calreticulin and RapM4 where a
distinct rim was not observed (Fig. 2, top and data not
shown). Therefore, putative NETs that did not resist pre-
extraction with detergent were compared in directly fixed
cells to emerin and calreticulin controls, revealing four
(20, 38, 46, and 62) that yielded a strong and distinctive
rim against the background of the overexpressed protein
in the ER (Fig. 2). The remaining 13 NETs out of the 30
analyzed either yielded no distinctive rim against the ER
background or different cellular targeting in the HT1080
cells.
Antibody staining of endogenous NETs confirms
that their primary residence is in the NE
To test if the accumulation in both the NE and ER with
overexpressed proteins reflects the targeting of the
endogenous NETs, peptide antibodies were generated to
several NETs, of which nine recognized bands of the
expected size for various splice forms on Western blots
(data not shown). Equivalent amounts of total protein
from NE and microsome preparations (as determined by
Bradford protein assay) were compared for NET levels by
quantitative Western blotting, and the percentage of the
total signal in NE or microsomal fractions was plotted
(Fig. 3). Most NETs had nearly all signal in the NE
fraction, and the ER controls calnexin and calreticulin
were mostly in the ER fraction. Another study compared
NE and microsome factions based on the assumption that
calnexin is similarly in the ONM as the ER instead of by
equal protein loading [14]: we also see calnexin in the NE
fractions when we overload NEs, but this means that our
NETs would be even more enriched in the NE using their
method. NET23 and NET33 had roughly a third of the
signal in the microsome fraction, and NET34 had nearly
all signal in the microsome fraction. Nonetheless, NET34
also resisted the pre-fixation detergent extraction, likely
indicating that some small pool of NET34 resides in the
INM.
Fig. 1 NE localization and detergent resistance of novel NETs. (a)
NETs fused to mRFP at their carboxy-termini (except NET25 fused at
its amino-terminus to an HA epitope tag) were transiently expressed
in HT1080 cells also expressing lamin A-GFP. Cells were pre-
extracted with Triton X-100 prior to fixation to remove membranes
and soluble proteins, which typically also distorts morphology. NETs
alone (left) and the merge between the NET (red) and lamin A (green)
are shown. In some panels adjacent untransfected cells are shown,
confirming that NE signal is not due to bleedthrough from the lamin
channel. Like the emerin control (top), all NETs shown resisted
detergent pre-extraction. Such resistance typically indicates associa-
tion with the lamin polymer. Scale bars 7.5 lm. (b) Controls showing
that the ER was fully removed by the detergent pre-extraction. Left
calreticulin fused to GFP (but colored red) was overexpressed in cells
either directly fixed or pre-extracted with detergent. No colocalization
with lamins (green) was observed, and no calreticulin remained after
extraction, though lamins did remain. Both direct fixed and pre-
extracted images were exposed for 2 s. Right untransfected cells were
similarly treated, then stained with the ER lipid dye DiOC6.
Endogenous ER staining did not exhibit notable accumulation at the
NE and was completely removed by the pre-extraction. Both images
were exposed for 500 ms. Scale bars 20 lm
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Rat liver cryosections were also stained with several of
the NET antibodies. These antibodies yielded nuclear rim
staining in multiple cells within any given field (Fig. 4). In
some cases very little staining was observed outside the
nuclear rim in the tissue sections, whereas in others some
other distinctive areas of cells were stained, particularly the
ER, consistent with the partial localization in microsomes
in Fig. 3. This is similar to the case of the well-charac-
terized NET emerin, which has been shown to also stain in
the cytoplasm of myotubes and interstitial discs in heart
tissue [24, 25].
Most of the NETs target to the INM
The wide range of NET characteristics observed here
highlighted the need to better distinguish their localization
between INM and ONM. It was also considered that NETs
that failed to resist the pre-fixation extraction with Triton
X-100 might preferentially localize to the ONM. A recent
study was able to distinguish between INM and ONM
localization by comparing staining for lamin B1 with nu-
cleoporins from the nuclear basket (Nup153) and
cyoplasmic filaments (Nup358) of the NPC using 3D
structured illumination microscopy (OMX; [26]). If a
protein localizes to the INM, it should co-localize in the
same plane as Nup153, but yield a separable more internal
staining compared to Nup358 (Fig. 5a). This same system
was directly applied to the well-characterized NET LAP2ß
fused to a fluorescent protein tag as a control and to several
similarly fused NETs (Fig. 5b). For all but NET23 and the
ER controls of those tested, the NET (red) and Nup153
(green) spots were observed in the plane of the INM, and
an internal NET (red) ring was observed compared to
Nup358 (green). The appearance of alternating spots as
opposed to co-localization further supports the quality of
the imaging as NPCs are positioned at perforations in the
nuclear membrane, whereas the NETs would be in the
plane of the inner membrane and so should not actually co-
localize. Although differing levels of the exogenously
expressed NETs had accumulated in the ER and so reduced
the clarity of the planar separation, the inner ring was still
clearly distinguishible.
Nup153 and Nup358 were also clearly distinguishable
from one another when stained in the same cell with de-
convolved images generated using a Deltavision
microscope system (Fig. 5c). In this case Nup153 is col-
ored red and Nup358 green to compare the two Nups in the
same cell. Remaining NETs were then tested using this
Fig. 2 NETs that did not resist detergent pre-extraction re-tested for
NE accumulation in directly fixed cells. HA-tagged NET62 and
mRFP-tagged NETs 20, 38, and 46 were transiently transfected into
HT1080 cells expressing lamin A-GFP. Tagged emerin and calret-
iculin were separately overexpressed as controls. The NET alone
(black and white) and the merge between the NET (red) and lamin A
(green) are shown. The new NETs yielded clear nuclear rims against
the high cytoplasmic accumulation, colocalizing with lamins (yellow
merge) similarly to emerin (top left). This staining pattern clearly
differs from the ER localization of calreticulin (top right). Scale bars
20 lm
Fig. 3 Relative amounts of NETs in the NE vs ER. NEs and
microsomal membranes representing ER were prepared, and an equal
amount of total protein for each fraction loaded on SDS-PAGE based
upon measurements with Bradford assay. The proteins were trans-
ferred to nitrocellulose membranes, reacted with NET antibodies and
fluorescent secondary antibodies, and fluorescent signals quantified
using a LI-COR Odyssey. The averaged results of three separate
Western blots are plotted showing the percentage of the combined
signal coming from NE and microsome lanes. Most NETs were
principally in the NE fraction, but NET34 was principally in the
microsome fraction
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system. LAP2ß, calreticulin, and NET55 were tested again
(in red), revealing that INM and ONM could be similarly
discriminated, though with slightly less clarity in resolu-
tion. Most of the remaining NETs tested similarly yielded
alternating red and green spots with Nup153 in the plane of
the inner ring and an inner NET ring compared to Nup358
(Fig. 5d). However, NET4, NET24, and NET31 joined
NET23 in appearing only in the ONM.
To confirm the validity of INM localization determina-
tions using this system, two NETs and controls were tested
by immunogold-EM with anti-GFP antibodies for locali-
zation to the INM. The secondary antibody-conjugated
gold particles were observed at the INM for both controls
emerin and SUN2, and additionally gold particles were
observed in both the ER and ONM, consistent with
expected accumulation in the ER when saturating binding
sites in the INM when overexpressed (Fig. 5e). The INM
could be readily distinguished from the ONM and ER
because of the denser appearance of chromatin and absence
of additional membrane systems on one side of the double
membrane and the lighter staining and appearance of ER
and mitochondrial membranes on the other. NET51 and
NET55 yielded similar patterns of gold particle distribution
with NET55 yielding an even higher proportion of gold
particles in the INM than the well-characterized INM
proteins SUN2 and emerin.
Some NETs only target in specific cell types
Intriguingly, in the liver tissue sections nuclear rim accu-
mulation was only observed in a subset of the cells within
any given field for NETs 29 and 30, as can be distinguished
by DAPI-stained nuclei sectioned in mid-plane that lack
nuclear rim staining with the antibody (Fig. 4). This sug-
gested that the failure of some NETs to target to the NE in
the HT1080 cells used in tagged NET expression experi-
ments might reflect the specific cell type used; i.e., they
might target in other cell types. Moreover, antibodies to
two NETs (NET29 and NET39) did not stain some cell
lines tested, but did others (data not shown). These two
NETs are expressed in a limited set of tissues according to
a large-scale transcriptome study [27]. Therefore, several
NETs that had not targeted in HT1080 cells were tested in
other cell lines.
NET45 in particular might be expected to have restric-
ted targeting because, according to transcriptome data [27],
it is expressed higher in liver than any other tissue. In the
HT1080 fibrosarcoma cells, NET45-mRFP was extractible
and accumulated too strongly in the cytoplasm for a firm
conclusion on NE targeting to be made, whereas in HepG2
cells that are derived from liver a distinct rim staining was
obtained (Fig. 6a). Thus, the liver cells might have partners
that tether NET45 in the NE that are absent in the HT1080
cells.
Thus, the NETs that failed to target in HT1080 cells
were retested in a variety of cell types: HepG2 (hepa-
tocyte), 293T (kidney), C2C12 (muscle), and 3T3-L1
(pre-adipocyte) cell lines (Fig. 6 and Table 1). Controls
emerin and NET59 targeted to the NE in all five lines.
NET32, previously reported to target to the NE and resist
pre-extraction in C2C12 cells [14], also targeted in 293T
cells, but not in HT1080, HepG2, or 3T3-L1 cells.
Fig. 4 Antibody staining in
liver tissue sections.
Cryosections of rat liver were
stained with various NET
antibodies and imaged on a
confocal microscope. Nuclear
rim staining could be observed
in multiple cells in all fields,
though for NET29 and NET30
not all cells in a given field
yielded nuclear rims (cells
indicated by arrows, as
determined by comparing DAPI
staining for mid-sectioned
nuclei). Some background
staining is observed with all
NETs in the cytoplasm: this was
slightly diminished with use of
an affinity-purified antibody for
NET30 (NET30AP), but may
also indicate multiple cellular
localizations for NETs. Scale
bars 10 lm
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NET11 and NET13 also targeted to the NE in a subset of
the cell lines (Fig. 6). To support this visual readout,
image pixel intensities were measured and a ratio of NE
over ER values generated (Fig. 6b). For an ER dye and
overexpressed calreticulin protein, the ratio was very
close to 1, indicating no enrichment at the NE. However,
the control emerin and novel NETs all had values
between *1.3 and 1.5 in the cells where they targeted,
and the p values indicated extremely high confidence that
these numbers were statistically significant compared to
the membrane and calreticulin controls (Table 2). It was
not possible to test if they resisted pre-extraction in the
cells where they targeted because transfection efficiencies
were low, and many cells are washed away in the
extraction procedure.
The cell-type specific targeting of exogenously expres-
sed NETs suggested that endogenous expression levels of
NETs might be prognostic for their NE targeting. Indeed,
slightly lower expression levels were observed by RT-PCR
in the HT1080 cells for NET11, NET13, and NET45, and
higher levels of NET45 were observed in the HepG2 cells
where it targeted best (Fig. 7). However, over the range of
cell lines tested there was no correlation between expres-
sion levels and targeting.
Fig. 5 INM versus ONM targeting. NETs were imaged using high-
resolution systems for localization in relation to the two sides of the
NPC using Nup153 from the nuclear basket and Nup358 from the
cytoplasmic filaments. (a) Schematic of expected patterns indicating
INM or ONM localization. If a protein is in the INM, the NET and
Nup153 signals should occur in the same plane, and the NET signal
should appear internal to the Nup358 signal. If the protein is in the
ONM, the Nup153 signal should be internal to the NET signal and the
Nup358 signal should occur in the same plane as the NET signal. (b)
Images using structured illumination show both characterized
(LAP2ß) and many novel NETs in the same plane of the inner
nuclear membrane with Nup153 and internal to Nup358. Only NET23
and controls Sec61ß and calreticulin yielded the pattern expected for
ONM residence. (c) High-resolution deconvolved Deltavision images
also can distinguish inner from outer nuclear membranes with
Nup153 shown in red and Nup358 shown in green. (d) Many
additional novel NETs appeared in the INM using again LAP2ß as a
control and NET55 that had been separately tested with the OMX
system. In contrast NETs 4, 24, and 31 together with the calreticulin
control yielded ONM targeting. Scale bars for b-d 5 lm. (e)
Immunogold-EM confirms the validity of OMX and Deltavision
results as 5-nm gold particles recognizing GFP antibodies for
expressed NET51 and NET55 proteins appeared in the INM, similarly
to controls. C and N denote cytoplasmic and nucleoplasmic sides
where NPCs are inserted in the membrane. Bars 100 nm
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Some putative NETs appear to not be integral
to the membrane
Most remaining putative NETs that failed to target were
tested in the same range of cell lines, some with both N-
terminal HA and C-terminal RFP epitope tags in case one
or the other tag or tag location interfered with proper
folding or blocked binding sites required for NE retention
(Table 1). In several cases (NETs 14, 17, 21, 35, 43, and
49) the tagged protein accumulated in the nucleoplasm/
nucleolus instead of the NE (data not shown). As this
suggested that the original membrane helix predictions
using TMPred [18] were erroneous, all putative NETs were
re-evalutated using the more stringent TMHMM v2.0 [19].
TMHMM predicted transmembrane helices in only 33 of
the 67 putative NETs. Of those tested here that TMHMM
failed to predict as transmembrane, 36% nonetheless gave
clear nuclear rim and ER distribution consistent with
membrane association, whereas 90% of those with
TMHMM membrane predictions yielded NE targeting
(Table 3). As TMHMM failed to predict membrane spans
for 22 of the 27 NETs that have not been tested for tar-
geting, few of them are likely to be NETs.
Several NETs exhibit significantly reduced NE
accumulation in lamin A/C knockout cells
The NE retention of NETs is thought to be driven by their
binding to lamins or chromatin [28], e.g., emerin accu-
mulates in the ER in cells lacking A/C lamins [29] and has
been shown to directly bind to A/C lamins [5]. To gauge
the percentage of NETs in this large dataset likely to
depend on lamin A for targeting, we compared the distri-
bution of the tagged proteins in matched mouse embryonic
fibroblasts that either expressed the endogenous lamin A
protein (Lmna ?/?) or carried a disruption in the LMNA
gene (Lmna -/-; [29]). Most had no difference between
the Lmna ?/? and the Lmna -/- cells, but several were
altered in distribution. The following scenarios were
observed: (1) distinctive NE accumulation in both cell lines
(NETs 8, 20, 29, 37, 46, 51, 55, and 59); (2) a significant
and reproducible lack of NE accumulation in the Lmna
Fig. 6 Some NETs only accumulate at the NE in certain cell types.
(a) NETs that failed to target to the NE in HT1080 (human
fibrosarcoma) cells were re-tested in other cell lines derived from
different tissues: HepG2 (human liver tumor), 293T (human embry-
onic kidney), C2C12 (mouse skeletal muscle), and 3T3-L1 (mouse
pre-adipocyte). HA-tagged NET32 and mRFP-tagged NETs 11, 13,
45, 59, and emerin were transiently transfected into the different cells.
To ensure that rim accumulation was not due to bleedthrough or
cross-reactivity with NE markers, cells were not co-transfected with
or stained for other NE proteins. Arrows mark cells in which different
NETs yielded discernible rim staining by having a strong distinct rim
as opposed to one that could be accounted by ER condensed against
the nucleus. Scale bars 20 lm. (b) To further validate NE targeting,
the relative pixel intensities in ER and NE were quantified compared
to ER controls. Pixel intensity was measured at a point in the nuclear
rim (based on DAPI staining) and at a point approximately 2 lm
distant into the ER, and the NE/ER ratio was calculated. Eight such
measurements were taken from each NET from 5 different cells, and
Tukey’s boxplots [45] for the 40 ratios for each NET in each cell line
are shown with the median (central line), two quartiles above and
below (box) and third quartile (error bars) shown. We compared each
sample to each control (DiOC6 or calreticulin expressed in HT1080
cells) with the null hypothesis that ‘control to sample differences are
by random chance.’ After analysis we reject the null hypothesis for
each sample at P \ 0.001 by Mann-Whitney (Wilcoxon) U test
(Table 2). The ER dye DiOC6 and calreticulin-GFP both were very
similar in intensity between the ER and NE, yielding a ratio of *1.
Though NET ratios tended to be in the 1.3–1.5 range, they were
highly statistically significant, even for NET11 in C2C12 cells where
a strong rim was not visually evident
b
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-/- cells compared to the Lmna ?/? cells (NETs 23, 26,
34, 50); (3) weak or no NE accumulation in the Lmna ?/?
cells so that a comparison could not be made (NETs 4, 5,
30, 33, 47 and 56) (Fig. 8). As both lines tested are mouse,
it is unlikely that differences between human and mouse
proteins would account for the mistargeting in the Lmna
-/- cells, the more so as they are highly conserved with
NET26, NET34, and NET50 all having over 77% amino
acid identity between human and mouse and NET23 hav-
ing 69% identity.
Alternate mechanisms for NE retention of NETs
in cells lacking lamin A
To further assess potential interactions of the NETs with
lamins, we investigated whether their resistance to detergent
extraction was altered by the presence or absence of lamin A.
This could only be assayed for the NETs with working
antibodies because the overexpressed NET accumulation in
the ER would interfere with quantification. Wild-type Jurkat
cells that normally lack lamin A and Jurkat cells stably
transfected with lamin A-GFP were extracted with 1% Tri-
ton X-100/50 mM NaCl. The insoluble material (e.g.,
lamins and associated NETs) that resisted extraction was
measured by immunoblotting and quantified as a percentage
of the relative levels in non-extracted lysates, which were set
to 100 (Fig. 9a). To improve solubility of the lamina in the
non-extracted lysates, they were first treated with detergent
and urea prior to heating in SDS-sample buffer; however,
lamin levels detected on Western blots were about 30%
higher in the extracted lysates than in the non-extracted
lysates. This could be due to greater accessibility for sub-
sequent solubilization in the sample buffer after removing
chromatin proteins such as histones.
Table 1 Failed putative NETs tested in different cell lines
NETs tested in 14-mRFP HA-14 16-GFP 17-mRFP
& HA-17
21-mRFP HA-35 35-mRFP 36-mRFP 43-mRFP
& HA-43
44-mRFP 49-mRFP
HT1080 n/d n/d – – – – n/d – – – –
293T n/d n/d – – n/d – n/d – – – –
C2C12 – – – – n/d – – – – – –
NIH 3T3-L1 – n/d – – n/d – – – – – –
HepG2 n/d n/d – – n/d – n/d – – – –
U2OS – – n/d n/d n/d – – – n/d n/d n/d
–, NETs did not target in this cell line; n/d, NETs not tested in this cell line
Table 2 Mann-Whitney U-test (Wilcoxon) P-values for comparison
of each protein to the DiOC6 control or the calreticulin control for
Tukey’s boxplot shown in Fig. 6b (all are significant)
NET in cell line With control DiOC6 With control calreticulin
W P-value W P-value
Emerin in HT1080 30 1.303e-13 8 2.571e-14
NET11 in C2C12 459.5 0.001065 336 8.13e-06
NET11 in NIH-3T3 303 1.765e-06 239.5 7.032e-08
NET13 in C2C12 343.5 1.135e-05 220 2.416e-08
NET32 in C2C12 279 5.441e-07 189.5 4.309e-09
NET45 in HT1080 346 1.270e-05 236 5.791e-08
NET45 in HepG2 58 9.585e-13 17 5.014e-14
NET59 in C2C12 168.5 1.255e-09 140 2.184e-10
Fig. 7 Expression profiles of NETs only sometimes correlate with
their targeting. mRNAs were prepared from the human cell lines used
in Fig. 6. RD myoblast cells (human) were used to represent muscle
because C2C12 myoblast cells are derived from mouse. RT-PCR
reactions were performed to determine the relative NET levels in the
cell lines, using peptidylprolyl isomerase A (Ppia) as a loading
control. Each was repeated at least three times, and representative gels
are shown




















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































NET targeting and lamin-dependence 1365
As expected, the negative control LAP2ß that has been
shown to bind lamin B [22] yielded no difference to
extraction between the Jurkat cells containing or lacking
lamin A; neither, however, did NETs 23 and 50 that were
strongly mislocalized in the lamin A/C null fibroblasts nor
the positive control emerin. Only NET33 showed a mini-
mal difference in resistance to extraction between the
Jurkat cells containing or lacking lamin A. NET23 and the
lamins alone fully resisted the detergent extraction from
Jurkat cells, even though these novel NETs resisted
extraction in multiple adherent cell types. LAP2ß resisted
extraction only to 80% of non-extracted levels and emerin
only to 50%. Novel NETs 33 and 50 weakly resisted the
extraction, retaining *30% of non-extracted levels.
As this result was unexpected, the same assay was
applied to two mouse fibroblast lines, one of which was
disrupted for endogenous lamin A as confirmed by
immunoblotting. In this case emerin, which was expected
to depend on lamin A for NE retention, was *29 more
resistant to detergent extraction in the wild-type fibroblasts
compared to those lacking A/C lamins (Fig. 9b). Yet nearly
40% resisted extraction in the lamin A null cells, indicating
that lamin A-independent mechanisms also exist for
retention of emerin at the NE in these fibroblasts. NET33,
which in Jurkat cells had shown only a slight benefit from
the presence of lamin A for its resistance to detergent
extraction, became entirely dependent on the presence of
lamin A for its resistance to detergent in the fibroblasts.
NET50 remained indifferent to lamin A. Surprisingly, only
about 50% of the LAP2ß resisted extraction in the lamin A
knockout fibroblasts, whereas most had resisted extraction
in both Jurkat lines. Lamin B1 levels measured were higher
in the Lmna -/- cells. This could be due to upregulation
by the cell to compensate for the loss of lamin A or might
reflect greater solubility of the B-type lamins in the absence
of lamin A that has previously been reported [30]. Thus,
multiple mechanisms must exist for the targeting and
association of the same NETs in different cell types.
Discussion
This study contributes three important findings: first it tests
the validity of proteomic results that previously greatly
expanded the number of putative NETs [12], confirming
many, but finding that roughly a third were erroneously
named ‘NET.’ Second, it shows that some valid NETs only
target to the NE in certain cell types, a finding that indi-
cates the need to carefully match studies of NETs with
appropriate cell types. Third, the differences among cell
types and between in vivo and in vitro results for both
extraction and targeting studies indicate that NETs likely
have different mechanisms for targeting to the NE in dif-
ferent cell types.
While this study has confirmed many novel NETs, it has
also shown that transmembrane predictions for others were
erroneous. Extrapolating from the NETs now tested, we
estimate that 30% of the 67 putative NETs cannot properly
be called NETs because of the absence of transmembrane
spans. Nonetheless, the failure of newer algorithms to
predict transmembrane helices for several NETs that we
and others have confirmed [14, 15] leaves open the possi-
bility that other NETs may be validated. Some of those
apparently lacking transmembrane segments may have
additional splice variants that encode membrane spans,
whereas others might function at the NE without a mem-
brane span: NET43/hALP is recruited to the NE through
binding SUN1 at the end of mitosis where it contributes to
chromosome decondensation [31]. Thus, in addition to
Fig. 8 NETs that mistarget in cells lacking lamin A/C. Mouse
embryonic fibroblasts extracted from a wild-type mouse (Lmna ?/?)
or from a matched LMNA knockout mouse (Lmna -/-) [29] were
transfected with NET fusion constructs. At 30 h post-transfection,
cells were directly fixed with formaldehyde and processed for
immunofluorescence microscopy. Upper panels above the break show
emerin and NETs that produced a distinctive rim in the Lmna ?/
? cells, but did not in the Lmna -/- cells. Other NETs tested yielded
no striking or reproducible differences in presence or absence of
lamin A/C (only NET51 and NET55 are shown in bottom panels).
Deconvolved images are shown. Scale bars 20 lm
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being at the NE only in certain cell types, some proteins
may have multiple subcellular locations and only reside
transiently at the NE during certain cell-cycle stages.
Transient nuclear envelope accumulation was also
reported previously for NET59/nicalin, which tends to
reside in the ER but accumulates in the NE when certain
co-factors are present [32]. Moreover, we have shown here
that its NE accumulation is in the INM and it resists
detergent extraction. Many NETs likely have multiple
cellular localizations as emerin, one of the most established
INM NETs [33], also functions in the ONM, ER, and
interstitial discs [23–25]. Moreover, a recent elegant pro-
teomic study suggests that at least a third of all proteins
have multiple cellular localizations [34]. Nonetheless, most
of the NETs for which we have antibodies yeilded their
principal accumulation in the NE compared to the ER.
The finding that some NETs only target to the NE in
particular cell types both by overexpression analysis and
antibody staining in tissue sections is consistent with the
hypothesis that specificity of NE functions in different
tissues and/or cell types might contribute to the tissue
preference of NE disease pathologies [35]. Although the
primary tissue-specific cell type of liver is hepatocytes
(estimated at *80%), there are also Kuppfer cells that are
liver specific, lipocytes (similar to adipocytes), as well as
epithelial cells and an extensive vasculature providing
endothelial cells. As functions have yet to be found for
most new NETs, it is early to speculate detailed molecular
mechanisms that would yield pathology. However, NETs
13, 39, 45, 55, and 59 have either been reported to directly
function in signaling or to be related to signaling proteins
[32, 36–40]. Thus, these NETs could be involved in signal
transduction pathways similar to those of the well-charac-
terized NET MAN1 in Smad/BMP/TGFß signaling [41].
Intriguingly, two of these NETs accumulate in the inner
membrane, whereas the other three accumulate in the outer
membrane. Moreover, NETs functioning in signaling
pathways might vary in localization between ONM and
INM depending on timing in the cell cycle. The restriction
in targeting to certain cell types for three of these signal-
ing-related NETs (NETs 13, 39, and 45) might reflect cell-
specific use of these signaling pathways, a possible
mechanism towards disease that further underscores the
need to test putative NETs in multiple cell types.
Historically, NE proteins have been thought to reside
exclusively in the inner membrane despite the fact that this
represents only half of the NE. Of the 18 NETs tested by
high-resolution microscopy, 4 appeared to localize to the
ONM only and not to the INM, indicating the need to
redefine the ONM as a separate and distinct cellular com-
partment and not just a subcompartment of the ER. INM
localization only generally correlated with detergent
resistance, with 79% of INM tested proteins resisting
detergent pre-extraction and 50% of ONM proteins tested
not resisting the pre-extraction.
Few NETs have been directly tested for binding to
lamins in general or to particular subtypes. Some bind
multiple lamin subtypes (e.g., LAP1 [22]) while others
Fig. 9 Indirect assay for lamin A interactions. If a NET that resists
detergent extraction depends on lamin A for its NE retention either
through direct or indirect binding, then it would be expected to be
more resistant to detergent extraction in cells that express lamin A.
Relative NET and lamin protein levels were quantified between lamin
A expressing and not expressing cells from lysates run on Western
blots using anti-NET and anti-lamin antibodies. The graphs show the
levels of the protein left in cells extracted with 1% Triton X-100 as a
percentage of the levels measured in unextracted cells. The numbers
used for NETs were normalized according to the amount of lamin B1
remaining after extraction, which is shown here as absolute values,
and three separate experiments were averaged to generate standard
deviations. (a) Jurkat cells are suspension cells derived from a T-cell
lymphoma that do not normally express lamin A. To test if adding
lamin A to these cells would affect NET resistance to detergent
extraction, Jurkats stably expressing lamin A-GFP were generated.
Several NETs that resisted detergent extraction in the HT1080
fibroblasts grown on coverslips did not resist extraction in the Jurkat
cells whether or not lamin A was present. Those that did resist showed
no difference between the lamin A expressing and non-expressing
cells. (b) Lmna -/- mouse fibroblasts (216-/-; [29]) and control
mouse fibroblasts (NIH3T3) were also compared. In the fibroblast
system emerin, LAP2ß, and NET33 differed in their extractibility
between the lamin A null cells and the lamin A-expressing cells
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bind specific subtypes (e.g., LBR with lamin B [22, 42] and
emerin with lamin A [5]). The mistargeting of some NETs
in cells lacking lamin A suggests that they are tethered at
the NE, either directly or indirectly, through binding to
lamin A. However, differences were observed in NETs for
lamin A-dependent resistance to detergent extraction
between the lymphoblasts and fibroblasts tested. Thus,
multiple mechanisms must exist for the targeting and
association of NETs with lamins in different cell types.
This can explain in part the tissue-preference of pathology
in NE diseases as it suggests that the NET’s NE retention
only depends on lamin A in certain cell types.
The confirmation of such a large set of NETs is an
important step in understanding the functioning and shared
characteristics of proteins in this organelle. For example,
the 31 of the liver NETs identified by proteomics now
confirmed may be enough for analyses by bioinformatics
experts to identify NE targeting sequences. Moreover, some
NETs that have more tissue-specific expression likely
interact with lamins and other NETs, and thus might con-
tribute to complexes involved in NE diseases. Of particular
note is NET39, which resisted pre-extraction with detergent
and was in the INM. It is expressed preferentially in skeletal
muscle in mouse and has been shown to be strongly induced
during myogenesis and to play a direct role in signaling
mechanisms for myogenesis [14, 43]. In humans NET39 is
preferentially expressed in heart [27]: as cardiomyopathy
has been linked to the lamina in humans [44], this protein
might be relevant for the tissue-specificity of this disease.
The differences we observed for several NETs in cellular
localizations in different cell types and targeting in the
Lmna -/- cells thus provide an important starting point
from which to address lamin-NET complexes.
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The Leukocyte Nuclear Envelope Proteome
Varies with Cell Activation and Contains Novel
Transmembrane Proteins That Affect Genome
Architecture*□S
Nadia Korfali‡, Gavin S. Wilkie‡, Selene K. Swanson§, Vlastimil Srsen‡,
Dzmitry G. Batrakou‡¶, Elizabeth A. L. Fairley‡, Poonam Malik‡, Nikolaj Zuleger‡,
Alexander Goncharevich‡, Jose de las Heras‡, David A. Kelly‡, Alastair R. W. Kerr‡,
Laurence Florens§, and Eric C. Schirmer‡**
A favored hypothesis to explain the pathology underlying
nuclear envelopathies is that mutations in nuclear enve-
lope proteins alter genome/chromatin organization and
thus gene expression. To identify nuclear envelope pro-
teins that play roles in genome organization, we analyzed
nuclear envelopes from resting and phytohemagglutinin-
activated leukocytes because leukocytes have a particu-
larly high density of peripheral chromatin that undergoes
significant reorganization upon such activation. Thus, nu-
clear envelopes were isolated from leukocytes in the two
states and analyzed by multidimensional protein identifi-
cation technology using an approach that used expected
contaminating membranes as subtractive fractions. A to-
tal of 3351 proteins were identified between both nuclear
envelope data sets among which were 87 putative nuclear
envelope transmembrane proteins (NETs) that were not
identified in a previous proteomics analysis of liver nu-
clear envelopes. Nuclear envelope localization was con-
firmed for 11 new NETs using tagged fusion proteins and
antibodies on spleen cryosections. 27% of the new pro-
teins identified were unique to one or the other of the two
leukocyte states. Differences in expression between ac-
tivated and resting leukocytes were confirmed for some
NETs by RT-PCR, and most of these proteins appear to
only be expressed in certain types of blood cells. Several
known proteins identified in both data sets have functions
in chromatin organization and gene regulation. To test
whether the novel NETs identified might include those
that also regulate chromatin, nine were run through two
screens for different chromatin effects. One screen found
two NETs that can recruit a specific gene locus to the
nuclear periphery, and the second found a different NET
that promotes chromatin condensation. The variation in
the protein milieu with pharmacological activation of the
same cell population and consequences for gene regula-
tion suggest that the nuclear envelope is a complex reg-
ulatory system with significant influences on genome
organization. Molecular & Cellular Proteomics 9:
2571–2585, 2010.
The nuclear envelope (NE)1 is a double membrane system
consisting of the intermediate filament nuclear lamin polymer
and associated proteins attached to the inner nuclear mem-
brane (INM) (1), nuclear pore complexes (NPCs) that direct
transport of soluble macromolecules in and out of the nucleus
(2), and the outer nuclear membrane (ONM) and associated
proteins. Structurally, the ONM is continuous with the endo-
plasmic reticulum (ER) and is studded with ribosomes (3), yet
it also contains unique proteins, many of which connect the
cytoskeleton to the NE (4). On the other side, lamins and many
INM proteins directly connect chromatin to the NE. Lamins
and an increasing number of nuclear envelope transmem-
brane proteins (NETs) have been linked to a similarly increas-
ing number of diseases ranging from muscular dystrophy to
neuropathy, dermopathy, lipodystrophy, bone disorders, and
progeroid aging syndromes (5, 6).
A favored hypothesis to explain how different NE proteins
can produce such a wide range of disease pathologies is that
chromatin-NE connections are disrupted with NE protein mu-
tations, yielding changes in gene regulation. This hypothesis
is supported by observations that the distribution of dense
peripheral chromatin is affected in fibroblasts from patients
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with NE-linked muscular dystrophy, cardiomyopathy, man-
dibuloacral dysplasia, and progeria (7–10). Furthermore, many
binding partners have been identified for NETs that are either
chromatin proteins, enzymes that modify chromatin proteins,
or regulators of gene expression (1, 11). These include mark-
ers of silent chromatin such as heterochromatin protein 1 (12)
and proteins that modify chromatin to a silent conformation
such as histone deacetylase 3 (13). The importance of the NE
to global genome organization has been underscored by sev-
eral recent studies that showed that affinity-based recruit-
ment of a specific chromosome locus by the NE both pulled
entire chromosomes to the periphery and affected gene reg-
ulation in complex ways (14–16).
To identify NE proteins likely to be involved in genome
organization, we turned to lymphocytes as a model system.
Lymphocytes in the resting state tend to have massive
amounts of dense peripheral chromatin as determined by
electron microscopy studies. Upon activation with phytohe-
magglutinin, this dense chromatin largely dissipates as the
cells actively express genes (17–20). Thus, to identify proteins
that might be involved in tethering heterochromatin to the NE
or in changing its organization, we analyzed the NE pro-
teomes of leukocyte populations (70% lymphocytes) in both
the resting and phytohemagglutinin (PHA)-activated states.
The previously validated subtractive approach was applied
(21) using microsomes and mitochondria, the principal mem-
brane contaminants expected, as subtractive fractions.
Many new NE proteins were identified that had not been
identified in previous NE proteomics investigations using liver
and neuroblastoma cells (21, 22). NE residence was con-
firmed for 12 novel NETs by expression of epitope-tagged
versions and using antibodies on tissue cryosections.
Roughly one-quarter of the proteins identified varied be-
tween the resting and activated states. Some NET differences
between the two data sets were confirmed by RT-PCR.
Among the known proteins identified were several that sug-
gest that changes in NE composition associated with PHA
activation contribute to gene regulation. Novel NETs identified
also appear to play significant roles in genome organization/
regulation as we found that several can either recruit a spe-
cific locus to the nuclear periphery or promote chromatin
condensation. As several studies have implicated misregula-
tion of chromatin organization in NE diseases (7, 8), these
newly identified NETs may contribute to the diverse patholo-
gies associated with NE diseases.
EXPERIMENTAL PROCEDURES
Preparation and Activation of Leukocytes—Human buffy coats
from healthy donors were obtained anonymously from the Scottish
National Blood Transfusion Service according to approved ethics
protocols. Buffy coats were diluted with phosphate-buffered saline
(PBS), and a peripheral blood mononuclear cell (PBMC) fraction was
isolated by centrifugation on Ficoll-Histopaque-1077 (Sigma) at
250  g for 30 min. Cells were diluted in PBS, pelleted, and resus-
pended in RPMI 1640 medium containing 10% fetal bovine serum
(FBS), 100 g/l penicillin, and 100 g/l streptomycin sulfate (In-
vitrogen). PBMCs were activated by addition of 2.5 g/ml PHA
(Sigma) for 7 days. To determine the composition of PBMC prepara-
tions, cells were analyzed by FACS using antibodies from Caltag
Medsystems to CD19 for resting B-cells and CD19/CD4 for activated
B-cells, CD3 for resting T-cells and CD3/CD45 for activated T-cells,
CD3/CD4 for resting helper T-cells and CD4/CD45 for activated
helper T-cells, CD3/CD8 for resting cytotoxic T-cells and CD8/CD45
for activated cytotoxic T-cells, and CD11b/CD14 for myeloid cells.
Preparation of Fractions—NEs were isolated using procedures
specifically modified for blood leukocytes and detailed previously
(23). In brief, nuclei were first isolated from PBMCs by hypotonic lysis
in 10 mM HEPES, pH 7.4, 1.5 mM MgCl2, 10 mM KCl, 2 mM DTT using
a “loose” Dounce homogenizer (Wheaton). Nuclei were pelleted at
1000  g for 10 min to separate them from small vesicles and
mitochondria that require higher speeds to pellet. To float/remove
contaminating membranes, nuclei were resuspended in SHKM (50
mM HEPES, pH 7.4, 25 mM KCl, 5 mM MgCl2, 1 mM DTT and 1.8 M
sucrose) and pelleted through a 5 ml 2.1 M sucrose cushion in an
SW28 swinging bucket rotor (Beckman) at 4 °C for 2 h at 82,000  g.
NEs were then prepared from isolated nuclei by two rounds of diges-
tion with DNase and RNase in 0.3 M sucrose, 10 mM HEPES, pH 7.4,
2 mM MgCl2, 0.5 mM CaCl2, 2 mM DTT for 20 min followed by layering
onto the same buffer with 0.9 M sucrose and centrifugation at 6000 
g for 10 min at 4 °C.
The PBMC cell populations had very little ER, so microsomes
representing contaminant membrane fractions were instead isolated
from rat liver using well established procedures (24, 25). In brief, liver
was diced and homogenized in SHKM using a motorized Dounce
homogenizer. After removing nuclei as for NE preparations, 0.5 mM
EDTA was added to inhibit metalloproteinases, and mitochondria and
other debris from postnuclear supernatants were also removed by
pelleting at 10,000  g for 15 min. The supernatant was made to 2 M
sucrose with SHKM and then overlaid with 1.86 and 0.25 M sucrose
layers. This was then subjected to centrifugation in an SW28 swinging
bucket rotor (Beckman) at 4 °C for 4 h at 57,000  g to float micro-
somes. The material between the 1.86 and 0.25 M layers was then
diluted 4-fold with 0.25 M SHKM and pelleted at 152,000  g in a type
45 Ti rotor (Beckman) for 1 h.
NE preparations were divided, and one portion was further ex-
tracted on ice with 400 mM NaCl, 25 mM HEPES, pH 8.0, 5 mM MgCl2,
10 mM DTT, 1% -D-octyl glucoside, and material used for mass
spectrometry analysis was pelleted at 15,000  g for 30 min and
washed in sterile H2O. Another portion of NEs and separate micro-
somes were further extracted with 0.1 N NaOH, 10 mM DTT, and the
material used for mass spectrometry was pelleted by centrifugation at
150,000  g for 30 min and washed three times in sterile H2O.
MudPIT—Two types of digestion were applied to NE and micro-
some pellets (supplemental Table S1). For the first, dried membrane
pellets were incubated overnight in 90% formic acid and 500 mg/ml
cyanogen bromide (CNBr). Ammonium hydroxide (NH4OH) was then
added to pH 8.5, solid urea was added to 8 M, and tris(2-carboxyl-
ethyl)phosphine hydrochloride (TCEP) was added to 5 M and incu-
bated for 30 min. Next free cysteines were alkylated with 20 mM
iodoacetamide (IAM) for 30 min prior to addition of endoproteinase
Lys-C (Roche Applied Science) at a 1:100 (w/w) enzyme to protein
ratio for 6 h at 37 °C. Urea was diluted to 2 M with 0.1 M Tris-HCl, pH
8.5, and CaCl2 (0.5 mM) and modified trypsin (1:100, w/w) were added
for 12 h at 37 °C. Digestions were quenched with 5% formic acid (25).
For the second digestion (Ti), pellets were solubilized in 0.1 M Tris-
HCl, pH 8.5, 8 M urea, 5 mM TCEP. IAM was added to 10 mM for 30
min, and endoproteinase Lys-C and trypsin digestion was performed
as above. Samples were centrifuged for 30 min at 17,500  g.
Supernatants were analyzed by MudPIT, whereas pellets were resus-
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pended in 0.1 M sodium carbonate (Na2CO3), pH 11.5, 8 M urea, 5 mM
TCEP for 30 min and then in 10 mM IAM for 30 min and then further
digested with proteinase K for 4 h at 37 °C and also analyzed by
MudPIT.
Each digested sample was analyzed independently by MudPIT as
described previously (26–28) using a flow rate of 200–300 nl/min.
12–15 cycles (supplemental Table S1) of 120 min each of increasing
salt concentrations followed by organic gradients (5–80% acetonitrile
with 0.1% formic acid) slowly released peptides directly into the mass
spectrometer (26). The last two or last five (of 12 or 15) chromatog-
raphy steps consisted of a high salt wash with 5% acetonitrile, 0.1%
formic acid, 500 mM ammonium acetate followed by the acetonitrile
gradient. The distal application of a 2.5-kV voltage electrosprayed the
eluting peptides directly into ion trap mass spectrometers equipped
with a nano-LC electrospray ionization source (ThermoFinnigan).
Each full MS scan (from 400 to 1600 m/z) was followed by three
(XP-Deca) or five (LTQ) MS/MS events (supplemental Table S1) using
data-dependent acquisition where the first most intense ion was
isolated and fragmented by collision-induced dissociation (at 35%
collision energy) followed by the second to third or fifth most intense
ions. The raw mass spectrometric data may be downloaded from
ProteomeCommons.org by going to the URL indicated in Table I and
then inserting the hash identifiers from Table I.
RAW files were extracted into ms2 file format (29) using RAW_
Xtract v.1.0 (30). For the human PBMC data set (supplemental
Table S2), MS/MS spectra were queried for peptide sequence infor-
mation using SEQUEST v.27 (revision 9) (31) against 30,552 human
proteins (non-redundant NCBI sequences on March 4, 2008) plus 162
sequences from usual contaminants (e.g. human keratins etc.) and
313 previously identified NETs (21). To estimate false discovery rates,
each non-redundant protein entry was randomized and added to the
database bringing the total search space to 61,864 sequences
(supplemental Table S1). For the mouse (supplemental Table S3) (21)
and rat (supplemental Table S4) liver microsomal membrane data
sets, the species-specific databases consisted of 29,998 mouse or
28,400 rat proteins (non-redundant NCBI sequences on June 22,
2007 and July 10, 2006, respectively) complemented as described
above with sequences for contaminants and previously identified
NETs as well as their corresponding randomized sequences
(supplemental Table S1). MS/MS spectra were searched without
specifying differential modifications, but 57 Da were added stati-
cally to cysteine residues to account for carboxamidomethylation. No
enzyme specificity was imposed during searches, setting a mass
tolerance of 3 amu for precursor ions and of 0.5 amu for fragment
ions.
Results from different runs were compared using DTASelect and
Contrast (32). Spectrum/peptide matches were retained if at least 7
amino acids long with ends complying with proteolytic specificity, e.g.
Met, Lys, or Arg before the amino terminus and at the carboxyl
terminus of peptides for those cleaved with CNBr prior to trypsin
digestion. Other criterion were Cn  0.08, XCorr  1.8 for singly, 2.0
for doubly, and 3.0 for triply charged spectra, and a maximum Sp rank
of 10. For proteinase K-digested samples, no specific peptide ends
were imposed, but the Cn cutoff was increased to 0.15 (33), and
XCorr minima were increased to 2.5 for doubly and 3.5 for triply
charged spectra (SEQUEST parameters for the spectrum to peptide
matches leading to the identification of proteins from human PBMC
NEs, mouse liver microsomes, and rat liver microsomes are provided
in supplemental Tables S2A, S3A, and S4A, respectively). Peptide hits
from all analyses were merged to establish a master list of proteins
identified by at least two peptides or one peptide with two indepen-
dent spectra (see supplemental Tables S2B, S3B, and S4B for the
detailed peptide and spectral counts of proteins detected by MudPIT
analysis of human PBMC NEs, mouse liver microsomes, and rat liver
microsomes, respectively). Based on the merged detected peptides,
proteins could fall into three categories following the parsimony prin-
ciple. (i) Proteins detected by the exact same set of peptides were
grouped together because they could not be distinguished based
on the available peptide data (see column named “Proteins in
Group” in supplemental Tables S2–S4), and only one arbitrarily
selected representative protein entry is reported for such groups
of proteins (see column labeled “Locus” in supplemental
Tables S2–S4). (ii) Proteins with at least one peptide uniquely
mapping to them were considered unique entries. (iii) Subset pro-
teins for which no unique peptides were detected were removed
from the final list of identified proteins.
Identifications mapping to shuffled peptides were used to estimate










 100 (Eq. 2)
Under these criteria, the final FDRs at the protein and peptide levels
were on average 1.5 and 0.5%, respectively (supplemental
Tables S2B–S4B, bottom).
To estimate relative protein levels, normalized spectral counts were








We implemented a new algorithm on this data set to refine spectral
counts to deal with peptides shared between multiple proteins (37).
For each run, dNSAFs were calculated based on distributed spectral
counts in which shared spectral counts were distributed based on
spectral counts unique to each isoform (supplemental Tables
S2B–S4B).
Bioinformatics Analysis—To be able to directly compare the lists of
proteins detected in the human PBMC NEs and rodent liver micro-
some data sets, proteins were mapped to an Ensembl gene to re-
move redundancy from differences in protein annotations. Human
gene orthologous groups were identified with Ensembl release 48 (38)
to remove redundancy and false variation that might have resulted
from differences in human and rodent gene assignments. Ortholo-
gous group IDs were sorted according to frequency of detection in
the NE and microsome runs, relative levels (determined by averaged
dNSAF values), membrane helix prediction (determined using
TMHMM 2.0; http://www.cbs.dtu.dk/services/TMHMM-2.0/ (39)), and
dNSAF ratios between values measured in NEs versus microsomes
(supplemental Table S5).
Biologically interesting GO terms and their corresponding child
terms were retrieved from the mySQL database AmiGO (http://
amigo.geneontology.org (40)). To ensure a fair comparison for term
enrichment, only human mapped genes in our data set were consid-
ered. These were compared with the genomics data set of human
Ensembl genes as well as those GO defined as having nuclear local-
ization. For a given GO term, the fraction of genes containing that
term or any of the child terms was calculated for all data sets. The
-fold difference was calculated by dividing this fractional value from
our data set of interest by the value from the reference group.
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Comparison of expression levels in different blood cell lineages
was done by downloading numbers for each NET and blood cell type
from BioGPS (http://biogps.gnf.org/#gotowelcome (41)) and calcu-
lating the -fold expression over the median value from all cell types
tested in this transcriptome database. Thus, the numbers not only
reflect differences among the blood cell lineages but also differences
with other tissues.
Antibodies and Western Blotting—Antibodies used were GAPDH
(Enogene, E1C604), Calreticulin (Cell Signaling Technology, 2891S),
Calnexin (Stressgen, SPA-860), lamins A and B1 (3262 and 3931;
Ref. 42), Nup153 (Covance), and Nup358 (raised against recombi-
nant human protein amino acids 2595–2881; a kind gift from F.
Melchior). NET antibodies were rabbit polyclonal antibodies gener-
ated to peptides from human sequences by Millipore, Tmem126
(06-1037), C17orf62 (06-1033), C17orf32 (06-1035), and MARCH5
(06-1036), and the previously characterized NETs NET31/
Tmem209 (06-1020), SUN2 (06-1038). All fluorophore-conjugated
secondary antibodies were minimally cross-reactivity from donkey
(Jackson ImmunoResearch Laboratories) or goat (Molecular Probes).
To increase lamina solubility, PBMC or liver NEs were incubated on
ice in 50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 2 mM MgCl2, 0.2%
Nonidet P-40 in the presence of protease inhibitor mixture (Roche
Applied Science, 11 873 580 001) for 15 min and then sonicated in a
4 °C sonic bath. Microsomes were treated similarly. Protein concen-
trations of liver NEs and microsomes (see Fig. 5) were determined by
Bradford assay before adding sample buffer (100 mM Tris, pH 6.8, 4
M urea, 2% SDS, 50 mM DTT, 15% sucrose), heating at 65 °C, and
then sonicating again in a 4 °C sonic bath. PBMC NEs and micro-
somes were adjusted for equal loading based on Coomassie Blue
staining on polyacrylamide gels (see Fig. 3A). Proteins were resolved
by SDS-PAGE and transferred to nitrocellulose membrane (LI-COR
Biosciences). Membranes were blocked in PBS, 5% milk, 0.2%
Tween. Primary antibodies were diluted in this buffer (1:200 for Milli-
pore NET peptide antibodies, 1:500 for calreticulin, 1:200 for calnexin,
and 1:2000 for lamin A) and allowed to incubate overnight at 4 °C.
Secondary IR800-conjugated goat anti-rabbit antibodies (LI-COR
Biosciences) were added at 1:5000 dilution at RT for 2 h. Visualization
and quantification were performed using a LI-COR Odyssey system
and software (Odyssey 3.0.16) using median background subtraction.
Three independent blots were run for each NET and control, and
averages from all three are presented in Fig. 5B.
Plasmid Construction—IMAGE clones for human NETs were ob-
tained from RZPD and Geneservice. NET gene names are followed by
IMAGE numbers or gene IDs in parentheses: STT3A (3891543),
TAPBPL (3916213), METTL7A (2900478), C17orf62 (2822930), IAG2
(3834858), Tmem109 (3453616), C20orf3 (3530962), C17orf32
(5429060), Sec11C (3895819), Tmem126A (1667589), AADACL1
(4815834), and Tmem41A (3838280). Coding sequences were ampli-
fied by PCR with added 5 and 3 restriction sites, sequenced from
both ends in intermediate cloning vectors, and then inserted into the
mammalian expression vector pmRFP with a carboxyl-terminal tag
(derived from Clontech pEGFP-N2 by replacing the GFP coding se-
quence with that of monomeric red fluorescent protein). Lamin A-GFP
was obtained from Anne Straube (Marie Curie Research Institute,
Oxted, UK), and calreticulin-GFP was obtained from Tom Rapoport
(Harvard, Boston, MA).
Cell Culture and Transient Transfection—HT1080, HT1080 5.1 (car-
rying a lac operator (lacO) array and lac repressor-GFP), HeLa cells
stably transfected with H2B-GFP, COS-7, and C2C12 cells were
maintained in high glucose DMEM with 4.5 g/liter glucose (Invitrogen)
supplemented with 10% fetal bovine serum (FBS), 100 g/l penicil-
lin, and 100 g/l streptomycin sulfate (Invitrogen). PBMCs were
maintained in RPMI 1640 medium with 10% FBS and antibiotics.
PBMCs were activated with 2.5 g/ml PHA (Sigma) for 7 days.
Adherent cells destined for microscopy were plated on coverslips,
and DNA was transfected the next day using FuGENE 6 (Roche
Applied Science) according to the manufacturer’s instructions.
Immunofluorescence Microscopy—After 30 h, cells were either
directly fixed for 7 min in 3.7% formaldehyde or washed with PBS;
then extracted for 1 min with 1% Triton X-100, 25 mM Tris, pH 8.0, 150
mM KOAc, 15 mM NaCl, 5 mM MgCl2; washed again with PBS; and
then fixed with formaldehyde. For antibody staining, cells that were
not pre-extracted were permeabilized for 6 min in 0.2% Triton X-100
after fixation. Cells were then blocked with 10% FBS, 200 mM glycine
in PBS and incubated for 40 min at RT with relevant antibodies. DNA
was visualized with Hoechst 33342 or 4,6-diamidino-2-phenylindole
dihydrochloride (DAPI) and coverslips mounted in Fluoromount-G
(EM Sciences). For structured illumination (OMX) microscopy, Alexa
Fluor secondary antibodies (Molecular Probes) were used. Most im-
ages were obtained using a Nikon TE-2000 microscope equipped
with a 1.45 numerical aperture 100 objective, Sedat quad filter set,
and CoolSnapHQ High Speed Monochrome charge-coupled device
camera (Photometrics). Structured illumination images (Fig. 4C) were
taken on the OMX system at the University of Dundee microscopy
facility (details described at http://microscopy.lifesci.dundee.ac.uk/
omx/).
For cryosections, fresh rat spleen cut into 2–3-mm cubes were
embedded in optimal cutting temperature compound (Tissue-Tek),
snap frozen in liquid nitrogen, and maintained at 80 °C. Sections
were cut on a Leica CM 1900 cryostat at 6–8-m thickness and fixed
in 20 °C methanol. After rehydration, sections were incubated with
NET antibodies overnight at 4 °C followed by secondary antibodies as
above. Cryosection images were recorded using an SP5 confocal
system (Leica) with 63 oil 1.4 numerical aperture objective using
argon and UV lasers. Micrographs were saved from source programs
as .tif files and prepared for figures using Photoshop 8.0.
The positional distribution of the lacO array was determined using
a macro (available on request) written in Visual Basic within Image Pro
Plus. In brief, the total nuclear area was automatically measured on
DAPI images, and the area was then divided into five equal regions of
interest through eroding 20% of the total area from the outer limits of
the DAPI-defined nucleus. The nuclear sector containing the lacO
spot was determined and exported to Microsoft Excel where the
results from each cell were summed.
Images of chromatin condensation in Fig. 8 were generated from
60-h post-transfection cells fixed with formaldehyde using a wide
field DeltaVision microscope (Applied Precision) using a 60 Plan
Apo oil objective. Image stacks (0.2-m steps) were deconvolved
using DeconQ and processed using SoftWorks.
Electron Microscopy—For transmission electron microscopy, whole
PBMCs or isolated NEs were fixed in 3% glutaraldehyde in 0.1 M
sodium cacodylate, pH 7.3 for 2 h; washed in 0.1 M sodium cacodylate;
postfixed in 1% osmium tetroxide for 45 min; washed again; and de-
hydrated in 50, 70, 90, and 100% normal grade acetones for 10 min
each and then for a further two 10-min changes in analar acetone.
Samples were then embedded in Araldite resin. 60-nm-thick sections
were cut on a Reichert OMU4 ultramicrotome (Leica), stained in uranyl
acetate and lead citrate, and then viewed in a Phillips CM120 transmis-
sion electron microscope. Images were taken at 100 kV at 11,000
magnification using a Gatan Orius charge-coupled device camera.
RESULTS
Generation of Lymphocyte-enriched Populations and NE
Fractions—NEs were prepared from PBMCs using methods
specially optimized for blood cells (23) (Fig. 1A). Central to
these methods is isolating clean nuclei from the rest of the cell
(Fig. 1B) that are subsequently digested with DNase and
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RNase and salt-washed to remove most of the nuclear con-
tents (Fig. 1C). Even after such isolation, NEs maintain strong
connections to partners such as peripheral chromatin (Fig.
1D). Prior to mass spectrometry, NEs were further extracted
with 1% -octyl glucoside, 400 mM NaCl or 0.1 N NaOH that
enriched for proteins associated with the insoluble intermedi-
ate filament lamin polymer or integral membrane proteins,
respectively. Some well characterized NETs distribute to one
or the other fraction (21, 22); hence, both detergent/salt- and
NaOH-extracted fractions were analyzed to be comprehen-
sive. Both extractions remove most contaminants so that only
strongly bound and relevant partners should remain.
PBMCs were 70% lymphocytes as determined by FACS
and antibody staining for CD antigens (Fig. 2A). PBMC NEs
were isolated with or without PHA stimulation, which mimics
immune responses (43) and increased activated cells 	3-fold
(Fig. 2, B and C). PHA activation also results in dissolution of
dense chromatin at the nuclear periphery (17–20). Staining of
cells with the DNA-binding dye acridine orange confirmed the
reduction of denser chromatin at the periphery. Acridine or-
ange has been reported to bind more strongly to single-
stranded DNA and thus gives a brighter signal in actively
transcribed chromatin regions with condensed chromatin not
allowing efficient intercalation (44). Thus, a weaker signal
concentrated largely at the periphery was observed in un-
stimulated lymphocytes, whereas a brighter signal that was
more diffuse through the nucleoplasm was observed for PHA-
activated cells (Fig. 2D). This was further confirmed at the
ultrastructural level as electron microscope images of the
cells revealed significant differences in the chromatin distri-
bution. Although patches could still be observed at the pe-
riphery in PHA-activated cells, they were less dense and
broken (Fig. 2E). Proteins identified in the PBMC data sets
would thus likely include proteins involved in chromatin re-
modeling, and some of these proteins might be highlighted by
differences between proteins identified in the unstimulated
and PHA-activated PBMC NE fractions.
Microsomes were prepared separately as a comparative/
subtractive fraction as they are rich in the main expected
transmembrane protein contaminants from the ER, which is
continuous with the NE. Thus, they provide a mechanism to
distinguish INM proteins and ONM-enriched proteins from
those such as ribosomes that inhabit both the ONM and ER.
Because isolated lymphocytes have very little ER, we used
rodent liver for production of microsomes. Actual contamina-
tion of NE fractions with ER was minimal because, although
some single membrane vesicles can be observed by electron
microscopy (see Fig. 1D), ER markers such as calreticulin and
calnexin were undetectable in the crude PBMC NE fractions
(Fig. 3). Conversely, NE proteins such as lamin A and the NET
LAP2 were not detectable in microsome fractions (Fig. 3),
indicating that the hypotonic lysis step only disrupted the
plasma membrane and did not contribute NE membranes to
the microsome fraction.
To remove donor variation as a factor in potential differ-
ences measured between unstimulated and PHA-activated
PBMCs, each PBMC preparation was divided in two: half was
FIG. 1. Cellular fractionation of PBMCs. A, method schematic.
Crude nuclei prepared from hypotonic lysis of PBMCs were cleaned
of contaminating cellular structures by gradient centrifugation to float
contaminating membranes while pelleting the denser nuclei. Crude
NEs were prepared by digesting/extracting nuclear contents from
isolated nuclei. Before MudPIT analysis, these were further extracted
with 1% -octyl glucoside, 400 mM NaCl or 0.1 N NaOH to enrich for
proteins associated with the insoluble lamin polymer or integral mem-
brane proteins, respectively. B, buffy coats from human blood were
separated on Ficoll-Hypaque density gradients to enrich for mono-
nuclear leukocytes (left panel). The cells were swollen hypotonically
(middle panel) and Dounce homogenized to release nuclei (right
panel), which were then further purified on sucrose gradients. Phase-
contrast light microscope images are shown. Scale bar, 10 m. C,
enrichment for NEs by chromatin digestion. DAPI staining for DNA
visualizes significant nuclear chromatin content in an isolated PBMC
nucleus (left panel) and the loss of most of this material after two
rounds of digestion with DNase and RNase, each followed by salt
washes (two right panels). A fluorescence microscope image is
shown. Scale bar, 5 m. D, ultrastructure of isolated NEs. Electron
micrographs of PBMC NEs show that most membranes in the pop-
ulation are the characteristic double membrane with little contamina-
tion from single membrane vesicles. Arrows point to positions of
NPCs. In some places, the hypotonic treatment used to swell the NEs
while digesting/extracting most of the chromatin resulted in mem-
brane blebbing. These NEs were further extracted with salt and
detergent to enrich for proteins associated with the intermediate
filament lamin polymer or with an alkaline treatment to enrich for
transmembrane proteins prior to analysis by MudPIT. After such
treatment, no structure remains that can be readily discerned by EM
with the characteristics of NEs. Scale bar, 0.2 m.
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treated with PHA, and the other half was used as unstimu-
lated. Some degree of variation between blood donors was
expected because of the wide variation in human immune
responses, so donor variation was averaged out within each
condition by combining NEs isolated from at least 15 separate
preparations for analysis. Combining this large number of
samples was necessary for the independent reason that the
vast majority of material was lost in isolating clean NEs from
PBMCs. In this study, it was not possible to further control for
variation due to factors such as age or racial differences as all
blood donor information was anonymous, but all buffy coats
were obtained within 2 days of donation. The combined NE
preparations were divided and extracted with either 0.1 M
NaOH or 1% -octyl glucoside, 400 mM NaCl, and insoluble
material was pelleted. The alkali extraction should have en-
riched for transmembrane proteins, and so vesicles were
pelleted at 150,000  g for 30 min, whereas the detergent/salt
extraction should have removed membranes and enriched for
both soluble and transmembrane proteins strongly associated
with the higher order intermediate filament lamin polymer;
these proteins were pelleted at 15,000  g for 30 min.
MudPIT Analysis—After extraction, pellets of isolated NE
fractions were digested with either a combined cyanogen
bromide-endoproteinase Lys-C-trypsin treatment or with a
combined endoproteinase Lys-C-trypsin treatment. For the
latter, treatment material that could be pelleted at 17,500  g
for 30 min was subsequently digested with proteinase K. The
multiple and processive digestions were favored over direct
FIG. 2. PBMC composition. A, cells treated as for NE purification
were incubated with CD markers for different blood cell types and
analyzed by flow cytometry. The percentage of each cell type for
PBMC composition in leukocytes is graphed. B, percentage of leu-
kocytes in the total population. C, percentage of lymphocyte activa-
tion in the different PBMC populations measured by appearance of
surface markers. Error bars in A, B, and C indicate standard deviation.
D, PHA activation gauged by changes in nucleotide distribution using
acridine orange dye. Acridine orange intercalates more strongly with
single-stranded DNA than double-stranded DNA, so intensity to some
degree measures “open” DNA that is being actively transcribed. A
dashed white line delineates the periphery of the nucleus. The unstimu-
lated PBMCs have weak staining at the periphery of the nucleus and no
staining in some central areas. PHA-activated lymphocytes have more
uniform distributions and brighter staining, indicating more open DNA.
E, PHA activation effects on chromatin organization assessed by elec-
tron microscopy. The unstimulated cell is smaller and has more com-
pacted chromatin concentrated at the nuclear periphery. In the PHA-
activated cell, much of this dense peripheral chromatin has become less
compact, and both the cell and nucleus have increased in volume as the
activated cells are now rapidly transcribing DNA and making protein.
Images were taken at 11,000. Scale bar, 1 m.
FIG. 3. Fraction purity. A, Coomassie-stained gel of NE and mi-
crosome fractions analyzed. B, Western blot of the above fractions
stained with organelle markers. ER markers calreticulin and calnexin
were absent from NEs, whereas NE markers lamin B2 and the NET
LAP2 were absent from microsomes. Similar amounts of total pro-
tein were loaded. MM, microsomal membranes.
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replicates on the limiting material to better access material
tightly associated with the intermediate filament lamin poly-
mer that is resistant to 2% Triton X-100, 2 M NaCl, and even
4 M urea. Indeed, additional identifications were made from
the proteinase K-digested material (supplemental Table S2B).
Five separate MudPIT (27, 28) runs were performed for each
of the unstimulated and PHA-activated PBMC NE fractions,
three for the NaOH-extracted and two for the salt/detergent-
extracted NEs. Thus, using different extraction conditions and
different digestions and performing multiple runs were ex-
pected to provide comprehensive coverage to identify all
proteins in the PBMC NE. After removing redundancy by
converting protein IDs to orthologous gene groups, 3351 pro-
teins were identified between the unstimulated and PHA-
activated PBMC NE data sets, 2923 from the unstimulated
and 2839 from the PHA-activated cells, 2411 of which were in
both (supplemental Table S2B).
To complement previously published microsome data sets
isolated from mouse liver (21), microsome data sets were
separately generated from rat liver as a subtractive fraction
(supplemental Table S4). These newly acquired microsome
factions were treated similarly to the NE fractions, i.e. di-
gested with trypsin and proteinase K and analyzed on LTQ ion
trap mass spectrometers (supplemental Table S1). Another
potential contaminant is mitochondria, but as the mitochon-
drial proteome has been extensively studied, lists of mito-
chondrial proteins were generated from a previous mass
spectrometry study of that organelle (45) for subtraction in-
stead of reanalyzing mitochondria (supplemental Table S5).
After subtracting 177 proteins that were previously identified
in mitochondria, 2756 proteins remained in unstimulated
PBMC NEs, 2760 remained in PHA-activated PBMC NEs, and
3174 remained in total. Using microsomes strictly as an ab-
solute subtractive fraction would have resulted in loss of
several well characterized NETs that have been demonstrated
to inhabit both the NE and ER. For example, emerin, one of
the most established INM NETs (46), was detected in both NE
and microsome data sets (supplemental Table S5) in agree-
ment with the fact that emerin also functions in the ONM, ER,
and interstitial discs (47–49). Moreover, as a recent elegant
proteomics study suggests that at least a third of all proteins
have multiple cellular localizations (50), we reasoned that
absolute subtraction would also remove relevant identifica-
tions. Thus, proteins were ordered according to an estimate of
abundance based on normalized spectral counts (dNSAF)
(35), and NE data sets were restricted to those proteins either
not detected in the microsomes or at least 5 more abundant
than in the microsome fractions based on their NSAF values,
leaving 2183 proteins in unstimulated PBMC NEs, 2141 in
PHA-activated, and 2542 in total (supplemental Table S5).
This large number of proteins associated with the NE in-
cludes chromatin proteins and other factors that are tethered
directly or indirectly to both INM and ONM proteins and so,
although they can associate with the NE, are not necessarily
primarily resident at the NE. The subset of NETs is more likely
to be enriched at the NE and constitutes the surest NE core
components in PBMCs. These proteins include all 13 of the
previously well characterized NETs, 39 NETs previously de-
tected in the liver NE data sets (21), and 423 proteins pre-
dicted to contain at least one transmembrane domain by
TMHMM or membrane anchor by SignalP. Based on available
GO terms and annotations, we selected 87 of these proteins
as putative blood NETs (supplemental Table S5). It is of note
that five of 12 proteins we further characterized for NE target-
ing (see below) did not pass the criterion of 5-fold enrichment
over microsomes once the new rat liver microsome data set
was acquired. However, NE residence was confirmed for all
five, indicating that our selection criteria were very stringent
and that additional NETs are likely to be found in this data set.
Confirmation of NE Residence—The putative NETs identi-
fied could be in the INM and/or in the ONM that is continuous
with the ER or be contaminants. To directly test the validity of
novel protein identifications, 12 putative NETs from PBMC
data sets were cloned as tagged fusions and expressed in
cells to determine whether they target to the NE. Adherent
tissue culture cells were used instead of freshly isolated PB-
MCs because lymphocytes are very difficult to transfect, and
their small cytoplasm made it difficult to distinguish the NE
from the ER. To be able to clearly distinguish the NE from the
ER and other cell membranes, adherent flat HT1080 cells
were used for this analysis because lymphocytes are round
suspension cells with little ER that is packed closely around
the nucleus. Another issue is that, when overexpressed, NETs
tend to saturate binding sites at the NE and accumulate in the
ER, making clear confirmation of NE targeting difficult (Fig.
4A, left panels). To get around this problem, most of this
extraneous material was removed with a prefixation detergent
extraction. Most previously characterized NETs resist a pre-
fixation extraction with 1% Triton X-100 and 400 mM KCl
presumably because of tight associations with the intermedi-
ate filament lamin polymer (e.g. emerin; Fig. 4A, top panels),
whereas most ER proteins (e.g. calreticulin; Fig. 4A, middle
panels) are extracted with this treatment. Staining for lamins is
also shown as co-localization (yellow) with this well defined
NE protein, indicating NE localization. One of the novel NETs
identified here, C20orf3, behaved similarly to the well charac-
terized NET emerin in this assay (Fig. 4A, bottom panels). In
all, ten of the 12 putative NETs tested were retained at the NE
after a prefixation detergent extraction (Fig. 4; all except
Tmem126A and METTL7A). The putative NETs Tmem41A and
Tmem126A both failed to be expressed in the HT1080 cells
first tested, but Tmem41A was expressed and targeted to the
NE in COS-7 cells and resisted the detergent pre-extraction
(Fig. 4B, bottom left). Tmem126A also failed to be expressed
in COS-7 cells but was expressed and targeted in lympho-
cytes, which due to their small size and being suspension
cells could not be properly tested for resistance to detergent
pre-extraction (Fig. 4B, bottom right). METTL7A exhibited a
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concentration at the nuclear periphery that co-localized with
lamins but was never observed after a pre-fixation detergent
extraction (data not shown).
As the NE is comprised equally of INM and ONM, some
NETs may preferentially accumulate in one or the other sub-
compartment. A recent study used three-dimensional struc-
tured illumination microscopy (OMX) to distinguish INM from
ONM localization of lamins in cells when co-stained for pro-
teins from the nuclear pore nucleoplasmic (Nup153) or cyto-
plasmic (Nup358) face (51). We have previously used this
system to test several NETs identified in the earlier liver pro-
teomics data sets (52). Control NET LAP2 and all the new
NETs tested here accumulated in the INM as both the NET
(red) and Nup153 (green) localize to the same ring, whereas an
inner NET ring was observed compared with Nup358 (Fig.
4C). In contrast to the NETs, a separable inner Nup153 ring
was observed against the ER protein calreticulin. Yellow co-
localization was not generally observed in this system be-
cause the resolution of OMX microscopy is sufficient to dis-
tinguish the NPC proteins that are at 120-nm gaps in the
membrane from NETs that are inserted in the membrane itself.
Even METTL7A, the putative NET that was not resistant to the
detergent pre-extraction, appeared in the INM.
To test localization of endogenous proteins, polyclonal an-
tibodies were generated to three novel NETs (C17orf32,
Tmem126A, and C17orf62). Each recognized a protein of the
correct size in immunoblots (Fig. 5A). First, to test whether
NETs were principally in the NE or inhabited multiple cellular
localizations as has been indicated for roughly 40% of the
human proteome (50), antibodies were used on Western blots
comparing NE and microsome fractions. Tmem126A and
C17orf62 were exclusively in the NE fraction, but about a third
of C17orf32 occurred in the microsome fraction (Fig. 5B). This
is similar to the previously characterized NET31/Tmem209
that was detected in both the PBMC NE data sets and the
earlier liver NE data set (52).
The Tmem126A and C17orf62 antibodies yielded strong
and distinctive staining at the nuclear periphery when used on
cryosections from rat spleen (Fig. 5C). The nuclei are clearly
visualized with the DAPI DNA stain, and the antibody staining
is concentrated in a crisp rim just surrounding the nucleus that
is very similar to that observed with antibodies to the well
characterized NET SUN2. C17orf62 and C17orf32 both re-
sisted pre-extraction with Triton X-100 when expressed as
fusions in cell lines, and similarly, the antibodies to these
NETs yielded a rim stain in cultured cells pre-extracted with
detergent. Adherent tissue culture cells were used again be-
cause lymphocytes have little cytoplasm and do not with-
FIG. 4. mRFP fusions confirm NE targeting for several novel
PBMC NETs. A, HT1080 cells expressing NETs fused to mRFP were
directly fixed (left) or extracted with Triton X-100 prior to fixation
(right). The NE is marked by lamin A in green so that yellow indicates
co-localization of the NET at the NE. The directly fixed emerin image
has part of an untransfected cell, confirming that none of the NET
staining at the nuclear rim is due to bleed-through from the lamin A
channel. Note that prefixation extraction affects morphology and
sometimes leaves aggregated protein in the cytoplasm. The emerin
control and new NET C20orf3 are retained after extraction, whereas
the ER protein calreticulin is not. Scale bar, 10 m. B, other NET-
mRFP fusions were similarly pre-extracted and retained at the NE.
Tmem41A is shown in COS-7 cells because it was not expressed in
HT1080 cells, and Tmem126A is shown in Jurkat cells because it
failed to be expressed in either HT1080 or COS-7 cells. Scale bar, 10
m. C, inner versus outer nuclear membrane targeting. If a NET (red)
is in the INM it should appear in the same plane as the nuclear basket
protein Nup153 (green, left) and internal to the cytoplasmic filament
protein Nup358 (green, right) using structured illumination micros-
copy. Characterized NET LAP2 and most new NETs tested ap-
peared in the INM. One INM NET, METTL7A, did not resist Triton
pre-extraction. Scale bars, 5 m.
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stand the prefixation extraction well. However, C2C12 cells
were used instead of the HT1080 cells used earlier for target-
ing of fusion proteins. According to available transcriptome
data, all the NETs for which we had antibodies were at least
weakly expressed in C2C12 cells, whereas some were not
expressed at all in HT1080 cells. This allowed confirmation
that Tmem126A also resists detergent pre-extraction (Fig.
5D). Several proteins identified in these data sets were previ-
ously characterized proteins that had other reported cellular
localizations. Among these was MARCH5, previously re-
ported to be a mitochondrial protein that possibly contributes
to perinuclear localization of mitochondria (53). Although
widely staining throughout the cytoplasm in non-extracted
cells (data not shown), antibodies to MARCH5 (Fig. 5A) also
yielded nuclear rim staining after the detergent pre-extraction
(Fig. 5D, right panels), indicating that the endogenous protein
has a separate function at the NE. Thus MARCH5 is among
the estimated 40% of cellular proteins that have multiple
cellular localizations (50).
Changes in PBMC NE Composition following PHA Activa-
tion—Of the 87 core putative new PBMC NETs (sup-
plemental Table S5), 14% uniquely appeared in the unstimu-
lated PBMC NE fraction, and 14% uniquely appeared in the
PHA-activated PBMC NE fractions with 72% shared between
both conditions. These numbers were similar when consider-
ing all transmembrane proteins identified (73% shared) or
both transmembrane and soluble proteins identified (72%
shared). Differences between the unstimulated and PHA-stim-
ulated fractions were also observed in RNA expression levels
for NETs that appeared in both fractions that correlated with
peptide recovery. For example, four peptides were recovered
for AADACL1 in the PHA-activated versus seven in the un-
stimulated lymphocytes (Fig. 6A and supplemental Table
S2B), and correspondingly, AADACL1 transcript levels were
reduced in PHA-activated lymphocytes to 60% of the level in
unstimulated lymphocytes (Fig. 6B). The trends for expression
changes also agreed with estimated protein levels for
C17orf62, TAPBPL, and FAM3C.
Many of the novel NETs identified that were directly tested
here varied not only between the unstimulated and PHA-
activated leukocytes but appeared to be uniquely expressed
in different blood cell lineages. Extracting relative transcript
levels from a large scale transcriptome data set that com-
pared RNA transcript levels across multiple tissues (41), most
of the novel NETs had completely distinct patterns of expres-
sion among 10 different blood cell types ranging from eryth-
roid cells to B-cells (Fig. 6C). Only IAG2 and Sec11C of those
shown had similar general patterns of expression, and only
Tmem41A and C17orf32 (not shown) were expressed similarly
in all lineages. The data are expressed relative to a median
value that was generated from a much wider range of tissues,
and these NETs ranged from 10 the median value to nearly
60 (Fig. 6C). Thus, many of the novel NETs identified from
the PBMC proteomics are reasonably restricted in the tissues
and cell types in which they are expressed. The interpretation
of these results is tempered by the observation that some
changes in the population composition occur upon PHA ac-
tivation (Fig. 2A). Myeloid cells were found to increase, and
this is consistent with some of the NETs being more specific
to myeloid dendritic cells (Fig. 6C); however, the percentage
of myeloid cell-associated proteins at the NE did not increase.
This could be attributed to having already made a full identi-
fication of myeloid cell-associated proteins in the unstimu-
lated cells. Interestingly, when considered as a percentage of
the total myeloid cell-associated proteins, roughly 10% occur
FIG. 5. Antibody staining confirms novel NET identifications.
A, NET antibody validation by Western blotting. C17orf32 and
Tmem126A antibodies were tested on human PBMC lysates,
whereas C17orf62 antibodies were tested on a C2C12 lysate to check
background in the cell line used to test pre-extraction in D. MARCH5
antibodies were tested using the Jurkat human blood cell line. Aster-
isks indicate expected molecular weight. B, comparison of relative
NET amounts in ER (microsome) and NE fractions by quantitative
Western blotting. LAP2 and Tmem209 antibodies are NET controls,
whereas calreticulin antibodies are an ER control. Blots were quanti-
fied using a LI-COR Odyssey system (three repeats averaged).
C, cryosections of rat spleen stained with antibodies to new NETs and
a SUN2 control. Nuclear rim staining was clearly observed for all
NETs tested. Scale bars, 10 m. D, antibody staining on Triton-pre-
extracted C2C12 cells. A nuclear rim staining was observed for the
control NET SUN2 and all novel NETs tested.
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at the NE, indicating this organelle as a dynamic player in cell
type specification.
PHA-induced changes include physiologically relevant
functions such as re-entering the active cell cycle (43) and
altering peripheral chromatin organization (17). Individual
NETs could contribute to chromatin organization and tran-
scriptional regulation to facilitate one of the individual lineages
observed in Fig. 6C. To gauge the likelihood of NE contribu-
tions to genome functions, the known proteins in the NE data
sets (both NETs and soluble proteins) that had functional
annotations in the GO database were extracted. A separate
data set was extracted for all proteins in the GO database
associated with the nucleus. GO functional annotations were
then applied to these data sets, and the fraction of proteins
within each data set with a particular GO functional annotation
was calculated. These fractions were compared with one
another to give the -fold enrichment of a particular function at
the NE compared with that function as a fraction of activity
within the nucleus in general (Fig. 6, D–F). For example, tran-
scription takes place throughout the nucleus, and the nuclear
periphery is considered to be a generally transcriptionally
repressive environment (54): the fraction of proteins identified
at the NE involved in transcription, as thus expected, is much
lower than that for the nucleus, yielding a negative -fold value
of 3.5 (Fig. 6D). In contrast, proteins involved in nucleocy-
toplasmic transport would be expected to be enriched at the
NE compared with the nucleus as a whole, and the value
obtained for NPC proteins showed enrichment of 3.5-fold at
the NE (Fig. 6D).
The general functional categories varied little between un-
stimulated and PHA-activated PBMC NEs; however, analysis
of more specific subcategories revealed interesting differ-
ences. RNA functions, as might be expected, varied little upon
PHA activation except that a few more end-processing pro-
teins were found at the NE (Fig. 6E), consistent with an in-
creased burden of RNAs to be exported from the nucleus with
the significant gene activation resulting from PHA treatment.
Functions in epigenetic regulation yielded more dynamic
changes upon leukocyte activation (Fig. 6F). Chromatin si-
lencing functions were less enriched at the NE with PHA
activation, clearly indicating that changes at the NE play a role
in the major chromatin reorganization that takes place. NuRD
complex proteins in contrast were specifically enriched at the
NE upon PHA activation.
Novel NET Functions in Chromatin/Genome Organization—
The finding of so many known proteins with chromatin regu-
latory functions in these data sets that change between the
data sets in ways that match the physiological changes ob-
served in chromatin upon PHA activation argues that some
novel proteins identified might also have chromatin functions.
To screen for such NETs, we tested nine PBMC NETs in
assays for effects on genome organization.
The first assay utilized an HT1080-derived cell line carrying
a lacO repeat insertion in chromosome 5, the position of
FIG. 6. Differences in NE composition with PHA activation and
effects on genome organization. A, differences in abundance esti-
mated from dNSAF values for some NETs with or without PHA acti-
vation. dNSAF values were taken from the two most equivalent runs
based on total protein coverage and identifications. B, RT-PCR of the
NETs in A revealed reproducible differences in expression that are
consistent with their abundance estimates based on peptide recov-
eries. C, transcript levels for several of the NETs identified differ
among blood cell lineages. Data from the BioGPS transcriptome
study comparing 84 different tissues/cell types are plotted relative to
the median value over all 84 tissues sampled. Ticks along the bottom
are for increments of 5-fold above the median. Each NET had its own
unique expression pattern. Surface markers defining cell populations
were CD71 for early erythroid cells, CD14 for monocytes, CD33 for
myeloid cells, CD56 for natural killer (NK) cells, CD8 for T-cells,
BDCA4 for myeloid dendritic cells, CD19 for B-cells, 721 for B-
lymphoblasts, CD105 for endothelial cells, and CD34 for polyploidy
progenitor cells. Error bars in B and C indicate standard deviation.
D, within the subset of proteins in NE data sets with GO annotations, the
fraction with a particular functional annotation was calculated. Similar
fractions were calculated against all “nuclear”-annotated proteins in
the GO database. The ratio of NE/nuclear fractions was then calcu-
lated, setting a 1:1 ratio to 0 so that positive values are -fold enrich-
ment and negative values are -fold deficiency at the NE compared
with the whole nucleus. Resting and activated PBMC data sets are
represented by gray and black bars, respectively. E, the same analysis
applied to the specific subset associated with RNA functions. F, the
same analysis applied to the specific subset associated with func-
tions in epigenetic regulation. PcG, Polycomb group.
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which is visualized with a lac repressor-GFP fusion that binds
to the array. This lacO array tends to be in the nuclear interior.
These cells were transfected with expression constructs for
NET-mRFP fusions and assayed for a change in the distribu-
tion of the lacO array position with respect to the nuclear
periphery. If a NET altered the position of the lacO array by
pulling it to the nuclear periphery it could be considered to
function in genome organization (Fig. 7A, left). To determine
lacO positioning, a previously published algorithm was uti-
lized that erodes the nucleus based on DAPI staining for DNA
into five concentric rings of roughly equal area (55). The ring
containing the lacO array was marked in each cell and re-
corded (Fig. 7A, right). The NET C20orf3 had no effect on the
position of the lacO array; however, TAPBPL expression in-
creased the occurrence of the array at the periphery (Fig. 7B).
The ring containing the lacO array was marked in 100 cells,
and the distribution was plotted (Fig. 7C). The lacO array
tended to be in the nuclear interior, occurring in the peripheral
ring only 20% of the time. Most blood NETs tested yielded
no significant differences, but in cells expressing STT3A and
TAPBPL, the occurrence at the periphery roughly doubled in
multiple separate experiments with p values 
0.0015 and
0.0001, respectively (Fig. 7C).
For the second assay, the same set of blood NETs was
transfected into a HeLa cell line stably expressing H2B-GFP,
and cells were observed for general changes in overall chro-
matin distribution. The two NETs that had strong effects in the
lacO screen had no effect in this screen, further indicating that
the interactions pulling the locus to the periphery are specific.
A different NET, IAG2, had a strong effect on chromatin con-
densation (Fig. 8; compare with cells transfected with
C20orf3, C17orf32, and METTL7A in upper panels), and this
effect was repeated in all of three independent experiments. A
FIG. 7. Cell-based screen for PBMC NETs that promote recruit-
ment of chromosome loci to nuclear periphery. A, schematic rep-
resentation of a screen to determine whether overexpression of a
particular NET can recruit a specific chromatin locus to the NE. NETs
were transfected into cells containing a lacO repeat integration that is
typically in the interior. The lacO position was visualized with GFP-lacI
(green) and measured using an algorithm that partitions the nucleus
based on DAPI staining (blue) into five concentric circles of roughly
equal area. B, example of NET-transfected cells. The position of the
lacO locus is highlighted by the white arrows. The lacO locus position
is unaffected by C20orf3 expression but moves to the periphery with
TAPBPL expression. DAPI staining added to the merged image con-
firms that the movement of the locus is not an artifact of generalized
chromatin condensation at the periphery. Deconvolved images are
shown. C, the ring containing the locus was recorded in roughly 100
transfected cells. p values were calculated for NETs that increased
the locus at the periphery in comparison with untransfected (UT) or
mRFP-transfected control cells using a 2 test.
FIG. 8. Screen for PBMC NETs that promote chromatin com-
paction. HeLa cells stably expressing H2B-GFP were transfected
with the same set of nine NETs used in Fig. 7. Only IAG2 displayed
strong chromatin condensation, whereas all other NETs (METTL7A,
C17orf32, and C20orf3 are shown) exhibited no differences in chro-
matin compaction or distribution compared with adjacent untrans-
fected cells. It is noteworthy that IAG2 had no effect in the lacO
screen and that NETs STT3A and TAPBPL, which altered lacO posi-
tioning, had no effect on chromatin compaction.
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ring of condensed chromatin is noticeable at the periphery,
although the effect has clearly propagated throughout the
nucleus. Distribution of the NET alone in the left panels clearly
indicates that, whereas some of the overexpressed protein
has accumulated in the ER, none is in the nucleoplasm: thus,
the effect must be propagated from the NE.
DISCUSSION
This analysis of the leukocyte NE proteome identified many
more NE-associated proteins and NETs than an earlier study
of liver NEs (21). Moreover, some proteome differences were
observed between unstimulated and PHA-activated leuko-
cytes, many of which correspond to proteins that are ex-
pressed in only specific blood cell lineages. Many of these
new NETs appear to be tissue-specific, and our results further
show that NE protein composition changes in response to
chemical stimulation. These findings indicate the potential of
other organelle proteomes to vary with chemical treatments or
between tissues.
Large scale changes have been reported in the organization
of leukocyte peripheral chromatin upon PHA stimulation (17–
20). These data sets should contain both NETs and tightly
bound chromatin proteins involved in making these changes.
As several NETs have known associations with chromatin-
silencing proteins (12, 13), it is not surprising that several of
the proteins identified here in association with the NE had
functions in gene regulation and RNA processing. The PHA-
induced general decrease in epigenetic silencing factors is
consistent with the observed reduction in dense peripheral
chromatin. Contrasting with this, the specific relative increase
in NuRD complex proteins at the NE is interesting as this
chromatin remodeling complex plays roles in development
and was recently shown to function in progeria defects
caused by NE mutations (56).
NET developmental roles are consistent with the blood cell
type specificity of the two NETs that affected positioning
of the lacO array (25-fold higher in blood cells over other
tissues). Several tissue-specific genes move from the NE to
the nuclear interior during differentiation (e.g. IgH locus,
Mash1, and CFTR) (57–59); however, the NE proteins that
regulate NE tethering and release have yet to be identified.
Recent studies showed that tethering lac repressor to an NE
protein could recruit the lacO array to the periphery by an
affinity-based mechanism (14–16). As lac repressor was not
fused to the NETs used in our screen, the specific effects of
TAPBPL and STT3A likely operate through affinity for other
chromosome regions on the same chromosome as the lacO
array. This is consistent with the earlier studies showing that
the whole chromosome accompanied the array to the periph-
ery (14, 16). The interaction cannot be due to a more general
affinity for chromatin because if so it would increase chroma-
tin density at the periphery, and these two NETs had no effect
in the second screen for chromatin compaction. Thus, our
identification here of endogenous NETs that can alter the
positioning of genes/chromosomes in the nucleus appears to
reflect the unique chromatin characteristics of lymphocytes.
As several studies have implicated misregulation of chromatin
organization in NE diseases (7, 8), these new blood NETs may
contribute to the diverse pathologies associated with NE
diseases.
Acknowledgments—We thank D. Tollervey and W. C. Earnshaw for
comments; W. Bickmore, F. Melchior, T. Rapoport, J. Stewart, M.
Waterfall, E. King, D. Kelly, T. Guan, and S. Mitchell for reagents/
technical assistance; and the Scottish National Blood Transfusion
Service.
* This work was supported in part by the Wellcome Trust (a senior
research fellowship to E. C. S.) and the Stowers Institute for Medical
Research (to L. F.). Use of the OMX microscope was supported by the
Scottish University Life Sciences Alliance.
□S This article contains supplemental Tables S1–S5.
¶ A Darwin Trust student.
 A Royal Society Dorothy Hodgkin fellow.
** To whom correspondence should be addressed: Wellcome Trust
Centre for Cell Biology, University of Edinburgh, Kings Bldgs., Swann
5.22, Mayfield Rd., Edinburgh EH9 3JR, UK. Tel.: 441316507075; Fax:
441316507360; E-mail: e.schirmer@ed.ac.uk.
REFERENCES
1. Schirmer, E. C., and Foisner, R. (2007) Proteins that associate with lamins:
many faces, many functions. Exp. Cell Res. 313, 2167–2179
2. Suntharalingam, M., and Wente, S. R. (2003) Peering through the pore:
nuclear pore complex structure, assembly, and function. Dev. Cell 4,
775–789
3. Callan, H. G., and Tomlin, S. G. (1950) Experimental studies on amphibian
oocyte nuclei. I. Investigation of the structure of the nuclear membrane
by means of the electron microscope. Proc. R. Soc. Lond. B Biol. Sci.
137, 367–378
4. Starr, D. A., and Fischer, J. A. (2005) KASH ’n Karry: the KASH domain
family of cargo-specific cytoskeletal adaptor proteins. BioEssays 27,
1136–1146
5. Stewart, C. L., Roux, K. J., and Burke, B. (2007) Blurring the boundary: the
nuclear envelope extends its reach. Science 318, 1408–1412
6. Worman, H. J., and Bonne, G. (2007) “Laminopathies”: a wide spectrum of
human diseases. Exp. Cell Res. 313, 2121–2133
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22. Dreger, M., Bengtsson, L., Schöneberg, T., Otto, H., and Hucho, F. (2001)
Nuclear envelope proteomics: novel integral membrane proteins of the
inner nuclear membrane. Proc. Natl. Acad. Sci. U.S.A. 98, 11943–11948
23. Korfali, N., Fairley, E. A., Swanson, S. K., Florens, L., and Schirmer, E. C.
(2009) Use of sequential chemical extractions to purify nuclear mem-
brane proteins for proteomics identification. Methods Mol. Biol. 528,
201–225
24. Walter, P., and Blobel, G. (1983) Preparation of microsomal membranes for
cotranslational protein translocation. Methods Enzymol. 96, 84–93
25. Florens, L., Korfali, N., and Schirmer, E. C. (2008) Subcellular fractionation
and proteomics of nuclear envelopes. Methods Mol. Biol. 432, 117–137
26. Florens, L., and Washburn, M. P. (2006) Proteomic analysis by multidimen-
sional protein identification technology. Methods Mol. Biol. 328,
159–175
27. Washburn, M. P., Wolters, D., and Yates, J. R., 3rd (2001) Large-scale
analysis of the yeast proteome by multidimensional protein identification
technology. Nat. Biotechnol. 19, 242–247
28. Wolters, D. A., Washburn, M. P., and Yates, J. R., 3rd (2001) An automated
multidimensional protein identification technology for shotgun proteom-
ics. Anal. Chem. 73, 5683–5690
29. McDonald, W. H., Tabb, D. L., Sadygov, R. G., MacCoss, M. J., Venable, J.,
Graumann, J., Johnson, J. R., Cociorva, D., and Yates, J. R., 3rd (2004)
MS1, MS2, and SQT-three unified, compact, and easily parsed file
formats for the storage of shotgun proteomic spectra and identifications.
Rapid Commun. Mass Spectrom. 18, 2162–2168
30. Venable, J. D., Dong, M. Q., Wohlschlegel, J., Dillin, A., and Yates, J. R.
(2004) Automated approach for quantitative analysis of complex peptide
mixtures from tandem mass spectra. Nat. Methods 1, 39–45
31. Eng, J., McCormack, A., and Yates, J. R. (1994) An approach to correlate
tandem mass spectral data of peptides with amino acid sequences in a
protein database. J. Am. Soc. Mass Spectrom. 5, 976–989
32. Tabb, D. L., McDonald, W. H., and Yates, J. R., 3rd (2002) DTASelect and
Contrast: tools for assembling and comparing protein identifications
from shotgun proteomics. J. Proteome Res. 1, 21–26
33. Zybailov, B. L., Florens, L., and Washburn, M. P. (2007) Quantitative shot-
gun proteomics using a protease with broad specificity and normalized
spectral abundance factors. Mol. Biosyst. 3, 354–360
34. Florens, L., Carozza, M. J., Swanson, S. K., Fournier, M., Coleman, M. K.,
Workman, J. L., and Washburn, M. P. (2006) Analyzing chromatin re-
modeling complexes using shotgun proteomics and normalized spectral
abundance factors. Methods 40, 303–311
35. Paoletti, A. C., Parmely, T. J., Tomomori-Sato, C., Sato, S., Zhu, D.,
Conaway, R. C., Conaway, J. W., Florens, L., and Washburn, M. P. (2006)
Quantitative proteomic analysis of distinct mammalian Mediator com-
plexes using normalized spectral abundance factors. Proc. Natl. Acad.
Sci. U.S.A. 103, 18928–18933
36. Zybailov, B., Mosley, A. L., Sardiu, M. E., Coleman, M. K., Florens, L., and
Washburn, M. P. (2006) Statistical analysis of membrane proteome ex-
pression changes in Saccharomyces cerevisiae. J. Proteome Res. 5,
2339–2347
37. Zhang, Y., Wen, Z., Washburn, M. P., and Florens, L. (2010) Refinements to
label free proteome quantitation: how to deal with peptides shared by
multiple proteins. Anal. Chem. 82, 2272–2281
38. Flicek, P., Aken, B. L., Beal, K., Ballester, B., Caccamo, M., Chen, Y.,
Clarke, L., Coates, G., Cunningham, F., Cutts, T., Down, T., Dyer, S. C.,
Eyre, T., Fitzgerald, S., Fernandez-Banet, J., Gräf, S., Haider, S., Ham-
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Several Novel Nuclear Envelope
Transmembrane Proteins Identified in Skeletal
Muscle Have Cytoskeletal Associations*□S
Gavin S. Wilkie‡§, Nadia Korfali‡§, Selene K. Swanson¶, Poonam Malik‡,
Vlastimil Srsen‡, Dzmitry G. Batrakou‡**, Jose de las Heras‡, Nikolaj Zuleger‡,
Alastair R. W. Kerr‡, Laurence Florens¶, and Eric C. Schirmer‡ ‡‡
Nuclear envelopes from liver and a neuroblastoma cell line
have previously been analyzed by proteomics; however,
most diseases associated with the nuclear envelope affect
muscle. To determine whether muscle has unique nuclear
envelope proteins, rat skeletal muscle nuclear envelopes
were prepared and analyzed by multidimensional protein
identification technology. Many novel muscle-specific pro-
teins were identified that did not appear in previous nuclear
envelope data sets. Nuclear envelope residence was con-
firmed for 11 of these by expression of fusion proteins and
by antibody staining of muscle tissue cryosections. More-
over, transcript levels for several of the newly identified
nuclear envelope transmembrane proteins increased dur-
ing muscle differentiation using mouse and human in vitro
model systems. Some of these proteins tracked with micro-
tubules at the nuclear surface in interphase cells and accu-
mulated at the base of the microtubule spindle in mitotic
cells, suggesting they may associate with complexes that
connect the nucleus to the cytoskeleton. The finding of
tissue-specific proteins in the skeletal muscle nuclear en-
velope proteome argues the importance of analyzing nu-
clear envelopes from all tissues linked to disease and sug-
gests that general investigation of tissue differences
in organellar proteomes might yield critical insights.
Molecular & Cellular Proteomics 10: 10.1074/mcp.
M110.003129, 1–16, 2011.
The nuclear envelope (NE)1 is an impenetrable membrane
barrier between the nucleus and the cytoplasm perforated by
nuclear pore complexes (NPCs) that regulate transport of solu-
ble macromolecules in and out of the nucleus (1, 2). Structurally,
the NE consists of the outer nuclear membrane (ONM) that is
continuous with the endoplasmic reticulum (ER) (3), a lumen, the
inner nuclear membrane (INM), and associated proteins includ-
ing the NPCs and the intermediate filament nuclear Lamin poly-
mer (4). Both the ONM and the INM have unique sets of trans-
membrane proteins, sometimes called NETs for nuclear
envelope transmembrane proteins. Lamins and several NETs
have been linked to an increasing number of relatively rare
diseases that range from forms of muscular dystrophy to neu-
ropathy, dermopathy, lipodystrophy, bone disorders, and ac-
celerated aging syndromes (5, 6).
The three favored molecular mechanisms to explain NE dis-
ease pathology are mechanical instability from disruption of
Lamin-cytoskeleton interactions, altered expression of genes
regulated from the nuclear periphery, and disabling of the cell
cycle/stem cell maintenance (6, 7). All of these may involve
additional associated proteins to produce pathology. Indeed, it
would seem that some proteins must be missing from the
system as those so far mutated in disease are widely ex-
pressed, yet each disease exhibits pathology in a particular
subset of the tissues in which the protein is expressed. Because
both gene regulation and cytoskeletal connections have been
implicated, NE proteins involved could reside in either the INM
or the ONM.
The mechanical stability of the NE is derived largely from
the nuclear Lamin polymer. Loss of Lamins (8–10) or their
mutation (11) greatly disturbs nuclear morphology and sta-
bility. This stability itself varies among different cell types as,
for example, neutrophils have highly lobulated nuclei and
have higher relative concentrations of the Lamin B2 subtype
(12), which is the least stable of the different Lamin sub-
types (13, 14). In contrast, muscle cells must withstand high
shear forces and have high concentrations of Lamin A, the
most stable subtype. Many NETs bind Lamins, some of
which also make connections across the lumen of the NE to
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ONM proteins (15), which in turn connect the NE to the
cytoskeleton (16, 17).
Mutations in the LMNA gene encoding Lamins A and C
cause forms of Emery-Dreifuss muscular dystrophy (EDMD)
(18, 19), limb-girdle muscular dystrophy (LGMD-1B) (20), and
dilated cardiomyopathy with conduction defect (CMD1A) (21),
which each affect different muscle groups, although all are
often also associated with cardiac conduction defects. Muta-
tions in the transmembrane proteins Emerin and Nesprin 1
cause other forms of EDMD (22, 23). Nesprins have been
shown to connect to cytoskeletal proteins (16, 17, 24, 25).
Thus, both Lamins and NETs involved in connecting Lamins
to the cytoskeleton can cause muscle disease in humans.
Postulating that other, more muscle-specific proteins might
also contribute to NE-cytoskeleton interactions, we sought to
determine whether additional NETs could be found in the NE
proteome of skeletal muscle. The previously validated sub-
tractive approach was applied (26) using microsomes/sarco-
plasmic reticulum (SR) and mitochondria, the principal mem-
brane contaminants expected, as subtractive fractions. Many
new NE proteins were identified that had not been identified in
previous NE proteomics investigations using liver, blood, and
neuroblastoma cells (26–28). NE residence was confirmed for
11 novel NETs by expression of epitope-tagged versions and
using antibodies on tissue cryosections.
Muscle-specific expression was determined for several
NETs both according to transcriptome databases (29) and by
direct testing with qRT-PCR. Moreover, some of the novel
skeletal muscle NETs were up-regulated in myogenesis. Ex-
pression of NETs as tagged fusions revealed that NETs
TMEM214 and KLHL31 concentrate at the nuclear surface
with partial overlap with microtubules, suggesting some con-
nectivity with the cytoskeleton. Moreover, TMEM214 and the
NET WFS1 have a unique distribution at the base of the
spindle poles in mitosis similar to that recently reported for
NET5/TMEM201/Samp1 (30). Thus, some of these newly
identified muscle NETs could potentially contribute to cy-
toskeletal defects in NE muscle diseases.
EXPERIMENTAL PROCEDURES
Preparation of Skeletal Muscle NEs and Microsomes/SR—Six to 10
week-old Sprague-Dawley rats were obtained from the University of
Edinburgh animal facility according to university ethics procedures.
For time and gradient size constraints, each individual preparation
was limited to six rats. The procedure is given with full details in Ref.
31, but briefly, hind leg muscle between the femur and hip was
isolated after discarding the sciatic nerve, and the muscle was
crudely chopped into roughly 0.5-cm pieces, rinsed, and weighed.
This was minced three times at 4 °C in 50 ml of ice-cold homogeni-
zation buffer (10 mM HEPES, pH 7.4, 60 mM KCl, 0.5 mM spermidine,
0.15 mM spermine, 2 mM EDTA, 0.5 mM EGTA, and 300 mM sucrose
with freshly added protease inhibitors and 2 mM DTT) and then
brought to a volume of 5 ml/g of starting muscle mass with homog-
enization buffer. A Potter-Elvehjem motorized Dounce homogenizer
with a 0.1–0.15-mm-clearance Teflon pestle was used at 900–1000
rpm to produce a crude homogenate that was then poured through
four layers of sterile cheesecloth on ice in a 4 °C room. Crude nuclei
were pelleted from the filtrate at 1000  g in a swinging bucket rotor
for 10 min at 4 °C. The supernatant was carefully removed and
processed for mitochondria and microsome/SR membranes (see be-
low). The crude nuclear pellet was washed with Percoll gradient buffer
(10 mM HEPES, pH 7.4, 60 mM KCl, 0.1 mM EDTA, 0.1 mM EGTA, and
300 mM sucrose), repelleted, and resuspended in 26.7 ml of ice-cold
Percoll gradient buffer. Percoll (Sigma 77237) was added to a final
concentration of 27% (v/v), and nuclei were pelleted at 27,000  g for
30 min at 4 °C in a swinging bucket rotor. Some fragmented myofi-
brils have a mass similar to that of nuclei but a different density, so the
isopycnic gradient accumulates them at the top (32). Nuclei were
collected from where they banded near the bottom of the tube.
Fractions were checked for nuclear enrichment by microscopy. The
nuclear fraction was diluted 10-fold with ice-cold SHKM buffer (50 mM
HEPES, pH 7.4, 25 mM KCl, 5 mM MgCl2, 1 mM DTT, and 0.25 M
sucrose) and pelleted by centrifugation at 4000  g for 20 min at 4 °C
in a swinging bucket rotor. This pellet still contains other membrane
and cytoplasmic contaminants, so the pellets were resuspended in 11
ml of ice-cold SHKM buffer using a hand-held Dounce homogenizer.
39 ml of SHKM buffer with 2.3 M sucrose was added to bring the
sucrose concentration to 1.85 M. 25 ml was removed to each SW28
ultracentrifuge tube and underlaid with 5 ml of ice-cold SHKM buffer
with 2.15 M sucrose and then a further 5 ml of SHKM buffer with
2.8 M sucrose using a 14-gauge needle. After centrifugation in an
SW28 swinging bucket rotor for 60 min at 82,000  g at 4 °C, the
nuclei occur at the interface of the 2.8 and 2.15 M sucrose layers.
Nuclei were collected, diluted 10-fold in SHKM buffer, centrifuged at
4000  g for 20 min at 4 °C, and then resuspended in SHKM buffer,
and nuclei were counted using a hemocytometer. At this stage, no
contaminants could be observed under the microscope.
NEs were then prepared from isolated nuclei by two rounds of
digestion with DNase I (Sigma D4527) and RNase A (Sigma R4875) in
0.3 M sucrose, 10 mM HEPES, pH 7.4, 2 mM MgCl2, 0.5 mM CaCl2, and
2 mM DTT (using a Dounce homogenizer to resuspend nuclei) for 20
min followed by layering onto the same buffer with 0.9 M sucrose and
centrifugation at 4000  g for 10 min at 4 °C to wash out and float
digested chromatin. The first round used nuclei at 1–2 million/ml with
10 units/ml DNase and 1.4 mg/ml RNase, and the second round used
nuclei at 2–4 million/ml with 50 units/ml DNase and 5 mg/ml RNase.
Digestions were followed by rapid staining of nuclei with 4,6-dia-
midino-2-phenylindole dihydrochloride (DAPI) using a fluorescence
microscope and extended if most of the DAPI signal had not been
washed out. NEs were snap frozen in liquid nitrogen and maintained
at 80 °C.
To prepare mitochondria and microsomes enriched in SR mem-
branes, 0.5 mM EDTA was added to the postnuclear supernatant to
inhibit metalloproteases. This homogenate was first centrifuged at
10,000  g at 4 °C for 20 min to pellet mitochondria. The postmito-
chondrial supernatant was then subjected to centrifugation at
100,000  g for 45 min at 4 °C to generate a crude microsomal/SR
pellet. This was resuspended in 5 ml of ice-cold SHKM buffer, and the
sucrose concentration was increased to 2 M by adding 2.7 volumes of
ice-cold 2.8 M SHKM buffer. 28 ml of these membranes was added to
SW28 ultracentrifuge tubes and overlaid with 7 ml of ice-cold SHKM
buffer with 1.85 M sucrose and again with 3 ml of regular SHKM
buffer. Microsomes were floated at 57,000  g for 4 h at 4 °C in an
SW28 swinging bucket rotor. Microsomes were recovered by aspira-
tion of material at the interphase between the 1.85 M sucrose layer
and the uppermost 0.25 M sucrose layer, diluted with 4 volumes of
SHKM buffer, and pelleted at 152,000  g in a 45 Ti rotor for 75 min.
NE preparations were accumulated and divided into aliquots. One
aliquot was extracted on ice with 400 mM NaCl, 25 mM HEPES, pH
8.0, 5 mM MgCl2, 10 mM DTT, and 1% -D-octyl glucoside. A separate
NE aliquot and a microsomal membrane aliquot were extracted with
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0.1 N NaOH and 10 mM DTT. The material used for mass spectrometry
was pelleted from the extracted material by centrifugation at
150,000  g for 30 min and washed three times in filtered H2O prior
to digestion.
MudPIT—Two biological replicate preparations of NaOH-extracted
NEs and SR were analyzed in duplicate, whereas two technical rep-
licates were obtained for one preparation of salt- and detergent-
extracted NEs (Table I and supplemental Table S1). Pellets were
solubilized in 0.1 M Tris-HCl, pH 8.5, 8 M urea, and 5 mM tris(2-
carboxylethyl)phosphine hydrochloride. Next, free cysteines were al-
kylated with 10 mM iodoacetamide for 30 min, and Endoproteinase
Lys-C (Roche Applied Science) was added at a 1:100 (w/w) enzyme to
protein ratio for 6 h at 37 °C. Urea was diluted to 2 M with 0.1 M
Tris-HCl, pH 8.5, and CaCl2 (0.5 mM) and modified Trypsin (1:100,
w/w) were added for 12 h at 37 °C. Digestions were quenched with
5% formic acid (33). Samples were centrifuged for 30 min at 17,500 
g. Supernatants (Ti Table 1) were directly analyzed by MudPIT,
whereas pellets were further resuspended in 0.1 M sodium carbonate
(Na2CO3), pH 11.5, 8 M urea, and 5 mM tris(2-carboxylethyl)phosphine
hydrochloride for 30 min; incubated with 10 mM iodoacetamide for 30
min; and then further digested with Proteinase K for 4 h at 37 °C and
separately analyzed by MudPIT (34).
MudPIT was performed as described previously (35) using a
200–300 nl/min flow rate over 12–15 cycles (Table I and
supplemental Table S1) of 120 min each of increasing salt concen-
trations followed by organic gradients (5–80% acetonitrile with 0.1%
formic acid) (35). The last two to five chromatography steps consisted
of a high salt wash with 5% acetonitrile, 0.1% formic acid, and 500
mM ammonium acetate followed by the acetonitrile gradient. Distal
application of a 2.5-kV voltage electrosprayed eluting peptides di-
rectly into a linear ion trap mass spectrometer (ThermoFinnigan).
Each full MS scan (from 400 to 1600 m/z) was followed by five MS/MS
events using data-dependent acquisition (at 35% collision energy).
The raw mass spectrometric data may be downloaded from
proteomecommons.org Tranche using the hash identifiers provided in
Table I and supplemental Table S1.
RAW files extracted into ms2 file format (36) using RAW_Xtract
v.1.0 (37) were queried for peptide sequence information using SE-
QUEST v.27 (revision 9) (38) against 28,400 rat proteins (non-redun-
dant NCBI sequences on July 10, 2006) plus 197 human and mouse
homologs of previously identified NETs (26) and 172 sequences from
usual contaminants (e.g. human keratins). To estimate false discovery
rates, each non-redundant protein entry was randomized and added
to the database, bringing the total search space to 57,538 sequences
(supplemental Table S1). MS/MS spectra were searched without
specifying differential modifications, but 57 Da were added stati-
cally to cysteine residues to account for carboxamidomethylation. No
enzyme specificity was imposed during searches, setting a mass
tolerance of 3 amu for precursor ions and of 0.5 amu for fragment
ions.
Different runs were compared using DTASelect and Contrast (39).
Spectrum/peptide matches were retained if at least 7 amino acids
long with ends complying with proteolytic specificity. Other criterion
were Cn  0.08; XCorr  1.8 for singly, 2.0 for doubly, and 3.0 for
triply charged spectra; and a maximum Sp rank of 10. For Proteinase
K-digested samples, no specific peptide ends were imposed, but the
Cn cutoff was increased to 0.15 (40), whereas XCorr minima were
increased to 2.5 for doubly and 3.5 for triply charged spectra
(SEQUEST parameters for the spectrum to peptide matches for all
detected proteins are provided in supplemental Table S2). Peptide
hits were merged from all analyses to establish a master list of
proteins identified by at least two peptides or one peptide with two
independent spectra. In addition, six previously described liver
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muscle NETs were manually selected although detected by single
peptides (annotated spectra for these proteins are provided in
supplemental Fig. S1). Based on the merged detected peptides,
proteins could fall into three categories following the parsimony prin-
ciple. (i) Proteins detected by the exact same set of peptides were
grouped together because they could not be distinguished based on
the available peptide data (see column named “Proteins in Group” in
supplemental Table S3), and only one arbitrarily selected represent-
ative protein entry is reported for such groups of proteins (see column
labeled “Locus” in supplemental Table S3). (ii) Proteins with at least
one peptide uniquely mapping to them were considered unique en-
tries. (iii) Subset proteins for which no unique peptides were detected
were removed from the final list of identified proteins.
Identifications mapping to shuffled peptides were used to estimate











 100 (Eq. 2)
Under these criteria, the final FDRs at the protein and peptide levels
were on average 2.2  0.9 and 0.3  0.09%, respectively
(supplemental Table S3).
Normalized spectral counts (NSAF) were calculated for each non-









To refine spectral counts to deal with peptides shared between
multiple proteins (44), dNSAFs were calculated based on distrib-
uted spectral counts for each run in which shared spectral counts
were distributed based on spectral counts unique to each isoform
(supplemental Table S3). For each protein, averaged dNSAF and
standard deviations (supplemental Table S3) were calculated
across several replicate analyses of NE and SR samples
(supplemental Table S1).
Bioinformatics Analysis—Proteins were mapped to an Ensembl
gene to remove redundancy from differences in protein annotations
and cross-referenced to the human genes with Ensembl release 48
(45). Orthologous group identities were sorted according to frequency
of detection in the NE and microsome runs, relative levels (determined
by averaged dNSAF values), membrane helix prediction (determined
using TMHMM 2.0; http://www.cbs.dtu.dk/services/TMHMM-2.0/;
Ref. 46), and dNSAF ratios between values measured in NEs versus
microsomes/SR (supplemental Table S3). Biologically interesting
gene ontology terms were retrieved from the mySQL database (http://
amigo.geneontology.org; Ref. 47) and added to tables. Comparison
of expression levels in different tissues was done by downloading
relative values from BioGPS (http://biogps.gnf.org/#gotowelcome;
Refs. 29 and 48) and calculating the -fold expression over the median
value from a wide variety of mouse tissues tested in this transcrip-
tome database.
Plasmid Construction—IMAGE clones for human NETs TMEM38A,
TMEM194, POPDC2, KLHL31, WFS1, TMEM70, MBOAT5, CKAP4,
TMEM214, RHBDD1, and TMEM201 were obtained from RZPD and
Geneservice. Coding sequences were amplified by PCR with added
5	 and 3	 restriction sites, sequenced from both ends in intermediate
cloning vectors, and then inserted into mammalian expression vector
pEGFP-N2 (Clontech) or pmRFP-N2 (derived from pEGFP-N2 by
replacing the GFP coding sequence with that of monomeric red
fluorescent protein). Sec61-GFP was obtained from Tom Rapoport
(Harvard, Boston, MA).
Antibodies and Western Blotting—Antibodies used were glyceral-
dehyde-3-phosphate dehydrogenase (GAPDH) (Enogene E1C604),
Calreticulin (Cell Signaling Technology 2891S), Calnexin (Stressgen
SPA-860), Lamin A (3262; Ref. 11), Nup153 (Covance MMS-102P),
Nup358 (raised against recombinant human protein amino acids
2595–2881; a kind gift from F. Melchior), SUN2 (Millipore 06-1038),
Tubulin (Sigma T6074), TMEM38A (Millipore 06-1005), POPDC2 (Mil-
lipore 06-1007), TMEM201 (Millipore 06-1013), and LOC203547 (Mil-
lipore 06-1008). All fluorophore-conjugated secondary antibodies
were minimally cross reactive from donkey (Jackson ImmunoRe-
search Laboratories) or goat (Molecular Probes).
Mitochondria prepared as described above were directly lysed in
sample buffer. Muscle NE and microsomes/SR were incubated on ice
in 50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 2 mM MgCl2, and 0.2%
Nonidet P-40 with protease inhibitors; then heated at 65 °C for 2 min;
and sonicated in a 4 °C sonic bath. Protein concentrations were
determined by Bradford assay before adding sample buffer. Mito-
chondrial loading was based on Coomassie staining compared with
NE and SR lanes.
All blots shown were run according to standard procedures, and
protein bands were visualized and quantified with IR800-conjugated
secondary antibodies using a LI-COR Odyssey imaging system and
software (Odyssey 3.0.16) using median background subtraction. For
Fig. 2, example blots are shown, whereas for Fig. 5, a graph from
averages of three independent blots for each NET and controls is
presented.
Cell Culture, Differentiation, and Transient Transfection—HT1080,
HeLa, U2OS, RD, and C2C12 cells were maintained in high glucose
DMEM (4.5 g/liter glucose; Invitrogen) supplemented with 10% fetal
bovine serum (FBS), 100 g/l penicillin, and 100 g/l streptomycin
sulfate (Invitrogen). RD and C2C12 cells were differentiated after 2
days of confluence by replacing the medium with 0.2% FBS medium
containing 10 g/ml 12-O-tetradecanoylphorbol-13-acetate and
0.1% FBS medium containing 5 g/ml insulin and 5 g/ml transferrin,
respectively. Successful differentiation into myotubes was confirmed
by light microscopy, counting that more than half of cell bodies
exhibited the lengthening characteristic of myotubes and were
multinucleate. Cells were extracted for RNA typically 2–3 days after
myotubes became prevalent. Adherent cells destined for microscopy
were plated on coverslips, and when indicated, DNA was transfected
the next day using FuGENE 6 (Roche Applied Science) according to
the manufacturer’s instructions.
Immunofluorescence Microscopy—After 30 h post-transfection,
cells were directly fixed for 7 min in 3.7% formaldehyde and pro-
cessed for microscopy after permeabilization for 6 min in 0.2% Triton
X-100. For the prefixation extractions in Fig. 5, cells were first washed
with PBS; then extracted for 1 min with 1% Triton X-100, 25 mM Tris,
pH 8.0, 150 mM KOAc, 15 mM NaCl, and 5 mM MgCl2; washed again
with PBS; and then fixed with formaldehyde. In both cases, cells were
then blocked with 10% FBS and 200 mM glycine in PBS and incu-
bated for 40 min at RT with relevant antibodies. DNA was visualized
with Hoechst 33342 or DAPI, and coverslips were mounted in Flu-
oromount-G (EM Sciences). Most images were obtained using a
Nikon TE-2000 microscope equipped with a 1.45 numerical aperture
100 objective, PIFOC Z-axis focus drive (Physik Instruments), Sedat
quad filter set, and CoolSnapHQ High Speed Monochrome charge-
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coupled device camera (Photometrics). Those in Fig. 4A were decon-
volved from 0.2-m sections using AutoquantX. Structured illumina-
tion images in Fig. 4B were taken on the OMX system at the University
of Dundee microscopy facility, and Alexa Fluor secondary antibodies
(Molecular Probes) were used (other details are available upon
request).
For cryosections, fresh rat heart or leg muscle was cut into 2–3-mm
cubes, embedded in optimal cutting temperature compound (Tissue-
Tek), snap frozen in liquid nitrogen, and maintained at 80 °C. Sec-
tions were cut on a Leica CM 1900 cryostat at 6–8-m thickness and
fixed in 20 °C methanol. After rehydration, sections were incubated
with NET antibodies overnight at 4 °C followed by secondary anti-
bodies as above. Cryosection images were recorded using an SP5
confocal system (Leica) with 63 oil 1.4 numerical aperture objective
using argon and UV lasers. Micrographs were saved from source
programs as .tif files and prepared for figures using Photoshop 8.0.
Electron Microscopy—Isolated skeletal muscle NEs were fixed in
3% glutaraldehyde in 0.1 M sodium cacodylate, pH 7.3, for 2 h;
washed in 0.1 M sodium cacodylate; postfixed in 1% osmium tetrox-
ide for 45 min; washed again; and dehydrated in 50, 70, 90, and 100%
normal grade acetones for 10 min each and then for a further two
10-min changes in analar acetone. Samples were then embedded in
Araldite resin. 60-nm-thick sections were cut on a Reichert OMU4
ultramicrotome (Leica), stained in uranyl acetate and lead citrate, and
then viewed in a Phillips CM120 transmission electron microscope.
Images were taken at 100 kV at 11,000 magnification using a Gatan
Orius charge-coupled device camera.
Semiquantitative and Quantitative RT-PCR—For differentiation ex-
periments, cells were lysed with TRI Reagent (Sigma), and total RNA
was extracted according to the manufacturer’s instructions from
C2C12 or RD myoblasts or 4-day differentiated myotubes. RT-PCRs
were carried out with 100 ng of total RNA using the Titan one-tube
RT-PCR system (Roche Applied Science) in accordance with the
manufacturer’s instructions except that the dNTP concentration was
increased to 500 M and MgCl2 was increased to 3 mM. Typical
reaction conditions were 30 min of reverse transcription at 50 °C; 2
min of denaturation at 94 °C; and then 24 cycles of 94 °C for 30 s,
60 °C for 30 s, and 68 °C for 45 s. Peptidylprolyl isomerase A (PPIA)
was used as a loading control, and creatine muscle kinase (CKM),
myogenin (MYOG), and myosin heavy chain 1 (MYH1) were used as
positive controls. Human (Hs) and mouse (Mm) primer sets used are
given in supplemental Table S4.
For tissue expression experiments, human tissue RNAs were pur-
chased from Stratagene except for blood RNA that was prepared
from peripheral blood mononuclear cells isolated from buffy coats
obtained from the Scottish National Blood Transfusion Service. 8 g
of RNA from each tissue was first converted into cDNA using a First
Strand cDNA Synthesis kit (Thermoscript, Invitrogen) using a mixture
of reverse primers for the cDNA to be amplified at a final concentra-
tion of 3 M. The quantitative real time RT-PCR control was CKM in
heart muscle. Standard curves were performed using a Roche Light-
cycler for each primer pair by serial dilutions of cDNA products of
heart muscle (1:5, 1:25, 1:125, and 1:625) to estimate PCR efficiency.
GAPDH was used as the internal control to normalize the cDNA
samples across the different tissues, and the relative abundance of
each mRNA within the tissues was calculated using heart as the
standard reference dilution. To avoid amplification of contaminating
genomic DNA, primers from each set were specific to different exons.
Primers used are given in supplemental Table S4.
RESULTS
Generation of Muscle NE Fractions—Rat leg muscle nuclei
were prepared using a method that first depleted collagen
from crude lysates (confirmed by Western blot; data not
shown), thus presumably removing most connective tissue
and enriching for myofiber nuclei. Myofibrillar material and
contaminating membranes were then removed on Percoll and
sucrose gradients (31) (Fig. 1, A and B). Isolated nuclei were
subsequently digested with DNase and RNase and salt-
washed to remove most of the nuclear contents (Fig. 1C).
Even after such isolation, NEs maintain strong connections to
various protein partners including a fraction of peripheral
chromatin as shown by electron microscopy (Fig. 1D). There-
fore, to further purify NEs prior to mass spectrometry analysis,
NE fractions were extracted with 1% -octyl glucoside and
400 mM NaCl or with 0.1 N NaOH (Fig. 1A), which enrich for
proteins associated with the insoluble intermediate filament
Lamin polymer and integral membrane proteins, respectively.
Both extracted fractions were separately analyzed (sup-
plemental Table S1) because previous NE proteome analyses
demonstrated that some well characterized NETs are distrib-
uted to one or the other fraction (26, 27).
Microsomes enriched in SR were separately prepared as a
comparative/subtractive fraction. Some SR would be ex-
pected to contaminate NEs because the ONM is continuous
with the SR, and also during nuclear isolation, some SR
vesicles may stick to the surface of nuclei. In contrast, as
nuclei are stable and pellet fully at low speeds, there should
be no NE contamination in the microsome/SR fraction. In-
deed, neither Lamins A/C nor the NET LAP2, used as NE
markers, were observed in the SR fraction by Western blot
analysis (Fig. 2, A and B). Therefore, as the only membrane in
the nucleus is the NE, all membrane proteins enriched in the
NE fractions compared with the SR fractions should be true
NETs. As expected, there were similar levels of the SR protein
Calnexin in NE fractions because half of the NE, the ONM, is
continuous with the SR (Fig. 2B). Mitochondria are also ex-
pected to stick to NEs during isolation, although most should
in theory be removed by Dounce homogenization and sucrose
gradients that float many contaminating membranes (Fig. 1A).
Indeed, just as the NE Lamin A/C proteins were undetectable
in a separately prepared mitochondrial fraction, the mitochon-
drial protein Porin was not detectable in the crude NE fraction
(Fig. 2C).
As the vast majority of material was lost in isolating clean
NEs from the skeletal muscle, NEs isolated from at least 15
separate preparations were combined prior to alkali or salt/
detergent extraction. Thus, variation between preparations
should have been averaged out.
MudPIT Analysis—After extraction, pellets of isolated NE
fractions were digested with Endoproteinase Lys-C and Tryp-
sin. Because some membrane proteins that associate with the
intermediate filament Lamin polymer resist extraction with 2%
Triton X-100 and 2 M NaCl, and the polymer itself is not
completely solubilized even in 8 M urea, a second digestion
was performed on material that remained insoluble after the
Endoproteinase Lys-C and Trypsin digestion. Thus, material
that could be pelleted at 17,500  g for 30 min was subse-
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quently digested with Proteinase K at high pH (34). The results
of each digestion and replicates can be compared in sup-
plemental Table S3. Five separate MudPIT runs were per-
formed for NaOH-extracted NEs (one with Proteinase K
digestion), and two were performed for the salt/detergent-
extracted NEs. Six MudPIT runs were performed on the SR
material extracted with NaOH (two with Proteinase K diges-
tion). Thus, using different extraction conditions and different
digestions and performing multiple runs were expected to
provide comprehensive coverage to identify all proteins in the
FIG. 1. Cellular fractionation of rat muscle. A, method schematic.
Nuclei were first prepared from diced and homogenized rat leg mus-
cle and cleaned of contaminating cellular structures by centrifugation
first on isopycnic gradients and then on sucrose to float contaminat-
ing membranes while pelleting the denser nuclei. Crude NEs were
prepared by digesting/extracting nuclear contents from isolated nu-
clei. Before MudPIT analysis, these were further extracted with 1%
-octyl glucoside and 400 mM NaCl or with 0.1 N NaOH to enrich for
proteins associated with the insoluble Lamin polymer and integral
membrane proteins, respectively. Microsomes/sarcoplasmic reticu-
lum preparations were generated separately and analyzed for com-
parison/subtraction as they contain most expected membrane con-
taminants of the NE. B, top panel, before running both gradients, the
crude nuclear fractions contained many chunks of myofibrillar mate-
rial (e.g. Z-bands; highlighted with white arrowheads) released during
homogenization. Bottom panels, after both gradients, isolated nuclei
were clean of these contaminants. Phase-contrast light microscope
images are shown. Scale bar, 10 m. C, enrichment for NEs by
chromatin digestion. DAPI staining for DNA visualizes significant nu-
clear chromatin content in an isolated muscle nucleus (left panels) and
the loss of most of this material after two rounds of digestion with
DNase and RNase each followed by salt washes (two right panels).
Fluorescence microscope images are shown. Scale bar, 5 m. D,
ultrastructure of isolated NEs. Electron micrographs of crude muscle
NEs show that most material in the population has the characteristic
double membrane structure of the NE with little contamination from
single membrane vesicles (a likely SR single membrane vesicle con-
taminant is highlighted by the white arrowhead). Arrows point to
positions of NPCs. These NEs were further salt/detergent- or alkali-
extracted prior to analysis by MudPIT. After such treatment, no struc-
ture remains that can be readily discerned by EM with the character-
istics of NEs. Scale bar, 0.2 m.
FIG. 2. Fraction purity. A, Coomassie-stained gel of NE and mi-
crosome/SR muscle fractions analyzed and also of a separately iso-
lated muscle mitochondrial fraction (Mito). B, the SR marker Calnexin
was present in both the SR and NE fractions because the ONM is
continuous with the SR and shares many proteins. In contrast, the SR
fraction was completely free of NE-specific markers, the NET LAP2
and Lamins A/C. Loading was the same as for A with similar amounts
of total protein loaded. C, the mitochondrial marker Porin was absent
from NEs, whereas Lamins A/C were absent from mitochondria.
Loading was the same as in A and B.
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skeletal muscle NE. A total of seven MudPIT runs were
acquired on the NE fractions because we postulated that
some tissue-specific NETs might not be highly abundant. To
test this, the frequency of NET detection of the seven NE runs
was plotted against an estimate of abundance based on
normalized spectral counts (dNSAF) (42, 44). A clear relation-
ship was observed with the more abundant NETs tending to
be detected not only in multiple analyses of the same tissue
but also in independent analyses of different tissues
(supplemental Fig. S2).
After removing redundancy by converting protein iden-
tities to orthologous gene groups, 1267 proteins were
identified in total for the skeletal muscle NE data sets
(supplemental Table S3). Separately, 1408 proteins were
identified in the SR data sets (supplemental Table S3). Al-
though fractions appeared to be clean of mitochondria by
Western blot analysis, to more fully test mitochondrial con-
tamination, data sets were compared with lists of mitochon-
drial proteins from a previous mass spectrometry study of that
organelle (49) (supplemental Table S3). After subtracting 74
proteins that were previously identified in mitochondria, 1193
proteins remained in the skeletal muscle NE fraction. Using
microsomes/SR strictly as an absolute subtractive fraction
would have resulted in the loss of several well characterized
FIG. 3. NET tissue specificity of ex-
pression. A, expression data were down-
loaded from the BioGPS transcriptome
database that compared over 60 mouse
tissues on microarrays. The median ex-
pression value was obtained over the
complete set of tissues, and data for a
subset of tissues are graphed relative to
this median value. Of the novel muscle
putative NETs represented on the arrays,
only one was not expressed notably
above the median value in either heart or
skeletal muscle (LPCAT3) with six ex-
pressed more than 100-fold over the me-
dian. In many cases, the median value
occurred at background levels of expres-
sion (see Table II), so NETs that tended to
be expressed around the median in most
tissues besides muscle are more uniquely
expressed in muscle. Error bars are
standard deviations from fluorescence
values from multiple microarrays. B,
quantitative real time PCR of the same
NETs and the control CKM over a smaller
set of tissues. The values were generated
in relation to GAPDH expression in the
same reactions, and each NET is graphed
as the -fold expression over its levels in
liver. Tissue-preferential expression was
also observed for several NETs directly
tested by qRT-PCR; however, expression
was sometimes observed in tissues that
were at background levels according to
the transcriptome data. Of particular
note, LPCAT3, the only NET that was not
up-regulated in skeletal muscle or heart
according to transcriptome data, was
up-regulated in skeletal muscle more
than 5-fold by qRT-PCR. The expression
of these new muscle NETs in blood and
liver was at low/background levels by
both methods, consistent with their hav-
ing been uniquely identified in the skel-
etal muscle NE. Error bars are standard
deviations from 3 Q-RT PCR replicates.
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NETs including LBR, Emerin, SUN2, and Nesprin 1 (50–54).
To some degree this is expected; for example, Emerin is not
unique to the INM, and separate functions have been reported
in the ONM, ER, and interstitial discs (55–57). Furthermore, a
recent proteomics study suggests that at least a third of all
proteins have multiple cellular localizations (58). Nonetheless,
the number of spectra recovered from NEs was much greater
than for ER for all the previously characterized NETs. Adding
spectra from all runs, LBR had only two spectra recovered
from the SR fraction compared with 94 from the NE fraction,
Emerin had one in the SR compared with 33 in the NE fraction,
SUN2 had 24 in the SR compared with 1490 in the NE, and
Nesprin 1 had two in the SR compared with 281 in the NE
(supplemental Table S3). Thus, instead of absolute subtrac-
tion, proteins were ordered according to their dNSAF estimate
of abundance (42, 44), and NE data sets were restricted to
those proteins either not detected in the microsomes or at
least 5 more abundant than in the microsome fractions
based on their NSAF values, which, again after subtracting all
mitochondrial proteins, left 710 proteins in the skeletal muscle
NE fraction (supplemental Table S3).
This protein set includes not only membrane proteins but
also many soluble proteins. Some of these soluble proteins
may have binding sites throughout the nucleus but nonethe-
less have relevant interactions at the NE. In contrast, the
subset of proteins harboring transmembrane spans (NETs) is
the most likely to be enriched at the NE and constitutes the
surest core NE components. This set of proteins include all 13
of the original well characterized NETs, which were ubiqui-
tously detected in our large scale analyses of nuclear enve-
lopes isolated from liver (26), blood (28), and now muscle;
these ubiquitous NETs were also recovered at high levels
(dNSAF values) and reproducibly in multiple analyses of mus-
cle NE (supplemental Fig. S2A and Table S5). An additional 28
liver NETs had been previously detected in liver NE data sets
(26), 14 of which have confirmed NE residence (supple-
mental Fig. S2B and Table S5). Another 109 proteins were
predicted to contain at least one transmembrane domain by
TMHMM v2.0 or membrane anchor by SignalP. Some of the
transmembrane proteins identified in the data sets were
known proteins that had not been detected previously at the
NE, many being ion transporters that likely function in mus-
cle SR. Others had no annotations at the time of data set
generation, and we selected 53 of these as putative novel
NETs, 24 of which were also detected in a concurrent pro-
teomics analysis of NEs from peripheral blood leukocytes
(Ref. 28; supplemental Fig. S2C and Table S5). Within the
“muscle-only” muscle NETs, one protein of high abundance
was detected in six of seven runs (TMEM38A), another group
of 11 proteins of lower abundance was detected in at least
two runs, whereas 21 proteins were detected only once and at
the lowest levels (supplemental Fig. S2D and Table S5). The
nuclear envelope targeting of over half of the proteins (48 of
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particular, 15 of the low abundance NETs have been directly
tested by us and by others (see below and supple-
mental Table S5) and confirmed at the NE.
Muscle-specific NETs—The identification of new NETs in
skeletal muscle that were not in previous liver, blood, and
neuroblastoma cell data sets (26–28) could reflect either their
preferential expression in muscle or differences in the sensi-
tivity of the mass spectrometers between the time of the
different studies. To distinguish between these possibilities, a
subset of novel putative rat skeletal muscle NETs was
searched for expression levels in the BioGPS transcriptome
database that compared relative expression for RNAs from
over 60 mouse tissues on microarrays (mouse was used
because very little rat transcriptome data were available) (29,
48). Although many NETs were widely expressed according to
the transcriptome data, others were preferentially expressed
in heart and/or skeletal muscle over other tissues (Fig. 3A). A
few of these were just 3–10-fold higher in the heart and/or
skeletal muscle than the median value for all other tissues, but
several reached levels greater than 100-fold over the median
value (Fig. 3A and Table II). Most of the eight putative NETs
shown were expressed at roughly background levels in liver
and bone marrow, explaining why they were not found in
previous liver (26) or leukocyte (28) NE data sets and further
reflecting tissue specificity in the NE proteome.
To confirm these results, qRT-PCR was performed on the
same eight muscle NETs over seven human tissues including
cardiac and skeletal muscle. Using GAPDH as a standard and
CKM as a positive control, all but TMX4 were more highly
expressed than in liver in at least one of the two muscle
tissues (Fig. 3B). The results did not precisely match the
BioGPS data for which there are many possible explanations,
but most of the NETs were preferentially expressed in muscle
over several other tissues in both systems.
The tissue specificity of NET expression based on the tran-
scriptome data was not always shared between species (Ta-
ble II). The BioGPS transcriptome database also compared
relative RNA expression levels for over 70 human tissues (29,
48). Some NETs like WFS1 and POPDC2 were highly ex-
pressed in heart muscle in both human and mouse systems.
However, GPR116 was very preferentially expressed in
mouse heart and skeletal muscle yet was expressed at the
median level in all human muscle groups (Table II). This may
indicate species differences as well as tissue differences in
the NE proteome.
Confirmation of NE Residence—To directly test NE resi-
dency for novel NETs as a measure of the validity of novel
protein identifications, 10 putative NETs from the skeletal
muscle data set were cloned as tagged fusions (GFP and/or
monomeric red fluorescent protein) and expressed in tissue
culture cells. Some were not expressed in the HT1080 cells
first used, but when a variety of different cell lines were
utilized, all 10 putative NETs were expressed and yielded a
discernible rim at the nuclear periphery (Fig. 4A). However,
FIG. 4. Confirmation of NE residence for NETs by targeting
tagged fusion proteins. A, NETs were tested as tagged fusions for
NE targeting, which is determined by their enrichment in a rim at the
limits of DNA staining. NET fusions are visualized in white in the left
panels and in red in the right panels, whereas DNA is visualized in
white in the right panels. NETs were sometimes expressed or targeted
better in certain cell types: all panels shown are U2OS osteosarcoma
cells except for TMEM38A in mouse C2C12 cells and TMEM70 and
CKAP4 in HeLa cells. All micrographs are on the same scale except
for CKAP4 with all scale bars at 10 m. B and C, inner versus outer
nuclear membrane targeting. Structured illumination microscopy can
distinguish proteins in the INM from those in the ONM when co-
stained with nuclear basket protein Nup153 and cytoplasmic filament
protein Nup358. B, an ONM NET or ER/ONM protein (red) should be
in the same plane with Nup358 (green) but should be external to
Nup153 (green), and this is observed for the control ER protein
Sec61 (upper schematic and images). Correspondingly, an INM NET
should be in the same plane as Nup153 and internal to Nup358 as is
observed for the control NET LAP2 (lower schematic and images). C,
all new NETs tested appeared in the same plane of the INM with
Nup153 and formed an internal ring to Nup358, indicating INM resi-
dence. Bars, 5 m.
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they were quite variable in the percentage of the protein
accumulating at the NE. For example, TMEM194 tended to
have a very crisp nuclear rim, whereas POPDC2 had higher
levels in the cytoplasm, although a rim could still be dis-
cerned. Those that had both NE and ER accumulation can be
explained by three possibilities. First, binding sites for the NET
at the NE might have become saturated due to overexpres-
sion, a phenomenon common among NETs. A corollary of this
possibility is that partner proteins involved in tethering the
NET in the NE are of low abundance in the cell lines used. This
FIG. 5. Antibody staining confirms novel NET identifications. A, Western blots testing antibodies generated to novel muscle NETs
TMEM38A, LOC203547, and POPDC2, control NET SUN2, and a NET previously identified in liver that appears to be much more abundant in
muscle, TMEM201/NET5. The correct size for each NET is indicated by an asterisk. B, comparison of the relative amounts of proteins in ER
(microsome) and NE fractions. Lamin A was used as a control for a NE-specific protein, whereas Calreticulin was used as a control for an ER
protein. Western blots of the two fractions similarly loaded for total protein were quantified on a LI-COR Odyssey imaging system, and the
percentage of the total signal between both microsome and NE lanes was plotted with NE signal in blue and microsome signal in yellow (three
repeats were averaged). The new muscle NETs were more enriched in the NE fraction than was the control NET SUN2. C, cryosections of rat
muscle stained with NET antibodies. NE staining was clearly observed for all NETs tested as determined by a rim around the DAPI-stained DNA.
Leg muscle is shown for TMEM38A, and heart is shown for the other two NETs. Bars, 10 m. D, antibody staining on pre-extracted cells. All
cells shown are C2C12 mouse myoblasts except in the case of TMEM201 where HeLa cells are shown. Cells were pre-extracted with detergent
(1% Triton X-100) to remove membranes and most soluble cytoplasmic material and then fixed and incubated with NET antibodies. A nuclear
rim staining was observed for the control NET SUN2 and all novel NETs tested. The resistance to detergent pre-extraction is consistent with
the INM localization indicated by OMX results in Fig. 4.
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is the possibility we consider most likely because of the high
degree of tissue specificity in expression of these NETs. Sec-
ond, the NET might normally have multiple cellular localiza-
tions as a recent proteomics study has suggested for nearly
40% of the mammalian proteome (58). Third, it is possible that
the GFP/red fluorescent protein fusion altered the NET protein
structure so that it is targeting aberrantly. In this latter case, it
is actually more likely that a reduction in affinity at an NE-
tethering site results in artifactual accumulation in the ER than
that the NE targeting is artifactual, although both are possible.
KLHL31 staining was highly filamentous and only sometimes
completely encircled the NE. High resolution deconvolved
images confirm its proximal association with the NE, but it
appeared in some cases of overexpression to concentrate in
membrane invaginations protruding into chromatin and in oth-
ers to form filaments that extended into the cytoplasm beyond
the NE.
The NE equally comprises INM and ONM, so NETs could
occur in one or the other subcompartment. Structured illumi-
nation microscopy (OMX) can distinguish INM from ONM
localization by co-staining for proteins from the NPC nuclear
basket (Nup153) or cytoplasmic filaments (Nup358) (59). The
NPC nuclear basket and cytoplasmic filaments both distend
more than 50 nm away from the NE, which itself is roughly 50
nm from the ONM to the INM. Therefore, the combined sep-
aration between NETs and these distal NPC components is
within the 100-nm-resolution limit of the OMX system. If a
NET is in the ONM, one would observe localization to the
same plane as Nup358 and some planar separation with
Nup153 (Fig. 4B, upper schematic), and this is what was
observed for the ONM control protein Sec61 (Fig. 4B, upper
image). The reverse should apply for an INM protein with
localization to the same plane as Nup153 and some planar
separation with Nup358 (Fig. 4B, lower schematic), and this is
what we observed for the INM control protein LAP2 (Fig. 4B,
image). Yellow co-localization is generally not observed in this
system because the OMX also resolves the 120-nm gaps in
the nuclear membrane where the NPCs are inserted from the
NETs in the membrane itself. Similarly to the control NET
LAP2, all the new skeletal muscle NETs tested here were
found to accumulate in the INM as both the NET (red) and
Nup153 (green) localized to the inner ring, whereas an inner
NET ring could be distinguished from an outer Nup358 ring
(Fig. 4C).
To test localization of endogenous protein, polyclonal anti-
bodies were generated to four novel NETs (TMEM38A,
POPDC2, LOC203547, and TMEM201). Antibodies were also
obtained for the control NET SUN2. Each antibody recognized
a protein of the correct size in immunoblots (Fig. 5A). Antibodies
against each NET were incubated with similar amounts of NE
and microsome preparations. Signals from the Western blots
were detected with fluorescent antibodies and quantified. The
total signal intensity from both NE and microsome bands were
measured, and the percentage of total signal for each was
plotted. Surprisingly, the control SUN2 had the highest percent-
age appearing in the microsome fraction (Fig. 5B). Thus, when
not overexpressed, these novel NETs are more exclusive to the
NE than one of the best characterized NETs.
POPDC2 and LOC203547 antibodies produced distinctive
nuclear rim staining on rat heart muscle cryosections (Fig.
5C). The nuclei were clearly visualized with DAPI, and the
antibody staining was concentrated in a crisp rim just sur-
rounding the nucleus. The TMEM38A antibodies produced
strong nuclear rim staining in rat leg skeletal muscle cryosec-
tions in addition to fainter staining in the SR (Fig. 5C). This is
consistent with supplemental data from a previous report on
this protein that introduced it as an SR protein (60). The
appearance of TMEM38A in the INM as well as the SR resem-
bles the well characterized NET Emerin that has been re-
ported in the cytoplasm of myotubes and interstitial discs of
heart tissue (55, 56, 61). Consistent with the immunofluores-
cence results, some peptides were obtained in the mass
spectrometry analysis of the SR fraction for TMEM38A,
Emerin, and SUN2 (supplemental Table S3).
Many previously characterized NETs resist a prefixation
extraction with 1% Triton X-100 and 400 mM KCl presumably
due to tight associations with the intermediate filament Lamin
polymer. The functioning antibodies enabled testing of this on
mouse C2C12 myoblast cells. C2C12 cells grown on cover-
slips were extracted with 1% Triton X-100 prior to fixation.
The antibodies concentrated in a rim around the DNA, con-
sistent with retention of these NETs after the detergent pre-
extraction and consistent with observations of INM targeting
by OMX. One of the NETs tested, LOC203547, had not been
FIG. 6. NE composition changes during muscle differentiation.
Expression levels of several muscle NETs were tested in both C2C12
(mouse) and RD (human) myoblast to myotube differentiation sys-
tems. RNA extracted from both untreated myoblast and chemically
differentiated myotube populations were subjected to RT-PCR for
each NET, and expression levels were quantified. The relative change
between myoblast and myotube populations was determined after
first normalizing values to the control peptidylprolyl isomerase A
(PPIA). Relative transcript levels for both human and mouse systems
are shown, and error bars indicate standard deviations between three
replicates for each differentiation system. Four NETs were induced
similarly to positive differentiation controls, MYOG and MYH1.
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cloned or tested by exogenous expression, bringing the num-
ber of new NETs with confirmed NE residence to 11. Another
of the NETs shown, TMEM201, was previously identified in
the liver data set as NET5 (26) but was tested here because it
had many more peptides in the skeletal muscle data set
(supplemental Table S3).
Several Muscle NETs Are Up-regulated during Muscle
Differentiation—Muscle-specific NETs could have functions
related to myogenic differentiation. Thus, expression levels
of several skeletal muscle NETs were analyzed in myogenic
differentiation systems where myoblast cell lines are grown
to confluency and then moved to reduced serum medium
containing pharmacological agents to induce differentiation.
The myoblasts then fuse to form multinucleate myotubes
with several characteristics of differentiated muscle. In both
human (RD; Ref. 62) and mouse (C2C12; Ref. 63, 64) sys-
tems, negative controls were unchanged, whereas
TMEM38A and KLHL31 were induced similarly to the posi-
tive controls, myogenin (MYOG) and myosin heavy chain
(MYH1) (Fig. 6). POPDC2 and TMEM161A were both up-
regulated only in the mouse system. The up-regulation of
certain NETs in myogenic differentiation is consistent with
their tissue-restricted expression patterns and the fact that
the antibodies yielded more distinctive nuclear rim staining
in skeletal and heart muscle cryosections than in cell lines.
Three Novel Skeletal Muscle NETs Appear to Associate
with the Cytoskeleton—Nesprins 1 and 2 in the ONM bind to
the actin cytoskeleton and contribute to nuclear positioning
(17), whereas Nesprin 3, originally identified by proteomics
of liver NEs (NET53; Ref. 26), binds plectin and thus pre-
sumably connects the NE to the intermediate filament cy-
toskeleton (24). These ONM NETs are also connected to the
INM SUN proteins that in turn bind Lamins, hence connect-
ing the cytoskeleton to the nucleoskeleton (15). Thus, NETs
in both the ONM and INM are involved in connecting cy-
toskeletal filaments to the nucleoskeleton. The importance
of such connections is illustrated by the recent discovery
that mutations in Nesprins 1 and 2 (23) also cause EDMD.
FIG. 7. Muscle NET alignment with
microtubules. U2OS cells expressing
various NET-GFP fusions were fixed and
stained for microtubules. Sections from
deconvolved images are shown for a fo-
cal plane at the upper nuclear surface.
DAPI staining for DNA is in blue, micro-
tubules are in green, and the NET is in
red. In the right columns, the microtu-
bules or NET are shown in grayscale.
Microtubule filaments are observed
crossing the nuclear surface in the SUN2
control-transfected cell, but the SUN2
staining on the surface is spotty, con-
sistent with previous reports. The same
was observed for RHBDD1 and most
muscle NETs tested; however, KLHL31,
which had a more filamentous appear-
ance in Fig. 4, exhibited filaments also
on the nuclear surface that partly
tracked with the microtubule filaments
(note both grayscale images for each
and some yellow co-localization in the
merge panel). TMEM214, although con-
sistently yielding a much crisper and
continuous rim at the nuclear periphery,
also exhibited filamentous accumulation
at the nuclear surface that exhibited
even more overlap with microtubules.
Scale bars, 10 m.
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NETs connecting microtubules to the nucleus have not
previously been identified, but it is clear that microtubules
have some interactions with the NE because they associate
with the NE prior to NE disassembly in mitosis (65), and
NET5/TMEM201/Samp1 associates with both the centro-
some and the mitotic spindle (30, 66). As muscle cells have
many unique cytoskeletal features, the novel NETs from skel-
etal muscle were screened for effects indicating any associ-
ations with microtubules.
The NETs were overexpressed in U2OS cells and co-visu-
alized with the microtubule cytoskeleton. Overexpression of
most NETs yielded no visible alterations in microtubule orga-
nization. However, cell sections at the upper surface of the
nucleus revealed a filamentous distribution for KLHL31 and
TMEM214 (Fig. 7) in nearly all transfected cells. This strongly
contrasted with the typical punctate distribution of NETs at
the nuclear surface (SUN2 and RHBDD1 shown). Overlaying
the NET and microtubule staining patterns in these sections
for KLHL31 and TMEM214 revealed significant co-localiza-
tion; however, the percentage of microtubules visible at the
nuclear surface that tracked with the NETs was highly variable
from cell to cell. The upper cell for TMEM214 shows also how
some of the overexpressed NET distributed in the ER also
tracked with the microtubules in the cytoplasm and the lack of
a clear microtubule-organizing center. The lower cell shows a
different defect with two microtubule-organizing centers at
the center of the nuclear surface.
Observations of NPC-associated proteins and the NE
Lamin proteins on the mitotic spindle (e.g. Lamin B, Importin
, and Ran; Refs. 67–69) provided the first evidence that NE
proteins have separate roles in mitosis. A more recent study
showed that NET5/TMEM201/Samp1 associates with the
base of the mitotic spindle in mitosis (30). During mitosis,
many NETs are redistributed into small vesicles that spread
throughout the cell except from the spindle area. This pattern
was observed for most NETs with SUN2 and RHBDD1 shown
as examples (Fig. 8). In contrast, TMEM214 exhibited an
increased concentration by the spindle base in most cells,
although it was excluded from the spindle poles themselves
(Fig. 8, upper right TMEM214 panel). Some cells exhibited an
even more striking microtubule association with clear co-
localization throughout the length of many spindle microtu-
bules (Fig. 8, lower TMEM214 panels). KLHL31 was distrib-
uted differently in mitosis, associating more with the mitotic
chromosomes than with microtubules. WFS1, although not
tracking with microtubules in interphase, exhibited a distribu-
tion similar to that of TMEM214 with a concentration around
the base of the spindle in mitosis (Fig. 8, bottom panels).
DISCUSSION
This analysis of the skeletal muscle NE proteome identified
many new NE-associated proteins and NETs not identified in
earlier studies of liver and neuroblastoma NEs (26, 27) or a
more recent study of blood NEs (28). Moreover, some of these
FIG. 8. Partial NET-microtubule associations are also observed
in mitosis. In mitosis, the NE breaks down, and several NPC proteins
and Lamins have previously been reported to partly assemble on the
mitotic spindle. The negative control SUN2 and the new muscle-
specific NET RHBDD1 were generally distributed throughout the mi-
totic cell but excluded from the spindle (white arrowheads point to
one of the spindles in each cell). No particular accumulation or
change in the NET distribution was observed with respect to the
mitotic spindle. As a positive control, TMEM201 (NET5/Samp1) is
shown as it has previously been shown to associate with the spindle.
TMEM214 exhibited in most cells a strong accumulation at the base
of the spindles close to the poles but was excluded from the poles
themselves. In other cells, the distribution was even more focused on
the spindle itself with significant co-localization with the microtubules.
A third muscle NET, WFS1, consistently yielded the first phenotype of
TMEM214; however, in many cases, an even more pronounced ac-
cumulation surrounding the spindle poles was observed. One spindle
pole in each cell (except the prophase TMEM214 cell) is marked by an
arrowhead. Scale bar, 10 m.
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proteins had very restricted tissue expression and were spe-
cifically up-regulated in myogenic differentiation systems.
Thus, each tissue likely has a different combination of proteins
in its NE proteome. That some of these more tissue-restricted
NETs track with the microtubule cytoskeleton has the poten-
tial to explain some of the tissue specificity of NE disease
phenotypes. The three favored hypotheses to explain how NE
protein mutation can yield pathology are altered expression of
genes regulated from the nuclear periphery, mechanical in-
stability from disruption of lamina-cytoskeleton interactions,
and disabling of the cell cycle/stem cell maintenance (6, 7).
That NET-microtubule associations indicated here appear to
occur in both interphase and mitosis provides potential mech-
anisms toward both mechanical instability and cell cycle reg-
ulation. That some of these proteins are tissue-restricted pro-
vides a potential explanation for the tissue preferences in NE
disease pathologies.
Much additional work will be required to determine such
disease links and whether associations are direct or indirect.
Nonetheless, the tracking of TMEM214 and KLHL31 with
microtubules on the nuclear surface is both striking and a
novel finding among all NETs identified thus far. The associ-
ation of TMEM214 and WFS1 at the base of the spindles in
mitosis resembles that observed for NET5/TMEM201/Samp1
(30). This finding followed observations that Ima1, the yeast
homolog of this NET, is involved in connecting the NE to the
centrosome (66). Thus, the potential link to cell cycle regula-
tion is even stronger.
The idea of more tissue-specific NETs participating in pro-
tein complexes at the NE whose disruption could lead to more
muscle-specific pathologies makes sense (70). It is hard oth-
erwise to explain how mutations in ubiquitous proteins like
Lamin A, Emerin, or the Nesprin proteins could result in tis-
sue-specific pathologies (18–23). Interestingly, WFS1 has al-
ready been linked to three disorders, although the function of
the protein remains obscure (71–73). These initial successes
in identifying tissue-specific NETs that have links to disease
indicate the importance of investigating the NE proteome in all
tissues linked to disease.
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Abstract
Disruption of cell cycle regulation is one mechanism proposed for how nuclear envelope protein mutation can cause
disease. Thus far only a few nuclear envelope proteins have been tested/found to affect cell cycle progression: to identify
others, 39 novel nuclear envelope transmembrane proteins were screened for their ability to alter flow cytometry cell cycle/
DNA content profiles when exogenously expressed. Eight had notable effects with seven increasing and one decreasing the
4N:2N ratio. We subsequently focused on NET4/Tmem53 that lost its effects in p532/2 cells and retinoblastoma protein-
deficient cells. NET4/TMEM53 knockdown by siRNA altered flow cytometry cell cycle/DNA content profiles in a similar way as
overexpression. NET4/TMEM53 knockdown did not affect total retinoblastoma protein levels, unlike nuclear envelope-
associated proteins Lamin A and LAP2a. However, a decrease in phosphorylated retinoblastoma protein was observed
along with a doubling of p53 levels and a 7-fold increase in p21. Consequently cells withdrew from the cell cycle, which was
confirmed in MRC5 cells by a drop in the percentage of cells expressing Ki-67 antigen and an increase in the number of cells
stained for ß-galactosidase. The ß-galactosidase upregulation suggests that cells become prematurely senescent. Finally, the
changes in retinoblastoma protein, p53, and p21 resulting from loss of NET4/Tmem53 were dependent upon active p38
MAP kinase. The finding that roughly a fifth of nuclear envelope transmembrane proteins screened yielded alterations in
flow cytometry cell cycle/DNA content profiles suggests a much greater influence of the nuclear envelope on the cell cycle
than is widely held.
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Introduction
Several proteins of the nuclear envelope are linked to human
diseases ranging from muscular dystrophies to neuropathy, bone
diseases, and progeroid aging syndromes [1,2]. These proteins
include the intermediate filament A/C Lamins and several
proteins integral to the nuclear membrane. Favored molecular
mechanisms to explain how mutations in nuclear envelope
proteins produce pathology include loss of nuclear mechanical
stability, alterations in gene expression, and cell cycle/stem cell
maintenance defects (reviewed in [2,3,4]). However, the known
functions of the proteins mutated in disease are insufficient to fully
explain the pathologies observed without assistance from partner
proteins that thus far have not been identified.
The first indication of a link between nuclear envelope diseases
and the cell cycle came from studies with specific mutations in the
nuclear envelope transmembrane protein (NET) Emerin linked to
Emery-Dreifuss muscular dystrophy. It was reported that two
disease-linked mutations prolonged S-phase from 12 h to 22 h
when overexpressed in COS-7 cells [5]; however similar effects
were not observed in all disease mutants and so this was not
investigated in further detail. In C. elegans disruption of Emerin
alone did not have a strong effect on the cell cycle, but when
combined with disruption of a second NET, MAN1, it did [6].
Loss of Emerin has also been reported to interfere with
retinoblastoma protein (pRb)-regulated genes in mouse and
consequently with myogenic differentiation [7], and the same
pRb-dependent cell cycle exit is disrupted in nuclear envelope-
linked muscular dystrophy [8]. pRb is a tumor suppressor that
regulates the cell cycle at the G1/S transition by regulating the
E2F family of transcription factors (reviewed in [9]). pRb also
interacts with Lamin A [10], but this is thought to principally
involve the nucleoplasmic and not the nuclear envelope pool of
Lamin A because it operates in a complex with LAP2a, a soluble
splice variant of the nuclear envelope protein LAP2 that is
principally found in the nucleoplasm [11,12,13].
To determine if any of several newly identified nuclear envelope
proteins play a role in the cell cycle, 39 novel confirmed NETs
were screened for their ability to alter flow cytometry cell cycle/
DNA content profiles when exogenously expressed. These NETs
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were identified in two recent proteomic analyses of liver and blood
cells [14,15]. Seven of the NETs tested showed an increase in the
4N:2N ratio while one showed a decrease. To determine if
pathways affected by these NETs involved the p53 master cell
cycle regulator, these eight NETs were retested in p532/2 cells.
The change in 4N:2N ratios still occurred in the absence of p53 for
most NETs, but the effect of NET4/Tmem53 and NET59/Ncln
was lost. NET4/Tmem53 was selected for a more detailed analysis
of how it interacts with the p53 pathway. Knockdown of NET4/
TMEM53 resulted in cell cycle withdrawal, apparently through
activation of the p38 kinase with consequent upregulation of p53
and p21 and downregulation of phosphorylated pRb.
Results
A screen for NETs that alter flow cytometry profiles
To identify nuclear envelope proteins that might contribute to
cell cycle progression, a collection of 39 NETs were screened for
their ability to affect flow cytometry cell cycle/DNA content
profiles. All NETs were fused to a monomeric red fluorescent
protein (mRFP) tag at their carboxyl-termini and were previously
confirmed to target to the nuclear envelope [14,15,16]. HEK293T
human embryonic kidney cells were used for the screen because
this cell line is efficiently transfected, easily recovered from plates
for the flow cytometry experiments, and has a relatively stable
karyotype compared to other commonly used lines such as HeLa,
U2OS or HT1080 cells. Tagged NETs were transiently
transfected into the HEK293T cells and after 40–48 h of
expression the frequency of live cells with 2N or 4N DNA content
was measured by flow cytometry.
DNA profiles were acquired for both the transfected cells
(mRFP positive) and the untransfected population for each
transfection. Thus the use of transient transfections provided an
internal control for each experiment that removed any cell cycle
variation between plates and/or due to the transfection reagent.
For each NET at least three independent flow cytometry
experiments were performed, each on different days and with a
minimum of 1,000 singlet transfected cells (and in most cases
.5,000 cells) analyzed. For those NETs where a strong effect was
observed, additional repeats were done with 20,000 transfected
cells analyzed to increase confidence.
Examples of flow cytometry cell cycle/DNA content profiles are
shown in Figure 1 with the untransfected cell traces (blue) overlaid
with those of the mRFP-expressing population (red). Cell
fragments and apoptosing cells were excluded based on propidium
iodide (PI) staining and FSC/SSC (from light scattering). The flow
cytometry profiles for the mRFP control and many other NETs
tested were indistinguishable from those of untransfected cells in
the same population or only exhibited minor differences. By
contrast, NET11/Sccpdh, NET31/Tmem209, NET59/Ncln,
Tmub1, Fam3c, Magt1 and Tmem126a all yielded striking
accumulations of cells with a 4N DNA content suggesting an
increased G2/M population (Figure 1). NET4/Tmem53 yielded a
different effect, exhibiting a reduction in cells with 4N DNA
content suggestive of more cells in the G1 phase of the cell cycle.
The percentages of cells in G1, S, and G2/M phases based on
DNA content are listed in Table 1. While effects of these eight
NETs were the most striking and reproducible, one cannot
discount that some NETs that caused minor changes might also be
relevant to the cell cycle.
It is possible that some NETs positive in the screen could have
altered flow cytometry DNA content profiles because of aberrant
nuclear morphologies as opposed to effects on cell cycle
progression (though this could in turn reflect problems with
cytokinesis). To test if this was a likely explanation, cells from the
transfected populations were imaged by fluorescence microscopy.
Representative images revealed no gross aberration in nuclear
morphology within the transfected population, indicating this is
unlikely to have affected the flow cytometry results (Figure 2).
Nuclear envelope targeting is not always extremely clear in the
HEK293T cells either because NETs have multiple localizations
or because the high expression saturates binding sites at the
nuclear envelope in these cells; however, all NETs tested here
were previously confirmed to target to the nuclear envelope
[14,15,16].
Some NETs depend on p53 and/or pRb for their effects
The cell cycle protein p53 is often referred to as a master
regulator because it has a role in a large number of cell cycle
pathways. The ability of the eight NETs identified in the initial
screen to alter the flow cytometry DNA content profiles was re-
examined in the HCT116 p532/2 cell line. The controls mRFP and
NET51/C14orf1 had not yielded changes in the flow cytometry
DNA content profile in the HEK293T cells and similarly yielded no
significant changes in the p532/2 cells (Figure 3A). Correspond-
ingly, NET11/Sccpdh, NET31/Tmem209, Tmub1, Fam3c,
Magt1, and Tmem126a that had exhibited increases in the 4N
population in the HEK293T cells yielded similar changes in the
p532/2 cells; so p53 does not appear to be involved in the potential
effects of these NETs on the cell cycle. By contrast, in the p532/2
cells NET59/Ncln no longer exhibited a 4N increase and NET4/
Tmem53 no longer exhibited a 4N decrease as had been observed
in the HEK293T cells. Thus changes in the flow cytometry profiles
from expression of NET59/Ncln and NET4/Tmem53 appear to
be p53 dependent. To better compare the results in the p53 positive
and negative cells, the 4N:2N ratios from both cell lines were plotted
for this set of NETs (Figure 3B). For NETs other than the two that
lost their effects a similar pattern was observed between the two cell
lines, although in some cases the 4N:2N ratio increase was slightly
higher in the HCT116 p532/2 cell line. NET4/Tmem53, a
previously uncharacterized protein with no known functional
domains, was subsequently followed in more detail.
Cell cycle effects dependent on p53 often involve changes in
pRb [17] and links have previously been identified between pRb
and nuclear envelope-associated proteins [10,11,12,13]. To
determine if pRb also plays a role in the NET4/Tmem53-directed
effects, flow cytometry cell cycle/DNA content profiles were
determined for cells expressing NET4/Tmem53 or controls in
HEK293T cells with normal or reduced levels of pRb, using
siRNA oligos to knock down pRb. The reduction in the 4N:2N
ratio caused by NET4/Tmem53 was lost in the pRb-depleted cells
(Figure 4A). As pRb phosphorylation is crucial for its role in cell
cycle progression [18,19,20], antibodies to a form of pRb
phosphorylated at serine 780 were utilized to test if phosphory-
lated pRb levels were affected in the NET4/Tmem53 transfected
cells. Because of low and variable transfection efficiencies this
could not be assayed at a population level; thus transfected cells
were stained with the antibodies and the levels of the phosphor-
ylated pRb in the nucleoplasm were quantified by measuring the
average pixel intensity (Figure 4B). Plotting these values revealed a
significant loss of phosphorylated pRb in cells expressing NET4/
Tmem53.
RNAi knockdown of NET4/Tmem53
Further study of the pathways through which NET4/Tmem53
affects cell cycle regulation would not be practical using exogenous
expression because transfection efficiencies were too low (5–10%)
to be able to quantify changes in pathway components by Western
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blot. The p53, p38 and p21 antibodies used in subsequent assays
were tested by immunocytochemistry, but proved inadequate for
quantification due both to a diffuse distribution throughout the cell
body and cell-to-cell variation in intensities that appears to result
from induction of stress pathways in some cells during transfection
(data not shown). Therefore, to further elucidate the pathways
through which NET4/Tmem53 affects the cell cycle, its
knockdown was attempted.
Figure 1. Changes in flow cytometry cell cycle profiles for cells overexpressing NETs. HEK293T cells expressing mRFP-NET fusions were
recovered by trypsinization and analyzed by flow cytometry at 48 h post-transfection. Data were analyzed using FlowJo software and histogram
overlays are displayed as %Max, scaling each curve to mode = 100%. The red line is the mRFP expressing cells in the population while the blue line is
the untransfected cells in the population (the majority of cells were not transfected). The transfected and untransfected populations were both set on
the scale to 100 for the 2N population so that increases or decreases in the 4N peak reveal changes in the cell distribution. Arrows indicate significant
changes in cell cycle profile between transfected and non-transfected cells.
doi:10.1371/journal.pone.0018762.g001
NET Flow Cytometry Screen
PLoS ONE | www.plosone.org 3 April 2011 | Volume 6 | Issue 4 | e18762
There are both long and short splice variants of NET4/
TMEM53 (Figure 5A). To determine whether it would be better to
design siRNA oligos to knock down one or both (the original
screen used the shorter variant), long and short splice variants of
NET4/TMEM53 with the GFP moiety at either terminus were
cloned and then tested to determine if both could produce the flow
cytometry cell cycle/DNA content ratio effect of the original
mRFP construct. All constructs yielded the same effect (Figure 5B).
Multiple siRNA oligos were then generated that should knock
down both long and short splice variants. Although the HEK293T
cells were ideal for the flow cytometry-based screen due to their
generally high transfection efficiencies and comparatively stable
DNA content, for subsequent more directed cell cycle experiments
MRC5 primary fibroblasts [21] and the U2OS osteosarcoma cell
line were used because they have comparatively more operational
checkpoint machinery. Moreover, the primary fibroblasts can
enter a state of senescence that is not possible for HEK293T cells.
Before proceeding, the ability of NET4/Tmem53-mRFP expres-
sion to alter flow cytometry DNA content profiles was evaluated in
both MRC5 primary fibroblasts and the U2OS cells, confirming
that a comparable effect to that observed in HEK293T cells
occurred in the MRC5 and U2OS cells (Figure 5C).
Two siRNA oligos (si1 and si2) that should each in theory knock
down both long and short splice variants (Figure 6A) effectively
knocked down NET4/TMEM53 transcripts in MRC5 cells
(Figure 6B). The si2 was slightly more effective than the si1 and
therefore initially used in preference, though all relevant findings
were subsequently verified with both oligos. As NET4/TMEM53 is
an uncharacterized gene with no direct evidence for its full range
of splicing possibilities, it is possible that additional splice variants
exist that the two siRNA oligos do not knock down. Therefore, an
esiRNA that should knock down any and all possible splice
variants of NET4/Tmem53 was also tested and found to be
effective in reducing NET4/TMEM53 transcripts in MRC5 cells
(Figure 6B). Knockdown of NET4/TMEM53 transcripts was also
successful in U2OS cells (Figure 6C).
Available NET4/Tmem53 antibodies could not be used to
determine if the NET4/Tmem53 protein was also being knocked
down because they recognized several closely migrating bands
where NET4/Tmem53 protein is expected to migrate on Western
blot. Nonetheless, the endogenous protein is very likely to be
reduced because cells expressing NET4/Tmem53-GFP prior to
addition of siRNA oligos for NET4/TMEM53 knockdown
exhibited a loss of the fusion protein with both GFP and
NET4/Tmem53 antibodies (Figure 6D and data not shown).
This indirect approach typically indicates knockdown of the
endogenous protein [22].
The effect of NET4/TMEM53 knockdown on flow cytometry
cell cycle/DNA content profiles was next determined. An increase
was observed in the population of cells with a 2N amount of DNA
that was similar to the increase resulting from exogenous NET4/
Tmem53 expression (Tables 1 and 2). A corresponding reduction
was observed in the population of cells with 4N DNA content both
with the knockdown and with overexpression. Both MRC5 and
U2OS cell lines were subsequently used in parallel for most
experiments to ascertain if any observed effects required the more
reliable cell cycle checkpoints of primary cells (MRC5) and thus
were not recapitulated in transformed cell lines such as the U2OS
Table 1. Percentage of cells in each cell cycle phase by flow
cytometry upon exogenous expression of NET-mRFP fusions.
NET mRFP negative mRFP positive
% G1 % S % G2/M % G1 % S % G2/M
untransfected 60 14 21 - - -
mRFP 61 14 20 62 13 20
NET4/Tmem53 62 14 20 74 8 14
NET11/Sccpdh 60 14 20 37 18 38
NET31/Tmem209 58 15 21 39 15 38
NET51/C14orf1 62 16 18 60 17 19
NET59/Ncln 59 15 22 37 19 35
Fam3c 62 10 18 44 10 30
Magt1 65 12 19 53 14 26
Tmub1 63 13 19 50 14 31
Tmem126a 65 13 14 53 17 26
doi:10.1371/journal.pone.0018762.t001
Figure 2. The changes in flow cytometry profile of cells expressing NETs are not caused by aberrant nuclear morphology of cells.
Images of HEK293T cells expressing NET-mRFP shows nuclear morphology depicted by DAPI staining (upper panel) compared to mRFP signal (lower
panel) indicating cells expressing NETs.
doi:10.1371/journal.pone.0018762.g002
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line that has stable p53- and pRb-dependent checkpoints but is
defective for p16INK [23,24].
NET4/TMEM53 knockdown causes premature senescence
in primary fibroblasts but only a cell cycle delay in the
transformed U2OS cells
When MRC-5 cells were transfected with siRNA oligos or
esiRNA for NET4/TMEM53 the number of cells per dish
appeared to be lower than in cultures transfected with the
scrambled control siRNA oligo, yet there did not seem to be an
increase in apoptotic cells. In order to establish the cause of this
difference, cell proliferation was assessed using antibodies to the
nuclear protein Ki-67 that is present only in proliferating cells
[25,26]. In cells knocked down for NET4/TMEM53 (Figure 7A,
upper graph) there was a notable decrease in the frequency of Ki-
67 positive cells from 57.6% in the control scrambled oligo
transfected cells to 26.9% for the NET4/TMEM53 si2 transfected
cells and 10.9% for the NET4/TMEM53 si1 transfected cells.
The esiRNA also confirmed the phenotype (39.6% Ki-67 positive
cells), further indicating its specificity to the NET4/Tmem53
knockdown.
The marked reduction in cell proliferation upon NET4/
TMEM53 knockdown could indicate a permanent arrest or a
temporary arrest from which cells could subsequently recover. ß-
Figure 3. Cell cycle effects of NET4/Tmem53 and NET59/Ncln
depend on p53. (A) Flow cytometry profiles of cells expressing NET-
mRFP fusions in HCT116 p532/2 cells. Most NETs that had produced
increases in the 4N population in Figure 1 yielded similar increases in
the 4N population in HCT116 p532/2 cells; however, NET4/Tmem53
and NET59/Ncln lost their effects. (B) The percentage of cells in the 4N
and 2N populations were calculated and 4N:2N ratios were plotted from
at least three separate experiments with standard errors shown. The
results for the HEK293T cells are shown above those for the HCT116
p532/2 cells.
doi:10.1371/journal.pone.0018762.g003
Figure 4. pRb is also involved in NET4/Tmem53 effects. (A) pRb
was knocked down by siRNA in HEK293T cells subsequently transfected
with NETs. Cell cycle profiles are shown for these cells expressing NET4/
Tmem53 or controls of mRFP alone or NET51/C14orf1 that had no effect
in the original flow cytometry screen. The 2N accumulation effect of
NET4/Tmem53 on the cell cycle profile observed in HEK293T cells was
lost when pRb levels were reduced. The knockdown of pRb is confirmed
in the lower left corner. (B) Photomicrographs of cells overexpressing
the RFP alone control or NET4/Tmem53. Cells were stained with an
antibody that recognizes pRb phosphorylated on serine 780. NET/mRFP
signal is shown in the left panels to identify transfected cells and
phospho-pRb staining in the right panels. In each panel two adjacent
cells are marked by arrowheads, one transfected and the other not
transfected. All micrographs were taken at the same exposure time. The
graph on the right shows quantification of the pixel intensity for the
phospho-pRb staining. The pixel intensity for untransfected controls
internal to each micrograph was set to 1 and average relative values
from 40 transfected cells and 40 untransfected cells for each
transfection are shown with standard errors.
doi:10.1371/journal.pone.0018762.g004
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galactosidase activity, a characteristic feature of senescent cells
[27], was therefore assessed in MRC5 primary fibroblasts knocked
down for NET4/TMEM53. At 72 h post transfection, the
percentage of ß-galactosidase positive cells was ,3 times higher
in cell cultures transfected with NET4/TMEM53 siRNA oligos or
esiRNA as compared to untransfected cultures or those transfected
with the control scramble oligo (Figure 7A, lower graph). This
suggests a tendency of NET4/Tmem53 deficient MRC-5 cells to
withdraw from the cell cycle due to premature senescence, which
is a programmed cell response to many extra- and intracellular
stresses with features similar to proliferative senescence and
leading to permanent cell cycle exit.
By contrast, when NET4/TMEM53 siRNA oligo si2 was
transfected into the transformed osteosarcoma U2OS cell line no
decrease of Ki-67 expression or increase of ß-galactosidase was
detected (data not shown), indicating that these cells do not fully
exit the cell cycle. This difference is likely due to the absence in
U2OS cells of p16INK, as this kinase has been reported to be
important for establishment of senescence [23,24]. Confirming
these reports, transcript levels of p16INK were undetectable in
Figure 5. Splice variants of NET4/TMEM53 and the effect of
knockdown in U2OS and MRC5 cells. (A) Two splice variants of
NET4/TMEM53 were cloned that differed only by a 33 amino acid
insertion roughly a third of the way into the protein. (B) Both long (l) and
short (s) splice variants had the same effect on cell cycle/DNA content
profiles and effects were independent of whether the GFP tag was on the
amino terminus or carboxyl terminus. (C) Because siRNAs failed to knock
down NET4/TMEM53 in HEK293T cells, the cell cycle/DNA content profile
effect of the original NET4/TMEM53-mRFP construct was tested on U2OS
and MRC5 cells as alternatives for knockdowns.
doi:10.1371/journal.pone.0018762.g005
Figure 6. Knockdown of NET4/TMEM53 in U2OS and MRC5
cells. (A) Splice variants and position of knockdown oligos. (B) NET4/
TMEM53 transcript levels were effectively knocked down in MRC5 cells
using both siRNA oligos and an esiRNA. Peptidylprolyl isomerase A
(PPIA) was used as a control for normalization. (C) NET4/TMEM53
transcript levels were also knocked down in the U2OS cell line using the
siRNA oligo TMEM53 si2. The scramble siRNA oligo had no effect. PPIA
was used as a control for normalization. (D) Western blot demonstrating
the knockdown of NET4/Tmem53. Because antibodies to NET4/Tmem53
recognized multiple bands on Western blot at the expected molecular
weight, knockdown of the protein was tested using a NET4/Tmem53-
GFP fusion and GFP antibodies. The siRNAs were transfected 24 h after
transfection of NET4/Tmem53-GFP in order to enable protein to be
generated from the plasmid prior to the beginning of knockdown.
doi:10.1371/journal.pone.0018762.g006
Table 2. Percentage of cells in each cell cycle phase by flow
cytometry for knockdown of NET4/TMEM53 and controls in
U2OS cells.
%G1 %S %G2/M
untransfected 58 10 32
scramble 59 11 30
oligo si 2 65 12 22
doi:10.1371/journal.pone.0018762.t002
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U2OS cells and strongly upregulated in senescent MRC5 cells
(Figure 7B). Knockdown of NET4/TMEM53 resulted in a small
increase in p16INK transcript levels (Figure 7B), consistent with
the hypothesis that its absence in U2OS cells underlies the failure
to become senescent. Despite the inability to senesce, some effects
on the cell cycle still occurred in U2OS cells knocked down for
NET4/TMEM53 as BrdU incorporation was reduced by nearly
50% (data not shown), indicating that the frequency of cells in S
phase was greatly reduced. This could indicate that these cells
spend an extended period in G1, consistent with the flow
cytometry data.
NET4/TMEM53 knockdown results in alteration of levels
of several cell cycle regulators
To further understand the pathways mediating the effect of
NET4/Tmem53 on the cell cycle, levels of various cell cycle
regulators before and after NET4/Tmem53 depletion were
quantified by Western blot. In both MRC5 and U2OS cells the
p53 protein level was increased ,2-fold upon loss of NET4/
Tmem53 while p21 levels increased ,7-fold (Figure 8A,B). Total
levels of pRb remained relatively unchanged, but pRb became
hypophosphorylated when NET4/Tmem53 was knocked down
and phosphorylated p38MAP kinase levels increased (Figure 8A,B).
It should be noted that although total pRb levels were unchanged
on average over several experiments with NET4/TMEM53
knockdown, there was reasonable variability in the levels of total
pRb among experiments. Thus the ratio of phosphorylated pRb to
total pRb was likely also somewhat variable, but levels of the
phosphorylated pRb were notably reduced in all experiments. To
confirm that the effect observed was specific for NET4/TMEM53
knockdown the experiment was repeated using oligos si1, si2, and
the esiRNA. The same result was observed with p53 and p21
increasing upon loss of NET4/Tmem53 (Figure 8C).
By contrast no changes were observed in levels for other NE
proteins previously shown to contribute to cell cycle regulation
Emerin, LAP2 (both soluble and transmembrane splice variants
alpha and beta), or Lamin A (Figure 9A). Neither were differences
observed in cyclins A, C, D, or E (Figure 9A,B). Cyclin B levels
may have been slightly reduced; however, considerable variability
was observed between all experiments and so no clear conclusion
could be drawn (data not shown).
NET4/Tmem53 effects on cell cycle protein levels are
mediated by the p38MAP kinase
The p38MAP kinase that was upregulated by NET4/TMEM53
knockdown mediates cell response to range of stresses, such as UV
irradiation, osmotic shock, heat shock, starvation and cytokines
[28]. p38 phosphorylates and stabilizes p53, which activates
transcription of the cdk inhibitor p21 that subsequently blocks the
cell cycle [17]. As this study has shown that p21 is also upregulated
by NET4/TMEM53 knockdown, it seemed likely that the effects
on cell cycle proteins p53, pRb and p21 are mediated by the
p38MAP kinase.
To further test if the increases in p53 and p21 were dependent
on p38MAP kinase, a specific p38 inhibitor SB203580 (Calbio-
Figure 7. NET4/TMEM53 knockdown results in cell cycle
withdrawal. (A) NET4/TMEM53 knockdown with both siRNAs and
the esiRNA all resulted in a reduced number of actively proliferating
cells as measured by Ki-67 staining (upper graph) and an increase in
senescent cells as measured by ß-galactosidase staining (lower graph).
The results from three separate experiments with standard errors are
shown. (B) Differences between MRC5 and U2OS cells in NET4/Tmem53-
induced senescence are likely due to the absence of p16INK in U2OS
cells. RT-PCR was used to detect transcript levels of p16INK. In U2OS
cells no transcripts were observed while in senescent MRC5 cells
transcript levels were greatly increased compared to cycling untrans-
fected MRC5 cells. Knockdown of NET4/Tmem53 also induced p16INK
expression in MRC5 cells, albeit less so than by full senescence.
doi:10.1371/journal.pone.0018762.g007
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chem) was added to the cultures 24 h after transfection with the
siRNA oligos. The cells were harvested 48 h later and levels of
p53, p21, and phosphorylated p38 measured by Western blot. In
all cases the increases resulting from knockdown of NET4/
TMEM53 were lost when p38MAP kinase was inhibited
(Figure 10A,B). Moreover, the NET4/TMEM53 knockdown-
mediated decrease in Ki-67 positive cells was partially abrogated
and the increase in ß-galactosidase staining cells was completely
abrogated (Figure 10C,D). Thus, p38MAP kinase appears to be
activated by NET4/TMEM53 knockdown and mediates most of
the NET4/Tmem53 effects on the cell cycle.
Figure 8. NET4/TMEM53 knockdown alters levels of several cell
cycle proteins. Protein lysates were recovered from both MRC5 and
U2OS cells that were either untransfected, transfected with a scrambled
siRNA, or transfected with the NET4/TMEM53 si2 oligo. (A) Western blots
reacted with antibodies to pRb phosphorylated on serine 780, total pRb,
p53, phosphorylated p38MAP kinase, p21, and actin as a loading control.
Note that some variation in total pRb levels was observed between
experiments, causing the ratio of phosphorylated pRb to total pRb to be
also somewhat variable. Because the phosphorylated form migrates
slightly differently on SDS-PAGE the change in the spread of the band
gives a greater appearance of such variability than is actually measured
upon quantification. (B) Quantification of levels of each protein
normalized to actin using a LI-COR Odyssey and fluorescent secondary
antibodies. Averages from three experiments are shown with standard
errors. (C) To ensure that results reflected effects of NET4/TMEM53
knockdown and not off-target effects both siRNA oligos and the esiRNA
were tested for effects on p53 and p21 levels. Similar results were
observed with all NET4/TMEM53 knockdowns.
doi:10.1371/journal.pone.0018762.g008
Figure 9. NET4/TMEM53 knockdown did not affect levels of
other nuclear envelope proteins linked to the cell cycle or
cyclins. (A) Protein lysates were recovered from U2OS cells treated as
in Figure 8 and reacted on Western blots with antibodies to the various
proteins. This experiment was repeated 3 times and a representative
Western blot is shown. (B) Cyclin levels were quantified from three
separate experiments analyzed by LI-COR using fluorescent secondary
antibodies and are plotted normalized to the actin control. Standard
errors are shown.
doi:10.1371/journal.pone.0018762.g009
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Discussion
This flow cytometry-based screen identified several NETs with
likely cell cycle functions. These NETs are generally uncharacter-
ized proteins, many of which have conserved domains of unknown
function. However, NET59/Ncln has separately been linked to a
pathway that could intersect with cell cycle regulation: this NET
interacts with Nomo1 that binds Smad proteins and thus intersects
with TGFß signaling pathways [29]. The NET MAN1 has also
been found to interact with Smad proteins [30,31] while the NET
Emerin interacts with ß-catenin [32] and disruption of these two
NETs yields cell cycle defects [6]. Thus, combined signaling/cell
cycle effects appear to be a common trait among NETs and it is
likely that further analysis of the other NETs identified in this
screen will yield some similar intersections of nuclear envelope
proteins with cell cycle pathways. That these 8 NETs represent
roughly 20% of the proteins tested in the flow cytometry cell
cycle/DNA content screen and that several recent studies have
found NETs associated with centrosomes or the mitotic spindle
[33,34,35] suggest that a great many nuclear envelope proteins
will be found to contribute to cell cycle regulation.
Here, additionally, NET4/Tmem53 has been demonstrated to
influence cell cycle regulation, affecting maintenance of the
proliferative state of cells. Although the mechanism by which
NET4/Tmem53 expression levels activate p38MAP kinase has
thus far been elusive, it is clear that the effect of NET4/Tmem53
on proliferation is through p38MAP kinase-dependent upregula-
tion of p53 and p21 with subsequent reduction in levels of
phosphorylated pRb. Thus unlike Lamin A and LAP2a that
exert effects directly on pRb to influence cell proliferation
[11,12,13], NET4/Tmem53 acts upstream through stress signal-
ing pathways.
NET4/Tmem53 was originally identified in a proteomic
analysis of liver nuclear envelopes [14] and high-resolution
microscopy on tagged exogenously expressed protein suggests
that it resides in the outer nuclear membrane [16]. Antibodies
generated to NET4/Tmem53 were previously shown to princi-
pally stain the nuclear periphery in liver tissue cryosections and
nuclear envelope versus microsomal fractions isolated from
rodent liver [16]; however, despite reactivity on tissue sections,
these antibodies recognize several additional bands at the
expected molecular weight of NET4/Tmem53 in cultured cells
and so could not be exploited in the current study. The indication
of NET4/Tmem53 as an outer nuclear membrane protein is not
inconsistent with NE functions on the cell cycle. For example,
Emerin, originally thought to reside only in the inner nuclear
membrane [36], affects signaling pathways and has recently
been shown to function also in the outer nuclear membrane and
ER [37].
A potential functional relevance for NET4/Tmem53-induced
cell cycle regulation is suggested by observations that NET4/
TMEM53 is highly expressed in liver cells and adipocytes
according to the BioGPS transcriptome database [38,39]. Recent
studies have shown that the differentiation of mesenchymal stem
cells (MSCs) is influenced by mechanical strain. In response to the
application of physical strain MSCs are prevented from
differentiating along an adipogenic lineage and instead are
redirected towards an osteoblast lineage [40], This gives rise to
the possibility the physical stress provides a homeostatic
mechanism for mesenchymal lineage selection. Since it has
already been shown the NE plays a key role in propagating stress
signaling and sensing [41], it is important to understand which
NE proteins interact with stress signaling pathways and how they
might influence stem cell self renewal and differentiation. We
believe that our data suggests that NET4/Tmem53 has such a
role. Future studies will focus on putative regulation of adipogenic
stem cells by NET4 and its possible involvement in Lamino-
pathies such as Dunnigan-type familial partial lipodystrophy
(FPLD; [42,43]) or mandibuloacral dysplasia (MADA; [44]).
Methods
Plasmid construction
NET expressing plasmids were generated from IMAGE clones
as previously described [14,15,16]. All were under regulation of
the CMV promoter with their carboxyl-termini fused to
monomeric red fluorescent protein (mRFP).
Cell culture and transient transfection
HEK293T (from ATCC; [45]), U2OS (from ATCC; [24]),
MRC5 (from the EUACC; [21]) and HCT116 p532/2 (kind gift
of B. Vogelstein, Johns Hopkins University; [46]) cells were
maintained in high glucose DMEM (Invitrogen) supplemented
Figure 10. p38MAP kinase mediates the NET4/Tmem53 effects
on cell cycle proteins. MRC5 and U2OS cells transfected with either
siRNA oligos or controls were treated 24 h after transfection with a
specific inhibitor of the p38MAP kinase. (A) Protein lysates were
generated after a further 48 h and analyzed by Western blot for levels
of p53, phosphorylated p38, and p21. This experiment was repeated 3
times and a representative Western blot is shown. (B) Levels of p53, p21
and phosphorylated p38 were quantified from three separate
experiments analyzed by LI-COR using fluorescent secondary antibodies
and are plotted normalized to the actin control with standard errors. In
all cases the p38MAP kinase inhibitor blocked the effects of NET4/
TMEM53 knockdown on levels of these cell cycle proteins. (C) The
change in the percentage of Ki-67 positive cells induced by NET4/
TMEM53 knockdown is partially abrogated by blocking the function of
p38 kinase. (D) Effects of NET4/TMEM53 knockdown on senescence, as
determined by ß-galactosidase staining, are abrogated by blocking
p38MAP kinase function.
doi:10.1371/journal.pone.0018762.g010
NET Flow Cytometry Screen
PLoS ONE | www.plosone.org 9 April 2011 | Volume 6 | Issue 4 | e18762
with 10% fetal calf serum, 100 units/ml penicillin and 100 mg/ml
streptomycin sulfate (Invitrogen). For U2OS siRNA assays cells
were seeded at 30% confluency and the next day transfected
using Dharmafect transfection reagent 1 according to the
manufacturer recommendations (Dharmacon RNA Technolo-
gies). MRC5 cells were trypsinized at ,80% confluency and
36106 cells were aliquoted for nucleofection using Kit R,
Program V-020 (Lonza). The cells were transfected with either
8 mg of siRNA oligo or 12 mg of esiRNA (esiRNA human
TMEM53, Sigma) and plated to 10 cm dishes with several
coverslips. At 48 or 72 h coverslips were removed and fixed for
immunocytochemistry and the remaining cells on the plate were
harvested by trypsinization and lysed in sample buffer for SDS-
PAGE and Western blotting. Alternatively they were lysed in
Trizol reagent (Sigma) for isolation of RNA. HEK293T cells
were either nucleofected using Kit V Program Q-001 (Lonza) or
were transfected using Fugene 6 or HD (Roche). For microscopy,
cells were generally plated on coverslips in 24 well dishes after
nucleofection or were first plated and then transfected using
Fugene. In this case, plating was at ,10% confluency so that cells
did not reach confluency before 30 h post-transfection when they
were fixed. Then, roughly 12 h after plating, DNA was
transfected using Fugene. For p38MAP kinase inhibitor exper-
iments the specific inhibitor SB203580 (Calbiochem) was added
to cultures at 10 mM concentration 12 h after transfection with
siRNA oligos.
Cell cycle assay
Plasmids encoding different NETs fused to mRFP were
transfected into HEK293T cells using Fugene 6 transfection
reagent (Roche). At 48 h post-transfection, the DNA stain Hoechst
33342 (Molecular Probes) was added to the cells at a final
concentration of 5 mg/ml and left to incubate at 37uC for a period
of 30 min to 60 min. Cells were harvested by trypsinization,
trypsin was inactivated with serum and cell pellets were collected
by centrifugation at 2506g for 5 min at RT, washed once in PBS
and resuspended in 1 ml of PBS. Cells were immediately analyzed
on an LSR II flow cytometer (BD Bioscience, UK) equipped with
488 nm and 350 nm lasers and appropriate filters. Cells with
fragmented DNA that might be undergoing necrosis or apoptosis
and cell aggregates were excluded from analysis by application of
electronic gates. Cell cycle analysis was carried out on the live
singlets gate using FlowJo software (TreeStar, Inc). At least 10,000
cells were scored for the total live singlets and 1,000 cells for the
mRFP positive live singlets. Each experiment was repeated at least
2 times for negative results and 3 times for those with a positive
effect on the cell cycle. For further confirmation NETs that
showed an effect on the cell cycle in 3 independent experiments
(NET4/Tmem53, NET11/Sccpdh, NET31/Tmem209, NET59/
Ncln, Tmub1, Fam3c, Magt1 and Tmem126a) were repeated a
4th time where at least 20,000 mRFP positive intact singlets were
counted. Data are displayed in the form of histogram overlays
using %Max option, which scales each population curve to
mode = 100%.
Antibodies
Antibodies to the following proteins were used: Ki-67 (610968,
BD Transduction Lab), total Rb (4H1 9309, Cell signaling),
phospho-Rb (9307, Cell Signaling), p21 (556430, BD Transduc-
tion lab), p53 rabbit (9282, Cell signaling), p53 mouse (NCL-p53-
DO1, Leica), p38 total (9212, Cell Signaling), active p38 (V3281
Anti-active MAPK Family Sampler, Promega), cyclin E mAb
clone HE12 (32-1600, Invitrogen), cyclin A mAb clone Cy-A1
(4710, Sigma), cyclin D (2922, Cell Signaling), cyclin B (SC245,
Santa Cruz), LAP2ß (06-1002, Millipore), Lap2a previously
described in [47], Lamin A and B1 (3262 and 3931) previously
described in [48]. All fluorophore-conjugated secondary antibod-
ies used for immunofluorescence were minimally cross-reactive
from donkey (Jackson ImmunoResearch) or goat (Molecular
Probes). For Western blotting IR800 conjugated goat anti-rabbit
antibodies (LI-COR Biosciences) were used.
Immunofluorescence microscopy
Cells transfected with NETs were fixed for 7 min in 3.7%
formaldehyde, permeabilized for 6 min in 0.1% Triton X-100,
blocked with 3% BSA in PBS, and reacted for 40 min at RT with
antibodies to Ki-67 or phospho-Rb. After washing, appropriate
fluorophore-conjugated secondary antibodies were added for
30 min at RT and washed. Cells were also stained with Hoechst
33342 (Molecular Probes) to visualize nuclei and mounted in
fluoromount G (EM Sciences). For ß-galactosidase assays,
histochemical staining at pH 6.0 was performed as described in
[27].
Images were obtained using a Nikon TE-2000 microscope
equipped with a 1.45 NA 1006 objective, Sedat quad filter set,
PIFOC Z-axis focus drive (Physik Instruments), and CoolSnapHQ
High Speed Monochrome CCD camera (Photometrics) run by
IPLab image acquisition software. Micrographs were saved from
source programs as .tif files and prepared for figures using
Photoshop 8.0.
Quantification of grey levels for NETs was performed using .tif
images from IPLab imported into Image Pro Plus. Cells fixed and
stained with phosho-Rb antibodies were imaged using identical
settings. Average grey scale values (pixel) intensity were measured
for at least 40 mRFP positive cells and as many untransfected cells
on the same coverslips.
Quantitative Western blotting
Cells were scraped and lysed in 50 mM Tris-HCl (pH 7.4),
150 mM NaCl, 2 mM MgCl2, 0.2% NP-40 in the presence of
protease inhibitor cocktail (Roche 11 873 580 001) by heating at
65uC for 2 min and sonication in a sonibath at 4uC. Protein
concentrations were determined using the Bradford Method
(BioRad). An equal volume of protein sample buffer (100 mM
Tris pH 6.8, 4 M Urea, 2% SDS, 50 mM DTT and 15% sucrose)
was added and the samples were boiled at 100uC for 5 min then
sonicated in a sonibath with high frequency for 10 min with 30 sec
interval on/off. Equal amounts of protein were resolved by SDS-
PAGE and transferred to Nitrocellulose membrane (LI-COR
Biosciences). Membranes were blocked in PBS, 5% milk, 0.2%
tween-20. Primary antibodies were diluted in this buffer and
allowed to incubate overnight at 4uC. Secondary antibodies IR800
conjugated goat anti-rabbit (LI-COR Biosciences) were added at
concentration 1/5000 at RT for 2 h. Visualization and quantifi-
cation were performed using a LI-COR Odyssey and software
(Odyssey 3.0.16) using median background subtraction. A
minimum of three independent blots was run for each NET and
control. The averages from all three are presented in figures with
standard error shown.
siRNA oligos
NET4/TMEM53 oligo si1: 59-AGAAGUGGGUGUGGAA-
GAGGG-39. NET4/TMEM53 oligo si2: 59- UAGUAAGUAGG-
GUAGUCACGG-39. Scramble control oligo 59-UCGAAGU-
AUUCCGCGUACG-39. Sigma NET4/TMEM53 esiRNA EH-
U027971.
pRb siRNA oligo: GCCCUUACAAGUUUCCUAG [49].
NET Flow Cytometry Screen
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RT-PCR analysis
Cells were lysed on tissue culture plates with Tri-Reagent
(Sigma), and total RNA was extracted according to the
manufacturers instructions. RT-PCR reactions were carried out
with 100 ng of total RNA using the Titan one tube RT-PCR
system (Roche) in accordance with the manufacturer’s instruc-
tions, except that the dNTP concentration was increased to
500 mM and MgCl2 increased to 3 mM. Typical reaction
conditions were 30 min reverse transcription at 50uC, 2 min
denaturation at 94uC, then 24 cycles of 94uC for 30 s, 60uC for
30 s and 68uC for 45 s. Peptidylprolyl isomerase A (PPIA) was
used as a loading control and reactions were repeated at least three
times.
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